<SEC-DOCUMENT>0001513162-19-000202.txt : 20190906
<SEC-HEADER>0001513162-19-000202.hdr.sgml : 20190906
<ACCEPTANCE-DATETIME>20190906170143
ACCESSION NUMBER:		0001513162-19-000202
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		63
CONFORMED PERIOD OF REPORT:	20190731
FILED AS OF DATE:		20190906
DATE AS OF CHANGE:		20190906

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anixa Biosciences Inc
		CENTRAL INDEX KEY:			0000715446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				112622630
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37492
		FILM NUMBER:		191080218

	BUSINESS ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118
		BUSINESS PHONE:		408-708-9808

	MAIL ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ITUS Corp
		DATE OF NAME CHANGE:	20140902

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPYTELE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<head><title>Form 10-Q</title> </head> <body vlink=#954f72 link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style="FONT-SIZE:14pt; COLOR:black">UNITED STATES</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style="FONT-SIZE:14pt; COLOR:black">SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:14pt; COLOR:black">Washington, D.C.&nbsp; 20549</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style="FONT-SIZE:14pt; COLOR:black">FORM 10-Q</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>OF THE SECURITIES EXCHANGE ACT OF 1934</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>For the quarterly period ended July 31, 2019</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Commission file number 0-11254</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:19pt>ANIXA BIOSCIENCES, INC.</font></b></p></div><div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:9pt>(Exact name of registrant as specified in its charter)</font></p>  <div align=center> <table width=933 bordercolor=transparent style="WIDTH:700pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=270 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:202.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Delaware</font></p></td> <td width=590 nowrap style="HEIGHT:15.75pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=232 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:174.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>11-2622630</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>(State or other jurisdiction of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>(I.R.S. Employer</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>incorporation or organization)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Identification No.)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>3150 Almaden Expressway, Suite 250</font></p></td> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>San Jose, CA</font></p></td> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>95118</font></p></td></tr></table></div> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> </div>  <div align=center> <table width=1092 bordercolor=transparent style="WIDTH:819pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>(Address of principal executive offices)</font></p></td> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;(Zip Code)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=270 nowrap style="HEIGHT:15pt; WIDTH:202.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=590 nowrap style="HEIGHT:15pt; WIDTH:442.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=232 nowrap style="HEIGHT:15pt; WIDTH:174.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=1092 colspan=3 nowrap style="HEIGHT:15pt; WIDTH:819pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>(408) 708-9808</font></p></td></tr></table></div> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:9pt>(Registrant's telephone number, including area code)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Securities registered pursuant to Section 12(b) of the Act:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 7.5pt 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <div align=center> <table width=635 bordercolor=transparent style=WIDTH:476.6pt cellpadding=0> <tr> <td width=254 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:190.85pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.75pt; PADDING-TOP:0.75pt; PADDING-LEFT:0.75pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 7.5pt 0pt 9pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=FONT-SIZE:10pt>Title of each class</font></b></p></td> <td width=124 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:0px; WIDTH:93pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.75pt; PADDING-TOP:0.75pt; PADDING-LEFT:0.75pt; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 7.5pt 0pt 9pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=FONT-SIZE:10pt>Trading symbol</font></b></p></td> <td width=249 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:186.75pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.75pt; PADDING-TOP:0.75pt; PADDING-LEFT:0.75pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 7.5pt 0pt 9pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=FONT-SIZE:10pt>Name of exchange on which registered</font></b></p></td></tr> <tr> <td width=254 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:190.85pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.75pt; PADDING-TOP:0.75pt; PADDING-LEFT:0.75pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 9pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=FONT-SIZE:10pt>Common Stock, par value $.01 per share</font></p></td> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:93pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.75pt; PADDING-TOP:0.75pt; PADDING-LEFT:0.75pt; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 7.5pt 0pt 9pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=FONT-SIZE:10pt>ANIX</font></p></td> <td width=249 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:186.75pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0.75pt; PADDING-TOP:0.75pt; PADDING-LEFT:0.75pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 7.5pt 0pt 9pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=FONT-SIZE:10pt>NASDAQ Capital Market</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp; Yes&nbsp;<u>&nbsp;&nbsp;X&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ___</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes&nbsp;<u>&nbsp;&nbsp;X&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No ___</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule 12b-2 of the Exchange Act.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 19.35pt 0pt 0in; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <div align=center> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Large accelerated filer [&nbsp;&nbsp; ]</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Accelerated filer [&nbsp;&nbsp; ]</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Non-accelerated filer [X]</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Smaller reporting company [X]</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Emerging growth company [&nbsp;&nbsp; ]</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 19.35pt 0pt 0in; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0.9pt 0pt 0in; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp; [&nbsp;&nbsp; ]</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes ____&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;<u>&nbsp;&nbsp;X&nbsp;</u>&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:10pt; COLOR:black">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">On September 5, 2019 the registrant had outstanding 20,207,261 shares of Common Stock, par value $.01 per share, which is the registrant&#146;s only class of common stock.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><b><u><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font></u></b>  <div align=center> <table width=934 bordercolor=transparent style="WIDTH:700.55pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=5% colspan=4 nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><u><font style=COLOR:black><a name=TOC>TABLE OF CONTENTS</a></font></u></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=85% colspan=3 nowrap style="HEIGHT:15pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#FI>PART I. FINANCIAL INFORMATION</a></p></td> <td width=5% nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=5% nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#FS>Item 1. </a></p></td> <td width=5% nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;<a href=#FS>Financial Statements.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"><a name=RANGE!C7 /></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#BS>Condensed Consolidated Balance Sheets as of July 31, 2019 (Unaudited) and October 31, 2018</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>1</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#OPERATI1>Condensed Consolidated Statements of Operations (Unaudited) for the nine months ended July 31, 2019 and 2018</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=_Hlk5634070><a name=RANGE!C11><font style=COLOR:black>&nbsp;&nbsp; </font></a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#OPER2>Condensed Consolidated Statements of Operations (Unaudited) for the three months ended July 31, 2019 and 2018</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#SCH1>Condensed Consolidated Statement of Shareholders&#146; Equity (Unaudited) for the nine months ended July 31, 2019</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>4</font></p></td></tr> </tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'><a href=#SSE3>Condensed Consolidated Statement of Shareholders&#146; Equity (Unaudited) for the three months ended July 31, 2019</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#SHCH2>Condensed Consolidated Statement of Shareholders&#146; Equity (Unaudited) for the nine months ended July 31, 2018</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>6</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'><a href=#SSE4>Condensed Consolidated Statement of Shareholders&#146; Equity (Unaudited) for the three months ended July 31, 2018</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>7</font></p></td></tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"><a name=RANGE!C17 /></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#CASH>Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended July 31, 2019 and 2018 </a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#NTCFS>Notes to Condensed Consolidated Financial Statements (Unaudited)</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>9</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#MDA>Item 2.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#MDA>Management's Discussion and Analysis of Financial Condition and Results of Operations.</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>25</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#QQD>Item 3.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#QQD>Quantitative and Qualitative Disclosures About Market Risk.</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>32</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#CP>Item 4.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#CP>Controls and Procedures.</a></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>32</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=85% colspan=3 nowrap style="HEIGHT:15pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#PART2>PART II. OTHER INFORMATION </a></p></td> <td width=5% nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=5% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#LP>Item 1.</a> </font></p></td> <td width=85% nowrap style="HEIGHT:15pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#LP>Legal Proceedings.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>33</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#RF>Item 1A.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#RF>Risk Factors.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>33</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#USESUP>Item 2.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#USESUP>Unregistered Sales of Equity Securities and Use of Proceeds.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>33</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#DUSS>Item 3.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#DUSS>Defaults Upon Senior Securities.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>33</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#MSD>Item 4.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#MSD>Mine Safety Disclosures.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>33</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#OI>Item 5.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#OI>Other Information.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>33</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#Ex>Item 6.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Ex>Exhibits.</a></font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>34</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=85% nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"><a name=RANGE!C43 /></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=85% colspan=3 nowrap style="HEIGHT:15.75pt; WIDTH:85%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a href=#SIGN>SIGNATURES</a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=5% nowrap style="HEIGHT:15.75pt; WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>35</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><u><font style=FONT-SIZE:11pt><a name=FI>PART I.&nbsp; FINANCIAL INFORMATION</a></font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=FS><b><font style=FONT-SIZE:11pt>Item 1.&nbsp; <u>Financial Statements.</a></u></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=6 nowrap style="HEIGHT:30pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><a name=BS><u><font style=COLOR:black>CONDENSED CONSOLIDATED BALANCE SHEETS</font></u></a></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(Unaudited)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>October 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2018</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>ASSETS</font></u></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Current assets:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,396,853</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,055,890 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Short-term investments in certificates of deposit</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,100,000</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,000,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Receivables</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,072</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>306,991 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Prepaid expenses and other current assets </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>129,644</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>175,491 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total current assets</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,627,569</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,538,372 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Patents, net of impairment of $1,001,729 and $582,979, respectively, and </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; accumulated amortization of $2,034,382 and $1,615,632, respectively</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>- </font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>837,500 </font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Property and equipment, net of accumulated depreciation of $86,789 and </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; $53,799, respectively</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>215,137</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>72,670 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,842,706 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,448,542 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>LIABILITIES AND EQUITY</font></u></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Current liabilities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accounts payable </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>567,778</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>582,012 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accrued expenses </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>875,771</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>683,099 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total current liabilities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,443,549</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,265,111 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Commitments and contingencies (Note 9)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Equity:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Shareholders&#146; equity:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Preferred stock, par value $100 per share; 19,860 shares authorized; no</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;shares issued or outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Series A convertible preferred stock, par value $100 per share; 140 shares</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;authorized; no shares issued or outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock, par value $.01 per share; 48,000,000 shares authorized;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;20,162,851 and 18,908,632 shares issued and outstanding, respectively</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>201,628</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>189,086 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Additional paid-in capital</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>185,326,706</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>175,415,931 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accumulated deficit </font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(179,729,770)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(170,170,209)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total shareholders&#146; equity </font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,798,564</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,434,808 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Noncontrolling interest (Note 1)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(399,407)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(251,377)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total equity</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,399,157</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,183,431 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total liabilities and equity</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,842,706</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,448,542 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=100% colspan=6 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>1</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=FS></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=6 nowrap style="HEIGHT:30pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black><a name=OPERATI1>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</a></font></u></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=30% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>For the Nine Months Ended</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2018</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Revenue</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>250,000</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,112,500</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Operating costs and expenses:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Inventor royalties, contingent legal fees, litigation and licensing</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;expenses related to patent assertion</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>166,250</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>767,180</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Amortization of patents</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>418,750</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>243,972</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Research and development expenses (including non-cash share-based</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;compensation expenses of $2,567,294 and $2,668,315, respectively)</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,602,239</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,380,137</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>General and administrative expenses (including non-cash share-based</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;compensation expenses of $2,335,218 and $2,558,701, respectively)</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,405,385</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,602,555</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Impairment in carrying amount of patent asset (Note 1)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>418,750</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total operating costs and expenses</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>10,011,374</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>9,993,844</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Loss from operations</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,761,374)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,881,344)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Interest income&nbsp;</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>53,783</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>29,780</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Loss before income taxes</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,707,591)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,851,564)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Provision for income taxes</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,707,591)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,851,564)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Less: Net loss attributable to noncontrolling interest</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(148,030)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(158,032)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss attributable to common shareholders</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,559,561)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,693,532)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss per common share attributable to common shareholders:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Basic and diluted</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(0.49)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(0.50)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Weighted average common shares outstanding:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Basic and diluted</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>19,638,833</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>17,257,546</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=100% colspan=6 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=6 nowrap style="HEIGHT:30pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><a name=OPER2><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</font></u></a></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=30% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>For the Three Months Ended</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>July 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2018</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Revenue</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>362,500</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Operating costs and expenses:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Inventor royalties, contingent legal fees, litigation and licensing</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;&nbsp;expenses related to patent assertion</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>241,157</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Amortization of patents</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>41,875</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>81,324</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Research and development expenses (including non-cash share-based</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;&nbsp;compensation expenses of $338,449 and $2,472,489, respectively)</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>1,085,574</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2,942,071</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:#cceeff; COLOR:black'>General and administrative expenses (including non-cash share-based</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br>&nbsp; compensation expenses of $492,449 and $2,155,844 respectively)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" /> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>1,056,963</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" /> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2,703,752</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Total operating costs and expenses</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2,184,412</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>5,968,304</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Loss from operations</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(2,184,412)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(5,605,804)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Interest income&nbsp;</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>18,364</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>12,228</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Loss before income taxes</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(2,166,048)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(5,593,576)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Provision for income taxes</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Net loss</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(2,166,048)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(5,593,576)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Less: Net loss attributable to noncontrolling interest</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(26,020)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(116,650)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Net loss attributable to common shareholders</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(2,140,028)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(5,476,926)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Net loss per common share attributable to common shareholders:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Basic and diluted</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(0.11)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(0.30)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Weighted average common shares outstanding:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Basic and diluted</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; 20,100,915</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>18,431,025</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=100% colspan=6 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>3</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font>&nbsp;</p></div> <div style=page:WordSection3> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:45pt> <td width=100% colspan=20 nowrap style="HEIGHT:45pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black><a name=SCH1>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS&#146; EQUITY</a></font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>FOR THE NINE MONTHS ENDED JULY 31, 2019 (UNAUDITED)</font></u></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Additional</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Paid-in</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Capital</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shareholders&#146;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Equity</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Non-</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>controlling</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Interest</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=18% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Common Stock</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Accumulated</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Deficit</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Equity</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Par Value</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Balance, October 31, 2018</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>18,908,632</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>189,086</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>175,415,931</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(170,170,209)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,434,808</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(251,377)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,183,431</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Stock option compensation to employees and&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; directors</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,808,910</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,808,910</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,808,910</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Stock options and warrants issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>139,161</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>139,161</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>139,161</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued upon exercise of stock </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; options</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>40,000</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>400</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>102,100</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>102,500</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>102,500</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Restricted stock award compensation to employee </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; pursuant to stock incentive plan</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,954,441</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,954,441</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,954,441</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued pursuant to employee</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;stock purchase plan</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,411</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>54</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>18,506</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>18,560</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>18,560</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued in at-the-market offering,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; net of offering expenses of $264,186</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp; 1,208,808</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12,088</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,887,657</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,899,745</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,899,745</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,559,561)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,559,561)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(148,030)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,707,591)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% nowrap style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=28% nowrap style="HEIGHT:15.75pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Balance, July 31, 2019</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>20,162,851</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>201,628</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>185,326,706</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(179,729,770)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,798,564</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(399,407)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,399,157</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=28% nowrap style="HEIGHT:15.75pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=100% colspan=20 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0in; TEXT-AUTOSPACE:'></a><a name=NTC>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>4</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; ' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:45pt> <td width=100% colspan=20 nowrap style="HEIGHT:45pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><a name=SSE3>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS&#146; EQUITY</a></font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>FOR THE THREE MONTHS ENDED JULY 31, 2019 (UNAUDITED)</font></u></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Additional</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Paid-in</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Capital</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Total</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Shareholders&#146;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Equity</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Non-</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>controlling</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Interest</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=17% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:17.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Common Stock</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Accumulated</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Deficit</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Total</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Equity</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Shares</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Par Value</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Balance, April 30, 2019</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>20,005,075</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>200,050</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>183,932,744</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style=FONT-SIZE:12pt face="Times New Roman">$</font> </p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;(177,589,742)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>6,543,052</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(373,387)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>6,169,665</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Stock option compensation to employees and <br>&nbsp;&nbsp;&nbsp; directors</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>784,246</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>784,246</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>784,246</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Stock options and warrants issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>46,652</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>46,652</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>46,652</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Common stock issued upon exercise of stock <br>&nbsp;&nbsp;&nbsp; options</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>10,000</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>100</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>22,600</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>22,700</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>22,700</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Common stock issued in at-the-market offering, <br>&nbsp;&nbsp;&nbsp; net of offering expenses of $111,275</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>147,776</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,478</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>540,464</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>541,942</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>541,942</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Net loss</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(2,140,028)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(2,140,028)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(26,020)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(2,166,048)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.96%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.72%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=31% nowrap style="HEIGHT:15.75pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Balance, July 31, 2019</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>20,162,851</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>201,628</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>185,326,706</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.96%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.68%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(179,729,770)</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>5,798,564</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(399,407)</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>5,399,157</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=31% nowrap style="HEIGHT:15.75pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% nowrap style="HEIGHT:15.75pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=100% colspan=20 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; ' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>5</p>  <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:45pt> <td width=100% colspan=20 nowrap style="HEIGHT:45pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black><a name=SHCH2>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS&#146; EQUITY</a></font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>FOR THE NINE MONTHS ENDED JULY 31, 2018 (UNAUDITED)</font></u></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Additional</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Paid-in</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Capital</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shareholders&#146;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Equity</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Non-</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>controlling</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Interest</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=16% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:16.92%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Common Stock</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Accumulated</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Deficit</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:13.16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Equity</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Par Value</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Balance, October 31, 2017</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>16,602,759</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>166,028</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>163,931,079</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;(156,174,184)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>7,922,923</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>7,922,923</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Stock option compensation to employees and&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; directors</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,598,986</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,598,986</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,598,986</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Stock options and warrants issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>254,090</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>254,090</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>254,090</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued upon exercise of stock </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; options</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>39,816</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>398</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(398)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Restricted stock award compensation to employee</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp; pursuant to stock incentive plan</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>1,500,000</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>15,000</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>1,358,940</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>-</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>1,373,940</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>-</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>1,373,940</p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,347</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>53</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>14,949</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>15,002</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>15,002</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued in at-the-market offering,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; net of offering expenses of $141,140</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>548,224</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,482</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,780,547</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,786,029</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,786,029</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Issuance of noncontrolling interest in Certainty </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; Therapeutics, Inc</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>68,974</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>68,974</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,318)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>64,656</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.38%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=9% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,693,532)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,693,532)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(158,032)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,851,564)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=32% nowrap style="HEIGHT:15pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=32% nowrap style="HEIGHT:15.75pt; WIDTH:32.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Balance, July 31, 2018</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>18,696,146</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>186,961</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8.38%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>171,007,167</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=9% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(164,867,716)</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,326,412</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(162,350)</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,164,062</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=32% nowrap style="HEIGHT:15.75pt; WIDTH:32.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=8% nowrap style="HEIGHT:15.75pt; WIDTH:8.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=8% nowrap style="HEIGHT:15.75pt; WIDTH:8.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=100% colspan=20 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>The accompanying notes are an integral part of these condensed consolidated financial statements.&nbsp;</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>6</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV><a href=#TOC><font color=#0066cc>Table of Contents</font></a><p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; ' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; ' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:45pt> <td width=100% colspan=20 nowrap style="HEIGHT:45pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><a name=SSE4>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS&#146; EQUITY</a></font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>FOR THE THREE MONTHS ENDED JULY 31, 2018 (UNAUDITED)</font></u></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Additional</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Paid-in</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Capital</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Total</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Shareholders&#146;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Equity</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Non-</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>controlling</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Interest</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=17% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:17.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Common Stock</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Accumulated</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Deficit</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12.54%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Total</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Equity</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Shares</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Par Value</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Balance, April 30, 2018</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>16,850,445</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>168,504</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>165,288,632</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$ </font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;(159,390,790)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>6,066,346</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(45,700)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>6,020,646</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Stock option compensation to employees and <br>&nbsp;&nbsp;&nbsp; directors</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>3,126,454</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>3,126,454</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>3,126,454</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Stock options and warrants issued to consultants</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>127,939</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>127,939</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>127,939</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in">&nbsp;</td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Restricted stock award compensation to employee<br>&nbsp;&nbsp;&nbsp; pursuant to stock incentive plan</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,500,000</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>15,000</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,358,940</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,373,940</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,373,940</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Common stock issued in at-the-market offering, <br>&nbsp;&nbsp;&nbsp; net of offering expenses of $58,198</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>345,701</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>3,457</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,105,202</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,108,659</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>1,108,659</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Net loss</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="HEIGHT:15pt; WIDTH:8.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>-</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(5,476,926)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(5,476,926)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(116,650)</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="HEIGHT:15pt; WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(5,593,576)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=31% nowrap style="HEIGHT:15pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=8% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.96%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:11.72%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=31% nowrap style="HEIGHT:15.75pt; WIDTH:31.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Balance, July 31, 2018</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>18,696,146</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=8% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>186,961</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>171,007,167</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.96%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.68%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(164,867,716)</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>6,326,412</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.68%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(162,350)</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:0.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>6,164,062</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=31% nowrap style="HEIGHT:15.75pt; WIDTH:31.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=8% nowrap style="HEIGHT:15.75pt; WIDTH:8.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.68%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:15pt> <td width=100% colspan=20 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>7</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=NTC></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> </div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font> <div style=page:WordSection4> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=6 nowrap style="HEIGHT:30pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=COLOR:black><a name=CASH>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</a></font></u></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=30% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>For the nine months ended</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;July 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2018</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cash flows from operating activities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Reconciliation of net loss to net cash used in operating activities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.2in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,707,591)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,851,564)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Stock option compensation to employees and directors</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,808,910</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,598,986</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Stock options and warrants issued to consultants</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>139,161</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>254,090</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Restricted stock award compensation to employee pursuant to stock&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp; incentive plan</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,954,441</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,373,940</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Common stock issued to consultants</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>15,002</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Depreciation of property and equipment</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>32,990</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>12,414</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Amortization of patents</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>418,750</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>243,972</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Impairment in carrying amount of patent assets</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>418,750</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Issuance of noncontrolling interest in Certainty Therapeutics, Inc. expensed</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp; &nbsp;as a license fee</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>64,656</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Change in operating assets and liabilities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Receivables</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>305,919</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(40,710)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Prepaid expenses and other current assets</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>45,847</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(163,211)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accounts payable</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(14,234)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(60,914)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accrued expenses</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>192,672</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>300,888</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net cash used in operating activities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(3,404,385)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(3,252,451)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cash flows from investing activities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Disbursements to acquire short-term investments in certificates of deposit&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(2,350,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,000,000)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Proceeds from maturities of short-term investments in certificates of deposit&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,250,000</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,750,000</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Purchase of property and equipment</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(175,457)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(31,853)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net cash (used in) provided by investing activities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(275,457)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>718,147</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cash flows from financing activities:</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net proceeds from sale of common stock in at-the-market offering</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,899,745</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,786,029</font></p></td></tr> <tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Proceeds from sale of common stock pursuant to employee stock purchase</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; plan</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>18,560</font></p></td> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:30pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:30pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Proceeds from exercise of employee stock options</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>102,500</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net cash provided by financing activities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,020,805</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,786,029</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net increase (decrease) in cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,340,963</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(748,275)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cash and cash equivalents at beginning of period</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,055,890</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,339,374</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cash and cash equivalents at end of period</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,396,853</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,591,099</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=100% colspan=6 nowrap style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>The accompanying notes are an integral part of these condensed consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>8</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></a><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u><font style=FONT-SIZE:11pt>ANIXA BIOSCIENCES, INC. AND SUBSIDIARIES</font></u></p> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"Times New Roman","serif"'><a name=NTCFS>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><u>(UNAUDITED)</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>BUSINESS&nbsp;AND&nbsp;FUNDING</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Description of Business&nbsp;</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>As used herein, &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; the &#147;Company&#148; or &#147;Anixa&#148; means Anixa Biosciences, Inc. and its consolidated subsidiaries.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our primary operations involve research and development of cancer therapeutics and diagnostics.&nbsp; Our cancer therapeutics programs consist of development of a vaccine against triple negative breast cancer (&#147;TNBC&#148;) and development of chimeric endocrine receptor T-cell (&#147;CER-T&#148;) technology, a novel form of CAR-T technology, initially focused on treating ovarian cancer. &nbsp;Our cancer diagnostics program consists of development of the artificial intelligence (AI) driven Cchek&#153; liquid biopsy platform for early cancer detection.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We hold an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by The Cleveland Clinic Foundation (&#147;Cleveland Clinic&#148;) related to certain breast cancer vaccine technology developed at Cleveland Clinic.&nbsp; We are working in collaboration with Cleveland Clinic to develop a method to vaccinate women against contracting breast cancer, focused specifically on TNBC, the most lethal form of the disease.&nbsp; A specific protein, alpha-lactalbumin, has been identified that is only present during lactation in healthy women, but reappears in many forms of breast cancer, especially TNBC.&nbsp; Animal studies have shown that vaccinating against this protein prevents breast cancer in mice.&nbsp; We are working with researchers at Cleveland Clinic to advance this vaccine toward human clinical testing, and we anticipate filing an Investigational New Drug (&#147;IND&#148;) application with the U.S. Food and Drug Administration (&#147;FDA&#148;) by the end of the 2019 calendar year.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our subsidiary, Certainty Therapeutics, Inc. (&#147;Certainty&#148;), is developing immuno-therapy drugs against cancer.&nbsp; Certainty holds an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by The Wistar Institute (&#147;Wistar&#148;) relating to Wistar&#146;s CER-T technology.&nbsp; We have initially focused on the development of a treatment for ovarian cancer, but we may also pursue applications of the technology for the development of treatments for additional solid tumors.&nbsp; The license agreement requires Certainty to make certain cash and equity payments to Wistar.&nbsp; With respect to Certainty&#146;s equity obligations to Wistar, Certainty issued to Wistar shares of its common stock equal to five percent (5%) of the common stock of Certainty.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Certainty, in collaboration with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&#147;Moffitt&#148;), is advancing toward human clinical testing of its CER-T technology for treating ovarian cancer.&nbsp; Certainty is working with researchers at Moffitt to complete studies necessary to submit an IND application with the FDA.&nbsp; We anticipate filing the IND with the FDA by the end of the 2019 calendar year, with human clinical trials commencing thereafter, in 2020. &nbsp;The collaboration between Certainty and Moffitt was recently extended through November 2020, so the parties may continue research on Certainty&#146;s CER-T technology.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>9</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our subsidiary, Anixa Diagnostics Corporation (&#147;Anixa Diagnostics&#148;), is developing Cchek&#153;, an AI driven platform of non-invasive blood tests for the early detection of cancer which is based on the body&#146;s immune response to the presence of a malignancy.&nbsp; We have demonstrated the efficacy of Cchek&#153; with 20 different types of cancer, including:&nbsp; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, prostate, bladder, cervical, head and neck, gastric and testicular cancers.&nbsp; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We are currently developing tests for the detection of multiple types of cancer and are working with our development and commercialization partner, ResearchDx, a CLIA-certified laboratory, to launch Cchek&#153; Prostate Cancer Confirmation as a Laboratory Developed Test during the fourth calendar quarter of 2019.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the next several quarters, we expect the development of our breast cancer vaccine, Certainty&#146;s CER-T technology and Anixa Diagnostic&#146;s Cchek&#153; to be the primary focus of the Company.&nbsp; As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&nbsp; We do not expect these activities to be a significant part of the Company&#146;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &nbsp;We have not generated any revenue to date from our cancer therapeutics and diagnostics programs. In addition, while we pursue our cancer therapeutics and diagnostics programs, we may also make investments in and form new companies to develop additional emerging technologies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p></a> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>10</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Funding and Management&#146;s Plans</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk523132922><a name=_Hlk2590843><a name=_Hlk9517505><font style=COLOR:black>Based on currently available information as of September 5, 2019, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next twelve months.&nbsp; </font></a><font style=COLOR:black>However, our projections of future cash needs and cash flows may differ from actual results.&nbsp; </font><font style=COLOR:black>If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies or new technology or technologies that are synergistic with or complementary to our technologies, we may be required to obtain more working capital.&nbsp; During the nine months ended July 31, 2019, we raised approximately $4,900,000 through our at-the-market equity offering of 1,208,808 shares of common stock which is currently effective (we can sell an additional 267,302 shares under our current at-the-market equity program) and may remain available for us to use in the future.&nbsp; Further, we have an additional at-the-market equity offering under which we may issue up to $50 million of common stock, which is currently effective and may remain available to us in the future.&nbsp; We may seek to obtain working capital during our fiscal year 2019 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&nbsp; W</font><font style=COLOR:black>e cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding, </font><font style=COLOR:black>the sale of additional equity securities or convertible debt could result in dilution to our stockholders.&nbsp; Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities.&nbsp; We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&nbsp; </font><font style=COLOR:black>If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations</font><font style=COLOR:black>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Basis of Presentation</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X.&nbsp; Accordingly, certain information and disclosures required by generally accepted accounting principles in annual financial statements have been omitted or condensed.&nbsp; These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures included in our Annual Report on Form 10-K for the year ended October 31, 2018.&nbsp; The accompanying October 31, 2018 consolidated balance sheet data was derived from the audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (&#147;US GAAP&#148;).&nbsp; The condensed consolidated financial statements include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of our financial position as of July 31, 2019, and results of operations and cash flows for the interim periods represented.&nbsp; The results of operations for the nine months ended July 31, 2019 are not necessarily indicative of the results to be expected for the entire year.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Noncontrolling Interest</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Noncontrolling interest represents Wistar&#146;s equity ownership in Certainty and is presented as a component of equity.&nbsp; The following table sets forth the changes in noncontrolling interest for the nine months ended July 31, 2019:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=83% nowrap style="HEIGHT:15pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Balance at October 31, 2018</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=15% nowrap style="HEIGHT:15pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(251,377)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=83% nowrap style="HEIGHT:15pt; WIDTH:83%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss attributable to noncontrolling interest</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(148,030)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=83% nowrap style="HEIGHT:15.75pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Balance at July 31, 2019</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(399,407)</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>11</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Revenue Recognition</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk507773489><font style=COLOR:black>Since fiscal 2016 our revenue has been derived solely from technology licensing and the sale of patented technologies.&nbsp; Revenue is recognized upon transfer of control of intellectual property rights and satisfaction of other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive.&nbsp; </font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 1, 2018 we adopted Accounting Standards Update 2014-09 (&#147;ASU 2014-09&#148;), Revenue from Contracts with Customers.&nbsp; Upon adoption of ASU 2014-09 we are required to make certain judgments and estimates in connection with the accounting for revenue.&nbsp; Such areas may include determining the existence of a contract and identifying each party&#146;s rights and obligations to transfer goods and services, identifying the performance obligations in the contract, determining the transaction price and allocating the transaction price to separate performance obligations, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services and evaluating whether a license transfers to a customer at a point in time or over time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our revenue arrangements provide for the payment of contractually determined, one-time, paid-up license fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&nbsp;&nbsp;These arrangements typically include some combination of the following:&nbsp;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&nbsp;&nbsp;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&nbsp;&nbsp;<a name=_Hlk9510034>Pursuant to the terms of these agreements, we have no further obligations with respect to the granted intellectual property rights, including no obligation to maintain or upgrade the technology, or provide future support or services.</a>&nbsp; Licensees obtained control of the intellectual property rights they have acquired upon execution of the agreement.&nbsp; As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is probable and all other revenue recognition criteria have been met.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black>Cost of Revenues </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Cost of revenues include the costs and expenses incurred in connection with our patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external counsel, other patent-related legal expenses paid to external counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.&nbsp;&nbsp;These costs are included under the caption &#147;Operating costs and expenses&#148; in the accompanying condensed consolidated statements of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>12</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Patents</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our only identifiable intangible assets are patents and patent rights related to our legacy patent licensing operations.&nbsp; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp; No patent acquisition costs were capitalized during the nine months ended July 31, 2019 and 2018. &nbsp;We recorded patent amortization expense of approximately $419,000 and $244,000 during the nine-month periods ended July 31, 2019 and 2018, respectively.&nbsp; In evaluating the carrying amount of capitalized patents at January 31, 2019, we determined that based on estimated undiscounted future cash flows a write-down of the carrying amount of approximately $419,000, to a carrying value of approximately $168,000, should be recorded as of January 31, 2019. The carrying value of capitalized patents has been amortized to $-0- as of July 31, 2019. Our estimates of future cash flows were based on our most recent assessment of the market for potential licensees, as well as the status of ongoing negotiations with potential licensees. While we may be able to generate future cash flows from this patent portfolio, as of July 31, 2019, we cannot reasonably determine an estimate of any such future cash flows.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 10pt; '><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; '>2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SUBSEQUENT EVENT</u></font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; '><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; '>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On August 21, 2019, the Company entered into a settlement agreement in connection with a putative shareholder derivative complaint filed in the Court of Chancery of the State of Delaware on November 5, 2018.<font style=COLOR:black>&nbsp;See Note 9 to these condensed consolidation financial statements for additional information.&nbsp; Management reviewed for subsequent events through the date of filing of this Quarterly Report on Form 10-Q and noted no other items requiring disclosure.</font></font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 10pt; '></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3.&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; <u>STOCK BASED COMPENSATION AND WARRANTS</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The Company maintains stock equity incentive plans under which the Company grants incentive stock options, non-qualified stock options, stock appreciation rights, stock awards, performance awards, or stock units to employees, directors and consultants.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Stock Option Compensation Expense </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The compensation cost for service-based stock options granted to employees and directors is measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, and is expensed on a straight-line basis over the requisite service period (the vesting period of the stock option).&nbsp; </font><a name=_Hlk17275104><a name=_Hlk523840797>We recorded stock-based compensation expense related to service-based stock options granted to employees and directors of approximately $2,433,000 and $1,153,000 during the nine months ended July 31, 2019 and 2018, respectively</a>, and approximately $784,000 and $702,000 during the three months ended July 31, 2019 and 2018, respectively.<a name=_Hlk523307783></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>For stock options granted to employees and directors that vest based on market conditions, such as the trading price of the Company&#146;s common stock exceeding certain price targets, we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&nbsp; </font><font style=COLOR:black>On May 8, 2018, we issued market condition options to purchase 1,500,000 shares of common stock, </font>to our Chairman, President and Chief Executive Officer, <font style=COLOR:black>vesting at target trading prices of $5.00 to $8.00 per share before May 31, 2021, with implied service periods of three to seven months.&nbsp; In October 2018, the first tranche of 500,000 shares of market condition options became exercisable upon achieving an average closing price above $5.00 per share for twenty consecutive trading days.&nbsp; </font>We recorded stock-based compensation expense related to market condition stock options granted to employees of approximately $376,000 and $2,446,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $-0- and $2,446,000 during the three months ended July 31, 2019 and 2018, respectively. &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 1, 2018 we adopted Accounting Standards Update 2018-07 (&#147;ASU 2018-07&#148;) for stock options granted to consultants.&nbsp; Upon adoption of ASU 2018-07 we estimated the fair value of unvested service-based and performance-based stock options at the date of adoption, using the Black-Scholes pricing model.&nbsp; Subsequent to adoption of ASU 2018-07, future grants to consultants are measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, consistent with our policy for grants to employees and directors.&nbsp; In prior periods, in accordance with US GAAP, we estimated the fair value of service-based and performance-based stock options granted to consultants at each reporting period using the Black-Scholes pricing model.&nbsp; We recognize the fair value of stock options granted to consultants as consulting expense over the requisite or implied service period of the grant.&nbsp; </font>We recorded stock-based consulting expense related to stock options granted to consultants of approximately $75,000 and $197,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $25,000 and $49,000 during the three months ended July 31, 2019 and 2018, respectively.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>13</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=_Hlk523307783></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Stock Option Activity </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk507419595>During the nine months ended July 31, 2019 and 2018, we granted options to purchase 10,000 shares and 3,897,000 shares of common stock, respectively, &nbsp;to employees, directors and consultants, with exercise prices ranging from $2.30 to $3.84 per share, pursuant to the Anixa Biosciences, Inc. 2010 Share Incentive Plan (the "2010 Share Plan&#148;) and the Anixa Biosciences, Inc. 2018 Share Plan (the &#147;2018 Share Plan&#148;)</a>.&nbsp; &nbsp;&nbsp;During the nine months ended July 31, 2019 and 2018, stock options to purchase 40,000 and 48,600 shares of common stock, respectively, were exercised with aggregate proceeds of approximately $103,000 and $-0-, respectively.&nbsp; Under certain circumstances, stock options may be exercised on a cashless basis. &nbsp;During the nine months ended July 31, 2019 and 2018, -0- and 8,784 shares of common stock, respectively, were withheld in connection with cashless exercises of stock options.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Stock&nbsp;Option&nbsp;Plans</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>As of July 31, 2019, we have three stock option plans:&nbsp; the Anixa Biosciences, Inc. 2003 Share Incentive Plan (the "2003 Share Plan"), the 2010 Share Plan and the 2018 Share Plan, which were adopted by our Board of Directors on April 21, 2003, July 14, 2010 and January 25, 2018, respectively.&nbsp; The 2018 Share Plan was approved by our shareholders on March 29, 2018.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><u>2003 Plan</u></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors and consultants.&nbsp; In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the ability to grant future options on April 21, 2013. &nbsp;Information regarding the 2003 Share Plan for the nine months ended July 31, 2019 is as follows:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:45pt> <td width=60% nowrap style="HEIGHT:45pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=16% style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted <br>Average Exercise Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate Intrinsic Value</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=60% nowrap style="HEIGHT:15pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2018</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>12,000</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=16% nowrap style="HEIGHT:15pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.77</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=60% nowrap style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Exercised</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=16% nowrap style="HEIGHT:15pt; WIDTH:16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.63</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=60% nowrap style="HEIGHT:15.75pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding and exercisable at <br>&nbsp;&nbsp;&nbsp;July 31, 2019</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>8,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=16% nowrap style="HEIGHT:15.75pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.34</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;&nbsp;23,694</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>14</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of July 31, 2019: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise <br>Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67 - $17.00</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% nowrap style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>0.19</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.34</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Information regarding the 2003 Share Plan for the nine months ended July 31, 2018 is as follows:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" rowspan=3> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate <br>Intrinsic <br>Value</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2017</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>30,600</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.16 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Exercised</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(10,600)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Forfeited</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 7.04</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding and exercisable at <br>&nbsp;&nbsp;&nbsp;July 31, 2018</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>12,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.77</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13,054</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of July 31, 2018: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;&nbsp; $ 0.67 - $17.00</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>12,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% nowrap style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>.99</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.77</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><u>2010 Plan</u></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors and consultants.&nbsp; As of July 31, 2019, the 2010 Share Plan had 889,200 shares available for future grants.&nbsp; Information regarding the 2010 Share Plan for the nine months ended July 31, 2019 is as follows: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2018</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,131,868</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.11</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Granted</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>10,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.64</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Exercised</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(32,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.27</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Forfeited</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(99,200)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.78</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at July 31, 2019</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,010,668</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.03</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;5,422,886</font></p></td></tr> <tr style=HEIGHT:17.25pt> <td width=52% nowrap style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options exercisable at July 31, 2019</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,639,556</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 1.92</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;4,609,165</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>15</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of July 31, 2019:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=48% colspan=6 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Outstanding</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=37% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining <br>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=13% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>938,000</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5.94</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>799,388</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% nowrap style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5.59</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.27 -$ 3.01</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>600,134</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3.81</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.58</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>600,134</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% nowrap style="HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3.81</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.58</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.46 -$ 5.75</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>472,534</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8.51</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 4.05</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>240,034</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% nowrap style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8.19</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 4.43</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk10191405>Information regarding the 2010 Share Plan for the nine months ended July 31, 2018 is as follows: </a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2017</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,637,246</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 1.50</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Granted</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>475,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.22</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Exercised</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(38,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Forfeited</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(49,800)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.15</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at July 31, 2018</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,024,446</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 1.90</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;2,965,764</font></p></td></tr> <tr style=HEIGHT:17.25pt> <td width=52% nowrap style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options exercisable at July 31, 2018</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,284,190</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 1.73</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;2,108,817</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk10190711>The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of July 31, 2018:</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=48% colspan=6 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Outstanding</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=37% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining <br>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=13% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>943,000</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>6.94</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>653,142</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% nowrap style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>6.18</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.27 -$ 3.01</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>729,712</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5.21</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.61</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>579,314</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% nowrap style="HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5.28</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.60</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.46 -$ 7.00</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>351,734</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8.74</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>51,734</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=13% nowrap style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>1.46</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=11% nowrap style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 5.27</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>16</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i><u>2018 Plan</u></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The 2018 Share Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, performance awards <font style=FONT-SIZE:11pt>and</font> stock units to employees, directors and consultants.&nbsp; As of July 31, 2019, the 2018 Share Plan had 2,008,000 shares available for future grants.&nbsp; Information regarding options outstanding under the 2018 Share Plan for the nine months ended July 31, 2019 is as follows:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2018</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,482,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Exercised</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.84</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Forfeited</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,000)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.84</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at July 31, 2019</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,470,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;3,337,300</font></p></td></tr> <tr style=HEIGHT:17.25pt> <td width=52% nowrap style="HEIGHT:17.25pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options exercisable at July 31, 2019</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,321,111</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:17.25pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:17.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;1,273,443</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2019: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=831 bordercolor=transparent style="WIDTH:622.95pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=6 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:16.5pt> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.70 -$ 4.61</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,470,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% nowrap style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8.78</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,321,111</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% nowrap style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8.77</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Information regarding the 2018 Share Plan for the nine months ended July 31, 2018 is as follows: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate <br>Intrinsic&nbsp; <br>Value</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2017</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -0-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Granted</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,422,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.71</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at July 31, 2018</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,422,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.71</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;-0-</font></p></td></tr> <tr style=HEIGHT:17.25pt> <td width=52% nowrap style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options exercisable at July 31, 2018</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>167,779</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-0-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>17</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2018: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=831 bordercolor=transparent style="WIDTH:622.95pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=6 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Options Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=6 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:16.5pt> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.70 -$ 3.84</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,422,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% nowrap style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>9.77</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.71</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>167,779</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% nowrap style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>9.76</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 3.73</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i><u>Outside of Share Plans</u></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>In addition to options granted under the 2003 Share Plan, the 2010 Share Plan and the 2018 Share Plan, the Board of Directors approved the grant of stock options to purchase 1,780,000 shares to employees and directors outside of Share Plans.&nbsp; Information regarding stock options outstanding that were granted outside of Share Plans for the nine months ended July 31, 2019 is as follows: </p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2018</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,780,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$1.58</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:17.25pt> <td width=52% nowrap style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding and exercisable at <br>&nbsp;&nbsp;&nbsp;July 31, 2019&nbsp;&nbsp; </font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,780,000</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$1.58</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;5,583,900</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>The following table summarizes information about stock options outstanding and exercisable that were granted outside of Share Plans as of July 31, 2019:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,046,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% nowrap style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3.05</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.58-$ 5.56</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>734,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% nowrap style="HEIGHT:15.75pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2.59</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.88 </font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Information regarding stock options outstanding that were granted outside of Share Plans for the nine months ended July 31, 2018 is as follows: </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=52% nowrap style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:16.5pt> <td width=52% nowrap style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding at October 31, 2017</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,780,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 1.58</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:17.25pt> <td width=52% nowrap style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Options outstanding and exercisable at <br>&nbsp;&nbsp;&nbsp;July 31, 2018&nbsp; </font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,780,000</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 1.58</font></p></td> <td width=2% nowrap style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$ &nbsp;&nbsp;&nbsp;3,206,700</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>18</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>The following table summarizes information about stock options outstanding and exercisable that were granted outside of Share Plans as of July 31, 2018:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=22% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=29% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,046,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=29% nowrap style="HEIGHT:15.75pt; WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>4.05</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 0.67</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.58-$ 5.56</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=22% nowrap style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>734,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=29% nowrap style="HEIGHT:15.75pt; WIDTH:29.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3.59</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$ 2.88</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black>Stock Awards </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk2789464>For stock awards granted to employees, directors and consultants that vest upon grant we recognize expense at the date of grant based on the grant date market price of the underlying common stock.&nbsp; During the nine months ended July 31, 2018, we issued 5,347 shares of common stock that vested upon grant to consultants for services rendered.&nbsp; We recorded consulting expense for the shares of common stock issued to consultants of approximately $15,000 for the nine months ended July 31, 2018 and $-0- for the three months ended July 31, 2018.&nbsp; We did not grant any stock awards that vested upon grant during the nine months ended July 31, 2019.</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>On May 8, 2018, a restricted stock award of 1,500,000 shares of common stock was granted under the 2018 Share Plan to our Chairman, President and Chief Executive Officer.&nbsp; The restricted stock award vests in its entirety upon achievement of a target trading price of $11.00 per share of the Company&#146;s common stock before May 31, 2021. &nbsp;&nbsp;<font style=COLOR:black>For restricted stock awards vesting </font>upon achievement of <font style=COLOR:black>a price target of our common stock we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&nbsp; </font>We recorded stock-based compensation expense related to the restricted stock award of approximately $1,954,000 and $1,374,000 during the nine months ended July 31, 2019 and 2018, respectively, and $-0- and approximately $1,374,000 during the three months ended July 31, 2019 and 2018, respectively.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Employee Stock Purchase Plan</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The Company maintains the Anixa Biosciences, Inc. Employee Stock Purchase Plan which permits eligible employees to purchase shares at not less than 85% of the market value of the Company&#146;s common stock on the offering date or the purchase date of the applicable offering period, whichever is lower.&nbsp; The plan was adopted by our Board of Directors on August 13, 2018 and approved by our shareholders on September 27, 2018.&nbsp; During the nine months ended July 31, 2019, employees purchased 5,411 shares at a purchase price of $3.43 per share pursuant to the plan.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Warrants</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>During the nine months ended July 31, 2019 we issued a warrant, expiring on November 1, 2023, to purchase 25,000 shares of common stock at $4.04 per share, vesting over 12 months, to a consultant for investor relations services. &nbsp;We recorded consulting expense of approximately $64,000 during the nine months ended July 31, 2019 and approximately $21,000 during the three months ended July 31, 2019, based on the fair value of the warrant recognized on a straight-line basis over the vesting period. &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>19</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In July 2018 we issued a warrant exercisable at $3.65 per share vested upon grant to purchase 25,000 shares of common stock to a consultant for investor relations services.&nbsp; We recorded consulting expense of approximately $57,000 during the three months ended July 31, 2018, based on the fair value of the warrant. &nbsp;This warrant was exercised in October 2018.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:40.5pt'>As of July 31, 2019, we also had warrants outstanding to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019 and warrants to purchase 500,000 shares of common stock at $5.03 per share expiring on November 30, 2021.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>FAIR VALUE MEASUREMENTS</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>US GAAP defines fair value and establishes a framework for measuring fair value. &nbsp;We have categorized our financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &nbsp;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=eolPage30><a name=FORM10Q_HTM_PAGE_40>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Financial assets and liabilities recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Level 1 - Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Level 2 - Financial assets and liabilities whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Level 3 &#150; Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#146;s own assumptions about the assumptions a market participant would use in pricing the asset and liabilities. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of July 31, 2019: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Level 1</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Level 2</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Level 3</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=46% nowrap style="HEIGHT:31.5pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Money market funds &#150;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; Cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,370,661</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,370,661</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=46% nowrap style="HEIGHT:31.5pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Certificates of deposit &#150;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; Cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>750,000</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>750,000 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;Short-term investments</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,100,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;2,100,000</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=46% nowrap style="HEIGHT:16.5pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total financial assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,370,661</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,850,000</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,220,661</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>20</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=FORM10Q_HTM_PAGE_40></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=FIS_UNIDENTIFIED_TABLE_18>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2018:<a name=FIS_UNIDENTIFIED_TABLE_19></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Level 1</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Level 2</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Level 3</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=46% nowrap style="HEIGHT:31.5pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Money market funds &#150;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; Cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,031,331</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,031,331</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=46% nowrap style="HEIGHT:31.5pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Certificates of deposit &#150;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; Cash and cash equivalents</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>750,000</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:31.5pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>750,000 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=46% nowrap style="HEIGHT:15.75pt; WIDTH:46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;Short-term investments</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,000,000</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,000,000</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=46% nowrap style="HEIGHT:16.5pt; WIDTH:46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total financial assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,031,331</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,750,000&nbsp; </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,781,331</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><a name=FIS_UNIDENTIFIED_TABLE_20>Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&nbsp; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&nbsp; Cash and cash equivalents are stated at carrying value which approximates fair value.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0in; TEXT-AUTOSPACE:ideograph-numeric'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>ACCRUED EXPENSES</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>Accrued expenses consist of the following as of:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 31, <br>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>October 31, <br>2018</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Payroll and related expenses</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>64,627 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>62,965 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accrued royalty and contingent legal fees</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>449,691</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>366,670 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accrued collaborative research and license expenses</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>351,994</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>187,500 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Accrued other</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>9,459</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>65,964 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>875,771</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>683,099 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>6.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>NET LOSS PER SHARE OF COMMON STOCK</u> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Basic net loss per common share (&#147;Basic EPS&#148;) is computed by dividing net loss by the weighted average number of common shares outstanding.&nbsp; Diluted net loss per common share (&#147;Diluted EPS&#148;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&nbsp; Diluted EPS for all periods presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&nbsp; For this reason, excluded from the calculation of Diluted EPS for the nine and three months ended July 31, 2019 and 2018, were stock options to purchase 7,268,668 and 7,238,446 shares, respectively, and warrants to purchase 545,000 and 854,400 shares, respectively.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>21</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=FIS_UNIDENTIFIED_TABLE_20></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#147;ASU 2014-09&#148;), Revenue from Contracts with Customers.&nbsp; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &nbsp;<a name=_Hlk501045300>The Company adopted ASU 2014-09 on November&nbsp;1, 2018.&nbsp; The adoption of ASU 2014-09 </a>did not have a material impact on our consolidated financial statements, other than required additional disclosure of accounting policies. &nbsp;See Note 1 regarding our revenue recognition policy.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#147;ASU 2016-02&#148;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities.&nbsp; The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method.&nbsp; The requirements of this standard include a significant increase in required disclosures.&nbsp; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&nbsp;and related disclosures, and our analysis is currently ongoing.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>22</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>INCOME TAXES </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We file Federal, New York and California state income tax returns.&nbsp; Due to net operating losses, the statute of limitations for Federal and New York State income tax returns remains open to examination by taxing authorities since the fiscal year ended October 31, 1999.&nbsp; We account for interest and penalties related to income tax matters, if any, in general and administrative expenses. &nbsp;There are no unrecognized income tax benefits as of </font>July 31<font style=COLOR:black>, 2019 and October 31, 2018.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&nbsp; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</font> We have substantial net operating loss carryforwards for Federal, New York State and California income tax returns. These net operating loss carryforwards could be subject to limitations under Internal Revenue Code section 382. Management has not performed an analysis of the potential limitations. We have provided a full valuation allowance against our deferred tax asset due to our historical pre-tax losses and the uncertainty regarding the realizability of these deferred tax assets.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>COMMITMENT AND CONTINGENCES</u>&nbsp; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=_Hlk18064185><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Litigation Matters</font></u></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman New"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>Other than below and lawsuits we have historically brought to enforce our patent rights, we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &nbsp;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 5, 2018, a putative shareholder derivative complaint was filed in the Court of Chancery of the State of Delaware, captioned Howland v. Kumar et al., C.A. No. 2018-0804-KSJM (the &#147;Derivative Action&#148;), that alleged claims for breach of fiduciary duty and unjust enrichment.&nbsp; The Derivative Action named as defendants certain of the Company&#146;s current and former officers and directors (the &#147;Individual Defendants&#148;), and the Company was named solely as a nominal defendant.&nbsp; <a name=_Hlk2854829>On August 21, 2019, the Company entered into a settlement pursuant to which the Company agreed to certain changes in its corporate governance policies and to reprice certain stock options that were repriced on September 6, 2017 to $0.67 to the option price immediately prior to that repricing.&nbsp; The Company also agreed to pay certain legal fees, with such fees to be paid from the Company&#146;s D&amp;O insurance.&nbsp; As a result of this settlement, all of the claims asserted in the Derivative Action will be dismissed.&nbsp; The Individual Defendants have denied, and continue to deny, any and all allegations of wrongdoing or liability asserted in the Derivative Action.&nbsp; The Individual Defendants have further asserted, and continue to assert, that at all relevant times, they acted in good faith and in a manner that they reasonably believed to be in the best interests of the Company and its stockholders.&nbsp; The Individual Defendants have entered into the settlement solely to eliminate the uncertainty, distraction, disruption, burden, risk, and expense of further litigation.</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>23</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a><br><br></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SEGMENT INFORMATION</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>We follow the accounting guidance of ASC 280 &#147;Segment Reporting&#148; (&#147;ASC 280&#148;).&nbsp; Reportable operating segments are determined based on the management approach.&nbsp; The management approach, as defined by ASC 280, is based on the way that the chief operating decision-maker organizes the segments within an enterprise for making operating decisions and assessing performance.&nbsp; While our results of operations are primarily reviewed on a consolidated basis, the chief operating decision-maker manages the enterprise in three reportable segments, each with different operating and potential revenue generating characteristics: (i) Cancer Diagnostics, (ii) Cancer Therapeutics and (iii) our legacy patent licensing activities.&nbsp; The following represents selected financial information for our segments for the nine and three months ended July 31, 2019 and 2018 and as of July 31, 2019 and October 31, 2018:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'></p>  <div align=center> <table width=867 bordercolor=transparent style="WIDTH:650pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>For the Nine Months Ended</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2018</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss:</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Diagnostics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,024,785)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(3,783,854)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Therapeutics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,807,668)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(4,583,070)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Patent licensing</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(875,138)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(484,640)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(9,707,591)</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(8,851,564)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:31.5pt> <td width=70% nowrap style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Operating costs and expenses excluding non-cash</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; share based compensation expense:</font></p></td> <td width=1% nowrap style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Diagnostics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,953,760 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,692,865</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Therapeutics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,084,694 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,807,515 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Patent licensing</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,070,408</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,266,448</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,108,862</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,766,828</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:31.5pt> <td width=70% nowrap style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Operating costs and expenses excluding non-cash</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; share based compensation expense</font></p></td> <td width=1% nowrap style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,108,862</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,766,828</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Plus non-cash share-based compensation expense</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,902,512</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,227,016</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total operating costs and expenses</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>10,011,374</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>9,993,844</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:30pt> <td width=70% nowrap style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=30% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>For the Three Months Ended</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 31,</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% nowrap style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2019</font></p></td> <td width=2% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2018</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Net loss:</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Diagnostics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(917,363)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(2,359,568)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Therapeutics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(1,203,468)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(2,901,708)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Patent licensing</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(45,217)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(332,300)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(2,166,048)</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>(5,593,576)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:31.5pt> <td width=70% nowrap style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Operating costs and expenses excluding non-cash&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; share based compensation expense:</font></p></td> <td width=1% nowrap style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Diagnostics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>507,356</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>569,512</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Therapeutics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>801,704</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>359,006</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Patent licensing</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>44,454</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>411,453</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,353,514</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,339,971</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:31.5pt> <td width=70% nowrap style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Operating costs and expenses excluding non-cash</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; share based compensation expense</font></p></td> <td width=1% nowrap style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,353,514</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,339,971</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Plus non-cash share-based compensation expense</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>830,898</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>4,628,333</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total operating costs and expenses</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,184,412</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>5,968,304</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=1% nowrap style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>July 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2019</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>October 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2018</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> </tr><tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total assets:</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Diagnostics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,201,233</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,545,803</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Cancer Therapeutics</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>3,279,496</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>2,157,359</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% nowrap style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Patent licensing</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>361,977</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>1,745,380</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Total</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,842,706</font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=COLOR:black>6,448,542</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>Operating costs and expenses excluding non-cash share-based compensation expense is the measurement the chief operating decision-maker uses in managing the enterprise.&nbsp; &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>24</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.0in'><b><font style=COLOR:black>Item 2.&nbsp; <a name=MDA><u>Management's Discussion and Analysis of Financial Condition and Results of Operations.</u>&nbsp;</a>&nbsp; </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>GENERAL</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We discuss the description of our business in the Notes to our Condensed Consolidated Financial Statements. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; PAGE-BREAK-AFTER:auto; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>RESULTS OF OPERATIONS</font></u></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0in; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Nine months ended July 31, 2019 compared with nine months ended July 31, 2018</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Revenue</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>For the nine months ended July 31, 2019, we recorded revenue of $250,000 from one license agreement.&nbsp; For the nine months ended July 31, 2018, we recorded revenue of $1,112,500 from two license agreements.&nbsp; These license agreements each provided for a one-time, non-recurring, lump sum payment in exchange for non-exclusive retroactive and future licenses, and covenants not to sue.&nbsp; Pursuant to the terms of these agreements, we have no further obligations with respect to the granted intellectual property rights, including no obligation to maintain or upgrade the technology, or provide future support or services.&nbsp; Accordingly, the earnings process from these licenses was complete and 100% of the revenue was recognized upon execution of the license agreement. &nbsp;As discussed in Note 1 to our consolidated financial statements, as part of our legacy operations, the Company remains engaged in limited patent licensing activities which we do not expect to be a significant part of our ongoing operations or revenue.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Inventor Royalties, Contingent Legal Fees and Litigation and Licensing Expenses Related to Patent Assertion</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk9515888>Inventor royalties, contingent legal fees, litigation and licensing expenses related to patent assertion activities decreased by approximately $601,000 to approximately $166,000 in the nine months ended July 31, 2019, compared to approximately $767,000 in the comparable prior year.&nbsp; The decrease was primarily due to the decrease in related revenues.&nbsp; Inventor royalties and contingent legal fees are expensed in the period that the related revenues are recognized.&nbsp; Litigation and licensing expenses related to patent assertion, other than contingent legal fees, are expensed in the period incurred.</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Amortization of Patents</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Amortization of patents increased by approximately $175,000 to approximately $419,000 in the nine months ended July 31, 2019, from approximately $244,000 in the nine months ended July 31, 2018.&nbsp; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp; The increase in amortization of patents was due to a reduction in the estimated economic useful life of capitalized patents.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>25</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=COLOR:black>Research and Development Expenses</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Research and development expenses are related to the development of our <font style=COLOR:black>cancer diagnostics and therapeutics programs and </font>increased by approximately $222,000 to approximately $4,602,000 in the nine months ended July 31, 2019, from approximately $4,380,000 in the nine months ended July 31, 2018.&nbsp; The increase in research and development expenses was primarily due to an increase in employee stock award compensation expense of approximately $481,000, an increase in outside research and development expense, excluding license expense, primarily related to Certainty's collaboration agreement with Moffitt and Anixa Diagnostics' agreement with our development partner, ResearchDx, of approximately $356,000 and an increase in employee compensation and related costs, other than equity-based compensation, of approximately $95,000, offset by a decrease of approximately $562,000 in employee stock option compensation expense and a decrease in license fees of approximately $190,000. License fees in fiscal year 2019 are related to our license with Cleveland Clinic. License fees in fiscal year 2018 are  related to our license with Wistar. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=COLOR:black>General and Administrative Expenses</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>General and administrative expenses decreased by approximately $198,000 to approximately $4,405,000 in the nine months ended July 31, 2019, from approximately $4,603,000 in the nine months ended July 31, 2018. The decrease in general and administrative expenses was principally due to a decrease in employee stock option compensation expense of approximately $228,000, a decrease in consultant stock option expense of approximately $105,000 and a decrease in investor and public relations expense of approximately $86,000, offset by a patent expense reimbursement to Cleveland Clinic of approximately $164,000 and an increase in employee stock award compensation expense of approximately $99,000.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Impairment in Carrying Amount of Patent Assets</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The impairment in carrying amount of patent assets related to our legacy patent licensing activities of approximately $419,000 in the nine months ended July 31, 2019 resulted from the write down of the value of our patent assets to the estimated undiscounted future cash flows we anticipated receiving from the patent assets as of January 31, 2019 of approximately $168,000.&nbsp; Our estimates of future cash flows were based on our most recent assessment of the market for potential licensees, as well as the status of ongoing negotiations with potential licensees.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Interest Income </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Interest income increased by approximately $24,000 to approximately $54,000 in the nine months ended July 31, 2019, from approximately $30,000 in the comparable prior year period as a result of greater amounts of cash, cash equivalents and short-term investments in certificates of deposit.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Net Loss Attributable to Noncontrolling Interest</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The net loss attributable to noncontrolling interest, representing Wistar&#146;s 5% ownership interest in Certainty&#146;s net loss, decreased by approximately $10,000 to approximately $148,000 in the nine months ended July 31, 2019, from approximately $158,000 in the nine months ended July 31, 2018, as Certainty&#146;s net loss decreased.&nbsp; The decrease in Certainty&#146;s net loss was primarily due to decreases in employee stock option compensation expense and employee stock award compensation expense.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>26</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0in; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Three months ended July 31, 2019 compared with three months ended July 31, 2018</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Revenue</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We had no revenue during the three months ended July 31, 2019.&nbsp; For the three months ended July 31, 2018, we recorded revenue of $362,500 from one license agreement.&nbsp; The license agreement provided for a one-time, non-recurring, lump sum payment in exchange for non-exclusive retroactive and future licenses, and covenants not to sue.&nbsp; Pursuant to the terms of the agreement, we have no further obligations with respect to the granted intellectual property rights, including no obligation to maintain or upgrade the technology, or provide future support or services.&nbsp; Accordingly, the earnings process from these licenses was complete and 100% of the revenue was recognized upon execution of the license agreement. &nbsp;As discussed in Note 1 to our consolidated financial statements, as part of our legacy operations, the Company remains engaged in limited patent licensing activities which we do not expect to be a significant part of our ongoing operations or revenue.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Inventor Royalties, Contingent Legal Fees and Litigation and Licensing Expenses Related to Patent Assertion</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We had no inventor royalties, contingent legal fees, litigation and licensing expenses related to patent assertion activities during the three months ended July 31, 2019, compared to approximately $241,000 in the comparable prior year.&nbsp; Inventor royalties and contingent legal fees are expensed in the period that the related revenues are recognized.&nbsp; Litigation and licensing expenses related to patent assertion, other than contingent legal fees, are expensed in the period incurred.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Amortization of Patents</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Amortization of patents decreased by approximately $39,000 to approximately $42,000 in the three months ended July 31, 2019, from approximately $81,000 in the three months ended July 31, 2018.&nbsp; &nbsp;We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp; The decrease in amortization of patents was due to a reduction in the carrying value of the patents.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=COLOR:black>Research and Development Expenses</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Research and development expenses are related to the development of our <font style=COLOR:black>cancer diagnostics and therapeutics programs and </font>decreased by approximately $1,856,000 to approximately $1,086,000 in the three months ended July 31, 2019, from approximately $2,942,000 in the three months ended July 31, 2018.&nbsp; The decrease in research and development expenses was primarily due to a decrease in employee stock option compensation expense of approximately $1,384,000 and a decrease in employee stock award compensation expense of approximately $769,000, offset by an increase in outside research and development expense, excluding license expense, primarily related to Certainty's collaboration agreement with Moffitt and Anixa Diagnostics' agreement with our development partner, ResearchDx, of approximately $149,000 and  approximately $100,000 of license fees paid to Cleveland Clinic.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>27</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'><font style=COLOR:black>General and Administrative Expenses</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>General and administrative expenses decreased by approximately $1,647,000 to approximately $1,057,000 in the three months ended July 31, 2019, from approximately $2,704,000 in the three months ended July 31, 2018. The decrease in general and administrative expenses was principally due to a decrease in employee stock option compensation expense of approximately $980,000, a decrease in employee stock award compensation expense of approximately $605,000, a decrease in legal and accounting fees of approximately $147,000 primarily related to a putative shareholder derivative complaint (see Note 9 to our condensed consolidated financial statements) and a decrease in investor and public relations expense of approximately $102,000, offset by a patent expense reimbursement to Cleveland Clinic of approximately $164,000.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Interest Income </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Interest income increased by approximately $6,000 to approximately $18,000 in the three months ended July 31, 2019, from approximately $12,000 in the comparable prior year period as a result of greater amounts of cash, cash equivalents and short-term investments in certificates of deposit.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Net Loss Attributable to Noncontrolling Interest</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The net loss attributable to noncontrolling interest, representing Wistar&#146;s 5% ownership interest in Certainty&#146;s net loss, decreased by approximately $91,000 to approximately $26,000 in the three months ended July 31, 2019, from approximately $117,000 in the three months ended July 31, 2018, as Certainty&#146;s net loss decreased.&nbsp; The decrease in Certainty&#146;s net loss was primarily due to decreases in employee stock option compensation expense and employee stock award compensation expense.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><b><u><font style=COLOR:black>LIQUIDITY AND CAPITAL RESOURCES</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our primary sources of liquidity are cash, cash equivalents and short-term investments.</font></p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>28</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Based on currently available information as of September 5, 2019, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next twelve months.&nbsp; </font><font style=COLOR:black>However, our projections of future cash needs and cash flows may differ from actual results.&nbsp; </font><font style=COLOR:black>If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies or new technology or technologies that are synergistic with or complementary to our technologies, we may be required to obtain more working capital.&nbsp; During the nine months ended July 31, 2019, we raised approximately $4,900,000 through our at-the-market equity offering of 1,208,808 shares of common stock which is currently effective (we can sell an additional 267,302 shares under our current at-the-market equity program) and may remain available for us to use in the future.&nbsp; Further, we have an additional at-the-market equity offering under which we may issue up to $50 million of common stock, which is currently effective and may remain available to us in the future.&nbsp; We may seek to obtain working capital during our fiscal year 2019 or thereafter through sales of our equity securities (including through the commencement of another at-the-market equity offering) or through bank credit facilities or public or private debt from various financial institutions where possible.&nbsp; W</font><font style=COLOR:black>e cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding, </font><font style=COLOR:black>the sale of additional equity securities or convertible debt could result in dilution to our stockholders.&nbsp; Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities.&nbsp; We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&nbsp; </font><font style=COLOR:black>If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations</font> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">During the nine months ended July 31, 2019, cash used in operating activities was approximately $3,404,000.&nbsp; Cash used in investing activities was approximately $275,000, resulting from the purchase of certificates of deposit totaling $2,350,000 and the purchase of property and equipment of approximately $175,000, which was offset by the proceeds on maturities of certificates of deposit totaling $2,250,000.&nbsp; Cash provided by financing activities was approximately $5,021,000, resulting from the sale of 1,208,808 shares of common stock in our at-the-market equity offering over the past nine months of approximately $4,900,000 (which is ongoing), the proceeds from sale of common stock pursuant to employee stock purchase plan of approximately $19,000 and the proceeds from exercise of stock options of approximately $103,000.&nbsp; As a result, our cash, cash equivalents, and short-term investments at July 31, 2019 increased approximately $1,441,000 to approximately $6,497,000 from approximately $5,056,000 at the end of fiscal year 2018.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>CRITICAL ACCOUNTING POLICIES</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>The Company&#146;s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America.&nbsp; In preparing these financial statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our condensed consolidated financial statements. &nbsp;We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances.&nbsp; Actual results could differ materially from these estimates under different assumptions or conditions. &nbsp;On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><a name=_aciHeader48>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>29</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=_aciHeader48></p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We believe that, of the significant accounting policies discussed in Note 2 to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended October 31, 2018, the following accounting policies require our most difficult, subjective or complex judgments:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Revenue Recognition; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Stock-Based Compensation.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black>Revenue Recognition</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><a name=_aciHeader49>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our revenue has been derived solely from technology licensing and the sale of patented technologies.&nbsp; Revenue is recognized upon transfer of control of intellectual property rights and satisfaction of other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 1, 2018 we adopted Accounting Standards Update 2014-09 (&#147;ASU 2014-09&#148;), Revenue from Contracts with Customers.&nbsp; Upon adoption of ASU 2014-09 we are required to make certain judgments and estimates in connection with the accounting for revenue.&nbsp; Such areas may include determining the existence of a contract and identifying each party&#146;s rights and obligations to transfer goods and services, identifying the performance obligations in the contract, determining the transaction price and allocating the transaction price to separate performance obligations, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services and evaluating whether a license transfers to a customer at a point in time or over time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our revenue arrangements provide for the payment of contractually determined, one-time, paid-up license fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&nbsp;&nbsp;These arrangements typically include some combination of the following:&nbsp;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&nbsp;&nbsp;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&nbsp;&nbsp;Pursuant to the terms of these agreements, we have no further obligations with respect to the granted intellectual property rights, including no obligation to maintain or upgrade the technology, or provide future support or services.&nbsp; Licensees obtained control of the intellectual property rights they have acquired upon execution of the agreement.&nbsp; As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is probable and all other revenue recognition criteria have been met.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black>Stock-Based Compensation</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><a name=_Hlk507405242><font style=COLOR:black>The compensation cost for service-based stock options granted to employees and directors is measured at</font></a>&nbsp;<font style=COLOR:black>the grant date, based on the fair value of the award using the Black-Scholes pricing model, and is expensed on a straight-line basis over the requisite service period (the vesting period of the stock option) which is one to four years.&nbsp; For employee options vesting if the trading price of the Company&#146;s common stock exceeds certain price targets we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>30</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>For stock awards granted to employees and directors that vest at date of grant we recognize expense based on the grant date market price of the underlying common stock.&nbsp; <font style=COLOR:black>For restricted stock awards vesting </font>upon achievement of <font style=COLOR:black>a price target of our common stock we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 1, 2018 we adopted Accounting Standards Update 2018-07 (&#147;ASU 2018-027&#148;) for stock-based compensation to non-employees.&nbsp; Upon adoption of ASU 2018-07 we estimated the fair value of unvested awards at the date of adoption, using the Black-Scholes pricing model.&nbsp; Future grants to consultants will be measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, consistent with our policy for grants to employees and directors.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The Black-Scholes pricing model and the Monte Carlo Simulation we use to estimate fair values requires valuation assumptions of expected term, expected volatility, risk-free interest rates and expected dividend yield.&nbsp; </font>The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&nbsp; For employees we use the simplified method, which is a weighted average of the vesting term and contractual term, to determine expected term.&nbsp; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options.&nbsp; For consultants we use the contract term for expected term.&nbsp; We estimate the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the grants.&nbsp; We estimate the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&nbsp; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>We will reconsider use of the Black-Scholes pricing model and Monte Carlo Simulation if additional information becomes available in the future that indicates other models would be more appropriate.&nbsp; If factors change and we employ different assumptions in future periods, the compensation expense that we record may differ significantly from what we have recorded in the current period.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u>EFFECT OF RECENTLY ISSUED PRONOUNCEMENTS</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We discuss the effect of recently issued pronouncements in the Notes to our Condensed Consolidated Financial Statements. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>31</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>FORWARD-LOOKING STATEMENTS</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Information included in this Quarterly Report on Form 10-Q (this &#147;Report&#148;) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;).&nbsp; Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results.&nbsp; We generally use the words &#147;believes,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;likely,&#148; &#147;will&#148; and similar expressions to identify forward-looking statements.&nbsp; Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.&nbsp;&nbsp; These risks, uncertainties and factors include, but are not limited to, those factors set forth in our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 and the condensed consolidated financial statements included in this Report.&nbsp; Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.&nbsp; You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Report.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Item 3.&nbsp; <u><a name=QQD>Quantitative and Qualitative Disclosures About Market Risk.</a></u></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>As of July 31, 2019, we had investments in short-term, fixed rate and highly liquid instruments that have historically been reinvested when they mature throughout the year. &nbsp;Although our existing instruments are not considered at risk with respect to changes in interest rates or markets for these instruments, our rate of return on these securities could be affected at the time of reinvestment, if any.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Item 4.&nbsp; <u><a name=CP>Controls and Procedures.</a></u></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We carried out an evaluation, under the supervision and with the participation of our management including our President and Chief Executive Officer and our Chief Operating Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13-15(b) of the Exchange Act.&nbsp; Based upon that evaluation, our President and Chief Executive Officer and our Chief Operating Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>There was no change in our internal control over financial reporting during the third quarter of fiscal year 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>32</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><u><font style=COLOR:black><a name=PART2>PART II.&nbsp; OTHER INFORMATION</a></font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><a name=LP>Item 1.&nbsp;&nbsp;&nbsp; <u>Legal Proceedings.</u></a></b>&nbsp; </p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>Other than as described below and lawsuits we have historically brought to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business.&nbsp; We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 5, 2018, a putative shareholder derivative complaint was filed in the Court of Chancery of the State of Delaware, captioned Howland v. Kumar et al., C.A. No. 2018-0804-KSJM (the &#147;Derivative Action&#148;), that alleged claims for breach of fiduciary duty and unjust enrichment.&nbsp; The Derivative Action named as defendants certain of the Company&#146;s current and former officers and directors (the &#147;Individual Defendants&#148;), and the Company was named solely as a nominal defendant.&nbsp; On August 21, 2019, the Company entered into a settlement pursuant to which the Company agreed to certain changes in its corporate governance policies and to reprice certain stock options that were repriced on September 6, 2017 to $0.67 to the option price immediately prior to that repricing.&nbsp; The Company also agreed to pay certain legal fees, with such fees to be paid from the Company&#146;s D&amp;O insurance.&nbsp; As a result of this settlement, all of the claims asserted in the Derivative Action will be dismissed.&nbsp; The Individual Defendants have denied, and continue to deny, any and all allegations of wrongdoing or liability asserted in the Derivative Action.&nbsp; The Individual Defendants have further asserted, and continue to assert, that at all relevant times, they acted in good faith and in a manner that they reasonably believed to be in the best interests of the Company and its stockholders.&nbsp; The Individual Defendants have entered into the settlement solely to eliminate the uncertainty, distraction, disruption, burden, risk, and expense of further litigation.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black><a name=RF>Item 1A.&nbsp; &nbsp;<u>Risk Factors</u>.</a></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2018.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><a name=USESUP>Item 2.&nbsp; &nbsp; &nbsp; <u>Unregistered Sales of Equity Securities and Use of Proceeds</u>.</a> </b>&nbsp;&nbsp;None.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=DUSS><b>Item 3.&nbsp; &nbsp; &nbsp; <u>Defaults Upon Senior Securities</u></b>.</a><b>&nbsp; </b>None.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=MSD><b>Item 4.</b>&nbsp; &nbsp; &nbsp; <b><u>Mine Safety Disclosures</u></b>.</a>&nbsp; Not Applicable.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a name=OI><b>Item 5.&nbsp; &nbsp; &nbsp; <u>Other Information</u></b>.</a> None.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>33</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#TOC><font color=#0066cc>Table of Contents</font></a><a name=IT4></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black><a name=Ex>Item 6.&nbsp; &nbsp; &nbsp; <u>Exhibits.</u></a></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>10.1&nbsp;&nbsp;&nbsp;&nbsp; </a><a href=exhibit10_1.htm>Exclusive License Agreement, dated July 8, 2019, between Anixa Biosciences, Inc. and The Cleveland Clinic Foundation.&nbsp; (Filed herewith.)&nbsp;<br> (Certain information has been redacted in the marked portions of the exhibit.)</a></p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>10.2&nbsp;&nbsp;&nbsp;&nbsp;<a href=exhibit10_2.htm> Amendment 1 to the Collaboration Agreement between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc.&nbsp; (Filed herewith.)</a><br><br></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>31.1&nbsp;&nbsp;&nbsp;&nbsp; <a href=exhibit31_1.htm>Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated September 6, 2019</a>.<br><br></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>31.2&nbsp;&nbsp;&nbsp;&nbsp; <a href=exhibit31_2.htm>Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated September 6, 2019.</a><br><br></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>32.1&nbsp;&nbsp;&nbsp;&nbsp; <a href=exhibit32_1.htm>Statement of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated September 6, 2019.</a><br><br></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>32.2&nbsp;&nbsp;&nbsp;&nbsp; <a href=exhibit32_2.htm>Statement of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated September 6, 2019.</a></p><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'><br clear=all style=></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>34</p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><a href=#TOC>Table of Contents</a></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><u><font style=COLOR:black><a name=SIGN>SIGNATURES</a></font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-33pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><br>&nbsp;</font></p> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="TEXT-TRANSFORM:uppercase; COLOR:black">ANIXA BIOSCIENCES, INC.</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:47%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:/s/ Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chairman, President and</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Executive Officer&nbsp;&nbsp;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>September 6, 2019&nbsp;&nbsp;&nbsp; </font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>(Principal Executive Officer)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:47%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:/s/ Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Operating Officer and</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Financial Officer</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>(Principal Financial and</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=52% nowrap style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>September 6, 2019</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accounting Officer)</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>35</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-AUTOSPACE:'><font style="COLOR:black;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></div></body>
<!-- EDGAR Validation Code: 8F5FE592 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit10_1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<head><title>Exhibit 10.1</title> </head> <body vlink=#954f72 link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b><font style=FONT-SIZE:11pt>Exhibit 10.1</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p>   <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>EXCLUSIVE LICENSE AGREEMENT</font></b></p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>between</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>THE CLEVELAND CLINIC FOUNDATION</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>and </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>ANIXA BIOSCIENCES, INC.</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>dated as of </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><a name=_cp_text_1_2><b><font style=FONT-SIZE:11pt>July</font></b></a><b><font style=FONT-SIZE:11pt> 8, 2019</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>EXCLUSIVE LICENSE AGREEMENT</font></b></p></div> <div style=page:WordSection2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>This Exclusive License Agreement (this &#147;<b>Agreement</b>&#148;) is made and entered into effective as of <a name=_cp_text_1_4>July </a>8, 2019 (the &#147;<b>Effective Date</b>&#148;), by and between The Cleveland Clinic Foundation, a nonprofit Ohio corporation (&#147;<b>Licensor</b>&#148;), and Anixa Biosciences, Inc.,&nbsp;a Delaware corporation (&#147;<b>Licensee</b>&#148;).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>RECITALS:</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>WHEREAS, Licensor owns certain patents and/or patent applications pertaining to</font> <font style=FONT-SIZE:11pt>the use of </font><font style=FONT-SIZE:11pt>vaccines for the treatment or prevention of Triple Negative Breast Cancer (TNBC) and other breast cancers, which express the </font><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">a-</font><font style=FONT-SIZE:11pt>lactalbumin protein, developed by Vincent K. Tuohy (who is an Inventor as defined below) that it believes should be developed and commercialized for the greater public good; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>WHEREAS, Licensor desires to grant to Licensee an exclusive license under such patents and/or patent applications in order to develop and commercialize such technology, and Licensee desires such license and agrees to use commercially reasonable efforts to develop and commercialize such technology, in each case subject to the terms, conditions and other provisions contained herein.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 1</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>DEFINITIONS</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><font style=FONT-SIZE:11pt>1.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Defined Terms</font></u><font style=FONT-SIZE:11pt>. In addition to such terms as are defined elsewhere in this Agreement, the capitalized terms in this Agreement shall have the following meanings:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Action</b>&#148; has the meaning set forth in <u>Section 10.1.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Affiliate</b>&#148; as to any Person, means any other Person that, directly or indirectly through one or more intermediaries, is in control of, is controlled by, or is under common control with, such Person. For purposes of this definition, "control" of a Person means the power, directly or indirectly, either to (a) vote 50% or more of the securities having ordinary voting power for the election of directors (or persons performing similar functions) of such Person or (b) direct or cause the direction of the management and policies of such Person, whether by contract or otherwise.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Agent</b>&#148; has the meaning set forth in <u>Section 23.3</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Agreement</b>&#148; has the meaning set forth in the Preamble.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Annual Update</b>&#148; has the meaning set forth in <u>Section 4.2(b)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Bankruptcy Code</b>&#148;&nbsp;means Title 11 of the United States Code, as amended from time to time, or any similar federal or state law for the relief of debtors.</font></p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Change in Control</b>&#148; of any Person means (a) a merger or consolidation of such Person, (b) a transaction or series of related transactions in which any Person or group of persons within the meaning of &#167; 13(d)(3) of the Securities Exchange Act of 1934, becomes the beneficial owner, directly or indirectly, of fifty percent (50%) or more of the combined voting power of the outstanding securities of such Person, or (c) the sale or other transfer to a third party of all or substantially all of such Person&#146;s assets </font><font style=FONT-SIZE:11pt>related to the subject matter of this Agreement.</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font>&nbsp;</p></div> <div style=page:WordSection3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Confidential Information</b>&#148; means all non-public, confidential or proprietary information of a party, or its Affiliates or Representatives, that is disclosed directly or indirectly from or on behalf of the Disclosing Party to the Receiving Party, whether in oral, written, electronic or other form or media, whether or not such information is marked, designated or otherwise identified as "confidential" and that, due to the nature of its subject matter or circumstances surrounding its disclosure, would reasonably be understood to be confidential or proprietary, including, without limitation, the Licensed Know-how and the terms and existence of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>Confidential Information does not include information that the Receiving Party can demonstrate by documentation or other evidence (i) was already known to the Receiving Party without restriction on use or disclosure prior to the receipt of such information directly or indirectly from or on behalf of the Disclosing Party; (ii)&nbsp;was independently developed by the Receiving Party without use of or reference to the Disclosing Party&#146;s Confidential Information; (iii)&nbsp;is or becomes generally known to the public or otherwise becomes publicly available, other than through a breach of this Agreement by the Receiving Party; or (iv)&nbsp;is or was made available to the Receiving Party on a non-confidential basis by a third party having the lawful right to do so without breaching any obligation of confidentiality to the Disclosing Party.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Cure Period</b>&#148; has the meaning set forth in <u>Section 4.1(b)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Debarred</b>&#148; has the meaning set forth in <u>Section 23.3</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Debtor Relief Law</b>&#148;&nbsp;means the Bankruptcy Code and all other liquidation, bankruptcy, assignment for the benefit of creditors, conservatorship, moratorium, receivership, insolvency, rearrangement, reorganization or similar debtor relief laws of the US or other applicable jurisdictions in effect from time to time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Declaring Party</b>&#148; has the meaning set forth in <u>Section 9.2.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Default</b>&#148; means any of the events specified in <u>Section 7.2</u>, <u>Section <a name=_cp_text_1_6>7.4</a></u>, or anywhere else in this Agreement, which results in (a) Licensor having the right to terminate this Agreement or (b) automatic termination of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Development Plan</b>&#148; means the initial plan to be attached hereto as <u>Exhibit A</u> pursuant to <u>Section 5.7</u>, setting forth the strategy and schedule for Licensee&#146;s research, development and testing of Licensed Products, including the estimated dates of initiation and completion of material development activities (to be performed by or on behalf of Licensee or Licensor) leading to Regulatory Approval and commercial sale of Licensed Products, and thereafter any updates to the development plan as provided by Licensee pursuant to <u>Section 4.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Development Report</b>&#148; means a written account of Licensee&#146;s progress under the Development Plan including the information specified in <u>Exhibit C</u> to this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Disclosing Party</b>&#148; has the meaning set forth in <u>Section 8.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Dispute</b>&#148; has the meaning set forth in <u>Section 9.2.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Earned Know-how Royalty</b>&#148; has the meaning set forth in <u>Section 3.2(b)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt><br>2<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font>&nbsp;</p></div> <div style=page:WordSection4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Earned Patent Royalty</b>&#148; has the meaning set forth in <u>Section 3.2(a)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Earned Royalties</b>&#148; means, collectively, the Earned Patent Royalty and the Earned Know-how Royalty.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Effective Date</b>&#148; has the meaning set forth in the Preamble.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>The expression &#147;<b>expiration</b>&#148; and &#147;<b>expire</b>&#148;, when referring to a claim in a Licensed Patent means any expiration, revocation, invalidation or other termination of a Licensed Patent incorporating the pending, issued or enforceable claim.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>FDA</b>&#148; has the meaning set forth in the definition of Regulatory Authority.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Field 1</b>&#148; means vaccines for the prevention of Triple Negative Breast Cancer (TNBC) and other breast cancers, which express the </font><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">a</font><font style=FONT-SIZE:11pt>-lactalbumin protein.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Field 2</b>&#148; means vaccines for the therapeutic treatment of Triple Negative Breast Cancer (TNBC) and other breast cancers, which express the </font><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">a</font><font style=FONT-SIZE:11pt>-lactalbumin protein.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Fields&#148;</b> means, collectively, Field 1 and Field 2.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>First Commercial Sale</b>&#148; means the first arms-length, non-clinical trial-related sale of a Licensed Product.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Force Majeure Event</b>&#148; has the meaning set forth in <u>Section 4.1(b)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>GAAP</b>&#148; means generally accepted accounting principles in the United States of America as in effect from time to time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Governmental Authority</b>&#148;&nbsp; means the government of any nation or any political subdivision thereof, whether at the national, state, territorial, provincial, municipal or any other level, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of, or pertaining to, government.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Indemnitee</b>&#148; has the meaning set forth in <u>Section 10.1.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Infringement Notice</b>&#148; has the meaning set forth in <u>Section 6.4.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Inventor</b>&#148; means each person listed as an inventor on any Licensed Patent.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Issue Fee</b>&#148; has the meaning set forth in <u>Section 3.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Law</b>&#148; means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement or rule of law of any Governmental Authority or Regulatory Authority.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt><br>3<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in; tab-stops:0in"><font style=FONT-SIZE:11pt>&#147;<b>Licensed Know-how</b>&#148; means any unpatentable or unpatented developments, proprietary knowledge, ideas, specifications, prototypes, drawings, know-how, formulas, information, data, methods, processes, tools, designs, testing programs, expertise, concepts or techniques, and similar knowledge not known by Licensee prior to Licensor disclosing such knowledge to Licensee, solely to the extent that they are (a) pertinent to the Licensed Patents, (b) not subject to the exclusive rights of any third parties or research sponsor restrictions, (c) (i) in existence, and known to the Inventor or members of his laboratory(ies), as of the Effective Date or (ii) generated by or on behalf Licensor (solely or jointly with others) during the Term through the exercise of Licensor&#146;s retained rights under <u>Section 2.4.1</u>, including non-clinical and clinical data (including clinical data generated in connection with the Phase I Clinical Trial for TNBC), and (d) applicable primarily within the Fields, further described in <u>Appendix A</u>.</font></p><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Licensed Know-how Product</b>&#148; means a product or part of a product in the Fields that is sold, transferred, or otherwise disposed of in a jurisdiction where (i) a Licensed Patent has expired; (ii) patent protection is not pursued, but the product or part of a product sold, transferred, or otherwise disposed of would be expected to infringe (with respect to Valid Claims of patent applications) any Valid Claim; or (iii) that was derived from, utilizes, uses, is used, or made through use of, embodies, contains, incorporates (in each case, in whole or in part), or uses any element of any of the Licensed Know-how.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Licensed Know-how Royalty Term</b>&#148; means, with respect to a particular Licensed Product in a particular country, the period of time commencing on the First Commercial Sale of such Licensed Product in such country and ending on the *** of such First Commercial Sale.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Licensed Patents</b>&#148; means the patents and patent applications listed on <u>Appendix A</u>, together with (a) all patents that issue therefrom, and (b) and all corresponding foreign patents and patent applications thereof, together with all divisionals, continuations (but excluding continuations-in-part), reissues, reexaminations, extensions or renewals of any of the foregoing having the same priority date as the parent and listing at least one of the Inventors as inventors.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Licensed Patent Challenge</b>&#148; has the meaning set forth in <u>Section 6.5(a)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Licensed Patent Royalty Term</b>&#148; means, with respect to a particular Licensed Product in a particular country, the period of time commencing on the First Commercial Sale of such Licensed Product in such country and continuing through the date of expiration of the last to expire Valid Claim of the Licensed Patents covering the sale of such Licensed Product in such country.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Licensed Patent Product</b>&#148; means any product or part of a product in the Fields the making, use, sale, offer to sell, or import of which infringes or would be expected to infringe (with respect to Valid Claims of patent applications) a Valid Claim, but for the license granted in this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Licensed Product</b>&#148; means (i) a Licensed Patent Product; or (ii) a Licensed Know-how Product.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Licensed Technology</b>&#148; means, collectively, the Licensed Patents and the Licensed Know-How.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Licensee</b>&#148; has the meaning set forth in the Preamble.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>&#147;<b>Licensor</b>&#148; has the meaning set forth in the Preamble.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Losses</b>&#148; means all losses, damages, liabilities, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties, fines, costs or expenses of whatever kind, including reasonable attorneys' fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&nbsp;&#147;<b>Net Sales</b>&#148; means the total gross amount of monies or cash equivalent or other consideration paid or payable to Licensee or any Sublicensee for sales of Licensed Products <i><u>less</u></i> the sum of the following amounts, without duplication:&nbsp; ***.&nbsp; <br><br></p></font><font style=FONT-SIZE:11pt> <p align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>4</font></p><div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>For non-cash and partial-cash sales, the applicable Licensed Product shall be considered sold at the fair market value of the consideration received.&nbsp; For sales not at arms-length, Net Sales shall be equal to the fair market price of such Licensed Products as when transferred in comparable arms-length transactions. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event that Licensed Products are used by Licensee or Sublicensees for demonstration or marketing purposes rather than sold, the Parties shall agree upon an appropriate Net Sales price, if at all applicable based upon the nature and circumstance regarding the demonstration or marketing purposes, for each such use. Further, any transfer or use of a Licensed Product for clinical trials or compassionate use will not be deemed a sale for purposes of calculating Net Sales. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the purposes of calculating Net Sales, all calculations of Net Sales shall be in accordance with GAAP and based on, or valued as if based on, bona fide arms' length transactions and not on any bundled, loss-leading or other blended or artificial selling or transfer price.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Sales shall not include Sublicensing Revenue.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Where Licensed Products are not sold, but are otherwise transferred or disposed of, the Net Sales amount of such Licensed Product for the purposes of computing the Earned Royalty shall be the average Net Sales price at which Licensed Products, sold in similar quantities and similar locations, are then currently being offered for sale by Licensee or its Sublicensees.&nbsp; Where such products are not then currently being offered for sale by Licensee or a Sublicensee, the Net Sales price of products otherwise disposed of, for the purpose of computing the Earned Patent Royalty and the Earned Know-how Royalty, shall be the average selling price at which products of similar kind and quality, sold in similar quantities and similar locations, are then currently being offered for sale by other manufacturers. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event that a Licensed Product is sold together with one or more products or services that are not Licensed Products for a single price (a &#147;<b>Combination</b>&#148;), the gross amount invoiced for such Licensed Product for purposes of calculating Net Sales shall be calculated by multiplying the gross amount invoiced for such Combination by the fraction A/(A+B), where &#147;A&#148; is the gross amount invoiced for such Licensed Product sold separately and &#147;B&#148; is the gross amount invoiced for such other product(s) or service(s) sold separately. In the event that such Licensed Product or such other product(s) or service(s) are not sold separately, the portion of the gross amount invoiced for such Combination that is attributable to Net Sales for purposes of royalty determination shall be mutually agreed by the Parties in good faith based upon the relative value of the Licensed Product and the other product(s) or service(s) included in the Combination.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The expression "<b>transferred or otherwise disposed of</b>" means (y) not sold but delivered, directly or indirectly, by Licensee or Sublicensees to others (including deliveries for export), regardless of any return or exchange consideration; or (z) exploited or otherwise used by Licensee or Sublicensees for any purpose other than routine testing of such Licensed Products.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Notice</b>&#148; has the meaning set forth in <u>Section 9.2.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Patenting Costs</b>&#148; means any and all reasonable, documented, out-of-pocket costs and expenses, including without limitation government fees and attorneys&#146; fees and costs, of preparing, filing, prosecuting, issuing and maintaining any of the Licensed Patents, including continuations, extensions, re-examinations, reissues and appeals.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Patent Reimbursement Amount</b>&#148; has the meaning set forth in <u>Section 6.2.1</u>.<br><br></p></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>5<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Person</b>&#148; means any individual, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, or other legal entity of any kind, foreign or domestic.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Phase I Clinical Trial</b>&#148; means an FDA (or other foreign regulatory authority) approved dose escalating safety study with respect to a Licensed Product.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Phase I Clinical Trial for TNBC</b>&#148; means the trial funded by the DoD for the purpose of identifying the maximally tolerated dose of </font><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">a</font><font style=FONT-SIZE:11pt>-lactalbumin and adjuvant in TNBC patients who have been in remission for 6 months and the minimally effective dose of </font><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">a</font><font style=FONT-SIZE:11pt>-lactalbumin and adjuvant in the same patients for eliciting a T-cell response.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Phase II Clinical Trial</b>&#148; means a human clinical study of a Licensed Product, the principal purpose of which is a determination of safety and efficacy in the target patient population, as described in 21 C.F.R. 312.21(b), or a similar human clinical study prescribed by the Regulatory Authority in a country other than the United States.&nbsp; Phase II Clinical Trial also includes the portion of any human clinical study that meets the foregoing definition, as in the case of a study designated as a &#147;Phase I/II&#148; clinical trial.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Phase III Clinical Trial</b>&#148; means a human clinical study of a Licensed Product, the design of which is acknowledged by the FDA to be sufficient for such clinical study to satisfy the requirements of 21 C.F.R. 312.21(c), or a similar human clinical study prescribed by the Regulatory Authority in a country other than the United States.&nbsp; Phase III Clinical Trial also includes (a) the portion of any human clinical study that meets the foregoing definition, as in the case of a study designated as a &#147;Phase II/III&#148; clinical trial, and (b) any other human clinical study serving as a pivotal study from which the data are actually submitted to the applicable Regulatory Authority in connection with an application for Regulatory Approval, whether or not such study is expressly designated as a &#147;Phase III&#148; clinical trial.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Product Report</b>&#148; has the meaning set forth in <u>Section 5.3</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Quarterly Period</b>"&nbsp;means each three-month period commencing on January 1, April 1, July 1 and October 1.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&nbsp;&#147;<b>Receiving Party</b>&#148; has the meaning set forth in <u>Section 8.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Regulatory Approval</b>&#148; means any approvals (including supplements, amendments, pre- and post-approvals and price approvals), licenses, registrations or authorizations, howsoever called, of any Regulatory Authority, which are necessary for the distribution, importation, exportation, manufacture, production, use, storage, transport or clinical testing and/or sale of a Licensed Product in a regulatory jurisdiction.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Regulatory Authority</b>&#148; means the United States Food and Drug Administration (&#147;<b>FDA</b>&#148;) or any counterpart of the FDA outside the United States, or other national, supra-national, regional, state or local regulatory agency, department, bureau, commission, council, ethics committee, review board or other entity with authority over the distribution, importation, exportation, manufacture, production, use, storage, transport or clinical testing and/or sale of a Licensed Product.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Regulatory Filings</b>&#148; means any filings, and all data contained therein, as may be required by the FDA or equivalent foreign Regulatory Authorities for the development, manufacture or commercialization of a Licensed Product hereunder.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Representatives</b>&#148;&nbsp;means a party's employees, officers, directors, consultants and legal advisors.<br><br></p></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>6<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Reserved Interests</b>&#148; has the meaning set forth in <u>Section 2.7</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Responsible Officer</b>&#148; with respect to any Person, means the chief executive officer, president or chief financial officer of such Person.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Review Period</b>&#148; has the meaning set forth in <u>Section 2.4.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>The terms &#147;<b>sale</b>&#148;, &#147;<b>sold</b>&#148; and &#147;<b>sell</b>&#148; as used in this Agreement include without limitation sales, leases, licenses, rentals and other modes of distribution or transfer of a product or its beneficial use.&nbsp; Licensed Products will be considered sold when delivered or invoiced, whichever occurs first.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Sublicense</b>&#148; shall mean an agreement in which Licensee (a) sublicenses any of the rights licensed to Licensee hereunder, (b) agrees not to assert such rights or to sue, prevent or seek a legal remedy for the practice of same, or (c) is under an obligation to grant, assign or transfer any such rights or non-assertion, or to forebear from granting or transferring such rights to any other entity.&nbsp; Agreements expressly considered Sublicenses includes without limitation licenses, option agreements, or similar agreements, to the extent that the rights granted therein relate to the rights licensed to Licensee hereunder.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Sublicense Fees</b>&#148; has the meaning set forth in <u>Section 3.4</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Sublicensee</b>&#148; shall mean any non-Affiliate third party to whom Licensee has granted a Sublicense.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Sublicensing Revenue</b>&#148; shall mean any and all consideration received by Licensee from sublicensing any of the rights granted to it under <u>Section 2.1</u> of this Agreement, including without limitation cash and cash equivalents, license issue fees and other licensing fees, option fees, milestone payments, or other payments of any kind, but excluding royalties on sales of Licensed Products and minimum annual royalties.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Taxes</b>&#148; means any and all present or future income, stamp or other taxes, levies, imposts, duties, deductions, charges, fees or withholdings imposed, levied, withheld or assessed by any Governmental Authority, together with any interest, additions to tax or penalties imposed thereon and with respect thereto.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Term</b>&#148; has the meaning set forth in <u>Section 7.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&#147;<b>Territory</b>&#148; means worldwide. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>&nbsp;&#147;<b>Valid Claim</b>&#148; means any pending or issued claim of any Licensed Patent that has not been admitted by Licensor or otherwise caused to be invalid or unenforceable through reissue, disclaimer or otherwise, or held invalid or unenforceable by a Governmental Authority of competent jurisdiction from whose judgment no appeal is allowed or timely taken. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>1.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt lang=EN-GB>Interpretation</font></u><font style=FONT-SIZE:11pt lang=EN-GB>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt lang=EN-GB>For purposes of this Agreement: (i) the words "include," "includes" and "including" shall be deemed to be followed by the words "without limitation"; (ii) the word "or" is not exclusive; and (iii) the words "herein," "hereof," "hereby," "hereto" and "hereunder" refer to this Agreement as a whole.<br><br></p></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>7<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>In the computation of periods of time from a specified date to a later specified date, the word "from" means "from and including;" the words "to" and "until" each mean "to but excluding;" and the word "through" means "to and including."</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt lang=EN-GB>The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined.&nbsp; Unless the context otherwise requires, references herein: (i) to Sections, Appendices and Exhibits refer to the Sections, Appendices and Exhibits attached to, this Agreement; (ii) to an agreement, instrument or other document means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof; and (iii) to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted. Any Appendices and Exhibits referred to herein shall be construed with, and as an integral part of, this Agreement to the same extent as if they were set forth verbatim herein.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>All accounting terms not specifically or completely defined herein shall be construed in conformity with, and all financial data required to be submitted pursuant to this Agreement shall be prepared in conformity with, GAAP as in effect from time to time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt lang=FR>Article 2</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt lang=FR>GRANT; SUBLICENSING</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt lang=FR>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>License Grant</u>.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee (i) the exclusive worldwide (as to the countries for which patent protection is sought) license, with the right to grant and authorize Sublicenses as set forth below, under the Licensed Patents to make, have made, use, offer to sell, sell and import Licensed Products in the Fields in the Territory, and (ii) a non-exclusive worldwide license, with the right to grant and authorize Sublicenses as set forth below, to use or practice the Licensed Know-How to make, have made, use, offer to sell, sell and import Licensed Products in the Fields in the Territory. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensor shall, within *** after the Effective Date, disclose the Licensed Know-how to Licensee in accordance with <u>Article 12</u>.&nbsp; Licensee acknowledges and agrees that the Licensed Know-how is considered Confidential Information and has independent value and will provide Licensee with a competitive advantage and/or commercial value.&nbsp; Licensed Know-how includes *** and other information as described in Appendix A.&nbsp; In addition, Licensor shall (i) disclose to Licensee all Licensed Know-how generated during the Term, including non-clinical and clinical data, within *** after such Licensed Know-how is generated, in an electronic format reasonably acceptable to Licensee, and (ii) obtain such consents from third parties as may be necessary to make such disclosures to Licensee, including informed consents from subjects participating in clinical trials, as applicable.&nbsp; For clarity, clinical data delivered in accordance with the preceding sentence shall include raw data and case report forms.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Sublicensing</u>. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; TEXT-INDENT:-0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensee may sublicense the rights granted to it under <u>Section 2.1</u>, ***, so long as, ***, (w) ***, (x) this Agreement has not been terminated, (y) Licensee is not in breach of its obligations hereunder (or there is not otherwise a continuing Default), and (z) the following criteria are satisfied:&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>8<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:1in'><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>the Sublicense is in writing; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:1in'><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>***; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:1in'><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>***;&nbsp; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:1in'><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>***.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensee will provide Licensor with (i) a fully signed, copy of each Sublicense granted by Licensee under this Agreement and any amendments thereto, including all exhibits, attachments and related documents, within thirty (30) days of executing the same, (ii) a copy of all reports provided to Licensee by Sublicensees during the term of the Sublicense on a quarterly basis; and (iii) notification of the termination of any Sublicense, in each case, which information will be Licensee&#146;s Confidential Information.&nbsp; Notwithstanding any Sublicense, Licensee shall remain primarily liable to Licensor for all of Licensee's duties and obligations contained in this Agreement, including, without limitation, the payment of all Earned Royalties due hereunder. Any act or omission of a Sublicensee that would be a breach of this Agreement if committed or omitted by Licensee will be a breach by Licensee. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Government Rights</u>.&nbsp; Notwithstanding anything herein to the contrary, any and all provisions contained herein, (including without limitation, the licenses and other rights granted hereunder and all representations and warranties of Licensor) are limited by and subject to the rights and requirements of the United States Government that may attach as a result of U.S. Government sponsorship, in any way, of research at Licensor in which one or more invention covered by the Licensed Patents was conceived or first actually reduced to practice, as set forth in 35 U.S.C.&nbsp; &#167;&#167;200-206, 37 C.F.R. Part 401 and in the relevant Government research contracts with Licensor, and as such rights and requirements may be amended or modified by Law.&nbsp; To the extent applicable, such rights and requirements include without limitation (i) the grant of a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the U.S. Government any of the Licensed Patents throughout the world (as set forth in 35 U.S.C. &#167;202(c)(4)), and (ii) the requirement that Licensed Products used or sold in the United States will be manufactured substantially in the United States (as set forth in 35 U.S.C. &#167;204) (provided that if Licensee seeks a waiver to manufacture Licensed Products outside of the United States, Licensor will reasonably cooperate at Licensee&#146;s cost and expense, where applicable).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Retained Rights; Requirements</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.4.1&nbsp;&nbsp;&nbsp; <u>Research Use Right</u>.&nbsp; Any and all licenses granted hereunder are subject to the right of Licensor, on behalf of itself and its investigators, to practice and use the Licensed Patents and the subject matter described and/or claimed therein, and to permit others at academic, government, and not-for-profit institutions to practice and use the Licensed Patents and the subject matter described and/or claimed therein, for its and their own research (including without limitation, pre-clinical, non-clinical and clinical research), testing, educational, internal or patient-care purposes. For avoidance of any doubt, any research previously performed, currently being performed, or performed in the future by Licensor, at Licensor&#146;s facilities or using Licensor&#146;s resources, or that Licensor or Inventor is in any way related to (whether as Principal Investigator, sponsor or otherwise) is subject to the retained rights in this <u>Section 2.4.1</u> (the &#147;<b>Permitted Research</b>&#148;).&nbsp; Permitted Research includes, without limitation, the Phase I Clinical Trial for TNBC and any research activities of Licensor or Inventor (while an employee of Licensor) that are funded in whole or in part by any Governmental Authorities or any philanthropic or similar sources. For clarity, Licensor agrees and acknowledges that this <u>Section 2.4.1</u> does not give Licensor the right to practice or use the Licensed Technology in connection with the commercial sale of any product or service. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>9<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.4.2&nbsp;&nbsp;&nbsp; <u>Right to Publish</u>.&nbsp; Licensee recognizes and accepts the importance of communicating medical study and scientific data and the necessity of conveying such information in a timely manner, and, therefore, encourages their publication in reputable scientific journals and at seminars or conferences, even if such publication includes Licensed Know-how.&nbsp; Licensee further recognizes and accepts that under Licensor&#146;s mission as an academic medical center, Licensor and its investigators must have a meaningful right to publish without Licensee&#146;s approval or editorial control.&nbsp; Licensor shall submit to Licensee for its review a copy of any proposed manuscript *** prior to the estimated date of submission for publication.&nbsp; Within *** of receiving such manuscript (the &#147;<b>Review Period</b>&#148;), if Licensee reasonably determines that the proposed publication contains patentable subject matter which requires protection for Licensee, Licensee may require the delay of publication for a period of time not to exceed *** for the purpose of filing patent applications. Further, Licensor and its investigators agree to remove from the proposed publication anything that Licensee identifies within the Review Period as Licensee&#146;s Confidential Information. If no written response is received from Licensee within the Review Period, it may be conclusively presumed that publication may proceed without delay. For avoidance of any doubt, Licensor and Inventor (while an employee of Licensor) retain the right to publish any medical study or scientific data arising from the Permitted Research, subject to compliance with this <u>Section 2.4.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Regulatory Affairs</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensor hereby grants Licensee, and its Affiliates and Sublicensees, a &#147;right of reference,&#148; as that term is defined in 21 C.F.R. &#167; 314.3(b), or a comparable right existing under the Laws of any other jurisdiction, to any Regulatory Filings owned or otherwise controlled by Licensor or its Affiliates to the extent relating to the research, development, manufacture or commercialization of a Licensed Product in the Fields in the Territory, and, upon request, shall promptly provide a signed statement to such effect in accordance with 21 C.F.R. &#167;314.50(g)(3) or the Laws of any other jurisdiction.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensee shall have the right to audit any clinical data included in the Licensed Know-how (&#147;<b>Licensed Clinical Data</b>&#148;) for accuracy and completeness, upon at least *** prior written notice, at Licensee&#146;s <a name=_cp_text_1_10>sole </a>expense<a name=_cp_text_1_11>, including but not limited to any incidental costs incurred by Licensor as a result of any such audit</a>.&nbsp; If a Regulatory Authority requests that Licensee provide additional information regarding any Licensed Clinical Data, then the parties shall discuss the scope of such request and, if the requested information is owned or otherwise controlled by Licensor, Licensor shall provide such information to Licensee in a reasonable amount of time and cooperate with Licensee in responding to such request.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensor shall provide Licensee with prompt written notice of an impending inspection by a Regulatory Authority relating to the Licensed Clinical Data and the results of such inspection, including any FDA Form 483 notices (or similar notices of other Regulatory Authorities).&nbsp; Further, if a Regulatory Authority makes any finding that impacts or could reasonably be expected to impact the Licensed Clinical Data, then Licensor shall provide Licensee with prompt written notice thereof and solicit (and reasonably consider) Licensee&#146;s feedback regarding any plan for remedial action.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><a name=_cp_text_1_12><font style=FONT-SIZE:11pt>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensor does not represent or warrant that any Licensed Clinical Data was created in accordance with or pursuant to any requirements under the C.F.R, or any comparable Laws of any jurisdiction.&nbsp; Furthermore, Licensor does not represent or warrant that any Licensed Clinical Data was created for submission to any Governmental Authority. </font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>10<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>No Grant of Other Technology or Patent Rights</u>.&nbsp; Except as otherwise expressly provided in this Agreement, under no circumstances shall Licensee, as a result of this Agreement obtain any ownership interest or license in or other right to any technology, know-how, patents, patent applications, products, or materials of Licensor, including items owned, controlled or developed by Licensor, at any time pursuant to this Agreement.&nbsp; This Agreement does not create, and shall under no circumstances be construed or interpreted as creating, an obligation on the part of Licensor to grant any license to Licensee other than as expressly set forth herein.&nbsp; Any further contract or license agreement between the parties shall be in writing.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Reserved Rights</u>.&nbsp; All rights and interests of Licensor not expressly granted to Licensee are reserved by Licensor (the &#147;<b>Reserved Interests</b>&#148;) for itself, its Affiliates and partners (other than Licensee) and other licensees and Sublicensees, including the rights to use and grant licenses under the Licensed Patents or any other technology owned or controlled by Licensor to make, have made, use, offer to sell, sell, have sold and import products (other than Licensed Products within the Fields for so long as Licensee has an exclusive license to Licensed Products within the Fields under this Agreement).&nbsp; It shall not be a breach of this Agreement for Licensor, acting directly or indirectly, to exploit its Reserved Interests in any manner anywhere in the Territory, whether or not such activity is competitive with the activities of Licensee, including the research, development and commercialization or licensing of others to research, develop and commercialize products (other than Licensed Products within the Fields for so long as Licensee has an exclusive license under the Licensed Patents to develop and commercialize products within the Fields under this Agreement), including products that potentially compete in the same product market as a Licensed Product); provided that the foregoing shall not be construed to be a grant of any license, implied or otherwise, by Licensee to Licensor or to permit Licensor to breach the confidentiality provisions of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 3</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>FINANCIAL CONSIDERATION</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Issue Fee</u>. In consideration of its license to the Licensed Technology hereunder, Licensee shall pay to Licensor a non-refundable, non-creditable license fee in an amount equal to *** dollars ($***) (the &#147;<b>Issue Fee</b>&#148;), payable to Licensor ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Earned Royalties</u>. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>In consideration of its license to the Licensed Patents hereunder, Licensee shall pay to Licensor a quarterly royalty equal to *** of the Net Sales (the &#147;<b>Earned Patent Royalty</b>&#148;) of a particular Licensed Product sold, transferred or otherwise disposed of in a particular country where a Valid Claim exists covering the sale of such Licensed Product in such Country during the Licensed Patent Royalty Term for such Licensed Product in such country.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>In consideration of its license to the Licensed Know-how hereunder, Licensee shall pay to Licensor a quarterly royalty equal to *** of the Net Sales (the &#147;<b>Earned Know-how Royalty</b>&#148;) of a particular Licensed Product sold, transferred or otherwise disposed of in a particular country where no Valid Claim exists covering the sale of such Licensed Product in such country during the Licensed Know-how Royalty Term for such Licensed Product in such country.&nbsp; For avoidance of doubt, during the Licensed Know-how Royalty Term for a particular Licensed Product in a particular country, Earned Know-how Royalties shall be payable in respect of sales of such Licensed Product in such country if there are no Valid Claims covering the sale of such Licensed Product in such country.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>11<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>The Earned Patent Royalty and the Earned Know-how Royalty shall not be cumulative, such that only one Earned Royalty (<i>i.e.</i>, the Earned Patent Royalty or the Earned Know-how Royalty, as applicable) will be payable with respect to any Licensed Product sold during the Term.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Annual Maintenance Fee</u>.&nbsp; In consideration of its license to the Licensed Technology hereunder,</font> <font style=FONT-SIZE:11pt>for the first calendar year beginning after the Effective Date and each subsequent calendar year thereafter, but before the year of the First Commercial Sale, Licensee shall pay to Licensor an &#147;<b>Annual Maintenance Fee</b>&#148; in the amount of $***. The first Annual Maintenance Fee shall be due and payable on or before January 15, 2021, and thereafter Licensee shall pay the Annual Maintenance Fee to Licensor within *** of the end of each calendar year for which an Annual Maintenance Fee is required.&nbsp; The Annual Maintenance Fee shall be fully creditable against any Milestone Payment received for such calendar year.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.4 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Sublicense Fees</u>. In consideration of its license to the Licensed Technology hereunder, Licensee shall pay to Licensor sublicense fees (&#147;<b>Sublicense Fees</b>&#148;) for any Sublicense executed by the milestone and in an amount equal to a percent of Sublicensing Revenue, in each case identified in the table below.&nbsp; Consideration received by Licensee as Sublicensing Revenue in the form of equity or other securities shall be paid to Licensor in kind, and consideration received as Sublicensing Revenue in the form of goods shall be paid to Licensor in cash based upon the fair market value of such goods received.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr> <td width=319 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Milestone</font></b></p></td> <td width=271 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Sublicense Rate</font></b></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><strike></strike>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>For purposes of this Section 3.4, ***.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Minimum Annual Royalty</u>. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In consideration of its license to the Licensed Technology hereunder, Licensee shall pay to Licensor a minimum annual royalty (each, a &#147;<b>MAR</b>&#148;) with respect to all Licensed Products, as set forth in the table below:</font></p> <div align=center> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr> <td width=319 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Year</font></b></p></td> <td width=271 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>MAR</font></b></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in'>&nbsp;</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; TEXT-INDENT:-0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Each year&#146;s MAR payment shall be due and payable within *** following the end of the calendar year to which it applies (e.g., the 2019 MAR is due and payable on or before February 14, 2020). &nbsp;If the total amount of Earned Royalties paid during any calendar year exceeds the MAR for such calendar year, then Licensee shall have no MAR payment obligation for such calendar year.&nbsp; In no event will the MAR be pro-rated for any partial calendar year. The MAR shall be fully creditable against any Milestone Payment received for such calendar year.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>12<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Product Development Milestone Payments</u>.&nbsp; In consideration of its license to the Licensed Technology hereunder, Licensee shall pay to Licensor the following payments (each, a &#147;<b>Milestone Payment</b>&#148;) within *** of the completion or occurrence of each Milestone Activity with respect to a Licensed Product:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <div align=center> <table bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=114 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:275pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Amount</font></b></p></td> <td width=241 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:180.45pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Milestone Activity</font></b></p></td></tr> <tr> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:85.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=241 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:180.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:85.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=241 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:180.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:85.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=241 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:180.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>For purposes of this Agreement, ***.&nbsp; For the avoidance of doubt, each Milestone Payment shall be paid only for the first Licensed Product to complete the Milestone Activity.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Payment Terms</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensee shall pay all Earned Royalties and Sublicense Fees for each Quarterly Period within *** of the end of such Quarterly Period.&nbsp; Licensee shall make all payments under this Agreement in US dollars. If any payments required hereunder are not received by Licensor on the date the same has become due and payable, Licensee shall pay to Licensor interest on the overdue undisputed payment from the date such payment was due to the date of actual payment at a rate of ***, or if lower, the maximum amount permitted under applicable Law.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt lang=EN-GB>Earned Royalties, MAR payments, Milestone Payments, Sublicense Fees and all other sums payable by Licensee under this Agreement </font><font style=FONT-SIZE:11pt>shall be made free and clear of and without deduction or withholding for any Taxes except as required by applicable Law</font><font style=FONT-SIZE:11pt lang=EN-GB>. </font><font style=FONT-SIZE:11pt>If Licensee is required by applicable Law to deduct or withhold any Taxes from such payments, then: </font><font style=FONT-SIZE:11pt lang=EN-GB>(i) </font><font style=FONT-SIZE:11pt>the amount payable by Licensee shall be increased so that after all such required deductions or withholdings are made (including deductions or withholdings applicable to additional amounts payable under this Section), Licensor receives an amount equal to the amount it would have received had no such deduction or withholding been made; and (ii) Licensee shall make such deductions or withholdings and timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable Law.&nbsp; As soon as practicable after any payment of Taxes by Licensee to a Governmental Authority pursuant to this Section, Licensee shall deliver to Licensor the original or certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the relevant return reporting such payment or other evidence of such payment reasonably satisfactory to Licensor</font><font style=FONT-SIZE:11pt lang=EN-GB>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt lang=EN-GB>For the purpose of converting the local currency in which any royalties or other payments arise into US dollars, the rate of exchange to be applied shall be the rate of exchange in effect on the last business day of the calendar quarter to which the payment relates as reported in the Wall Street Journal.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>If at any time any payment made by Licensee under this Agreement is rescinded or must otherwise be restored or returned upon the insolvency, bankruptcy or reorganization of Licensee or otherwise, Licensee&#146;s obligation to make such payment shall be reinstated as though such payment had not been made.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>13<br></font><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Royalty Stacking</u>. If Licensee determines that it is necessary that Licensee obtain a license from any third party (&#147;<b>Third Party License</b>&#148;) in order to avoid infringing that third party&#146;s intellectual property rights in the manufacture, use, sale and/or importation of the Licensed Products, the royalty rate paid to Licensor shall be reduced by *** of the royalty rate paid for such additional patent or intellectual property rights (i.e. ***); <u>provided</u>, <u>however</u>, that in no event shall the royalty rate paid to Licensor be less than *** for Licensed Patent Products or *** for Licensed Know-how Products.&nbsp; Upon request, Licensee will promptly provide to Licensor reasonable documentation supporting the determination contemplated by this Section, provided that Licensee will not be required to disclose information subject to the attorney-client privilege.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11.5pt>This Section applies only to any prospective earned royalty payable to third parties for rights required to permit Licensee to make, use, offer to sell, sell and import the Licensed Product as provided in this Agreement, and no deduction of any Earned Royalty is allowed for payments to any third party of lump sum license fees, milestone payments, minimum annual royalties in excess of accrued royalties, any amounts paid for past infringement of any third-party's rights or any amount not paid for rights required to permit Licensee to make, use, offer to sell, sell and import the Licensed Product as provided in this Agreement.</font></p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 4</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>COMMERCIALIZATION AND DEVELOPMENT COVENANTS</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Commercialization and Development Milestones</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensee agrees to use commercially reasonable efforts to ***.&nbsp; In furtherance of, and without limiting, the foregoing, Licensee agrees to cause the occurrence of each of the following milestones (each, a &#147;<b>Milestone</b>&#148;) by the corresponding milestone date (each, a &#147;<b>Milestone Date</b>&#148;):</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <div align=center> <table bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=319 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Milestone</font></b></p></td> <td width=271 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:11pt>Milestone Date</font></b></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr> <tr style=HEIGHT:7.6pt> <td width=319 style="BORDER-TOP:0px; HEIGHT:7.6pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:239.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td> <td width=271 style="BORDER-TOP:0px; HEIGHT:7.6pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:203.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>When Licensee completes a Milestone by the applicable Milestone Date, it will provide Licensor with written notice of the achievement of the Milestone within </font><font style=FONT-SIZE:11pt>***</font><font style=FONT-SIZE:11pt> of such completion, together with documentation evidencing such achievement.&nbsp; Any efforts of Licensee or its Affiliates and Sublicensees, or of Licensor or its Affiliates, will be deemed to be the efforts of Licensee for purposes of satisfying the obligations of this Section 4.1.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>For purposes of this Section 4.1, </font><font style=FONT-SIZE:11pt>***</font><font style=FONT-SIZE:11pt>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>***.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Updates</u>. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not later than July 31 of each year prior to the First Commercial Sale, Licensee shall deliver a Development Report to Licensor. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>14<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not later than July 31 of each year prior to the First Commercial Sale, Licensee will provide to Licensor an update on the activities described in the Development Plan, in form and substance reasonably acceptable to Licensor in its reasonable discretion, describing in reasonable detail the material activities to be undertaken during the next *** and the estimated timing of such activities, including the estimated dates of the initiation and completion of such activities and a summary of Licensee&#146;s material product development activities since the prior Annual Update (the &#147;<b>Annual Update</b>&#148;).&nbsp; Licensee&#146;s obligation to provide Licensor with Annual Updates will continue for a Licensed Product until the First Commercial Sale of such Licensed Product.&nbsp; All such Development Reports and Annual Updates under this <u>Section 4.2</u> shall be deemed Licensee&#146;s Confidential Information.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the Term, Licensor shall promptly deliver to Licensee copies of such periodic reports that Licensor provides to the Department of Defense or other source of grant funding in connection with the development of Licensed Products (including progress reports and financial reports) and shall promptly provide Licensee with copies of all material correspondence with any such source of grant funding relating to the development of Licensed Products. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Regulatory Approval</u>.&nbsp; Licensee and its Affiliates and Sublicensees will be solely responsible, at their sole cost and expense, for making all Regulatory Filings and securing all Regulatory Approvals, except to the extent performed by Licensor in accordance with <u>Section 2.4.1</u>.&nbsp; Licensee will provide notice to Licensor of the submission of all Regulatory Filings (including amendments to prior filings and correspondence related to any such filings) to Licensor within *** following the submission thereof.&nbsp; Licensee will provide copies of all Regulatory Approvals to Licensor within *** following the receipt thereof. Licensor will provide reasonable cooperation through providing Licensee, upon Licensee&#146;s written request and in a timely fashion, with all documentation and information reasonably necessary to secure such Regulatory Approval, to the extent such documentation and information is in Licensor&#146;s possession and not subject to any confidentiality or non-disclosure obligations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 5</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>ADDITIONAL COVENANTS; CLOSING CONDITIONS</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in' align=justify><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Books and Records</u>.&nbsp; Licensee will maintain documentation detailing Licensee&#146;s efforts to develop Licensed Products for commercial sale in the Fields in the Territory, and thereafter will maintain accurate records detailing all commercial sales of Licensed Products.&nbsp; Such documentation may include invoices for studies advancing development of Licensed Products, laboratory notebooks, internal job cost records, filings made to the Internal Revenue Service to obtain tax credit, if available, for research and development of Licensed Products, records relating to obtaining Regulatory Approval, and sales records of Licensee or Sublicensees.&nbsp; Such books and records will be preserved for a period not less than *** after they are created during and after the Term.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Financial Audit</u>. Upon reasonable notice and during regular business hours, Licensee will allow Licensor or its designee, at Licensor&#146;s sole expense, to review (and audit) all books and records, including financial records, and inspect Licensee&#146;s research and development facilities, in each case solely to verify the accuracy of Licensee&#146;s Development Reports and Product Reports and Licensee&#146;s compliance with its obligations, covenants and agreements under this Agreement; provided that Licensor will conduct such audit no more than ***, upon reasonable notice, in a manner that does not interrupt Licensee&#146;s operations, and not later than *** following the rendering of any such records pursuant to <u>Section 5.1</u>.&nbsp; Licensee shall also use commercially reasonable efforts to obtain a comparable right for Licensee to audit any Sublicensees, and, in the event Licensee obtains such right, shall perform a comparable audit of a Sublicensee and provide Licensor a summary of such audit upon Licensor&#146;s written request.&nbsp; Should any of the foregoing examinations reveal an underpayment, then Licensee shall immediately pay to Licensor the underpaid amount, plus interest in the amount provided for in <u>Section 3.6</u> (Payment Terms).&nbsp; Further, if such underpayment exceeds *** of the amount paid by Licensee to Licensor in the previous calendar year under this Agreement, then Licensee shall bear the reasonable out-of-pocket cost of such audit, including accountants&#146; and attorneys&#146; fees and expenses, and shall immediately reimburse Licensor for all such costs incurred by Licensor.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>15<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Product Reports</u>.&nbsp; Commencing in the Quarterly Period in which the First Commercial Sale occurs, within *** of the end of each Quarterly Period, Licensee shall deliver to Licensor a complete and accurate product report (each, a &#147;<b>Product Report</b>&#148;), giving such particulars of the business conducted by Licensee and Sublicensees during the preceding Quarterly Period under this Agreement as shall be pertinent to a royalty accounting hereunder.&nbsp; Without limiting the generality of the foregoing, the Product Reports shall be in substantially the form of <u>Exhibit B</u> attached hereto and include at least the following on a Licensed Product-by-Licensed Product basis:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>***</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Upon termination of this Agreement, Product Reports accompanied by any applicable Earned Royalties and Sublicense Fees shall continue to be due until a final Product Report is submitted, which shall be due within *** following the termination of this Agreement. All Product Reports shall be deemed Licensee&#146;s Confidential Information.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Compliance Certificate</u>. Together with each Product Report, Licensee shall deliver a duly executed compliance certificate from a Responsible Officer stating that (a) all such reports are true, accurate and correct in all material respects, (b) Licensee during such period has observed and performed all of the covenants and other agreements, and satisfied every condition contained in this Agreement to be observed, performed or satisfied by it, and that there has not occurred any Default except as specified in such certificate.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Affirmative and Negative Covenants</u>.&nbsp; During the Term, Licensee shall:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>not take any action, or omit to take any action, if in the reasonable judgment of Licensor such act or omission has had, or could reasonably be expected to have, </font><font style=FONT-SIZE:11pt>an </font><font style=FONT-SIZE:11pt>adverse impact upon or to the brand, name, goodwill or image of Licensor; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>not use, practice, commercialize or otherwise exploit the Licensed Technology outside the Fields, excluding Licensed Know-how that becomes generally known to the public or otherwise becomes publicly available, other than through a breach of this Agreement by Licensee;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>comply with all Laws applicable to the conduct of Licensee&#146;s business and activities related to developing, manufacturing, marketing, offering for sale, selling, importing and exporting Licensed Products. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Notices</u>.&nbsp; Licensee shall promptly give notice to Licensor of:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>the occurrence of the First Commercial Sale; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>the occurrence of any Default.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>5.7</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><font style=FONT-SIZE:11pt>Development Plan</font></u><font style=FONT-SIZE:11pt>.&nbsp; Licensee shall provide to Licensor a copy of a Development Plan after Completion (as defined in <u>Section 3.4</u>) of a Phase I Clinical Trial and prior to the </font><font style=FONT-SIZE:11pt>dosing of the first patient in a Phase II Clinical Trial</font><font style=FONT-SIZE:11pt>, which shall be attached hereto as Exhibit A, which Development Plan shall be deemed to be Licensee&#146;s Confidential Information. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>16<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 6</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>PATENT PROSECUTION; INFRINGEMENT</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Patent Prosecution</u>.&nbsp; Licensor shall have exclusive responsibility for the preparation, filing, prosecution, issuance and maintenance of the Licensed Patents,<b> </b>using counsel reasonably acceptable to Licensee<b>.&nbsp; </b>Licensor shall keep Licensee informed of patent prosecution, shall keep Licensee reasonably informed and copied on all correspondence, shall provide Licensee with copies of all prosecution documentation (including office actions and draft patent applications) reasonably in advance of applicable deadlines such that Licensee has a reasonable opportunity to review and comment, will consider Licensee&#146;s comments and suggestions prior to taking material actions for the same, and will take all prosecution actions reasonably recommended by Licensee that would expand the scope of rights sought.&nbsp; The parties shall reasonably cooperate with each other to insure that each Licensed Patent reflects and will reflect, to the extent practicable and to the best of Licensee&#146;s knowledge, all items of commercial interest to Licensee.&nbsp; Licensor shall notify Licensee at least *** prior to any deadline if it intends to abandon, or otherwise elect to forego its rights in, any Licensed Patents and Licensee shall have the right (but not the obligation) to assume control of the preparation, filing, prosecution, issuance and maintenance of such Licensed Patents in the name of Licensor and at Licensee&#146;s expense. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Patent Reimbursements</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.2.1&nbsp;&nbsp;&nbsp; Licensee shall reimburse Licensor for all Patenting Costs incurred by Licensor as of the Effective Date (the &#147;<b>Patent Reimbursement Amount</b>&#148;) in an amount equal to $***. Payment by Licensee of the Patent Reimbursement Amount shall be due ***.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.2.2&nbsp;&nbsp;&nbsp; Licensee will be responsible for the payment of all Patenting Costs incurred or to be incurred by Licensor after the Effective Date. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.2.3&nbsp;&nbsp;&nbsp; With respect to any action necessary to protect a particular Licensed Patent in a particular country in the Territory, if Licensee instructs Licensor in writing not to take such action, the rights protected by such Licensed Patent shall be excluded from the license granted herein and Licensee shall be relieved from its obligation to pay for future Patenting Costs relating to such Licensed Patent in such country.&nbsp; Thereafter, Licensor shall have the right to (i) abandon some or all of such rights at Licensor&#146;s sole discretion, or (ii) incur those costs at its own expense; in either case, Licensor shall be free to license such rights to third parties without any further obligation to Licensee. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>[Reserved]</u>&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Enforcement of Licensed Patents</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.4.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Notice</font></u><font style=FONT-SIZE:11pt>.&nbsp; If either party becomes aware of any infringement, anywhere in the Territory, of any issued patent within the Licensed Patents, such party will notify the other party of such infringement in writing as soon as reasonably practical thereafter (the &#147;<b>Infringement Notice</b>&#148;). </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>17<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.4.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Infringement of Licensed Patents by Third Parties</font></u><font style=FONT-SIZE:11pt>&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 1in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the case of any infringement within the Fields of any Licensed Patent by any third party during the Term, Licensee will have the first right, but not the obligation, at Licensee&#146;s expense, to cause such third party to cease infringement and to otherwise enforce such Licensed Patent, or to defend the Licensed Patent, or to defend the Licensed Patent in any declaratory judgment action brought by third parties that alleges the invalidity, unenforceability or non-infringement of the rights associated with the Licensed Patent in the Fields; <u>provided</u>, <u>however</u>, that Licensee will (i) use counsel reasonably acceptable to Licensor, (ii) keep Licensor reasonably informed regarding the progress of any litigation and settlement discussions with any alleged infringer, and (iii) copy Licensor on, or provide Licensor with copies of, all external documents and correspondence (i.e., documents and correspondence sent by Licensee to a third party or received by Licensee from a third party).&nbsp; Licensee will have control of the conduct of any such action that it brings, provided that Licensor will have the right to provide ongoing comments on documents prior to submission and advice regarding its position and interests in such action, which advice and comments will be considered in good faith by Licensee and incorporated or adopted by Licensee to the extent they are reasonable or support the validity, enforceability or scope of claims of a Licensed Patent, and (y) Licensee will not enter into any settlement, consent judgment or other voluntary disposition of any such action without the prior written consent of Licensor, which consent will not be unreasonably withheld, delayed or conditioned.&nbsp; For the purposes of this <u>Section 6.4.2</u> (and without limiting generality of the foregoing) it will be reasonable to Licensor to withhold consent to a settlement if the settlement would admit the invalidity or unenforceability of or limit in any way any patent owned by Licensor.&nbsp; Licensor will, at the request and expense of Licensee, provide reasonable cooperation and assistance in any action described in this <u>Section 6.4.2</u>.&nbsp; Except for providing such reasonable assistance, Licensor will have no obligation regarding the legal actions described herein; <u>provided</u>, <u>however</u>, that Licensor will join such action at Licensee&#146;s request and expense if such joinder is, in the opinion of Licensee&#146;s counsel, required to enable Licensee to initiate or continue such action.&nbsp; Licensor, however, will have the right to participate in any such action through its own counsel and, except as provided in this <u>Section 6.4.2(a)</u>, at its own expense.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If Licensee does not, within a reasonable period after becoming aware of such infringement but no less than *** from the date of the Infringement Notice, (i) initiate legal proceedings against such threatened or actual infringement, or defend legal proceedings brought by a third party, as provided in <u>Section 6.4.2(a)</u>, or (ii) cause such infringement to terminate, Licensor may thereafter take such action as it deems necessary to enforce its rights in the Licensed Patent, including the right, but not the obligation, to bring, at its own expense, an infringement action or file any other appropriate action or claim related to such infringement against any third party; <u>provided</u>, <u>however</u>, that Licensor shall have no obligation to bring any suit, action or other proceeding against any alleged infringer of any Licensed Patent.&nbsp;&nbsp; Licensee shall and hereby does irrevocably and unconditionally waive any objection to Licensor's joinder of Licensee to any proceeding described in <u>Section 6.4.2(a)</u> on any grounds whatsoever, including on the grounds of personal jurisdiction, venue or <i>forum non conveniens</i>. If Licensor brings or defends any such proceeding, Licensee shall reasonably cooperate in all respects with Licensor in the conduct thereof, and assist in all reasonable ways, including having its employees testify when requested and make available for discovery or trial exhibit relevant records, papers, information, samples, specimens, and the like at Licensee's own cost.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.4.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Infringement of Third Party Rights</font></u><font style=FONT-SIZE:11pt>.&nbsp; In the event that any action, suit or proceedings brought against, or written notice of threat thereof is provided to Licensee alleging infringement of any patent or unauthorized use or misappropriation of technology arising out of or in connection with Licensee&#146;s exercise to Licensed Patents, Licensee shall have the right to defend at its own expense such action, suit or proceeding.&nbsp; Licensee shall hold harmless and indemnify Licensor from and against any order to pay costs arising without fault of Licensor that may be made against Licensee or Licensor in such proceedings.&nbsp; Licensor agrees to cooperate with Licensee at Licensee&#146;s expense (excluding salaries, rent, utilities and other expenses typically treated as overhead) in connection with Licensee&#146;s response to or defense of such action, suit or proceeding, or notice of threat thereof. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>18<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.4.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Recovery</font></u><font style=FONT-SIZE:11pt>.&nbsp; If either party shall undertake the enforcement and/or defense of the Licensed Patents by litigation pursuant to <u>Sections 6.4.2</u> and <u>Section 6.4.3</u>, any recovery or damages (whether by way of settlement or otherwise) received as a result of any such suit shall be applied first in satisfaction of any unreimbursed expenses and legal fees of either party, and then the remainder (related to the Licensed Patents) shall be divided between the Parties as follows:&nbsp; ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>6.4.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>March-in Rights</font></u><font style=FONT-SIZE:11pt>.&nbsp; If any suit, action or other proceeding alleging invalidity or non-infringement of any Licensed Patent is brought against Licensee, Licensor, at its option, shall have the right, within *** after commencement of such suit, action or other proceeding, to intervene and take over the sole defense of the suit, action or other proceeding at its own expense.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Licensed Patent Challenges</u>. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event that Licensee directly or indirectly disputes, challenges, or assists in the challenge of the validity, scope, construction, enforceability or Licensor&#146;s ownership of any issued patent comprising the Licensed Patents or any claims thereof, or opposes or assists in the opposition of the grant of any Letters Patent comprising the Licensed Patents, either in a court of law, before the U.S. Patent and Trademark Office, or other agency or tribunal (&#147;<b>Licensed Patent Challenge</b>&#148;), then (i) Licensor has the right to immediately terminate this Agreement upon written notice to Licensee and with no opportunity for Licensee to cure, and (ii) Licensee shall pay all of Licensor&#146;s costs, fees and expenses associated with its defense of such challenge or opposition.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensee shall include provisions in all Sublicenses permitted under <u>Section 2.2</u> providing that if the Sublicensee brings or participates in a Licensed Patent Challenge, the Sublicense will immediately terminate effective as of the first date of the Sublicensee's first filing or participation in the Licensed Patent Challenge. The failure to include such automatic termination provision in a Sublicense hereunder shall constitute a material breach of this Agreement. If a Sublicensee undertakes a Licensed Patent Challenge, Licensee, shall immediately terminate the applicable Sublicense upon becoming aware of such Licensed Patent Challenge. Any failure to immediately terminate the Sublicense as required by this <u>Section 6.5(b)</u> shall constitute a material breach of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If Licensee directly or indirectly institutes or participates in a Licensed Patent Challenge and Licensor elects not to terminate this Agreement in accordance with <u>Section 6.5(a)</u>, then ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Patent Extensions</u>.&nbsp; Licensee and Licensor shall use reasonable efforts in its good faith determination to extend the Licensed Patents, which may include extensions provided under U.S. law at 35 U.S.C. &#167;154(b), 155A, and 156, provided that Licensee shall have final decision-making authority with respect to any patent term extension with respect to Licensed Products.&nbsp; Licensee hereby agrees to provide Licensor with all necessary assistance in securing such extensions, including without limitation, providing all information regarding applications for Regulatory Approval, approvals granted, and the timing of same.&nbsp; To the extent applicable, Licensee acknowledges that extensions under 35 U.S.C. &#167;156 must be applied for within *** of the date that a Licensed Product receives permission under the provision of law under which the applicable regulatory review period occurred for commercial marketing or use and that Licensee&#146;s failure to promptly provide the necessary information or assistance to Licensor during such *** period (with respect to a Licensed Patent for which Licensee has elected to pursue a patent term extension) will cause serious injury to Licensor, for which Licensee will be liable.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>19<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 7</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>TERM AND TERMINATION</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Contract Term</u>.&nbsp; This Agreement shall commence on the Effective Date and, unless terminated earlier in accordance with this <u>Article 7</u> or any other applicable provisions herein (including, without limitation, <u>Section 6.5</u>, <u>Section 7.2</u>, <u>Section 7.3</u><a name=_cp_text_1_14>, </a><u>Section 7.4</u><a name=_cp_text_1_15> or <u>Section 7.5</u></a>) shall continue until the later to occur of (i) the five (5)<b> </b>year anniversary of the expiration of the last to expire Valid Claim of the Licensed Patents or (ii) the ten (10) year anniversary of the First Commercial Sale in each jurisdiction. The period set forth in this <u>Section 7.1</u>, or such shorter periods as may result from the earlier termination of this Agreement in accordance with this Article 7 or any other provision of this Agreement, shall collectively be referred to as the &#147;<b>Term</b>&#148;. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Licensor Termination due to Licensee Insolvency</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensor shall have the right to immediately terminate this Agreement upon written notice if Licensee: </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>becomes subject, voluntarily or involuntarily, to any proceeding under any Debtor Relief Law, which is not fully stayed within *** or is not dismissed or vacated within *** after filing; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>is dissolved or liquidated; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>makes a general assignment for the benefit of creditors; or </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>has a receiver, trustee, custodian or similar agent appointed by order of any court of competent jurisdiction to take charge of or sell any material portion of its property or business.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><a name=_cp_text_1_16><font style=FONT-SIZE:11pt>7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Licensor Termination due to Breach of Contract Claim</u></font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in' align=justify><a name=_cp_text_1_18><a name=_cp_blt_1_17><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>L</font></a><font style=FONT-SIZE:11pt>icensor shall have the right to immediately terminate this Agreement upon written notice if Licensee claims that Licensor breached this Agreement through the exercise by Licensor or an academic, government, or not-for-profit institution of any of the retained rights provided in Section 2.4 of this Agreement to:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1.5in; TEXT-INDENT:-0.5in' align=justify><a name=_cp_text_1_20><a name=_cp_blt_1_19><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>perform r</font></a><font style=FONT-SIZE:11pt>esearch regarding the Licensed Technology;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><a name=_cp_text_1_22><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>publish any results of the research described in Section 7.3(a)(i), provided such publication is made in compliance with <u>Section 2.4.2</u>; or</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><a name=_cp_text_1_24><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>disclose any results of the research described in Section 7.3(a)(i) to any Governmental Authorities, provide such disclosure is made in compliance with <u>Section 2.4.2</u>.</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><a name=_cp_text_1_26><font style=FONT-SIZE:11pt>7.4</font></a><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Licensor Termination for Cause</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>In addition to any rights of Licensor to terminate this Agreement as provided elsewhere in this Agreement, Licensor shall have the right, in its sole discretion, to terminate this Agreement upon written notice to Licensee for any of the following events:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>20<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>if Licensee fails to pay any undisputed amount under this Agreement when due and such failure remains unremedied for a period of *** after written notice to Licensee from Licensor;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>if any representation, warranty, certification or other statement of fact made by or on behalf of Licensee herein, or in any certificate, document, report, financial statement or other document furnished by or on behalf of Licensee under or in connection with this Agreement or any other agreement between Licensee and Licensor, proves to have been false or misleading in any material respect on or as of the date made and remains unremedied for a period of *** after written notice to Licensee from Licensor;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>if Licensee fails to perform or observe any other material covenant, term, condition or agreement contained in this Agreement and, if such failure is curable, such failure continues unremedied for a period of *** after written notice to Licensee from Licensor</font>; or</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensee institutes a Licensed Patent Challenge as set forth in <u>Section 6.5(a)</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Notwithstanding the foregoing, if Licensee disputes the grounds for such termination in accordance with <u>Section <a name=_cp_text_1_28>7.4</a>(a)</u>, Licensee shall provide written notice of the dispute to Licensor, and Licensor&#146;s right to terminate this Agreement for cause in accordance with <u>Section <a name=_cp_text_1_30>7.4</a>(a)</u> shall be tolled, pending final resolution of such dispute pursuant to <u>Section 9.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Notwithstanding the foregoing, non-payment of the Issue Fee pursuant to <u>Section 3.1</u> or non-payment of the Patent Reimbursement Amount pursuant to <u>Section 6.2.1</u>, in each case within *** of the applicable payment date shall result in Licensor having the right to terminate this Agreement immediately upon written notice to Licensee.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Licensee Termination</u>. Licensee may, at its option, terminate this Agreement upon any material breach by Licensor under this Agreement, which Licensor fails to remedy within *** after notice thereof by Licensee.&nbsp; In addition, Licensee may terminate this Agreement at any time, for any business reason based on Licensee&#146;s reasonable business judgment, upon at least *** prior written notice to Licensor.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>7.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Disposition of Licensee Developments</u>.&nbsp; In the event of termination of this Agreement pursuant to <u>Section 7.2</u><a name=_cp_text_1_32>, </a><u>Section 7.3</u><a name=_cp_text_1_33>, or <u>Section 7.4</u></a>, Licensee shall ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>7.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Accrued Obligations</u>.&nbsp; Expiration or termination of the Agreement will not release either party from any obligation that matured prior to the effective date of such expiration or termination. Nothing herein shall be construed to release Licensee from any obligations (including, without limitation and by way of example only, obligations (a) in respect of Earned Royalties for sales of Licensed Products that occurred on or before the termination date and (b) to pay or reimburse Licensor for Patenting Costs that relate to any period before the termination date).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>7.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Effects of Termination</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.8.1&nbsp;&nbsp;&nbsp; <u>Termination of License</u>.&nbsp; Upon a termination of this Agreement in its entirety under <u>Section <a name=_cp_text_1_35>7.4</a></u> or <u>Section <a name=_cp_text_1_37>7.5</a></u>, Licensee&#146;s rights to the Licensed Technology granted hereunder and all use thereof will terminate and any and all rights in the Licensed Technology will revert back to Licensor.&nbsp; Upon Licensor&#146;s request and at Licensor&#146;s sole option, Licensee will destroy or return all copies, except for the copies to be retained by Licensee&#146;s legal counsel, of any media or materials that are the property of and previously received from Licensor, including all documentation, notes, plans, drawings, copies, samples and computer code. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>21<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.8.2&nbsp;&nbsp;&nbsp; <u>Effect on Sublicenses</u>.&nbsp; Any Sublicense granted by Licensee under this Agreement shall, subject to the prior written consent of Licensor (which consent shall not be unreasonably withheld, conditioned or delayed<a name=_cp_text_2_38> and which consent shall not be required if the applicable Sublicensee is a Sublicensee approved by Licensor in accordance with <u>Section 2.2</u> and is not then in breach of this Agreement</a>), survive termination of this Agreement, in which case such Sublicense shall be considered a direct license from Licensor to the applicable Sublicensee granting such Sublicensee a license to the Licensed Technology that was sublicensed to such Sublicensee in the sublicensed field, and such direct license will otherwise be on the terms and conditions of the Sublicense (to the extent applicable to the Licensed Technology); <u>provided</u>, <u>however</u>, that in the event of any inconsistencies between this Agreement and the Sublicense, this Agreement shall control.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.8.3&nbsp;&nbsp;&nbsp; ***. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.8.4&nbsp;&nbsp;&nbsp; <u>Survival</u>.&nbsp; Upon expiration or termination of this Agreement, <u>Section 2.5</u> (Regulatory Affairs), <u>Article 3</u> (Financial Consideration), <u>Section 5.1</u> (Books and Records), <u>Section 5.2</u> (Financial Audits), <u>Section 5.3</u> (Product Reports), <u>Section 6.2</u> (Patent Reimbursements), this <u>Article 7</u> (Term and Termination), <u>Article 8</u> (Confidential Information), <u>Article 9</u> (Governing Law; Dispute Resolution), <u>Article 10</u> (Indemnification and Insurance), <u>Section 11.3</u> (Disclaimers) and 11.4 (Exclusion of Consequential and Other Indirect Damages), <u>Article 12</u> (Notices), <u>Article 13</u> (Assignment) , <u>Article 14</u> (Use of Name) and <u>Article 23</u> (Miscellaneous Provisions) will, along with all defined terms used herein (whether defined in <u>Article 1</u> (Definitions) or elsewhere in this Agreement) and any right, obligation or required performance of the parties in this Agreement which, by its express terms or nature and context is intended to survive termination or expiration of this Agreement, survive and remain in full force and effect.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 8</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>CONFIDENTIALITY</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Confidentiality Obligations</u>.&nbsp; Each party (the &#147;<b>Receiving Party</b>&#148;) acknowledges that in connection with this Agreement it will gain access to Confidential Information of the other party (the &#147;<b>Disclosing Party</b>&#148;). As a condition to being provided with Confidential Information, the Receiving Party shall:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>not use the Disclosing Party's Confidential Information other than as necessary to exercise its rights and perform its obligations under this Agreement; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>maintain the Disclosing Party's Confidential Information in strict confidence and, subject to <u>Section 8.2</u>, not disclose the Disclosing Party's Confidential Information without the Disclosing Party's prior written consent, provided, however, the Receiving Party may disclose the Confidential Information to its Representatives who:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>have a need to know the Confidential Information for purposes of the Receiving Party's performance, or exercise of its rights concerning the Confidential Information, under this Agreement;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>have been apprised of this restriction; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>are themselves bound by written non-disclosure and non-use agreements at least as restrictive as those set forth in this <u>Section 8.1</u>, provided further that the Receiving Party shall be responsible for ensuring its Representatives' compliance with, and shall be liable for any breach by its Representatives of, this <u>Section 8.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>22<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>The Receiving Party shall use reasonable care, at least as protective as the efforts it uses for its own confidential information, to safeguard the Disclosing Party's Confidential Information from use or disclosure other than as permitted hereby.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name=a542105><u>Exceptions</u>. If the Receiving Party becomes legally compelled to disclose any Confidential Information, the Receiving Party shall:</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>provide prompt written notice to the Disclosing Party so that the Disclosing Party may seek a protective order or other appropriate remedy or waive its rights pursuant to <u>Article 12</u>; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>disclose only the portion of Confidential Information that it is legally required to furnish.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>If a protective order or other remedy is not obtained, or the Disclosing Party waives compliance in accordance with <u>Article 12</u> and <u>Article 21</u>, the Receiving Party shall, at the Disclosing Party's expense, use reasonable efforts to obtain assurance that confidential treatment will be afforded the Confidential Information.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Confidential Terms</u>. Notwithstanding anything to the contrary herein, the parties may disclose the terms and existence of this Agreement to potential or actual investors, acquirers, Sublicensees, collaboration partners, consultants, advisors and others on a reasonable need to know basis subject to customary confidentiality restrictions, or as required by securities or other applicable Laws.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 9</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>GOVERNING LAW; DISPUTE RESOLUTION</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Governing Law</u>.&nbsp; This Agreement and all related documents, and all matters arising out of or relating to this Agreement, are governed by, and construed in accordance with, the laws of the State of Ohio, United States of America, without regard to the conflict of laws&#146; provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than those of the State of Ohio.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in' align=justify><font style=FONT-SIZE:11pt>9.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Dispute Resolution</font></u><font style=FONT-SIZE:11pt>.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><a name=a999101><font style=FONT-SIZE:11pt>9.2.1&nbsp;&nbsp;&nbsp; <u>Exclusive Dispute Resolution Mechanism</u>. The parties shall resolve any dispute, controversy or claim arising out of or relating to this Agreement, or the breach, termination or invalidity hereof (each, a &#147;<b>Dispute</b>&#148;), under the provisions of this <u>Section 9.2</u>. The procedures set forth in this <u>Section 9.2</u> shall be the exclusive mechanism for resolving any Dispute that may arise from time to time</font></a><font style=FONT-SIZE:11pt>, subject to <u>Section 23.7</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>9.2.2&nbsp;&nbsp;&nbsp; <u>Good Faith Negotiations</u>. If a party believes that a Dispute exists, then such party (the &#147;<b>Declaring Party</b>&#148;) shall provide notice of such Dispute to the other party (the &#147;<b>Notice</b>&#148;), which Notice shall specify the nature and cause of the Dispute and the action that the Declaring Party deems necessary to resolve such Dispute.&nbsp; Following receipt of the Notice, the parties shall use good faith efforts to resolve the Dispute, including making personnel with appropriate decision-making authority available to the other party to discuss resolution of the Dispute.&nbsp; If a Dispute is not resolved within </font><font style=FONT-SIZE:11pt>*** of the date of the non-Declaring Party&#146;s receipt of the Notice, then the Dispute shall be submitted to mandatory, final and binding arbitration before the American Arbitration Association, in accordance with the then-current rules of the American Arbitration Association, as modified herein.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>23<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>9.2.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Arbitration</font></u><font style=FONT-SIZE:11pt>. The parties shall use a panel of three arbitrators.&nbsp; The Declaring Party shall select one arbitrator, and the other party shall select a second arbitrator, and the two arbitrators so selected shall select a third arbitrator.&nbsp; The three arbitrators shall hear the Dispute.&nbsp; Such arbitrators shall be knowledgeable in intellectual property law and related matters. The arbitrators shall make each determination in a manner that is consistent with this Agreement, including the parties&#146; intent as expressed herein.&nbsp; Without limiting the foregoing, the parties agree that the arbitrators are empowered to make determinations regarding the reasonableness of a party&#146;s acts or omissions.&nbsp; All decisions of the arbitrators shall be binding upon the parties.&nbsp; Each party shall be solely responsible for its own attorneys&#146; fees and expenses, legal expenses and witness fees and expenses.&nbsp; Any other usual and customary expenses incurred by the arbitrators or the expense of such arbitration proceeding shall be equally divided between the parties, irrespective of the outcome of such proceeding.&nbsp; The arbitration will be conducted in Cleveland, Ohio.&nbsp; The arbitrators are to apply the laws of the State of Ohio, without regard to its conflict of laws&#146; provisions.&nbsp; The parties agree that any award, order, or judgment pursuant to the arbitration is final and may be entered and enforced in any court of competent jurisdiction.&nbsp; The parties agree that all aspects of the dispute resolution process, including the arbitration, shall be conducted in confidence.&nbsp; The parties agree that all statements made in connection with informal dispute resolution efforts shall not be considered admissions or statements against interest by any party.&nbsp; The parties further agree that they will not attempt to introduce such statements at any later trial, arbitration or mediation between the parties.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Waiver of Jury Trial</u>.&nbsp; Each party irrevocably and unconditionally waives any right it may have to a trial by jury for any legal action arising out of or relating to this Agreement or the transactions contemplated hereby.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 10</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>INDEMNIFICATION AND INSURANCE</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>10.1&nbsp;&nbsp;&nbsp;&nbsp; <u>Indemnification</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>10.1.1&nbsp; <u>Licensee Indemnification</u>. Subject to <u>Section 10.1.3</u>, Licensee will indemnify, defend and hold harmless Licensor and its respective trustees, directors, officers, medical and professional staff, employees, students, and agents and their respective successors, heirs, and assigns (each a &#147;<b>Licensor Indemnitee</b>&#148;), against all Losses arising from any third party claim, suit, action or other proceeding (each, an &#147;<b>Action</b>&#148;) which may be made or instituted against any Licensor Indemnitee related to, arising out of or resulting from (a) Licensee's material breach of any representation, warranty, covenant or obligation under this Agreement, (b) use by Licensee or its Sublicensee or any of the foregoing Persons&#146; respective transferees of Licensed Technology, (c) any use, sale, transfer or other disposition by Licensee or its Sublicensee or any of the foregoing Persons' respective transferees of Licensed Products or any other products made by use of Licensed Technology, or (d) (i) Licensee&#146;s enforcement or defense of the Licensed Patents or (ii) prosecution actions in respect of the Licensed Patents, to the extent such prosecution actions were taken at the request of or under the direction or guidance of Licensee, except to the extent any such Action arises from any matter for which Licensor is obligated to provide indemnification pursuant to <u>Section 10.1.2</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>10.1.2&nbsp; <u>Licensor Indemnification</u>. Subject to <u>Section 10.1.3</u>, to the extent allowed under applicable Laws, Licensor will indemnify, defend and hold harmless Licensee and its respective directors, officers, employees, consultants, and agents and their respective successors, heirs, and assigns (each a &#147;<b>Licensee Indemnitee</b>&#148;), against all Losses arising from any Action which may be made or instituted against any Licensee Indemnitee related to, arising out of or resulting from (a) Licensor's material breach of any representation, warranty, covenant or obligation under this Agreement, or (b) a Licensor Indemnitee&#146;s negligence, willful misconduct, or breach of any applicable Law, except to the extent any such Action arises from any matter for which Licensee is obligated to provide indemnification pursuant to <u>Section 10.1.1</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>24<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>10.1.3&nbsp; <u>Indemnification Procedure</u>. An Indemnitee (whether a Licensor Indemnitee or a Licensee Indemnitee) that intends to claim indemnification under this <u>Section 10.1</u> will give notice to the indemnifying party of any Action which might be covered by this <u>Section 10.1</u>.&nbsp; The indemnifying party shall immediately take control of the defense and investigation of the Action, including selection of counsel reasonably acceptable to the Indemnitee, at the indemnifying party&#146;s sole cost and expense; <u>provided</u>, <u>however</u>, that the indemnifying party will not, without the prior written consent of the Indemnitee, settle or consent to the entry of any judgment with respect to such Action (a) that does not release the Indemnitee from all liability with respect to such Action, or (b) that may adversely affect the Indemnitee or under which the Indemnitee would incur any obligation or liability, other than one as to which the indemnifying party has an indemnity obligation hereunder.&nbsp; The Indemnitee agrees to cooperate and provide reasonable assistance to such defense at the indemnifying party&#146;s expense.&nbsp; The Indemnitee at all times reserves the right to select and retain counsel of its own at its own expense to defend its interests, provided that the indemnifying party will remain in control of the defense. The Indemnitee&#146;s failure to perform any obligations under this <u>Section 10.1.3</u> shall not relieve the indemnifying party of its obligation under <u>Section 10.1</u> except to the extent that the indemnifying party can demonstrate that it has been materially prejudiced as a result of the failure.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 21pt; TEXT-INDENT:-21pt' align=justify><font style=FONT-SIZE:11pt>10.2</font><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp; <u>Insurance</u>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><u></u>&nbsp;</p> <h4 style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>Prior to using, selling, transferring or otherwise disposing of any Licensed Product (including for the purpose of obtaining regulatory approvals), Licensee shall, at its sole cost and expense, obtain, pay for and maintain commercial general liability and professional liability (Errors and Omissions) insurance in commercially reasonable and appropriate amounts that provides product liability coverage concerning the Licensed Products , including without limitation coverage for human trials, and contractual liability coverage for Licensee's defense and indemnification obligations under this Agreement.&nbsp; To the extent any insurance coverage required under this <u>Section 10.2</u> is purchased on a "claims-made" basis, such insurance shall cover all prior acts of Licensee during the Term, and be continuously maintained until at least *** beyond the expiration or termination of the Term, or Licensee shall purchase "tail" coverage, effective upon termination of any such policy or upon termination or expiration of the Term, to provide coverage for at least *** from the occurrence of either such event.&nbsp; Promptly upon Licensor&#146;s request, Licensee will present evidence to Licensor that the coverage is being maintained.&nbsp; In addition, Licensee will provide Licensor with at least *** prior written notice of any material change in or cancellation of the insurance coverage.</h4> <h4 style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in' align=justify>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>Licensee shall insert this <u>Section 10.2</u> in any Sublicense, with the name of the Sublicensee substituted for the name of Licensee therein. </h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>10.3&nbsp;&nbsp;&nbsp;&nbsp; <u>Lapse of Coverage</u>. If Licensor elects to terminate this Agreement pursuant to (and subject to the cure period set forth in) <u>Section <a name=_cp_text_1_40>7.4</a></u> for any breach of <u>Section 10.2</u>, then such termination shall occur and become effective pursuant to <u>Section <a name=_cp_text_1_42>7.4</a></u>.&nbsp; Nothing herein shall be construed to release either party from any obligation that matured prior to the effective date of such termination.&nbsp; Notwithstanding the foregoing, in the *** period subsequent to the date of such a termination of this Agreement pursuant to <u>Section <a name=_cp_text_1_44>7.4</a></u>, to the extent that such rights are still available for licensing, Licensee shall have the right to reinstate the effectiveness of this Agreement by obtaining the required insurance, whereupon this Agreement shall automatically become effective as of the date of reinstatement of said insurance and shall remain in full force and effect without any further action of the parties.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>25<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 11</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>REPRESENTATIONS AND WARRANTIES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>11.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Representations and Warranties of Licensee</font></u><font style=FONT-SIZE:11pt>. Licensee represents and warrants to Licensor as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>to the Licensee&#146;s knowledge, Licensee has not received any notice or threat of any claim, suit, action or proceeding, and has no knowledge or reason to know of any information, that could: (i) invalidate or render unenforceable any claim of any Licensed Patent; (ii) prove that the Licensed Products are not covered by any claim of any Licensed Patent; or (iii) cause any claim of any Licensed Patent to fail to issue or be materially limited or restricted as compared with its currently pending scope;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>to the Licensee&#146;s knowledge, the execution and performance of Licensee&#146;s obligations under this Agreement does not conflict with, cause a default under, or violate any existing contractual obligation that may be owed by Licensee to any third party;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>all Licensed Products will be manufactured in all material respects in accordance with applicable Laws, including, without limitation, all applicable Laws of the FDA and any other applicable Regulatory Authority; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Licensee is a corporation duly organized, validly existing and in good standing under the laws of the state of its jurisdiction of organization;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>(e)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=FONT-SIZE:11pt>to the Licensee&#146;s knowledge, Licensee has all requisite corporate power and authority, and the legal right, to execute and deliver this Agreement and to perform its obligations hereunder; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(f)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>to the Licensee&#146;s knowledge, the execution and delivery of this Agreement by Licensee and the performance of its obligations hereunder have been duly authorized by all necessary corporate action in accordance with all applicable Laws. Licensee has duly executed and delivered this Agreement; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(g)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>this Agreement is a valid, legal and binding obligation of Licensee, enforceable against Licensee in accordance with its terms. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>11.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Representations and Warranties of Licensor</font></u><font style=FONT-SIZE:11pt>.&nbsp; Licensor represents and warrants to Licensee as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>to Licensor&#146;s knowledge, it is the exclusive owner of all rights, title and interests in the Licensed Patents and has the right, power and authority to grant Licensee the licenses in <u>Section 2.1</u></font><font style=FONT-SIZE:11pt> and it does not own any patents or patent applications other than the Licensed Patents the claims of which would dominate any practice of the Licensed Technology in the Fields</font><font style=FONT-SIZE:11pt>. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>to Licensor&#146;s knowledge, the execution and performance of Licensor&#146;s obligations under this Agreement do not conflict with, cause a default under, or violate any existing contractual obligation that may be owed by Licensor to any third party. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=FONT-SIZE:11pt>Licensor is a nonprofit corporation duly organized, validly existing and in good standing and has all requisite power and authority to execute and deliver, and perform its obligations under, this Agreement;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>26<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>to Licensor&#146;s knowledge, the execution and performance of Licensor&#146;s obligations under this Agreement do not conflict with, cause a default under, or violate any existing contractual obligation that may be owed by Licensor to any third party;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify>(e)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=FONT-SIZE:11pt>this Agreement is a valid, legal and binding obligation of Licensor, enforceable against Licensor in accordance with its terms; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(f)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>as of the Effective Date, to Licensor&#146;s knowledge, there is no infringement claim pending or threated in writing against Licensor related to any of the Licensed Patents. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>For purposes of this <u>Section 11.2</u>, &#147;knowledge&#148; means the actual knowledge of Vincent K. Tuohy and individuals employed by Licensor in the group known as &#147;Cleveland Clinic Innovations&#148; as of the Effective Date. For purposes of this Agreement, &#147;Cleveland Clinic Innovations&#148; means Tony Giordano and Greg Frykman.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in' align=justify><font style=FONT-SIZE:11pt>11.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Disclaimer of Representations and Warranties</font></u><font style=FONT-SIZE:11pt>.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Except as expressly provided herein, Licensee acknowledges and agrees that all rights licensed by Licensor hereunder are licensed &#147;as is&#148; and without any representation, indemnification or warranty with respect to possible infringement of third party rights.&nbsp; Except as expressly provided herein, nothing in this Agreement shall be construed as (i) a warranty or representation by Licensor as to the validity or scope of any Licensed Patents, (ii) a warranty or representation that anything made, used, imported, developed, promoted, offered for sale, sold, or otherwise disposed of under any license granted in this Agreement does not or will not infringe patents, trade secrets, copyrights or other intellectual or proprietary rights of third parties; (iii) a representation or warranty of operability or that development of a commercial products is possible; (iv) an obligation to bring or prosecute actions or suits against third parties for infringement; (v) conferring the right to use in advertising, publicity or otherwise any trademark, trade name, or names, or any contraction, abbreviation, simulation or adaptation thereof of Licensee or Licensor; (vi) conferring by implication, estoppel or otherwise any license or rights under any patents of Licensor other than the Licensed Patents; and (vii) any other representations or warranties, either express or implied, unless specified in this Agreement.&nbsp; Except as expressly provided herein, the furnishing of Confidential Information by either party shall not be interpreted to convey any grant of rights, titles, interests, options or licenses to the receiving party under any intellectual property rights owned or controlled by such party, other than the license under the Licensed Technology.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=justify><font style=FONT-SIZE:11pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>EXCEPT AS EXPRESSLY PROVIDED HEREIN, EACH PARTY EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, WHETHER WRITTEN, ORAL, EXPRESS, IMPLIED STATUTORY OR OTHERWISE, CONCERNING THE VALIDITY, ENFORCEABILITY AND SCOPE OF THE LICENSED PATENTS, THE ACCURACY, COMPLETENESS, SAFETY, USEFULNESS FOR ANY PURPOSE OR, LIKELIHOOD OF SUCCESS (COMMERCIAL, REGULATORY OR OTHER) OF THE LICENSED PRODUCTS, LICENSED KNOW-HOW AND ANY OTHER TECHNICAL INFORMATION, TECHNIQUES, MATERIALS, METHODS, PRODUCTS, PROCESSES OR PRACTICES AT ANY TIME MADE AVAILABLE BY LICENSOR INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY, QUALITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT AND WARRANTIES ARISING FROM A COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OR TRADE PRACTICE. WITHOUT LIMITATION TO THE FOREGOING, LICENSOR SHALL HAVE NO LIABILITY WHATSOEVER TO LICENSEE OR ANY OTHER PERSON FOR OR ON ACCOUNT OF ANY INJURY, LOSS, OR DAMAGE, OF ANY KIND OR NATURE, SUSTAINED BY, OR ANY DAMAGE ASSESSED OR ASSERTED AGAINST, OR ANY OTHER LIABILITY INCURRED BY OR IMPOSED ON LICENSEE OR ANY OTHER PERSON, ARISING OUT OF OR IN CONNECTION WITH OR RESULTING FROM: (X) THE MANUFACTURE, USE, OFFER FOR SALE, SALE, OR IMPORT OF A LICENSED PRODUCT, OR THE PRACTICE OF THE LICENSED PATENTS; (Y) THE USE OF OR ANY ERRORS OF OMISSIONS IN ANY KNOW-HOW, TECHNICAL INFORMATION, TECHNIQUES, OR PRACTICES DISCLOSED BY LICENSOR; OR (Z) ANY ADVERTISING OR OTHER PROMOTIONAL ACTIVITIES CONCERNING ANY OF THE FOREGOING. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>27<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=justify><font style=FONT-SIZE:11pt>11.4&nbsp;&nbsp;&nbsp;&nbsp; <u>Exclusion of Consequential and Other Indirect Damages</u>. EXCEPT FOR DAMAGES ARISING FROM A BREACH OF ARTICLE 8, FRAUD, WILLFUL MISCONDUCT, OR GROSS NEGLIGENCE, OR AS MAY BE PAYABLE PURSUANT TO A PARTY&#146;S INDEMNIFICATION OBLIGATIONS UNDER ARTICLE 10, IN NO EVENT WILL EITHER PARTY, OR THE LICENSOR INDEMNITEES OR THE LICENSEE INDEMNITEES, BE LIABLE TO THE OTHER PARTY FOR ANY INJURY TO OR LOSS OF GOODWILL, REPUTATION, BUSINESS, PRODUCTION, REVENUES, PROFITS, ANTICIPATED PROFITS, CONTRACTS OR OPPORTUNITIES (REGARDLESS OF HOW THESE ARE CLASSIFIED AS DAMAGES), OR FOR ANY CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY, SPECIAL, PUNITIVE OR ENHANCED DAMAGES WHETHER ARISING OUT OF BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, PRODUCT LIABILITY OR OTHERWISE (INCLUDING THE ENTRY INTO, PERFORMANCE OR BREACH OF THIS AGREEMENT), REGARDLESS OF WHETHER SUCH LOSS OR DAMAGE WAS FORESEEABLE OR THE PARTY AGAINST WHOM SUCH LIABILITY IS CLAIMED HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSS OR DAMAGE, AND NOTWITHSTANDING THE FAILURE OF ANY AGREED OR OTHER REMEDY OF ITS ESSENTIAL PURPOSE.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 12</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>NOTICES</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Any payment, notice or other communication to be given pursuant to the provisions of this Agreement shall be in writing </font><font style=FONT-SIZE:11pt lang=EN-GB>by means of a letter or electronic mail directed:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b><i>If to Licensor</i></b>:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>General correspondence to</i>:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Cleveland Clinic Foundation</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9500 Euclid Avenue, Mailstop GCIC10</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cleveland, OH&nbsp; 44195</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attn:&nbsp; CCF Innovations &#150; Executive Director<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: giordat@ccf.org</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>With a copy to: ccilicense@ccf.org</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>Payments to:</i></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><i><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></i><font style=FONT-SIZE:11pt>***</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>With copies to:</i></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><i><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></i><font style=FONT-SIZE:11pt>Law Department</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Cleveland Clinic Foundation</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3050 Science Park Drive, AC321</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beachwood, OH&nbsp; 44122</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attn:&nbsp; Chief Legal Counsel, CC Innovations</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: legalcontracts@ccf.org</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With a copy to: cicarej@ccf.org</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>28<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b><i>If to Licensee:</i></b></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><i><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:0.5in'><i><font style="FONT-SIZE:11pt; COLOR:black">General correspondence to:</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 1in'><font style="FONT-SIZE:11pt; COLOR:black">Anixa Biosciences, Inc.<br>3150 Almaden Expressway, Suite 250<br>San Jose, CA&nbsp; 95118<br></font><font style=FONT-SIZE:11pt lang=SV>Attn:</font><font style=FONT-SIZE:11pt>&nbsp; Amit Kumar, CEO<br>Email: ak@anixa.com</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt' align=justify><font style=FONT-SIZE:11pt>Notices sent in accordance with this <u>Section 12</u> shall be deemed effectively given: (a) when received, if sent by a nationally or internationally recognized courier (receipt requested); or (b) on the date sent by e-mail (with confirmation of transmission), if sent during normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 13</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>ASSIGNMENT</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>This Agreement will be binding upon and will inure to the benefit of each party and each party&#146;s respective transferees, successors and assigns.&nbsp; Notwithstanding the foregoing, Licensee may not transfer, delegate or assign this Agreement or any rights or obligations hereunder <a name=_cp_text_2_45>(for clarity, excluding the grant of Sublicenses approved by Licensor in accordance with <u>Section 2.2</u>) </a>without the prior written consent of Licensor (not to be unreasonably withheld, conditioned or delayed).&nbsp; For purposes of this <u>Article 13</u>, transfer or assignment that will require such prior written consent will include any express assignment, Change in Control of Licensee, or other transfer or assignment by operation of law<a name=_cp_text_2_46>; provided that such consent will not be required in the case of transfer or assignment in connection with a Change in Control </a>in which the successor entity is a Sublicensee approved by Licensor in accordance with <u>Section 2.2</u>. Upon written request, Licensee may obtain Licensor&#146;s prior written consent to the transfer or assignment of this Agreement to a particular entity in connection with a Change in Control in advance of the negotiation of such Change in Control.&nbsp; Any such request shall identify the potential successor entity(ies), but shall not be required to contain any terms or conditions of the potential Change in Control. &nbsp;Licensor shall respond to any such request within *** of receipt.&nbsp; Any failure by Licensor to respond to any such request within such period shall be deemed to constitute Licensor&#146;s prior written consent to the transfer or assignment of this Agreement to the entity(ies) identified in such request.&nbsp; In addition, any such consent given (or deemed to have been given) by Licensor shall remain in effect with respect to each potential successor entity for *** after the effective date of such consent and shall apply to the applicable entity(ies) identified in such request and any Affiliates thereof.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>29<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 14</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>USE OF NAME</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Licensee shall not use the name, logo, likeness, trademarks, or image of Licensor for advertising, marketing, endorsement or any other purposes without the specific prior written consent of an authorized representative of Licensor as to each such use.&nbsp; Licensee shall not make any public announcements, make any public statements, issue any press releases or otherwise communicate with any news media in respect of this Agreement or the transactions contemplated hereby without the specific prior written consent of an authorized representative of Licensor. &nbsp;Licensee shall not be required to attain consent under this Article 14 for use that is pursuant to applicable law or regulation, including Licensee&#146;s obligations under disclosure rules of the Securities and Exchange Commission (SEC).&nbsp;Licensor&#146;s specific prior written consent to one use shall apply only to other uses of substantially similar form and content (e.g. various iterations of investor presentations)&nbsp;but not to any other uses.&nbsp;Notwithstanding anything to the contrary contained herein, Licensor shall have the right to withdraw any consent previously provided (e.g., if Licensor has previously consented to Licensee&#146;s use of Licensor&#146;s name and logo on Licensee&#146;s website or in investor presentations).&nbsp; For clarity, this Article 14 shall not restrict Licensee (or its Affiliates or Sublicensees) from publicly disclosing information regarding the status of the development,<font size=+0>&nbsp;</font>or<font size=+0>&nbsp;</font>manufacture or commercialization of any Licensed Product, provided that any such disclosure does not use the name, logo, likeness, trademark or image of Licensor.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 15</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>EXPORT CONTROLS; REGULATORY CLEARANCE</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>15.1&nbsp;&nbsp;&nbsp;&nbsp; <u>Export Controls</u>. Neither Licensee nor any of its Sublicensees shall, directly or indirectly, export (including any "deemed export"), nor re-export (including any "deemed re-export") the Licensed Products (including any associated products, items, articles, computer software, media, services, technical data, and other information) in violation of any applicable U.S. Laws. Licensee and each Sublicensee shall include a provision identical in substance to this <u>Section 15.1</u> in its agreements with its Sublicensees, third party wholesalers, distributors, customers and end-users requiring that these Persons comply with all applicable U.S. Laws, including all applicable U.S. export Laws. For the purposes of this <u>Section 15.1</u>, the terms "deemed export" and "deemed re-export" have the meanings set forth in Section 734.2(b)(2)(ii) and Section 734.2(b)(4), respectively, of the Export Administration Regulations (EAR) (<i>15 CFR &#167;&#167; 734.2(b)(2)(ii) and 734.2(b)(4)</i>). </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>15.2&nbsp;&nbsp;&nbsp;&nbsp; <u>Regulatory Clearances</u>.&nbsp; Licensee shall, at Licensee's expense, comply with all regulations and safety standards concerning Licensed Products developed and commercialized by or under the authority of Licensee and obtain all necessary governmental approvals for the development, production, distribution, sale and use of Licensed Products developed and commercialized by or under the authority of Licensee, including any safety or clinical studies. Licensee shall have responsibility for and provide suitable warning labels, packaging and instructions as to the use for such Licensed Products.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 16</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>MARKING</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Licensee shall and shall require any Sublicensee to comply with any applicable patent marking provisions of 35 USC &#167; 287(a) by marking all Licensed Products with the word "patent" or the abbreviation "pat." and either the numbers of the relevant Licensed Patents or a web address that is freely accessible to the public and that associates the Licensed Products with the relevant Licensed Patents. Licensee shall include in all Sublicenses a patent marking requirement substantially identical to this Article 16. Licensee shall and shall require any Sublicensee to also comply with the patent marking laws of the relevant countries in the Territory.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 17</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>SEVERABILITY</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon a determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>30<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 18</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>ANTI-KICKBACK AND STARK LAW</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Licensee agrees to comply with all applicable Laws.&nbsp; Without limiting the foregoing, by entering into this Agreement, the Licensee will comply with all applicable laws, rules and regulations including (i) the federal anti-kickback statute (42 U.S.C.&nbsp; &#167;1320a-7b) and the related safe harbor regulations; and (ii) the Limitation on Certain Physician Referrals, also referred to as the &#147;Stark Law&#148; (42 U.S.C. 1395nn).&nbsp; Accordingly, no part of any consideration paid hereunder is a prohibited payment for the recommendation of or arranging for the referral of business or the ordering of items or services; nor are the payments intended to induce illegal referrals of business.&nbsp; In the event that any part of this Agreement is determined to violate federal, state, or local laws, rules or regulations, the Parties agree to negotiate in good faith revisions to the provision or provisions that are in violation.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 19</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>CONFLICT OF INTEREST</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Licensor maintains and adheres to a Conflict of Interest Policy.&nbsp; In that connection Licensee represents that no Licensor employees, officers, trustees or directors are consultants, employees, officers or directors or, to the best of Licensee&#146;s knowledge, owners of Licensee or any of its Affiliates or serve on any boards or committees of or in any advisory capacity with Licensee or any of its Affiliates, except as disclosed in <u>Exhibit D</u> attached hereto. Any payments made to such parties listed on <u>Exhibit D</u> are at fair market value for services rendered</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 20</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>HEADERS</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>The descriptive headings of this Agreement are for convenience only and will be of no force or effect in construing or interpreting any of the provisions of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 21</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>BENEFIT AND WAIVER</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>The failure of either party to comply with any obligation, covenant, agreement or condition under this Agreement may be waived by the party entitled to the benefit thereof only by a written instrument signed by the party on granting such waiver, but such waiver or failure to insist upon strict compliance with such obligation, covenant, agreement or condition will not operate as a waiver of, or estoppel with respect to, any subsequent or other failure.&nbsp; The failure of any party to enforce at any time any of the provisions of this Agreement will in no way be construed to be a waiver of any such provision, nor in any way to affect the validity of the Agreement or any part thereof or the right of any party thereafter to enforce each and every such provision.&nbsp; No waiver of any breach of such provisions will be held to be waiver of any other or subsequent breach.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>31<br></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>Article 22</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u><font style=FONT-SIZE:11pt>ENTIRE AGREEMENT</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>This Agreement (together with any exhibits, schedules or appendices attached hereto) constitutes the entire agreement between the Parties hereto with respect to the subject matter hereof and supersedes all previous or contemporaneous negotiations, commitments, and writings with respect to such subject matter.&nbsp; Neither party shall be obligated by any undertaking nor representation regarding the subject matter hereof other than those expressly stated herein or as may be subsequently agreed to by the parties hereto in writing.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>Article 23</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=justify><u><font style=FONT-SIZE:11pt>MISCELLANEOUS PROVISIONS</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Amendment</font></u><font style=FONT-SIZE:11pt>. No amendment, modification or supplement of any provision of this Agreement will be valid or effective unless made in writing and signed by a duly authorized officer of each party.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Further Assurances</font></u><font style=FONT-SIZE:11pt>. Each party shall, upon the request of the other party, promptly execute such documents and take such further actions as may be necessary to give full effect to the terms of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Debarment</font></u><font style=FONT-SIZE:11pt>. Licensee hereby represents and warrants that it has not been debarred, suspended, excluded or otherwise determined to be ineligible to participate in federal healthcare programs or federal procurement and non-procurement programs (collectively, &#147;<b>Debarred</b>&#148;) and Licensee agrees not to engage or assign any employee, agent or contractor (&#147;<b>Agent</b>&#148;) to perform services under this Agreement who has been Debarred.&nbsp; Licensee acknowledges that Licensor shall have the right to terminate this Agreement in accordance with <u>Section <a name=_cp_text_1_48>7.4</a></u> in the event that Licensee or an Agent is Debarred and not promptly removed.&nbsp; Accordingly, Licensee shall provide Licensor with immediate notice if during the Term of this Agreement Licensee (a) receives notice of action or threat of action with respect to its Debarment or (b) becomes Debarred.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Independent Contractors</font></u><font style=FONT-SIZE:11pt>. Both parties are independent contractors under this Agreement.&nbsp; Nothing contained in this Agreement will be deemed to create an employment, agency, joint venture or partnership relationship between the Parties hereto or any of their agents or employees, or any other legal arrangement that would impose liability upon one Party for the act or failure to act of the other Party.&nbsp; Neither Party will have any express or implied power to enter into any contracts or commitments or to incur any liabilities in the name of, or on behalf of, the other Party, or to bind the other Party in any respect whatsoever.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Tax Exempt Status</font></u><font style=FONT-SIZE:11pt>. The parties recognize that Licensor is a non-profit, tax-exempt organization and agree that this Agreement will take into account and be consistent with Licensor&#146;s tax-exempt status.&nbsp; If any part or all of this Agreement is determined to jeopardize the overall tax-exempt status of Licensor and/or any of its exempt Affiliates, the parties will negotiate in good faith an amendment of this Agreement </font><font style=FONT-SIZE:11pt>pursuant </font><font style=FONT-SIZE:11pt>to Article 17 so as to address such tax consideration while effecting the original intent of the parties as closely as possible in a mutually acceptable manner.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.6<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Waiver of Automatic Stay</font></u><font style=FONT-SIZE:11pt>. In the event Licensee is the subject of any voluntary or involuntary proceeding under the Bankruptcy Code, Licensee hereby unconditionally and irrevocably agrees that Licensor is immediately entitled, without notice, demand or any other action, to relief from the automatic stay so as to allow Licensor to enforce its rights and remedies under this Agreement, or at law and in equity under applicable state law. Licensee hereby consents to the immediate lifting, without notice, demand or any other action, of any such automatic stay and agrees that it shall not, in any manner, contest or otherwise delay any motion filed by Licensor for relief from the automatic stay. Licensor's enforcement of this stay waiver is subject to the approval of the bankruptcy court in which the case is then pending.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>32<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt>23.7<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Equitable Relief</font></u><font style=FONT-SIZE:11pt>.&nbsp; Each party acknowledges that a breach by the other party of this Agreement may cause the non-breaching party irreparable harm, for which an award of damages would not be adequate compensation and, in the event of such a breach or threatened breach, the non-breaching party shall be entitled to seek equitable relief, including in the form of a restraining order, orders for preliminary or permanent injunction, specific performance and any other relief that may be available from any court, and the parties hereby waive any requirement for the securing or posting of any bond or the showing of actual monetary damages in connection with such relief. These remedies shall not be deemed to be exclusive but shall be in addition to all other remedies available under this Agreement at law or in equity, subject to any express exclusions or limitations in this Agreement to the contrary.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=justify><font style=FONT-SIZE:11pt lang=EN-GB>23.8<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><u><font style=FONT-SIZE:11pt>Counterparts</font></u><font style=FONT-SIZE:11pt>. This Agreement may be executed in any number of counterparts, each of which need not contain the signature of more than one party but all such counterparts taken together will constitute one and the same agreement. </font><font style=FONT-SIZE:11pt lang=EN-GB>A signed copy of this Agreement delivered by e-mail to which a PDF copy is attached shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><i><font style=FONT-SIZE:11pt>[SIGNATURE PAGE FOLLOWS]</font></i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>33<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p><i><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font></i> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized representatives effective as of the Effective Date.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><b><font style=FONT-SIZE:11pt>The Cleveland Clinic Foundation</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><font style=FONT-SIZE:11pt>By&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/ Steven C. Glass</u>_______________</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><font style=FONT-SIZE:11pt>Name&nbsp;&nbsp; <u>Steven C. Glass</u>_________________</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><font style=FONT-SIZE:11pt>Title&nbsp;&nbsp;&nbsp;&nbsp; <u>Chief Financial Officer</u>___________</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><b><font style=FONT-SIZE:11pt>Anixa Biosciences, Inc.</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><font style=FONT-SIZE:11pt>By&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/ Michael J. Catelani</u>_____________</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><font style=FONT-SIZE:11pt>Name&nbsp;&nbsp; <u>Michael J. Catelani</u>________________</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'><font style=FONT-SIZE:11pt>Title&nbsp;&nbsp;&nbsp;&nbsp; <u>COO &amp; CFO</u>_____________________</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt>34<br></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p>  </div><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'></font> <div style=page:WordSection5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>Appendix A</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:11pt>LICENSED TECHNOLOGY</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u></u></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><i><u>Licensed Patents</u></i>:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><i><u><font style=FONT-SIZE:11pt>Licensed Know-how</font></u></i><font style=FONT-SIZE:11pt>:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>***</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Appendix A-</font><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>1</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></div><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font> <div style=page:WordSection6> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>Exhibit A</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:11pt>DEVELOPMENT PLAN</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><u></u>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>To be provided pursuant to <u>Section 5.7</u>.</font></p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>A-</font><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>1</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>Exhibit B</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:11pt>FORM OF ROYALTY REPORT</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u></u></b>&nbsp;</p> <div align=center> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-5.4pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Licensee/Sublicensee:</font></p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=137 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:103pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Agreement Effective Date:</font></p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Period Reported:</font></p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="HEIGHT:15pt; WIDTH:77.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:32.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=55 nowrap style="HEIGHT:15.75pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15.75pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15.75pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15.75pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15.75pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15.75pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15.75pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="HEIGHT:15.75pt; WIDTH:77.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:32.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15.75pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15.75pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15.75pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:61.5pt> <td width=55 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 2.25pt double; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Product name or Catalog number</font></b></p></td> <td width=121 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Description</font></b></p></td> <td width=60 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Activity Type (External Sales / Internal Sales)</font></b></p></td> <td width=55 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Country</font></b></p></td> <td width=87 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Sold to:</font></b></p></td> <td width=56 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Number of units sold</font></b></p></td> <td width=81 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Total Quarterly Gross Sales</font></b></p></td> <td width=103 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Less Allowable Deductions</font></b></p></td> <td width=44 colspan=2 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Net Sales</font></b></p></td> <td width=53 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:0.55in; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Royalty Rate</font></b></p></td> <td width=81 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.4pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Other Income (including Sublicensing Revenue)</font></b></p></td> <td width=76 style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:61.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:57.25pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Total Due</font></b></p></td></tr> <tr style=HEIGHT:19.5pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 2.25pt double; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(US, Canada, Japan, etc.)</font></p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:7pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(Note CCF Sales)</font></p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:0.55in; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:windowtext 2.25pt double; HEIGHT:19.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:40.95pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 2.25pt double; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:90.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:44.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:41.35pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:65.25pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:42.05pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.95pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:77.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:32.7pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:0.55in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.4pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:57.25pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.55in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 2.25pt double; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:0.55in; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:40.95pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 2.25pt double; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Total:</font></p></td> <td width=121 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:90.55pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Total:</font></p></td> <td width=60 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:44.9pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:41.35pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:65.25pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:42.05pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.95pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:77.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:32.7pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:0.55in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.4pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:57.25pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=55 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:40.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 2.25pt double; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:90.55pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:44.9pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:41.35pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:65.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:42.05pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.95pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:77.45pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:32.7pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:0.55in; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:60.4pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 2.25pt double; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=55 nowrap style="HEIGHT:16.5pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:16.5pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:16.5pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:16.5pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:16.5pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:16.5pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:16.5pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="HEIGHT:16.5pt; WIDTH:77.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="HEIGHT:16.5pt; WIDTH:32.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:16.5pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:16.5pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:16.5pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=55 nowrap style="HEIGHT:15.75pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15.75pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15.75pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15.75pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15.75pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15.75pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15.75pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=147 colspan=3 nowrap style="HEIGHT:15.75pt; WIDTH:110.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Total Royalties Due</font></b></p></td> <td width=53 nowrap style="HEIGHT:15.75pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15.75pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="HEIGHT:15pt; WIDTH:77.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:32.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=200 colspan=4 nowrap style="HEIGHT:15pt; WIDTH:149.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Prior Quarterly Payments:</font></p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=103 nowrap style="HEIGHT:15pt; WIDTH:77.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:32.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=119 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:89pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Minimum Annual</font></p></td> <td width=28 style="HEIGHT:15pt; WIDTH:21.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=119 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:89pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="HEIGHT:15pt; WIDTH:21.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:40.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=121 nowrap style="HEIGHT:15pt; WIDTH:90.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=60 nowrap style="HEIGHT:15pt; WIDTH:44.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=55 nowrap style="HEIGHT:15pt; WIDTH:41.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=87 nowrap style="HEIGHT:15pt; WIDTH:65.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=56 nowrap style="HEIGHT:15pt; WIDTH:42.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=119 colspan=2 nowrap style="HEIGHT:15pt; WIDTH:89pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Cumulative Net Sales:</font></p></td> <td width=28 style="HEIGHT:15pt; WIDTH:21.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=53 nowrap style="HEIGHT:15pt; WIDTH:0.55in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=81 nowrap style="HEIGHT:15pt; WIDTH:60.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=76 nowrap style="HEIGHT:15pt; WIDTH:57.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr>  <tr> <td width=56 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=128 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=61 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=57 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=87 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=56 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=81 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=103 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=15 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=28 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=54 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=83 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=76 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=></font> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>B-1</font></p></font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>Exhibit C</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:11pt>FORM OF DEVELOPMENT REPORT</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt' align=justify><u><font style=FONT-SIZE:11pt>Date development plan initiated and time period covered by this report.</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in' align=justify><u><font style=FONT-SIZE:11pt>Development Report.</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 40.5pt; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Activities completed since last report including the object and parameters of the development, when initiated, when completed, a summary of the data collected, and the results.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 40.5pt; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Activities currently under investigation, <i>i.e.</i>, ongoing activities including object and parameters of such activities when initiated, and projected date of completion.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in' align=justify><u><font style=FONT-SIZE:11pt>Future Development Activities.</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Activities to be undertaken before next report including the type and object of any studies conducted and their projected starting and completion dates.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Estimated total development time remaining before a product will be commercialized.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in' align=justify><u><font style=FONT-SIZE:11pt>Changes to initial Development Plan.</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Reasons for change.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Variables that may cause additional changes.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in' align=justify><u><font style=FONT-SIZE:11pt>Items&nbsp;to be provided if applicable:</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Information relating to Licensed Product that has become publicly available, <i>e.g.</i>, published Sections, competing products, patents, etc.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Development work being performed by third parties other than Licensee to include name of third party, reasons for use of third party, planned future uses of third parties including reasons why and type of work.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>Update of competitive information trends in industry, government compliance (if applicable) and market plan.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in' align=justify><font style="FONT-SIZE:11pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:11pt>*** estimate of Net Sales</font></p> <p align=center><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>C-</font><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>1</font></p></font> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:11pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Redactions with respect to certain portions hereof denoted with &#147;***&#148;</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></div><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'></font></b> <div style=page:WordSection8> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:11pt>Exhibit D</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:11pt>CONFLICT OF INTEREST</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>None.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p>  </div></body>
<!-- EDGAR Validation Code: 0533DE0E -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit10_2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<head><title>Exhibit 10.2</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=right><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>Exhibit 10.2</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=right>&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>AMENDMENT 1 TO THE COLLABORATION AGREEMENT</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>BETWEEN</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>CERTAINTY THERAPEUTICS, INC.</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>AND</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=center><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"'>H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple" align=center>&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Moffitt Agreement Identifier:&nbsp; Anixa-CERTainty Contract (Conejo-Garcia) 17-0173</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Project Title:&nbsp; Development of CAR-T/CER-T Therapies for Ovarian and Prostate Cancer</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>Moffitt Principle Investigator:&nbsp; Dr. Jose Conejo-Garcia</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>The Agreement described above was previously entered into on November 17, 2017 (hereinafter "Effective Date) by and between H. Lee Moffitt Cancer Center and Research Institute, Inc. a non-profit Florida corporation organized pursuant to Section 1004.43, Florida Statutes, whose address is 12902 Magnolia Drive, Tampa, Florida 33612 ("Moffitt") and Certainty Therapeutics, Inc., a corporation duly organized under the laws of Delaware whose address is 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (hereinafter "Company"). Moffitt and Company are hereinafter referred to individually as "Party" and collectively as "Parties."</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>WHEREAS, Moffitt requests an extension of the Agreement end date from November 17, 2019 to November 17, 2020; and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple"><font style=FONT-SIZE:12pt><font style='FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.1pt'>WHEREAS, </font><font style='FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>Company agrees to Moffitt&#146;s extended participation in the investigation set forth in the Research Plan attached as Exhibit B to the original Agreement; and</font></font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>WHEREAS, Moffitt and Company agree this amendment will continue to be governed by the Research Plan and milestone payment schedule defined in the original Agreement. </font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>WHEREAS, Moffitt and Company agree to this modification as set forth by procedures described in Section 13.9 of the original Agreement. &nbsp;</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.1pt'>NOW, THEREFORE, in consideration of the foregoing recitals, which are incorporated herein as covenants, and the mutual promises herein made and exchanged, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Company and Moffitt agree to the following modification:</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>ARTICLE 7&nbsp;&nbsp;&nbsp;&nbsp; Term and Termination.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt; TEXT-AUTOSPACE:; punctuation-wrap:simple"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This Agreement will commence as of the Effective Date set forth in the first paragraph of this Agreement and unless terminated otherwise as provided herein, this Agreement will expire thirty-six (36) months from such date, unless extended upon mutual written agreement of the Parties (&#147;Term&#148;).</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple">&nbsp;</p> <table width=739 bordercolor=transparent style="WIDTH:554pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=287 colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:215pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>CERTAINTY THERAPEUTICS, INC.</font></p></td> <td width=117 nowrap style="HEIGHT:15.75pt; WIDTH:88pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=335 colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:251pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>H. LEE MOFFITT CANCER CENTER<br>AND RESEARCH INSTITUTE, INC.</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=57 nowrap style="HEIGHT:15.75pt; WIDTH:43pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=229 nowrap style="HEIGHT:15.75pt; WIDTH:172pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=117 nowrap style="HEIGHT:15.75pt; WIDTH:88pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=64 nowrap style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=271 nowrap style="HEIGHT:15.75pt; WIDTH:203pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=57 nowrap style="HEIGHT:15.75pt; WIDTH:43pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>BY:</font></p></td> <td width=229 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:172pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>/s/ Amit Kumar</font></p></td> <td width=117 nowrap style="HEIGHT:15.75pt; WIDTH:88pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=64 nowrap style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>BY:</font></p></td> <td width=271 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:203pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>/s/ Margaret J. Fonner</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=57 nowrap style="HEIGHT:15.75pt; WIDTH:43pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Name:</font></p></td> <td width=229 nowrap style="HEIGHT:15.75pt; WIDTH:172pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Amit Kumar</font></p></td> <td width=117 nowrap style="HEIGHT:15.75pt; WIDTH:88pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=64 nowrap style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Name:</font></p></td> <td width=271 nowrap style="HEIGHT:15.75pt; WIDTH:203pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Margaret J. Fonner</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=57 nowrap style="HEIGHT:15.75pt; WIDTH:43pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Title:</font></p></td> <td width=229 nowrap style="HEIGHT:15.75pt; WIDTH:172pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Chief Executive Officer (CEO)</font></p></td> <td width=117 nowrap style="HEIGHT:15.75pt; WIDTH:88pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=64 nowrap style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Title:</font></p></td> <td width=271 nowrap style="HEIGHT:15.75pt; WIDTH:203pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Director, Office of Sponsored Research</font></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:Courier; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple">&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 9F9660DC -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<head><title>Exhibit 31.1</title> </head> <body lang=EN-US> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1' align=right><b><u><font style=FONT-SIZE:12pt>Exhibit 31.1</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1' align=center><u><font style=FONT-SIZE:12pt>CERTIFICATION</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'><font style=FONT-SIZE:12pt>I, Dr. Amit Kumar, certify that:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'><font style=FONT-SIZE:12pt>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this quarterly report on Form 10-Q of Anixa Biosciences, Inc.; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'><font style=FONT-SIZE:12pt>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'><font style=FONT-SIZE:12pt>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'><font style=FONT-SIZE:12pt>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style="FONT-SIZE:12pt; LAYOUT-GRID-MODE:line">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:12pt><font style="LAYOUT-GRID-MODE:line; COLOR:black">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D</font>esigned such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:12pt><font style="LAYOUT-GRID-MODE:line; COLOR:black">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style=LAYOUT-GRID-MODE:line>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></font></font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; PADDING-RIGHT:0px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:12pt><font style="LAYOUT-GRID-MODE:line; COLOR:black">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=LAYOUT-GRID-MODE:line>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</font></font></font></font></p> <p align=center><hr> <DIV style="PAGE-BREAK-BEFORE: always"> </DIV></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'><font style=FONT-SIZE:12pt>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:0px; page:WordSection1'><font style=FONT-SIZE:12pt>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:0px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:0px; page:WordSection1'><font style=FONT-SIZE:12pt>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <div style=page:WordSection1> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; /s/ Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; Chairman, President and </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; Chief Executive Officer </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>September 6, 2019</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp; (Principal Executive Officer)</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p></body>
<!-- EDGAR Validation Code: 71C79879 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<head><title>Exhibit 31.2</title> </head> <body lang=EN-US> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1' align=right><b><u>Exhibit 31.2</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1' align=center><u>CERTIFICATION</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>I, Michael J. Catelani, certify that:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this quarterly report on Form 10-Q of Anixa Biosciences, Inc.; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style=LAYOUT-GRID-MODE:line>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style="LAYOUT-GRID-MODE:line; COLOR:black">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D</font>esigned such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style="LAYOUT-GRID-MODE:line; COLOR:black">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=LAYOUT-GRID-MODE:line>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; TEXT-INDENT:-46px; page:WordSection1'><font style="LAYOUT-GRID-MODE:line; COLOR:black">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=LAYOUT-GRID-MODE:line>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</font></p> <p align=center><hr> <DIV style="PAGE-BREAK-BEFORE: always"> </DIV></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; page:WordSection1'>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 96px; TEXT-AUTOSPACE:; page:WordSection1'>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p> <div style=page:WordSection1> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>/s/ Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Chief Operating Officer and </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Chief Financial Officer</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(Principal Financial and</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>September 6, 2019</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Accounting Officer)</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection1'>&nbsp;</p></body>
<!-- EDGAR Validation Code: A0CCD96A -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<head> <title>Exhibit 32.1</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=right><b><u>Exhibit 32.1</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>Statement of Chief Executive Officer</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>Pursuant to Section 1350 of Title 18 of the United States Code</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, <font style=COLOR:black>Dr. Amit Kumar</font>, the Chairman, President and Chief Executive Officer of Anixa Biosciences, Inc., hereby certifies that:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <ol type=1 style="MARGIN-BOTTOM:0in; MARGIN-TOP:0in"> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>The Company's Form 10-Q Quarterly Report for the period ended July 31, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and </li></ol> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:'>&nbsp;</p> <ol type=1 style="MARGIN-BOTTOM:0in; MARGIN-TOP:0in" start=2> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </li></ol> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; /s/ Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; Chairman, President and </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp;&nbsp; Chief Executive Officer </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>September 6, 2019</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>&nbsp; (Principal Executive Officer)</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=LETTER-SPACING:-0.15pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<head> <title>Exhibit 32.2</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=right><b><u>Exhibit 32.2</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>Statement of Chief Financial Officer</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>Pursuant to Section 1350 of Title 18 of the United States Code</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Michael J. Catelani, the Chief Operating Officer and Chief Financial Officer of Anixa Biosciences, Inc., hereby certifies that:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <ol type=1 style="MARGIN-BOTTOM:0in; MARGIN-TOP:0in"> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>The Company's Form 10-Q Quarterly Report for the period ended July 31, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and </li></ol> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <ol type=1 style="MARGIN-BOTTOM:0in; MARGIN-TOP:0in" start=2> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </li></ol> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>/s/ Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LETTER-SPACING:-0.15pt'>Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Chief Operating Officer and</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Chief Financial Officer</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(Principal Financial and </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=40% nowrap style="HEIGHT:15pt; WIDTH:40%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>September 6, 2019</font></p></td> <td width=10% nowrap style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Accounting Officer)</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>anix-20190731.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Fri Sep 06 16:14:09 EDT 2019 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:anix="http://www.anixa.com/20190731" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:compsci="http://compsciresources.com" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="anix-20190731.xsd"/>
  <context id="c0_From1Nov2018To31Jul2019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c1_AsOf5Sep2019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2019-09-05</instant>
    </period>
  </context>
  <context id="c2_AsOf31Jul2019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c3_AsOf31Oct2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c4_AsOf31Jul2019_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c5_AsOf31Oct2018_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c6_AsOf31Jul2019_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c7_AsOf31Oct2018_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c8_From1May2019To31Jul2019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c9_From1May2018To31Jul2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c10_From1Nov2017To31Jul2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c11_From1May2019To31Jul2019_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c12_From1May2018To31Jul2018_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c13_From1Nov2018To31Jul2019_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c14_From1Nov2017To31Jul2018_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c15_From1May2019To31Jul2019_SellingGeneralAndAdministrativeExpensesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c16_From1May2018To31Jul2018_SellingGeneralAndAdministrativeExpensesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c17_From1Nov2018To31Jul2019_SellingGeneralAndAdministrativeExpensesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c18_From1Nov2017To31Jul2018_SellingGeneralAndAdministrativeExpensesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c19_AsOf31Oct2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c20_AsOf31Oct2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c21_AsOf31Oct2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c22_AsOf31Oct2018_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c23_AsOf31Oct2018_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c25_From1Nov2018To31Jul2019_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c26_From1Nov2018To31Jul2019_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c27_From1Nov2018To31Jul2019_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c28_From1Nov2018To31Jul2019_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c29_AsOf31Jul2019_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c30_AsOf31Jul2019_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c31_AsOf31Jul2019_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c32_AsOf31Jul2019_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c33_AsOf31Jul2019_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c34_AsOf30Apr2019_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-04-30</instant>
    </period>
  </context>
  <context id="c35_AsOf30Apr2019_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-04-30</instant>
    </period>
  </context>
  <context id="c36_AsOf30Apr2019_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-04-30</instant>
    </period>
  </context>
  <context id="c37_AsOf30Apr2019_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-04-30</instant>
    </period>
  </context>
  <context id="c38_AsOf30Apr2019_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-04-30</instant>
    </period>
  </context>
  <context id="c39_AsOf30Apr2019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2019-04-30</instant>
    </period>
  </context>
  <context id="c40_From1May2019To31Jul2019_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c41_From1May2019To31Jul2019_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c42_From1May2019To31Jul2019_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c43_From1May2019To31Jul2019_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c44_From1May2019To31Jul2019_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c45_AsOf31Oct2017_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c46_AsOf31Oct2017_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c47_AsOf31Oct2017_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c48_AsOf31Oct2017_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c49_AsOf31Oct2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c51_From1Nov2017To31Jul2018_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c52_From1Nov2017To31Jul2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c53_From1Nov2017To31Jul2018_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c54_From1Nov2017To31Jul2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c55_AsOf31Jul2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c56_AsOf31Jul2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c57_AsOf31Jul2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c58_AsOf31Jul2018_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c59_AsOf31Jul2018_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c60_AsOf31Jul2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c61_AsOf30Apr2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-04-30</instant>
    </period>
  </context>
  <context id="c62_AsOf30Apr2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-04-30</instant>
    </period>
  </context>
  <context id="c63_AsOf30Apr2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-04-30</instant>
    </period>
  </context>
  <context id="c64_AsOf30Apr2018_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-04-30</instant>
    </period>
  </context>
  <context id="c65_AsOf30Apr2018_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-04-30</instant>
    </period>
  </context>
  <context id="c66_AsOf30Apr2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2018-04-30</instant>
    </period>
  </context>
  <context id="c67_From1May2018To31Jul2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c68_From1May2018To31Jul2018_ParentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c69_From1May2018To31Jul2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c70_From1May2018To31Jul2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c71_From1May2018To31Jul2018_NoncontrollingInterestMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c72_From1Nov2018To31Jul2019_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c73_From1Nov2018To31Jul2019_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c74_From1Nov2017To31Jul2018_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c75_AsOf30Jan2019_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-01-30</instant>
    </period>
  </context>
  <context id="c76_AsOf31Jan2019_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-01-31</instant>
    </period>
  </context>
  <context id="c77_AsOf31Jul2019_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c78_From1Nov2018To31Jul2019_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c79_From1Nov2017To31Jul2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c80_From1May2019To31Jul2019_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c81_From1May2018To31Jul2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c82_From8May2018To8May2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-08</startDate>
      <endDate>2018-05-08</endDate>
    </period>
  </context>
  <context id="c83_From8May2018To8May2018_MinimumMember_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-08</startDate>
      <endDate>2018-05-08</endDate>
    </period>
  </context>
  <context id="c84_From8May2018To8May2018_MaximumMember_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-08</startDate>
      <endDate>2018-05-08</endDate>
    </period>
  </context>
  <context id="c85_From1Nov2018To31Jul2019_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c86_From1Nov2017To31Jul2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c87_From1May2019To31Jul2019_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c88_From1May2018To31Jul2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c89_From1Nov2018To31Jul2019_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c90_From1Nov2017To31Jul2018_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c91_From1May2019To31Jul2019_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c92_From1May2018To31Jul2018_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c93_From1Nov2018To31Jul2019_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanAnd2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c94_From1Nov2017To31Jul2018_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanAnd2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c95_From1Nov2017To31Jul2018_MinimumMember_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanAnd2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c96_From1Nov2017To31Jul2018_MaximumMember_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanAnd2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c97_From1Nov2018To31Jul2019_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanAnd2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c98_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanAnd2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c99_AsOf31Jul2019_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c100_AsOf31Jul2019_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c101_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c102_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c103_From1May2018To31Jul2018_EmployeeStockOptionMember_CommonStockMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c104_From1Nov2018To31Jul2019_EmployeeStockOptionMember_CommonStockMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c105_From8May2018To8May2018_RestrictedStockMember_A2018SharePlanMember_ChairmanPresidentAndChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ChairmanPresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-08</startDate>
      <endDate>2018-05-08</endDate>
    </period>
  </context>
  <context id="c106_From1Nov2018To31Jul2019_RestrictedStockMember_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c107_From1Nov2017To31Jul2018_RestrictedStockMember_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c108_From1May2019To31Jul2019_RestrictedStockMember_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c109_From1May2018To31Jul2018_RestrictedStockMember_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c110_From1May2018To31Jul2018_EmployeeStockPurchasePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c111_From1Nov2018To31Jul2019_EmployeeStockPurchasePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c112_AsOf31Jul2019_EmployeeStockPurchasePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c113_AsOf31Jul2019_WarrantMember_ConsultantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c114_From1Nov2018To31Jul2019_WarrantMember_ConsultantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c115_From1May2019To31Jul2019_WarrantMember_ConsultantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c116_AsOf31Jul2018_WarrantMember_ConsultantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c117_From1Nov2017To31Jul2018_WarrantMember_ConsultantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">anix:ConsultantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c118_AsOf31Jul2019_WarrantWithExercisePriceOf925Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">anix:WarrantWithExercisePriceOf925Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c119_AsOf31Jul2019_WarrantWithExercisePriceOf13875Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">anix:WarrantWithExercisePriceOf13875Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c120_From1Nov2018To31Jul2019_WarrantWithExercisePriceOf925Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">anix:WarrantWithExercisePriceOf925Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c121_From1Nov2018To31Jul2019_WarrantWithExercisePriceOf13875Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">anix:WarrantWithExercisePriceOf13875Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c122_AsOf31Jul2019_WarrantWithExercisePriceOf503Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">anix:WarrantWithExercisePriceOf503Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c123_From1Nov2018To31Jul2019_WarrantWithExercisePriceOf503Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">anix:WarrantWithExercisePriceOf503Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c124_From1Nov2018To31Jul2019_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c125_AsOf31Jul2019_A2003SharePlanMember_RangeOfExercisePrices067To1700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067To1700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c126_From1Nov2018To31Jul2019_A2003SharePlanMember_RangeOfExercisePrices067To1700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067To1700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c127_AsOf31Jul2018_A2003SharePlanMember_RangeOfExercisePrices067To1700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067To1700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c128_From1Nov2017To31Jul2018_A2003SharePlanMember_RangeOfExercisePrices067To1700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067To1700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c129_From1Nov2018To31Jul2019_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c130_AsOf31Oct2018_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c131_AsOf31Oct2017_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c132_From1Nov2017To31Jul2018_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c133_AsOf31Jul2018_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c134_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c135_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c136_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices227To301Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c137_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices227To301Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c138_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices346To575Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c139_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices346To575Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c140_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c141_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c142_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices227To301Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c143_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices227To301Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c144_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices346To700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c145_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices346To700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c146_From1Nov2018To31Jul2019_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c147_AsOf31Oct2018_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c148_AsOf31Oct2017_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c149_From1Nov2017To31Jul2018_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c150_AsOf31Jul2018_A2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c151_AsOf31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices370To461Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c152_From1Nov2018To31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices370To461Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c153_AsOf31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices370To384Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c154_From1Nov2017To31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:A2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices370To384Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c155_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c156_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c157_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c158_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c159_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c160_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c161_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c162_From1Nov2017To31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c163_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-07-31</instant>
    </period>
  </context>
  <context id="c164_From1Nov2017To31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">anix:StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">anix:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c165_AsOf31Jul2019_MoneyMarketFundsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFff3V94A/j32DU7427Jw8InVI47JA69IOx7V4lOXX/2m3HByT2wphuUafpSj5RBg+CV/W7y65PyzbhN3cS/eE3Ah61Tb0kL40rQIGzbvZnkSeW4cs+KHNoxbadqKVhfaprcl9NS0UUK/] CSR-->
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c166_AsOf31Jul2019_MoneyMarketFundsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c167_AsOf31Jul2019_MoneyMarketFundsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c168_AsOf31Jul2019_MoneyMarketFundsMember_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c169_AsOf31Jul2019_CertificatesOfDepositMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c170_AsOf31Jul2019_CertificatesOfDepositMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c171_AsOf31Jul2019_CertificatesOfDepositMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c172_AsOf31Jul2019_CertificatesOfDepositMember_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c173_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c174_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c175_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c176_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c177_AsOf31Jul2019_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c178_AsOf31Jul2019_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c179_AsOf31Jul2019_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c180_AsOf31Oct2018_MoneyMarketFundsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c181_AsOf31Oct2018_MoneyMarketFundsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c182_AsOf31Oct2018_MoneyMarketFundsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c183_AsOf31Oct2018_MoneyMarketFundsMember_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c184_AsOf31Oct2018_CertificatesOfDepositMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c185_AsOf31Oct2018_CertificatesOfDepositMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c186_AsOf31Oct2018_CertificatesOfDepositMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c187_AsOf31Oct2018_CertificatesOfDepositMember_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c188_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c189_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c190_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c191_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c192_AsOf31Oct2018_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c193_AsOf31Oct2018_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c194_AsOf31Oct2018_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c195_From1Nov2018To31Jul2019_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c196_From1May2019To31Jul2019_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c197_From1Nov2017To31Jul2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c198_From1May2018To31Jul2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c199_From1Nov2018To31Jul2019_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c200_From1May2019To31Jul2019_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c201_From1Nov2017To31Jul2018_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c202_From1May2018To31Jul2018_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c203_AsOf21Aug2019_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-08-21</instant>
    </period>
  </context>
  <context id="c204_From1Nov2018To31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c205_From1Nov2017To31Jul2018_OperatingSegmentsMember_CancerDiagnosticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c206_From1Nov2018To31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c207_From1Nov2017To31Jul2018_OperatingSegmentsMember_CancerTherapeuticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c208_From1Nov2018To31Jul2019_OperatingSegmentsMember_PatentLicensingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:PatentLicensingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-11-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c209_From1Nov2017To31Jul2018_OperatingSegmentsMember_PatentLicensingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:PatentLicensingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-11-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c210_From1May2019To31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c211_From1May2018To31Jul2018_OperatingSegmentsMember_CancerDiagnosticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c212_From1May2019To31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c213_From1May2018To31Jul2018_OperatingSegmentsMember_CancerTherapeuticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c214_From1May2019To31Jul2019_OperatingSegmentsMember_PatentLicensingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:PatentLicensingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-05-01</startDate>
      <endDate>2019-07-31</endDate>
    </period>
  </context>
  <context id="c215_From1May2018To31Jul2018_OperatingSegmentsMember_PatentLicensingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:PatentLicensingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-07-31</endDate>
    </period>
  </context>
  <context id="c216_AsOf31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c217_AsOf31Oct2018_OperatingSegmentsMember_CancerDiagnosticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c218_AsOf31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c219_AsOf31Oct2018_OperatingSegmentsMember_CancerTherapeuticsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:CancerTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="c220_AsOf31Jul2019_OperatingSegmentsMember_PatentLicensingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:PatentLicensingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-07-31</instant>
    </period>
  </context>
  <context id="c221_AsOf31Oct2018_OperatingSegmentsMember_PatentLicensingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">anix:PatentLicensingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <dei:DocumentType contextRef="c0_From1Nov2018To31Jul2019">10-Q</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="c0_From1Nov2018To31Jul2019">2019-07-31</dei:DocumentPeriodEndDate>
  <dei:EntityRegistrantName contextRef="c0_From1Nov2018To31Jul2019">Anixa Biosciences Inc</dei:EntityRegistrantName>
  <dei:EntityCurrentReportingStatus contextRef="c0_From1Nov2018To31Jul2019">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityInteractiveDataCurrent contextRef="c0_From1Nov2018To31Jul2019">Yes</dei:EntityInteractiveDataCurrent>
  <dei:EntityFilerCategory contextRef="c0_From1Nov2018To31Jul2019">Non-accelerated Filer</dei:EntityFilerCategory>
  <dei:EntitySmallBusiness contextRef="c0_From1Nov2018To31Jul2019">true</dei:EntitySmallBusiness>
  <dei:EntityEmergingGrowthCompany contextRef="c0_From1Nov2018To31Jul2019">false</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="c0_From1Nov2018To31Jul2019">false</dei:EntityExTransitionPeriod>
  <dei:EntityShellCompany contextRef="c0_From1Nov2018To31Jul2019">false</dei:EntityShellCompany>
  <dei:AmendmentFlag contextRef="c0_From1Nov2018To31Jul2019">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="c0_From1Nov2018To31Jul2019">--10-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="c0_From1Nov2018To31Jul2019">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="c0_From1Nov2018To31Jul2019">2019</dei:DocumentFiscalYearFocus>
  <dei:EntityCentralIndexKey contextRef="c0_From1Nov2018To31Jul2019">0000715446</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf5Sep2019" decimals="INF">20207261</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">4396853</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">3055890</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">2100000</us-gaap:ShortTermInvestments>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">2000000</us-gaap:ShortTermInvestments>
  <us-gaap:ReceivablesNetCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">1072</us-gaap:ReceivablesNetCurrent>
  <us-gaap:ReceivablesNetCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">306991</us-gaap:ReceivablesNetCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">129644</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">175491</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">6627569</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">5538372</us-gaap:AssetsCurrent>
  <anix:FiniteLivedPatentsNet unitRef="usd" contextRef="c2_AsOf31Jul2019" xs:nil="true"/>
  <anix:FiniteLivedPatentsNet unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">837500</anix:FiniteLivedPatentsNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">215137</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">72670</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">6842706</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">6448542</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">567778</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">582012</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">875771</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">683099</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">1443549</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">1265111</us-gaap:LiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c2_AsOf31Jul2019" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c3_AsOf31Oct2018" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c2_AsOf31Jul2019" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c3_AsOf31Oct2018" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c4_AsOf31Jul2019_PreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c5_AsOf31Oct2018_PreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c6_AsOf31Jul2019_SeriesAPreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c7_AsOf31Oct2018_SeriesAPreferredStockMember" xs:nil="true"/>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">201628</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">189086</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">185326706</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">175415931</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">-179729770</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">-170170209</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">5798564</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">5434808</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">-399407</us-gaap:MinorityInterest>
  <us-gaap:MinorityInterest unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">-251377</us-gaap:MinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">5399157</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">5183431</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">6842706</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">6448542</us-gaap:LiabilitiesAndStockholdersEquity>
  <anix:FiniteLivedPatentsImpairment unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">1001729</anix:FiniteLivedPatentsImpairment>
  <anix:FiniteLivedPatentsImpairment unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">582979</anix:FiniteLivedPatentsImpairment>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">2034382</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">1615632</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">86789</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">53799</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c4_AsOf31Jul2019_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c5_AsOf31Oct2018_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c4_AsOf31Jul2019_PreferredStockMember" decimals="INF">19860</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c5_AsOf31Oct2018_PreferredStockMember" decimals="INF">19860</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c4_AsOf31Jul2019_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c5_AsOf31Oct2018_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c4_AsOf31Jul2019_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c5_AsOf31Oct2018_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c6_AsOf31Jul2019_SeriesAPreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c7_AsOf31Oct2018_SeriesAPreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c6_AsOf31Jul2019_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c7_AsOf31Oct2018_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c6_AsOf31Jul2019_SeriesAPreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c7_AsOf31Oct2018_SeriesAPreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c6_AsOf31Jul2019_SeriesAPreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c7_AsOf31Oct2018_SeriesAPreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c2_AsOf31Jul2019" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c3_AsOf31Oct2018" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c2_AsOf31Jul2019" decimals="INF">48000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c3_AsOf31Oct2018" decimals="INF">48000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c2_AsOf31Jul2019" decimals="INF">20162851</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c3_AsOf31Oct2018" decimals="INF">18908632</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c2_AsOf31Jul2019" decimals="INF">20162851</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c3_AsOf31Oct2018" decimals="INF">18908632</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Revenues unitRef="usd" contextRef="c8_From1May2019To31Jul2019" xs:nil="true"/>
  <us-gaap:Revenues unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">362500</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">250000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">1112500</us-gaap:Revenues>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c8_From1May2019To31Jul2019" xs:nil="true"/>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">241157</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">166250</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">767180</us-gaap:RoyaltyExpense>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">41875</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">81324</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">418750</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">243972</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">1085574</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">2942071</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">4602239</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">4380137</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">1056963</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">2703752</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">4405385</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">4602555</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill unitRef="usd" contextRef="c8_From1May2019To31Jul2019" xs:nil="true"/>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill unitRef="usd" contextRef="c9_From1May2018To31Jul2018" xs:nil="true"/>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">418750</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" xs:nil="true"/>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">2184412</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">5968304</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">10011374</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">9993844</us-gaap:CostsAndExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">-2184412</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">-5605804</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-9761374</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-8881344</us-gaap:OperatingIncomeLoss>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">18364</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">12228</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">53783</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">29780</us-gaap:InvestmentIncomeInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">-2166048</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">-5593576</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-9707591</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-8851564</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1May2019To31Jul2019" xs:nil="true"/>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1May2018To31Jul2018" xs:nil="true"/>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" xs:nil="true"/>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" xs:nil="true"/>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">-2166048</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">-5593576</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-9707591</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-8851564</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">-26020</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">-116650</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-148030</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-158032</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">-2140028</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">-5476926</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-9559561</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-8693532</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c8_From1May2019To31Jul2019" decimals="2">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c9_From1May2018To31Jul2018" decimals="2">-0.30</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c0_From1Nov2018To31Jul2019" decimals="2">-0.49</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c10_From1Nov2017To31Jul2018" decimals="2">-0.50</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c8_From1May2019To31Jul2019" decimals="INF">20100915</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c9_From1May2018To31Jul2018" decimals="INF">18431025</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c0_From1Nov2018To31Jul2019" decimals="INF">19638833</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c10_From1Nov2017To31Jul2018" decimals="INF">17257546</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c11_From1May2019To31Jul2019_ResearchAndDevelopmentExpenseMember" decimals="0">338449</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c12_From1May2018To31Jul2018_ResearchAndDevelopmentExpenseMember" decimals="0">2472489</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c13_From1Nov2018To31Jul2019_ResearchAndDevelopmentExpenseMember" decimals="0">2567294</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c14_From1Nov2017To31Jul2018_ResearchAndDevelopmentExpenseMember" decimals="0">2668315</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c15_From1May2019To31Jul2019_SellingGeneralAndAdministrativeExpensesMember" decimals="0">492449</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c16_From1May2018To31Jul2018_SellingGeneralAndAdministrativeExpensesMember" decimals="0">2155844</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c17_From1Nov2018To31Jul2019_SellingGeneralAndAdministrativeExpensesMember" decimals="0">2335218</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c18_From1Nov2017To31Jul2018_SellingGeneralAndAdministrativeExpensesMember" decimals="0">2558701</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c19_AsOf31Oct2018_CommonStockMember" decimals="INF">18908632</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c19_AsOf31Oct2018_CommonStockMember" decimals="0">189086</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c20_AsOf31Oct2018_AdditionalPaidInCapitalMember" decimals="0">175415931</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c21_AsOf31Oct2018_RetainedEarningsMember" decimals="0">-170170209</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c22_AsOf31Oct2018_ParentMember" decimals="0">5434808</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c23_AsOf31Oct2018_NoncontrollingInterestMember" decimals="0">-251377</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">2808910</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">2808910</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">2808910</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">139161</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">139161</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">139161</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c26_From1Nov2018To31Jul2019_CommonStockMember" decimals="INF">40000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c26_From1Nov2018To31Jul2019_CommonStockMember" decimals="0">400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">102100</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">102500</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">102500</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">1954441</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">1954441</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">1954441</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans unitRef="shares" contextRef="c26_From1Nov2018To31Jul2019_CommonStockMember" decimals="INF">5411</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan unitRef="usd" contextRef="c26_From1Nov2018To31Jul2019_CommonStockMember" decimals="0">54</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan unitRef="usd" contextRef="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">18506</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">18560</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">18560</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <anix:StockIssuedDuringPeriodSharesAtTheMarketOffering unitRef="shares" contextRef="c26_From1Nov2018To31Jul2019_CommonStockMember" decimals="INF">1208808</anix:StockIssuedDuringPeriodSharesAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c26_From1Nov2018To31Jul2019_CommonStockMember" decimals="0">12088</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c24_From1Nov2018To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">4887657</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">4899745</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">4899745</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c27_From1Nov2018To31Jul2019_RetainedEarningsMember" decimals="0">-9559561</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c25_From1Nov2018To31Jul2019_ParentMember" decimals="0">-9559561</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c28_From1Nov2018To31Jul2019_NoncontrollingInterestMember" decimals="0">-148030</us-gaap:ProfitLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c29_AsOf31Jul2019_CommonStockMember" decimals="INF">20162851</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c29_AsOf31Jul2019_CommonStockMember" decimals="0">201628</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c30_AsOf31Jul2019_AdditionalPaidInCapitalMember" decimals="0">185326706</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c31_AsOf31Jul2019_RetainedEarningsMember" decimals="0">-179729770</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c32_AsOf31Jul2019_ParentMember" decimals="0">5798564</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c33_AsOf31Jul2019_NoncontrollingInterestMember" decimals="0">-399407</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c34_AsOf30Apr2019_CommonStockMember" decimals="INF">20005075</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c34_AsOf30Apr2019_CommonStockMember" decimals="0">200050</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c35_AsOf30Apr2019_AdditionalPaidInCapitalMember" decimals="0">183932744</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c36_AsOf30Apr2019_RetainedEarningsMember" decimals="0">-177589742</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c37_AsOf30Apr2019_ParentMember" decimals="0">6543052</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c38_AsOf30Apr2019_NoncontrollingInterestMember" decimals="0">-373387</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c39_AsOf30Apr2019" decimals="0">6169665</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c40_From1May2019To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">784246</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c41_From1May2019To31Jul2019_ParentMember" decimals="0">784246</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">784246</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c40_From1May2019To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">46652</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c41_From1May2019To31Jul2019_ParentMember" decimals="0">46652</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">46652</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c42_From1May2019To31Jul2019_CommonStockMember" decimals="INF">10000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c42_From1May2019To31Jul2019_CommonStockMember" decimals="0">100</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c40_From1May2019To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">22600</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c41_From1May2019To31Jul2019_ParentMember" decimals="0">22700</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">22700</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <anix:StockIssuedDuringPeriodSharesAtTheMarketOffering unitRef="shares" contextRef="c42_From1May2019To31Jul2019_CommonStockMember" decimals="INF">147776</anix:StockIssuedDuringPeriodSharesAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c42_From1May2019To31Jul2019_CommonStockMember" decimals="0">1478</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c40_From1May2019To31Jul2019_AdditionalPaidInCapitalMember" decimals="0">540464</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c41_From1May2019To31Jul2019_ParentMember" decimals="0">541942</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">541942</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c43_From1May2019To31Jul2019_RetainedEarningsMember" decimals="0">-2140028</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c41_From1May2019To31Jul2019_ParentMember" decimals="0">-2140028</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c44_From1May2019To31Jul2019_NoncontrollingInterestMember" decimals="0">-26020</us-gaap:ProfitLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c45_AsOf31Oct2017_CommonStockMember" decimals="INF">16602759</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c45_AsOf31Oct2017_CommonStockMember" decimals="0">166028</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c46_AsOf31Oct2017_AdditionalPaidInCapitalMember" decimals="0">163931079</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c47_AsOf31Oct2017_RetainedEarningsMember" decimals="0">-156174184</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c48_AsOf31Oct2017_ParentMember" decimals="0">7922923</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c49_AsOf31Oct2017" decimals="0">7922923</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">3598986</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">3598986</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">3598986</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">254090</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">254090</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">254090</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="INF">39816</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="0">398</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">-398</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross unitRef="shares" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="INF">1500000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">1358940</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">1373940</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">1373940</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="INF">5347</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="0">53</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">14949</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">15002</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">15002</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <anix:StockIssuedDuringPeriodSharesAtTheMarketOffering unitRef="shares" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="INF">548224</anix:StockIssuedDuringPeriodSharesAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c52_From1Nov2017To31Jul2018_CommonStockMember" decimals="0">5482</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">1780547</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">1786029</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">1786029</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance unitRef="usd" contextRef="c50_From1Nov2017To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">68974</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">68974</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance unitRef="usd" contextRef="c53_From1Nov2017To31Jul2018_NoncontrollingInterestMember" decimals="0">-4318</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">64656</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c54_From1Nov2017To31Jul2018_RetainedEarningsMember" decimals="0">-8693532</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c51_From1Nov2017To31Jul2018_ParentMember" decimals="0">-8693532</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c53_From1Nov2017To31Jul2018_NoncontrollingInterestMember" decimals="0">-158032</us-gaap:ProfitLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c55_AsOf31Jul2018_CommonStockMember" decimals="INF">18696146</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c55_AsOf31Jul2018_CommonStockMember" decimals="0">186961</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c56_AsOf31Jul2018_AdditionalPaidInCapitalMember" decimals="0">171007167</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c57_AsOf31Jul2018_RetainedEarningsMember" decimals="0">-164867716</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c58_AsOf31Jul2018_ParentMember" decimals="0">6326412</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c59_AsOf31Jul2018_NoncontrollingInterestMember" decimals="0">-162350</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c60_AsOf31Jul2018" decimals="0">6164062</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c61_AsOf30Apr2018_CommonStockMember" decimals="INF">16850445</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c61_AsOf30Apr2018_CommonStockMember" decimals="0">168504</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c62_AsOf30Apr2018_AdditionalPaidInCapitalMember" decimals="0">165288632</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c63_AsOf30Apr2018_RetainedEarningsMember" decimals="0">-159390790</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c64_AsOf30Apr2018_ParentMember" decimals="0">6066346</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c65_AsOf30Apr2018_NoncontrollingInterestMember" decimals="0">-45700</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="usd" contextRef="c66_AsOf30Apr2018" decimals="0">6020646</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c67_From1May2018To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">3126454</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c68_From1May2018To31Jul2018_ParentMember" decimals="0">3126454</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">3126454</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c67_From1May2018To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">127939</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c68_From1May2018To31Jul2018_ParentMember" decimals="0">127939</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">127939</anix:AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross unitRef="shares" contextRef="c69_From1May2018To31Jul2018_CommonStockMember" decimals="INF">1500000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c69_From1May2018To31Jul2018_CommonStockMember" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c67_From1May2018To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">1358940</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c68_From1May2018To31Jul2018_ParentMember" decimals="0">1373940</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">1373940</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <anix:StockIssuedDuringPeriodSharesAtTheMarketOffering unitRef="shares" contextRef="c69_From1May2018To31Jul2018_CommonStockMember" decimals="INF">345701</anix:StockIssuedDuringPeriodSharesAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c69_From1May2018To31Jul2018_CommonStockMember" decimals="0">3457</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c67_From1May2018To31Jul2018_AdditionalPaidInCapitalMember" decimals="0">1105202</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c68_From1May2018To31Jul2018_ParentMember" decimals="0">1108659</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <anix:StockIssuedDuringPeriodValueAtTheMarketOffering unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">1108659</anix:StockIssuedDuringPeriodValueAtTheMarketOffering>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c70_From1May2018To31Jul2018_RetainedEarningsMember" decimals="0">-5476926</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c68_From1May2018To31Jul2018_ParentMember" decimals="0">-5476926</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c71_From1May2018To31Jul2018_NoncontrollingInterestMember" decimals="0">-116650</us-gaap:ProfitLoss>
  <anix:CommonStockOfferingExpenses unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">264186</anix:CommonStockOfferingExpenses>
  <anix:CommonStockOfferingExpenses unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">111275</anix:CommonStockOfferingExpenses>
  <anix:CommonStockOfferingExpenses unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">141140</anix:CommonStockOfferingExpenses>
  <anix:CommonStockOfferingExpenses unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">58198</anix:CommonStockOfferingExpenses>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">2808910</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">3598986</us-gaap:StockOptionPlanExpense>
  <anix:StockOptionsAndWarrantsIssuedToConsultants unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">139161</anix:StockOptionsAndWarrantsIssuedToConsultants>
  <anix:StockOptionsAndWarrantsIssuedToConsultants unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">254090</anix:StockOptionsAndWarrantsIssuedToConsultants>
  <anix:StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">1954441</anix:StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan>
  <anix:StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">1373940</anix:StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan>
  <anix:IssuanceOfStockForServicesOrClaims unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" xs:nil="true"/>
  <anix:IssuanceOfStockForServicesOrClaims unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">15002</anix:IssuanceOfStockForServicesOrClaims>
  <us-gaap:Depreciation unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">32990</us-gaap:Depreciation>
  <us-gaap:Depreciation unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">12414</us-gaap:Depreciation>
  <anix:IssuanceOfNoncontrollingInterestExpensedAsALicenseFee unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" xs:nil="true"/>
  <anix:IssuanceOfNoncontrollingInterestExpensedAsALicenseFee unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">64656</anix:IssuanceOfNoncontrollingInterestExpensedAsALicenseFee>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-305919</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">40710</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-45847</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">163211</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-14234</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-60914</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">192672</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">300888</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-3404385</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-3252451</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquireShortTermInvestments unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">2350000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:PaymentsToAcquireShortTermInvestments unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">4000000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfShortTermInvestments unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">2250000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfShortTermInvestments unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">4750000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">175457</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">31853</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">-275457</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">718147</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">4899745</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">1786029</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromStockPlans unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">18560</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProceedsFromStockPlans unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" xs:nil="true"/>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">102500</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" xs:nil="true"/>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">5020805</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">1786029</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">1340963</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">-748275</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c49_AsOf31Oct2017" decimals="0">3339374</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c60_AsOf31Jul2018" decimals="0">2591099</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;a name=&quot;_DV_M76&quot;&gt;&lt;/a&gt;1.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;BUSINESS&amp;#xa0;AND&amp;#xa0;FUNDING&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 12pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;Description of Business &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;As used herein, &amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221; &amp;#8220;our,&amp;#8221; the &amp;#8220;Company&amp;#8221; or &amp;#8220;Anixa&amp;#8221; means Anixa Biosciences, Inc. and its consolidated subsidiaries.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Our primary operations involve research and development of cancer therapeutics and diagnostics.&amp;#xa0; Our cancer therapeutics programs consist of development of a vaccine against triple negative breast cancer (&amp;#8220;TNBC&amp;#8221;) and development of chimeric endocrine receptor T-cell (&amp;#8220;CER-T&amp;#8221;) technology, a novel form of CAR-T technology, initially focused on treating ovarian cancer. &amp;#xa0;Our cancer diagnostics program consists of development of the artificial intelligence (AI) driven Cchek&amp;#8482; liquid biopsy platform for early cancer detection.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;We hold an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by The Cleveland Clinic Foundation (&amp;#x201c;Cleveland Clinic&amp;#x201d;) related to certain breast cancer vaccine technology developed at Cleveland Clinic.&amp;#xa0; We are working in collaboration with Cleveland Clinic to develop a method to vaccinate women against contracting breast cancer, focused specifically on TNBC, the most lethal form of the disease.&amp;#xa0; A specific protein, alpha-lactalbumin, has been identified that is only present during lactation in healthy women, but reappears in many forms of breast cancer, especially TNBC. Animal studies have shown that vaccinating against this protein prevents breast cancer in mice.&amp;#xa0; We are working with researchers at Cleveland Clinic to advance this vaccine toward human clinical testing, and we anticipate filing an Investigational New Drug (&amp;#x201c;IND&amp;#x201d;) application with the U.S. Food and Drug Administration (&amp;#x201c;FDA&amp;#x201d;) by the end of the 2019 calendar year.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Our subsidiary, Certainty Therapeutics, Inc. (&amp;#8220;Certainty&amp;#8221;), is developing immuno-therapy drugs against cancer.&amp;#xa0; Certainty holds an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by The Wistar Institute (&amp;#8220;Wistar&amp;#8221;) relating to Wistar&amp;#8217;s CER-T technology.&amp;#xa0; We have initially focused on the development of a treatment for ovarian cancer, but we may also pursue applications of the technology for the development of treatments for additional solid tumors.&amp;#xa0; The license agreement requires Certainty to make certain cash and equity payments to Wistar.&amp;#xa0; With respect to Certainty&amp;#8217;s equity obligations to Wistar, Certainty issued to Wistar shares of its common stock equal to five percent (5%) of the common stock of Certainty.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certainty, in collaboration with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&amp;#x201c;Moffitt&amp;#x201d;), is advancing toward human clinical testing of its CER-T technology for treating ovarian cancer. Certainty is working with researchers at Moffitt to complete studies necessary to submit an IND application with the FDA.&amp;#xa0; We anticipate filing the IND with the FDA by the end of the 2019 calendar year, with human clinical trials commencing thereafter, in 2020. &amp;#xa0;The collaboration between Certainty and Moffitt was recently extended through November 2020, so the parties may continue research on Certainty&amp;#x2019;s CER-T technology.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Our subsidiary, Anixa Diagnostics Corporation (&amp;#8220;Anixa Diagnostics&amp;#8221;), is developing Cchek&amp;#8482;, an AI driven platform of non-invasive blood tests for the early detection of cancer which is based on the body&amp;#8217;s immune response to the presence of a malignancy.&amp;#xa0; We have demonstrated the efficacy of Cchek&amp;#8482; with 20 different types of cancer, including:&amp;#xa0; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, prostate, bladder, cervical, head and neck, gastric and testicular cancers.&amp;#xa0; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;We are currently developing tests for the detection of multiple types of cancer and are working with our development and commercialization partner, ResearchDx, a CLIA-certified laboratory, to launch Cchek&amp;#8482; Prostate Cancer Confirmation as a Laboratory Developed Test during the fourth calendar quarter of 2019.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Over the next several quarters, we expect the development of our breast cancer vaccine, Certainty&amp;#8217;s CER-T technology and Anixa Diagnostic&amp;#8217;s Cchek&amp;#8482; to be the primary focus of the Company.&amp;#xa0; As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&amp;#xa0; We do not expect these activities to be a significant part of the Company&amp;#8217;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &amp;#xa0;We have not generated any revenue to date from our cancer therapeutics and diagnostics programs. In addition, while we pursue our cancer therapeutics and diagnostics programs, we may also make investments in and form new companies to develop additional emerging technologies.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;Funding and Management&amp;#8217;s Plans&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; background: white; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;a name=&quot;_Hlk523132922&quot;&gt;&lt;/a&gt;&lt;a name=&quot;_Hlk2590843&quot;&gt;&lt;/a&gt;&lt;a name=&quot;_Hlk9517505&quot;&gt;&lt;/a&gt;&lt;font style=&quot;color: black;&quot;&gt;Based on currently available information as of September 5, 2019, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next twelve months.&amp;#xa0; &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;However, our projections of future cash needs and cash flows may differ from actual results.&amp;#xa0; &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies or new technology or technologies that are synergistic with or complementary to our technologies, we may be required to obtain more working capital.&amp;#xa0; During the nine months ended July 31, 2019, we raised approximately $4,900,000 through our at-the-market equity offering of 1,208,808 shares of common stock which is currently effective (we can sell an additional 267,302 shares under our current at-the-market equity program) and may remain available for us to use in the future.&amp;#xa0; Further, we have an additional at-the-market equity offering under which we may issue up to $50 million of common stock, which is currently effective and may remain available to us in the future.&amp;#xa0; We may seek to obtain working capital during our fiscal year 2019 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&amp;#xa0; W&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;e cannot be certain that additional funding will be available on acceptable terms, or at all.&amp;#xa0; If we do identify sources for additional funding, &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;the sale of additional equity securities or convertible debt could result in dilution to our stockholders.&amp;#xa0; Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities.&amp;#xa0; We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&amp;#xa0; &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&amp;#xa0; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X.&amp;#xa0; Accordingly, certain information and disclosures required by generally accepted accounting principles in annual financial statements have been omitted or condensed.&amp;#xa0; These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures included in our Annual Report on Form 10-K for the year ended October 31, 2018.&amp;#xa0; The accompanying October 31, 2018 consolidated balance sheet data was derived from the audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (&amp;#8220;US GAAP&amp;#8221;).&amp;#xa0; The condensed consolidated financial statements include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of our financial position as of July 31, 2019, and results of operations and cash flows for the interim periods represented.&amp;#xa0; The results of operations for the nine months ended July 31, 2019 are not necessarily indicative of the results to be expected for the entire year.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Noncontrolling Interest&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Noncontrolling interest represents Wistar&amp;#8217;s equity ownership in Certainty and is presented as a component of equity.&amp;#xa0; The following table sets forth the changes in noncontrolling interest for the nine months ended July 31, 2019:&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Balance at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(251,377)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:83%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Net loss attributable to noncontrolling interest&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(148,030)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Balance at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(399,407)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;_Hlk507773489&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Since fiscal 2016 our revenue has been derived solely from technology licensing and the sale of patented technologies.&amp;#xa0; Revenue is recognized upon transfer of control of intellectual property rights and satisfaction of other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive.&amp;#xa0; &lt;/font&gt;&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;On November 1, 2018 we adopted Accounting Standards Update 2014-09 (&amp;#8220;ASU 2014-09&amp;#8221;), Revenue from Contracts with Customers.&amp;#xa0; Upon adoption of ASU 2014-09 we are required to make certain judgments and estimates in connection with the accounting for revenue.&amp;#xa0; Such areas may include determining the existence of a contract and identifying each party&amp;#8217;s rights and obligations to transfer goods and services, identifying the performance obligations in the contract, determining the transaction price and allocating the transaction price to separate performance obligations, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services and evaluating whether a license transfers to a customer at a point in time or over time.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Our revenue arrangements provide for the payment of contractually determined, one-time, paid-up license fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&amp;#xa0;&amp;#xa0;These arrangements typically include some combination of the following:&amp;#xa0;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&amp;#xa0;&amp;#xa0;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&amp;#xa0;&amp;#xa0;&lt;a name=&quot;_Hlk9510034&quot;&gt;Pursuant to the terms of these agreements, we have no further obligations with respect to the granted intellectual property rights, including no obligation to maintain or upgrade the technology, or provide future support or services.&lt;/a&gt;&amp;#xa0; Licensees obtained control of the intellectual property rights they have acquired upon execution of the agreement.&amp;#xa0; As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is probable and all other revenue recognition criteria have been met.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cost of Revenues &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cost of revenues include the costs and expenses incurred in connection with our patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external counsel, other patent-related legal expenses paid to external counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.&amp;#xa0;&amp;#xa0;These costs are included under the caption &amp;#8220;Operating costs and expenses&amp;#8221; in the accompanying condensed consolidated statements of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;text-decoration: underline;&quot;&gt;Patents&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;Our only identifiable intangible assets are patents and patent rights related to our legacy patent licensing operations.&amp;#xa0; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&amp;#xa0; No patent acquisition costs were capitalized during the nine months ended July 31, 2019 and 2018. &amp;#xa0;We recorded patent amortization expense of approximately $419,000 and $244,000 during the nine-month periods ended July 31, 2019 and 2018, respectively.&amp;#xa0; In evaluating the carrying amount of capitalized patents at January 31, 2019, we determined that based on estimated undiscounted future cash flows a write-down of the carrying amount of approximately $419,000, to a carrying value of approximately $168,000, should be recorded as of January 31, 2019.&amp;#xa0; The carrying value of capitalized patents has been amortized to $-0- as of July 31, 2019. Our estimates of future cash flows were based on our most recent assessment of the market for potential licensees, as well as the status of ongoing negotiations with potential licensees. While we may be able to generate future cash flows from this patent portfolio, as of July 31, 2019, we cannot reasonably determine an estimate of any such future cash flows.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c2_AsOf31Jul2019" decimals="2">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">4900000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c0_From1Nov2018To31Jul2019" decimals="INF">1208808</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c0_From1Nov2018To31Jul2019" decimals="INF">267302</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c72_From1Nov2018To31Jul2019_MaximumMember" decimals="-6">50000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c73_From1Nov2018To31Jul2019_PatentsMember" decimals="0">419000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c74_From1Nov2017To31Jul2018_PatentsMember" decimals="0">244000</us-gaap:AmortizationOfIntangibleAssets>
  <anix:FiniteLivedPatentsNet unitRef="usd" contextRef="c75_AsOf30Jan2019_PatentsMember" decimals="0">419000</anix:FiniteLivedPatentsNet>
  <anix:FiniteLivedPatentsNet unitRef="usd" contextRef="c76_AsOf31Jan2019_PatentsMember" decimals="0">168000</anix:FiniteLivedPatentsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet unitRef="usd" contextRef="c77_AsOf31Jul2019_PatentsMember" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsNet>
  <anix:ScheduleOfChangesInNoncontrollingInterestTableTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Balance at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(251,377)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:83%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Net loss attributable to noncontrolling interest&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(148,030)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Balance at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(399,407)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</anix:ScheduleOfChangesInNoncontrollingInterestTableTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt;&quot;&gt;2.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;SUBSEQUENT EVENT&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;On August 21, 2019, the Company entered into a settlement agreement in connection with a putative shareholder derivative complaint filed in the Court of Chancery of the State of Delaware on November 5, 2018. See Note 9 to these condensed consolidation financial statements for additional information. Management reviewed for subsequent events through the date of filing of this Quarterly Report on Form 10-Q and noted no other items requiring disclosure.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt;&quot;&gt;3.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;STOCK BASED COMPENSATION AND WARRANTS&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The Company maintains stock equity incentive plans under which the Company grants incentive stock options, non-qualified stock options, stock appreciation rights, stock awards, performance awards, or stock units to employees, directors and consultants.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock Option Compensation Expense &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;The compensation cost for service-based stock options granted to employees and directors is measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, and is expensed on a straight-line basis over the requisite service period (the vesting period of the stock option).&amp;#xa0; &lt;/font&gt;We recorded stock-based compensation expense related to service-based stock options granted to employees and directors of approximately $2,433,000 and $1,153,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $784,000 and $702,000 during the three months ended July 31, 2019 and 2018, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;For stock options granted to employees and directors that vest based on market conditions, such as the trading price of the Company&amp;#x2019;s common stock exceeding certain price targets, we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&amp;#xa0; &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;On May 8, 2018, we issued market condition options to purchase 1,500,000 shares of common stock, &lt;/font&gt;to our Chairman, President and Chief Executive Officer, &lt;font style=&quot;color: black;&quot;&gt;vesting at target trading prices of $5.00 to $8.00 per share before May 31, 2021, with implied service periods of three to seven months.&amp;#xa0; In October 2018, the first tranche of 500,000 shares of market condition options became exercisable upon achieving an average closing price above $5.00 per share for twenty consecutive trading days.&amp;#xa0; &lt;/font&gt;We recorded stock-based compensation expense related to market condition stock options granted to employees of approximately $376,000 and $2,446,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $-0- and $2,446,000 during the three months ended July 31, 2019 and 2018, respectively. &amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;On November 1, 2018 we adopted Accounting Standards Update 2018-07 (&amp;#8220;ASU 2018-07&amp;#8221;) for stock options granted to consultants.&amp;#xa0; Upon adoption of ASU 2018-07 we estimated the fair value of unvested service-based and performance-based stock options at the date of adoption, using the Black-Scholes pricing model.&amp;#xa0; Subsequent to adoption of ASU 2018-07, future grants to consultants are measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, consistent with our policy for grants to employees and directors.&amp;#xa0; In prior periods, in accordance with US GAAP, we estimated the fair value of service-based and performance-based stock options granted to consultants at each reporting period using the Black-Scholes pricing model.&amp;#xa0; We recognize the fair value of stock options granted to consultants as consulting expense over the requisite or implied service period of the grant.&amp;#xa0; &lt;/font&gt;We recorded stock-based consulting expense related to stock options granted to consultants of approximately $75,000 and $197,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $25,000 and $49,000 during the three months ended July 31, 2019 and 2018, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock Option Activity &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;_Hlk507419595&quot;&gt;During the nine months ended July 31, 2019 and 2018, we granted options to purchase 10,000 shares and 3,897,000 shares of common stock, respectively, &amp;#xa0;to employees, directors and consultants, with exercise prices ranging from $2.30 to $3.84 per share, pursuant to the Anixa Biosciences, Inc. 2010 Share Incentive Plan (the &quot;2010 Share Plan&amp;#8221;) and the Anixa Biosciences, Inc. 2018 Share Plan (the &amp;#8220;2018 Share Plan&amp;#8221;)&lt;/a&gt;.&amp;#xa0; &amp;#xa0;&amp;#xa0;During the nine months ended July 31, 2019 and 2018, stock options to purchase 40,000 and 48,600 shares of common stock, respectively, were exercised with aggregate proceeds of approximately $103,000 and $-0-, respectively.&amp;#xa0; Under certain circumstances, stock options may be exercised on a cashless basis. &amp;#xa0;During the nine months ended July 31, 2019 and 2018, -0- and 8,784 shares of common stock, respectively, were withheld in connection with cashless exercises of stock options.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock&amp;#xa0;Option&amp;#xa0;Plans&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;As of July 31, 2019, we have three stock option plans:&amp;#xa0; the Anixa Biosciences, Inc. 2003 Share Incentive Plan (the &quot;2003 Share Plan&quot;), the 2010 Share Plan and the 2018 Share Plan, which were adopted by our Board of Directors on April 21, 2003, July 14, 2010 and January 25, 2018, respectively.&amp;#xa0; The 2018 Share Plan was approved by our shareholders on March 29, 2018.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;2003 Plan&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors and consultants.&amp;#xa0; In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the ability to grant future options on April 21, 2013. &amp;#xa0;Information regarding the 2003 Share Plan for the nine months ended July 31, 2019 is as follows:&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:45pt&quot;&gt; &lt;td style=&quot;HEIGHT:45pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 16%;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted &lt;br /&gt;Average Exercise Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate Intrinsic Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;12,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.63&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;23,694&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of July 31, 2019: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise &lt;br /&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 - $17.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;0.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Information regarding the 2003 Share Plan for the nine months ended July 31, 2018 is as follows:&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; rowspan=&quot;3&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate &lt;br /&gt;Intrinsic &lt;br /&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;30,600&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.16 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(10,600)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(8,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 7.04&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;12,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;13,054&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of July 31, 2018: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0; $ 0.67 - $17.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;12,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;.99&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;2010 Plan&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors and consultants.&amp;#xa0; As of July 31, 2019, the 2010 Share Plan had 889,200 shares available for future grants.&amp;#xa0; Information regarding the 2010 Share Plan for the nine months ended July 31, 2019 is as follows: &lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,131,868&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;10,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.64&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(32,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(99,200)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.78&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,010,668&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;5,422,886&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,639,556&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.92&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;4,609,165&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of July 31, 2019:&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;800&quot; style=&quot;WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining &lt;br /&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;938,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;799,388&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.27 -$ 3.01&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;600,134&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.81&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;600,134&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.81&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.46 -$ 5.75&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;472,534&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.51&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 4.05&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;240,034&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 4.43&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;_Hlk10191405&quot;&gt;Information regarding the 2010 Share Plan for the nine months ended July 31, 2018 is as follows: &lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,637,246&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.50&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;475,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.22&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(38,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(49,800)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,024,446&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.90&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;2,965,764&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,284,190&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;2,108,817&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;_Hlk10190711&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of July 31, 2018:&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;800&quot; style=&quot;WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining &lt;br /&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;943,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;653,142&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6.18&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.27 -$ 3.01&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;729,712&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.21&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;579,314&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.28&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.46 -$ 7.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;351,734&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.74&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;51,734&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1.46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 5.27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;i&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;2018 Plan&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The 2018 Share Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, performance awards &lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;and&lt;/font&gt; stock units to employees, directors and consultants.&amp;#xa0; As of July 31, 2019, the 2018 Share Plan had 2,008,000 shares available for future grants.&amp;#xa0; Information regarding options outstanding under the 2018 Share Plan for the nine months ended July 31, 2019 is as follows:&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,482,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(8,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;3,337,300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,321,111&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;1,273,443&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2019: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;831&quot; style=&quot;WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.70 -$ 4.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.78&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,321,111&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Information regarding the 2018 Share Plan for the nine months ended July 31, 2018 is as follows: &lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate &lt;br /&gt;Intrinsic&amp;#xa0; &lt;br /&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -0-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,422,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.71&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,422,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.71&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;-0-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;167,779&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;-0-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2018: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;831&quot; style=&quot;WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.70 -$ 3.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,422,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.71&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;167,779&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9.76&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;i&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Outside of Share Plans&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;In addition to options granted under the 2003 Share Plan, the 2010 Share Plan and the 2018 Share Plan, the Board of Directors approved the grant of stock options to purchase 1,780,000 shares to employees and directors outside of Share Plans.&amp;#xa0; Information regarding stock options outstanding that were granted outside of Share Plans for the nine months ended July 31, 2019 is as follows: &lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2019&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;5,583,900&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The following table summarizes information about stock options outstanding and exercisable that were granted outside of Share Plans as of July 31, 2019:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,046,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.05&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58-$ 5.56&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;734,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2.59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.88 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;Information regarding stock options outstanding that were granted outside of Share Plans for the nine months ended July 31, 2018 is as follows: &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2018&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;3,206,700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The following table summarizes information about stock options outstanding and exercisable that were granted outside of Share Plans as of July 31, 2018:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,046,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4.05&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58-$ 5.56&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;734,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:29.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.88&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Stock Awards &lt;a name=&quot;_DV_M176&quot;&gt;&lt;/a&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;_Hlk2789464&quot;&gt;For stock awards granted to employees, directors and consultants that vest upon grant we recognize expense at the date of grant based on the grant date market price of the underlying common stock.&amp;#xa0; During the nine months ended July 31, 2018, we issued 5,347 shares of common stock that vested upon grant to consultants for services rendered.&amp;#xa0; We recorded consulting expense for the shares of common stock issued to consultants of approximately $15,000 for the nine months ended July 31, 2018 and $-0- for the three months ended July 31, 2018.&amp;#xa0; We did not grant any stock awards that vested upon grant during the nine months ended July 31, 2019.&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;On May 8, 2018, a restricted stock award of 1,500,000 shares of common stock was granted under the 2018 Share Plan to our Chairman, President and Chief Executive Officer.&amp;#xa0; The restricted stock award vests in its entirety upon achievement of a target trading price of $11.00 per share of the Company&amp;#x2019;s common stock before May 31, 2021. &amp;#xa0;&amp;#xa0;&lt;font style=&quot;color: black;&quot;&gt;For restricted stock awards vesting &lt;/font&gt;upon achievement of &lt;font style=&quot;color: black;&quot;&gt;a price target of our common stock we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&amp;#xa0; &lt;/font&gt;We recorded stock-based compensation expense related to the restricted stock award of approximately $1,954,000 and $1,374,000 during the nine months ended July 31, 2019 and 2018, respectively, and $-0- and approximately $1,374,000 during the three months ended July 31, 2019 and 2018, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Employee Stock Purchase Plan&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The Company maintains the Anixa Biosciences, Inc. Employee Stock Purchase Plan which permits eligible employees to purchase shares at not less than 85% of the market value of the Company&amp;#8217;s common stock on the offering date or the purchase date of the applicable offering period, whichever is lower.&amp;#xa0; The plan was adopted by our Board of Directors on August 13, 2018 and approved by our shareholders on September 27, 2018.&amp;#xa0; During the nine months ended July 31, 2019, employees purchased 5,411 shares at a purchase price of $3.43 per share pursuant to the plan.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;During the nine months ended July 31, 2019 we issued a warrant, expiring on November 1, 2023, to purchase 25,000 shares of common stock at $4.04 per share, vesting over 12 months, to a consultant for investor relations services. &amp;#xa0;We recorded consulting expense of approximately $64,000 during the nine months ended July 31, 2019 and approximately $21,000 during the three months ended July 31, 2019, based on the fair value of the warrant recognized on a straight-line basis over the vesting period. &amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In July 2018 we issued a warrant exercisable at $3.65 per share vested upon grant to purchase 25,000 shares of common stock to a consultant for investor relations services.&amp;#xa0; We recorded consulting expense of approximately $57,000 during the three months ended July 31, 2018, based on the fair value of the warrant. &amp;#xa0;This warrant was exercised in October 2018.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:40.5pt&quot;&gt;As of July 31, 2019, we also had warrants outstanding to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019 and warrants to purchase 500,000 shares of common stock at $5.03 per share expiring on November 30, 2021.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c78_From1Nov2018To31Jul2019_EmployeeStockOptionMember" decimals="0">2433000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c79_From1Nov2017To31Jul2018_EmployeeStockOptionMember" decimals="0">1153000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c80_From1May2019To31Jul2019_EmployeeStockOptionMember" decimals="0">784000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c81_From1May2018To31Jul2018_EmployeeStockOptionMember" decimals="0">702000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod unitRef="shares" contextRef="c82_From8May2018To8May2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="INF">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c83_From8May2018To8May2018_MinimumMember_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="2">5.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c84_From8May2018To8May2018_MaximumMember_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="2">8.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c83_From8May2018To8May2018_MinimumMember_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">P3M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c84_From8May2018To8May2018_MaximumMember_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember">P7M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c82_From8May2018To8May2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c82_From8May2018To8May2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="2">5.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c85_From1Nov2018To31Jul2019_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="0">376000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c86_From1Nov2017To31Jul2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="0">2446000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c87_From1May2019To31Jul2019_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="0">0</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c88_From1May2018To31Jul2018_EmployeeStockOptionMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="0">2446000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c89_From1Nov2018To31Jul2019_EmployeeStockOptionMember_ConsultantMember" decimals="0">75000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c90_From1Nov2017To31Jul2018_EmployeeStockOptionMember_ConsultantMember" decimals="0">197000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c91_From1May2019To31Jul2019_EmployeeStockOptionMember_ConsultantMember" decimals="0">25000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c92_From1May2018To31Jul2018_EmployeeStockOptionMember_ConsultantMember" decimals="0">49000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c93_From1Nov2018To31Jul2019_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember" decimals="INF">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c94_From1Nov2017To31Jul2018_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember" decimals="INF">3897000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c95_From1Nov2017To31Jul2018_MinimumMember_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember" decimals="2">2.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c96_From1Nov2017To31Jul2018_MaximumMember_EmployeeStockOptionMember_A2010SharePlanAnd2018SharePlanMember" decimals="2">3.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c97_From1Nov2018To31Jul2019_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember" decimals="INF">40000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c98_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember" decimals="INF">48600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c97_From1Nov2018To31Jul2019_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember" decimals="0">103000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c98_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember" decimals="0">0</us-gaap:ProceedsFromStockOptionsExercised>
  <anix:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises unitRef="shares" contextRef="c97_From1Nov2018To31Jul2019_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember" decimals="INF">0</anix:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises>
  <anix:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises unitRef="shares" contextRef="c98_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_A2010SharePlanAnd2018SharePlanMember" decimals="INF">8784</anix:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="INF">889200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="INF">2008000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c101_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="INF">1780000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c102_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_ConsultantMember" decimals="INF">5347</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <anix:ConsultationExpense unitRef="usd" contextRef="c102_From1Nov2017To31Jul2018_EmployeeStockOptionMember_CommonStockMember_ConsultantMember" decimals="0">15000</anix:ConsultationExpense>
  <anix:ConsultationExpense unitRef="usd" contextRef="c103_From1May2018To31Jul2018_EmployeeStockOptionMember_CommonStockMember_ConsultantMember" decimals="0">0</anix:ConsultationExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c104_From1Nov2018To31Jul2019_EmployeeStockOptionMember_CommonStockMember_ConsultantMember" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c105_From8May2018To8May2018_RestrictedStockMember_A2018SharePlanMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="INF">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c105_From8May2018To8May2018_RestrictedStockMember_A2018SharePlanMember_ChairmanPresidentAndChiefExecutiveOfficerMember" decimals="2">11.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c106_From1Nov2018To31Jul2019_RestrictedStockMember_A2018SharePlanMember" decimals="0">1954000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c107_From1Nov2017To31Jul2018_RestrictedStockMember_A2018SharePlanMember" decimals="0">1374000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c108_From1May2019To31Jul2019_RestrictedStockMember_A2018SharePlanMember" decimals="0">0</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c109_From1May2018To31Jul2018_RestrictedStockMember_A2018SharePlanMember" decimals="0">1374000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent unitRef="pure" contextRef="c110_From1May2018To31Jul2018_EmployeeStockPurchasePlanMember" decimals="2">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward unitRef="shares" contextRef="c111_From1Nov2018To31Jul2019_EmployeeStockPurchasePlanMember" decimals="INF">5411</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased unitRef="usdPershares" contextRef="c112_AsOf31Jul2019_EmployeeStockPurchasePlanMember" decimals="2">3.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c113_AsOf31Jul2019_WarrantMember_ConsultantMember_CommonStockMember" decimals="INF">25000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c113_AsOf31Jul2019_WarrantMember_ConsultantMember_CommonStockMember" decimals="2">4.04</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c114_From1Nov2018To31Jul2019_WarrantMember_ConsultantMember_CommonStockMember">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <anix:ConsultationExpense unitRef="usd" contextRef="c114_From1Nov2018To31Jul2019_WarrantMember_ConsultantMember_CommonStockMember" decimals="0">64000</anix:ConsultationExpense>
  <anix:ConsultationExpense unitRef="usd" contextRef="c115_From1May2019To31Jul2019_WarrantMember_ConsultantMember_CommonStockMember" decimals="0">21000</anix:ConsultationExpense>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c116_AsOf31Jul2018_WarrantMember_ConsultantMember_CommonStockMember" decimals="2">3.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c116_AsOf31Jul2018_WarrantMember_ConsultantMember_CommonStockMember" decimals="INF">25000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <anix:ConsultationExpense unitRef="usd" contextRef="c117_From1Nov2017To31Jul2018_WarrantMember_ConsultantMember_CommonStockMember" decimals="0">57000</anix:ConsultationExpense>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c118_AsOf31Jul2019_WarrantWithExercisePriceOf925Member" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c119_AsOf31Jul2019_WarrantWithExercisePriceOf13875Member" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c118_AsOf31Jul2019_WarrantWithExercisePriceOf925Member" decimals="2">9.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c119_AsOf31Jul2019_WarrantWithExercisePriceOf13875Member" decimals="3">13.875</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <invest:InvestmentWarrantsExpirationDate contextRef="c120_From1Nov2018To31Jul2019_WarrantWithExercisePriceOf925Member">2019-08-19</invest:InvestmentWarrantsExpirationDate>
  <invest:InvestmentWarrantsExpirationDate contextRef="c121_From1Nov2018To31Jul2019_WarrantWithExercisePriceOf13875Member">2019-08-19</invest:InvestmentWarrantsExpirationDate>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c122_AsOf31Jul2019_WarrantWithExercisePriceOf503Member" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c122_AsOf31Jul2019_WarrantWithExercisePriceOf503Member" decimals="2">5.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <invest:InvestmentWarrantsExpirationDate contextRef="c123_From1Nov2018To31Jul2019_WarrantWithExercisePriceOf503Member">2021-11-30</invest:InvestmentWarrantsExpirationDate>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c124_From1Nov2018To31Jul2019_A2003SharePlanMember">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:45pt&quot;&gt; &lt;td style=&quot;HEIGHT:45pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 16%;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted &lt;br /&gt;Average Exercise Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate Intrinsic Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;12,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.63&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;23,694&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; rowspan=&quot;3&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate &lt;br /&gt;Intrinsic &lt;br /&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;30,600&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.16 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(10,600)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(8,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 7.04&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;12,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;13,054&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c3_AsOf31Oct2018" decimals="INF">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c3_AsOf31Oct2018" decimals="2">2.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c0_From1Nov2018To31Jul2019" decimals="INF">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_From1Nov2018To31Jul2019" decimals="2">3.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c2_AsOf31Jul2019" decimals="INF">8000</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c2_AsOf31Jul2019" decimals="2">2.34</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">23694</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c49_AsOf31Oct2017" decimals="INF">30600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c49_AsOf31Oct2017" decimals="2">3.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c10_From1Nov2017To31Jul2018" decimals="INF">10600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c10_From1Nov2017To31Jul2018" decimals="2">0.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c10_From1Nov2017To31Jul2018" decimals="INF">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c10_From1Nov2017To31Jul2018" decimals="2">7.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c60_AsOf31Jul2018" decimals="INF">12000</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c60_AsOf31Jul2018" decimals="2">2.77</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c60_AsOf31Jul2018" decimals="0">13054</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c124_From1Nov2018To31Jul2019_A2003SharePlanMember">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise &lt;br /&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 - $17.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;0.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0; $ 0.67 - $17.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;12,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;.99&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c125_AsOf31Jul2019_A2003SharePlanMember_RangeOfExercisePrices067To1700Member" decimals="INF">8000</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm contextRef="c126_From1Nov2018To31Jul2019_A2003SharePlanMember_RangeOfExercisePrices067To1700Member">P69D</anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c125_AsOf31Jul2019_A2003SharePlanMember_RangeOfExercisePrices067To1700Member" decimals="2">2.34</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c127_AsOf31Jul2018_A2003SharePlanMember_RangeOfExercisePrices067To1700Member" decimals="INF">12000</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm contextRef="c128_From1Nov2017To31Jul2018_A2003SharePlanMember_RangeOfExercisePrices067To1700Member">P361D</anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c127_AsOf31Jul2018_A2003SharePlanMember_RangeOfExercisePrices067To1700Member" decimals="2">2.77</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,131,868&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;10,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.64&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(32,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(99,200)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.78&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,010,668&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;5,422,886&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,639,556&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.92&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;4,609,165&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,637,246&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.50&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;475,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.22&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(38,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(49,800)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,024,446&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.90&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;2,965,764&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,284,190&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;2,108,817&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c130_AsOf31Oct2018_A2010SharePlanMember" decimals="INF">2131868</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c130_AsOf31Oct2018_A2010SharePlanMember" decimals="2">2.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember" decimals="INF">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember" decimals="2">3.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember" decimals="INF">32000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember" decimals="2">2.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember" decimals="INF">99200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember" decimals="2">3.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="INF">2010668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="2">2.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="0">5422886</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="INF">1639556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="2">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c99_AsOf31Jul2019_A2010SharePlanMember" decimals="0">4609165</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c131_AsOf31Oct2017_A2010SharePlanMember" decimals="INF">1637246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c131_AsOf31Oct2017_A2010SharePlanMember" decimals="2">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c132_From1Nov2017To31Jul2018_A2010SharePlanMember" decimals="INF">475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c132_From1Nov2017To31Jul2018_A2010SharePlanMember" decimals="2">3.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c132_From1Nov2017To31Jul2018_A2010SharePlanMember" decimals="INF">38000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c132_From1Nov2017To31Jul2018_A2010SharePlanMember" decimals="2">0.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c132_From1Nov2017To31Jul2018_A2010SharePlanMember" decimals="INF">49800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c132_From1Nov2017To31Jul2018_A2010SharePlanMember" decimals="2">2.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c133_AsOf31Jul2018_A2010SharePlanMember" decimals="INF">2024446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c133_AsOf31Jul2018_A2010SharePlanMember" decimals="2">1.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c133_AsOf31Jul2018_A2010SharePlanMember" decimals="0">2965764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c133_AsOf31Jul2018_A2010SharePlanMember" decimals="INF">1284190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c133_AsOf31Jul2018_A2010SharePlanMember" decimals="2">1.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c133_AsOf31Jul2018_A2010SharePlanMember" decimals="0">2108817</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c129_From1Nov2018To31Jul2019_A2010SharePlanMember">&lt;table width=&quot;800&quot; style=&quot;WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining &lt;br /&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;938,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;799,388&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.27 -$ 3.01&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;600,134&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.81&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;600,134&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.81&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.46 -$ 5.75&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;472,534&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.51&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 4.05&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;240,034&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 4.43&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;800&quot; style=&quot;WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining &lt;br /&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;943,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;653,142&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6.18&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.27 -$ 3.01&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;729,712&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.21&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;579,314&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5.28&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.46 -$ 7.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;351,734&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.74&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;51,734&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1.46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 5.27&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c134_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">938000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c135_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member">P5Y343D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c134_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c134_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">799388</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c135_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member">P5Y215D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c134_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c136_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="INF">600134</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c137_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member">P3Y295D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c136_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="2">2.58</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c136_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="INF">600134</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c137_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member">P3Y295D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c136_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="2">2.58</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c138_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member" decimals="INF">472534</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c139_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member">P8Y186D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c138_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member" decimals="2">4.05</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c138_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member" decimals="INF">240034</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c139_From1Nov2018To31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member">P8Y69D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c138_AsOf31Jul2019_A2010SharePlanMember_RangeOfExercisePrices346To575Member" decimals="2">4.43</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c140_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">943000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c141_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member">P6Y343D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c140_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c140_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">653142</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c141_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member">P6Y65D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c140_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c142_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="INF">729712</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c143_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member">P5Y76D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c142_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="2">2.61</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c142_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="INF">579314</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c143_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member">P5Y102D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c142_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices227To301Member" decimals="2">2.60</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c144_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member" decimals="INF">351734</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c145_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member">P8Y270D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c144_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member" decimals="2">3.73</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c144_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member" decimals="INF">51734</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c145_From1Nov2017To31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member">P1Y167D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c144_AsOf31Jul2018_A2010SharePlanMember_RangeOfExercisePrices346To700Member" decimals="2">5.27</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c146_From1Nov2018To31Jul2019_A2018SharePlanMember">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,482,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(8,000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;3,337,300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,321,111&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;1,273,443&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate &lt;br /&gt;Intrinsic&amp;#xa0; &lt;br /&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -0-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,422,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.71&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,422,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.71&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;-0-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options exercisable at July 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;167,779&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;-0-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c147_AsOf31Oct2018_A2018SharePlanMember" decimals="INF">3482000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="2">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c146_From1Nov2018To31Jul2019_A2018SharePlanMember" decimals="INF">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c146_From1Nov2018To31Jul2019_A2018SharePlanMember" decimals="2">3.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c146_From1Nov2018To31Jul2019_A2018SharePlanMember" decimals="INF">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c146_From1Nov2018To31Jul2019_A2018SharePlanMember" decimals="2">3.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="INF">3470000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="0">3337300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="INF">1321111</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="2">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c100_AsOf31Jul2019_A2018SharePlanMember" decimals="0">1273443</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c148_AsOf31Oct2017_A2018SharePlanMember" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c149_From1Nov2017To31Jul2018_A2018SharePlanMember" decimals="INF">3422000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c149_From1Nov2017To31Jul2018_A2018SharePlanMember" decimals="2">3.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c150_AsOf31Jul2018_A2018SharePlanMember" decimals="INF">3422000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c150_AsOf31Jul2018_A2018SharePlanMember" decimals="2">3.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c150_AsOf31Jul2018_A2018SharePlanMember" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c150_AsOf31Jul2018_A2018SharePlanMember" decimals="INF">167779</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c150_AsOf31Jul2018_A2018SharePlanMember" decimals="2">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c150_AsOf31Jul2018_A2018SharePlanMember" decimals="0">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c146_From1Nov2018To31Jul2019_A2018SharePlanMember">&lt;table width=&quot;831&quot; style=&quot;WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.70 -$ 4.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,470,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.78&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,321,111&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;8.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;831&quot; style=&quot;WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;6&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;6&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.70 -$ 3.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,422,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.71&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;167,779&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9.76&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 3.73&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c151_AsOf31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member" decimals="INF">3470000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c152_From1Nov2018To31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member">P8Y284D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c151_AsOf31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member" decimals="2">3.73</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c151_AsOf31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member" decimals="INF">1321111</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c152_From1Nov2018To31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member">P8Y281D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c151_AsOf31Jul2019_A2018SharePlanMember_RangeOfExercisePrices370To461Member" decimals="2">3.73</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c153_AsOf31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member" decimals="INF">3422000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c154_From1Nov2017To31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member">P9Y281D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c153_AsOf31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member" decimals="2">3.71</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c153_AsOf31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member" decimals="INF">167779</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c154_From1Nov2017To31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member">P9Y277D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c153_AsOf31Jul2018_A2018SharePlanMember_RangeOfExercisePrices370To384Member" decimals="2">3.73</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c101_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2019&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;5,583,900&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:17.25pt&quot;&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Options outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;July 31, 2018&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 1.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ &amp;#xa0;&amp;#xa0;&amp;#xa0;3,206,700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c155_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="INF">1780000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c155_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="2">1.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c155_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="INF">1780000</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c155_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="2">1.58</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c155_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="0">5583900</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c156_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="INF">1780000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c156_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="2">1.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c156_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="INF">1780000</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c156_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="2">1.58</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c156_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" decimals="0">3206700</anix:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c101_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,046,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.05&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58-$ 5.56&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;734,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2.59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.88 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Number&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;and&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; rowspan=&quot;5&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Average&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,046,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4.05&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 0.67&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.58-$ 5.56&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;734,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:29.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3.59&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$ 2.88&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c157_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">1046000</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm contextRef="c158_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member">P3Y18D</anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c157_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c159_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member" decimals="INF">734000</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm contextRef="c160_From1Nov2018To31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member">P2Y215D</anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c159_AsOf31Jul2019_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member" decimals="2">2.88</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c161_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">1046000</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm contextRef="c162_From1Nov2017To31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member">P4Y18D</anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c161_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c163_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member" decimals="INF">734000</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm contextRef="c164_From1Nov2017To31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member">P3Y215D</anix:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm>
  <anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c163_AsOf31Jul2018_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_RangeOfExercisePrices258To556Member" decimals="2">2.88</anix:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt;&quot;&gt;4.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;FAIR VALUE MEASUREMENTS&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;US GAAP defines fair value and establishes a framework for measuring fair value. &amp;#xa0;We have categorized our financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &amp;#xa0;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Financial assets and liabilities recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Level 1 - Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Level 2 - Financial assets and liabilities whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;Level 3 &amp;#8211; Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&amp;#8217;s own assumptions about the assumptions a market participant would use in pricing the asset and liabilities. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of July 31, 2019: &lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,370,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,370,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit &amp;#x2013;&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,100,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;2,100,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,370,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,850,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6,220,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;FIS_UNIDENTIFIED_TABLE_18&quot;&gt;&lt;/a&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2018:&lt;a name=&quot;FIS_UNIDENTIFIED_TABLE_19&quot;&gt;&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,031,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,031,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit &amp;#x2013;&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,000,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,000,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,031,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,750,000&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,781,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;&lt;a name=&quot;FIS_UNIDENTIFIED_TABLE_20&quot;&gt;&lt;/a&gt;Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&amp;#xa0; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&amp;#xa0; Cash and cash equivalents are stated at carrying value which approximates fair value.&amp;#xa0; &lt;a name=&quot;eolPage32&quot;&gt;&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,370,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,370,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit &amp;#x2013;&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,100,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;2,100,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,370,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,850,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6,220,661&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;&quot; width=&quot;733&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,031,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,031,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 31.5pt;&quot;&gt;
&lt;td style=&quot;height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit &amp;#x2013;&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,000,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,000,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,031,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,750,000&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,781,331&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c165_AsOf31Jul2019_MoneyMarketFundsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember" decimals="0">3370661</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c166_AsOf31Jul2019_MoneyMarketFundsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c167_AsOf31Jul2019_MoneyMarketFundsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c168_AsOf31Jul2019_MoneyMarketFundsMember_FairValueMeasurementsRecurringMember" decimals="0">3370661</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c169_AsOf31Jul2019_CertificatesOfDepositMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c170_AsOf31Jul2019_CertificatesOfDepositMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember" decimals="0">750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c171_AsOf31Jul2019_CertificatesOfDepositMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c172_AsOf31Jul2019_CertificatesOfDepositMember_FairValueMeasurementsRecurringMember" decimals="0">750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c173_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c174_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember" decimals="0">2100000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c175_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c176_AsOf31Jul2019_ShortTermInvestmentsMember_FairValueMeasurementsRecurringMember" decimals="0">2100000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c177_AsOf31Jul2019_FairValueInputsLevel1Member" decimals="0">3370661</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c178_AsOf31Jul2019_FairValueInputsLevel2Member" decimals="0">2850000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c179_AsOf31Jul2019_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">6220661</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c180_AsOf31Oct2018_MoneyMarketFundsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember" decimals="0">2031331</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c181_AsOf31Oct2018_MoneyMarketFundsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c182_AsOf31Oct2018_MoneyMarketFundsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c183_AsOf31Oct2018_MoneyMarketFundsMember_FairValueMeasurementsRecurringMember" decimals="0">2031331</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c184_AsOf31Oct2018_CertificatesOfDepositMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c185_AsOf31Oct2018_CertificatesOfDepositMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember" decimals="0">750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c186_AsOf31Oct2018_CertificatesOfDepositMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c187_AsOf31Oct2018_CertificatesOfDepositMember_FairValueMeasurementsRecurringMember" decimals="0">750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c188_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueInputsLevel1Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c189_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueInputsLevel2Member_FairValueMeasurementsRecurringMember" decimals="0">2000000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c190_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueInputsLevel3Member_FairValueMeasurementsRecurringMember" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c191_AsOf31Oct2018_ShortTermInvestmentsMember_FairValueMeasurementsRecurringMember" decimals="0">2000000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c192_AsOf31Oct2018_FairValueInputsLevel1Member" decimals="0">2031331</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c193_AsOf31Oct2018_FairValueInputsLevel2Member" decimals="0">2750000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c194_AsOf31Oct2018_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">4781331</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in -0.15in 12pt 0in; text-autospace: ideograph-numeric;&quot;&gt;5.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;ACCRUED EXPENSES&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;Accrued expenses consist of the following as of:&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31, &lt;br /&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;October 31, &lt;br /&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;64,627 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;62,965 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accrued royalty and contingent legal fees&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;449,691&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;366,670 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accrued collaborative research and license expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;351,994&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;187,500 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accrued other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9,459&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;65,964 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;875,771&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;683,099 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;table width=&quot;733&quot; style=&quot;WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31, &lt;br /&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;October 31, &lt;br /&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;64,627 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;62,965 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accrued royalty and contingent legal fees&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;449,691&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;366,670 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accrued collaborative research and license expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;351,994&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;187,500 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accrued other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9,459&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;65,964 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;875,771&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;683,099 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">64627</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">62965</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <anix:AccruedRoyaltyAndContingentLegalFees unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">449691</anix:AccruedRoyaltyAndContingentLegalFees>
  <anix:AccruedRoyaltyAndContingentLegalFees unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">366670</anix:AccruedRoyaltyAndContingentLegalFees>
  <anix:AccruedCollaborativeResearchAndLicenseExpenses unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">351994</anix:AccruedCollaborativeResearchAndLicenseExpenses>
  <anix:AccruedCollaborativeResearchAndLicenseExpenses unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">187500</anix:AccruedCollaborativeResearchAndLicenseExpenses>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c2_AsOf31Jul2019" decimals="0">9459</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c3_AsOf31Oct2018" decimals="0">65964</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:EarningsPerShareTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0in;&quot;&gt;6.&amp;#xa0;&amp;#xa0; &amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;NET LOSS PER SHARE OF COMMON STOCK&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Basic net loss per common share (&amp;#8220;Basic EPS&amp;#8221;) is computed by dividing net loss by the weighted average number of common shares outstanding.&amp;#xa0; Diluted net loss per common share (&amp;#8220;Diluted EPS&amp;#8221;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&amp;#xa0; Diluted EPS for all periods presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&amp;#xa0; For this reason, excluded from the calculation of Diluted EPS for the nine and three months ended July 31, 2019 and 2018, were stock options to purchase 7,268,668 and 7,238,446 shares, respectively, and warrants to purchase 545,000 and 854,400 shares, respectively.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c195_From1Nov2018To31Jul2019_EmployeeStockOptionMember" decimals="INF">7268668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c196_From1May2019To31Jul2019_EmployeeStockOptionMember" decimals="INF">7268668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c197_From1Nov2017To31Jul2018_EmployeeStockOptionMember" decimals="INF">7238446</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c198_From1May2018To31Jul2018_EmployeeStockOptionMember" decimals="INF">7238446</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c199_From1Nov2018To31Jul2019_WarrantMember" decimals="INF">545000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c200_From1May2019To31Jul2019_WarrantMember" decimals="INF">545000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c201_From1Nov2017To31Jul2018_WarrantMember" decimals="INF">854400</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c202_From1May2018To31Jul2018_WarrantMember" decimals="INF">854400</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0in;&quot;&gt;7.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In May 2014, the Financial Accounting Standards Board (&quot;FASB&quot;) issued Accounting Standards Update 2014-09 (&amp;#8220;ASU 2014-09&amp;#8221;), Revenue from Contracts with Customers.&amp;#xa0; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &amp;#xa0;&lt;a name=&quot;_Hlk501045300&quot;&gt;The Company adopted ASU 2014-09 on November&amp;#xa0;1, 2018.&amp;#xa0; The adoption of ASU 2014-09 &lt;/a&gt;did not have a material impact on our &lt;a name=&quot;_Hlk502247174&quot;&gt;consolidated financial statements,&lt;/a&gt; other than required additional disclosure of accounting policies. &amp;#xa0;See Note 1 regarding our revenue recognition policy.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In February 2016, the FASB issued Accounting Standards Update 2016-02 (&amp;#8220;ASU 2016-02&amp;#8221;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities.&amp;#xa0; The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method.&amp;#xa0; The requirements of this standard include a significant increase in required disclosures.&amp;#xa0; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&amp;#xa0;and related disclosures, and our analysis is currently ongoing.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt;&quot;&gt;8.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;INCOME TAXES &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;We file Federal, New York and California state income tax returns.&amp;#xa0; Due to net operating losses, the statute of limitations for Federal and New York State income tax returns remains open to examination by taxing authorities since the fiscal year ended October 31, 1999.&amp;#xa0; We account for interest and penalties related to income tax matters, if any, in general and administrative expenses. &amp;#xa0;There are no unrecognized income tax benefits as of &lt;/font&gt;July 31&lt;font style=&quot;COLOR:black&quot;&gt;, 2019 and October 31, 2018.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&amp;#xa0; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/font&gt; We have substantial net operating loss carryforwards for Federal, New York State and California income tax returns. These net operating loss carryforwards could be subject to limitations under Internal Revenue Code section 382. Management has not performed an analysis of the potential limitations. We have provided a full valuation allowance against our deferred tax asset due to our historical pre-tax losses and the uncertainty regarding the realizability of these deferred tax assets.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Courier New&apos;; font-size:  10pt; &quot;&gt;
&lt;p style=&quot;font-size: 10pt; font-family: &apos;Courier New&apos;; text-align: justify; margin: 0in 0in 0pt;&quot;&gt;&lt;font style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;;&quot;&gt;9.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;COMMITMENT AND CONTINGENCES&lt;/font&gt;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;a name=&quot;_Hlk18064185&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;Litigation Matters&lt;/font&gt;&lt;/font&gt;&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Other than below and lawsuits we have historically brought to enforce our patent rights, we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &amp;#xa0;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;On November 5, 2018, a putative shareholder derivative complaint was filed in the Court of Chancery of the State of Delaware, captioned Howland v. Kumar et al., C.A. No. 2018-0804-KSJM (the &amp;#8220;Derivative Action&amp;#8221;), that alleged claims for breach of fiduciary duty and unjust enrichment.&amp;#xa0; The Derivative Action named as defendants certain of the Company&amp;#8217;s current and former officers and directors (the &amp;#8220;Individual Defendants&amp;#8221;), and the Company was named solely as a nominal defendant.&amp;#xa0; &lt;a name=&quot;_Hlk2942011&quot;&gt;&lt;/a&gt;&lt;a name=&quot;_Hlk2854829&quot;&gt;On August 21, 2019, the Company entered into a settlement pursuant to which the Company agreed to certain changes in its corporate governance policies and to reprice certain stock options that were repriced on September 6, 2017 to $0.67 to the option price immediately prior to that repricing.&amp;#xa0; The Company also agreed to pay certain legal fees, with such fees to be paid from the Company&amp;#8217;s D&amp;amp;O insurance.&amp;#xa0; As a result of this settlement, all of the claims asserted in the Derivative Action will be dismissed.&amp;#xa0; The Individual Defendants have denied, and continue to deny, any and all allegations of wrongdoing or liability asserted in the Derivative Action.&amp;#xa0; The Individual Defendants have further asserted, and continue to assert, that at all relevant times, they acted in good faith and in a manner that they reasonably believed to be in the best interests of the Company and its stockholders.&amp;#xa0; The Individual Defendants have entered into the settlement solely to eliminate the uncertainty, distraction, disruption, burden, risk, and expense of further litigation.&lt;/a&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:SharePrice unitRef="usdPershares" contextRef="c203_AsOf21Aug2019_SubsequentEventMember" decimals="2">0.67</us-gaap:SharePrice>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;div style=&quot;font-family:  &apos;Times New Roman&apos;,&apos;serif&apos;; font-size:  12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;10.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration: underline;&quot;&gt;SEGMENT INFORMATION&lt;/font&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;We follow the accounting guidance of ASC 280 &amp;#8220;Segment Reporting&amp;#8221; (&amp;#8220;ASC 280&amp;#8221;).&amp;#xa0; Reportable operating segments are determined based on the management approach.&amp;#xa0; The management approach, as defined by ASC 280, is based on the way that the chief operating decision-maker organizes the segments within an enterprise for making operating decisions and assessing performance.&amp;#xa0; While our results of operations are primarily reviewed on a consolidated basis, the chief operating decision-maker manages the enterprise in three reportable segments, each with different operating and potential revenue generating characteristics: (i) Cancer Diagnostics, (ii) Cancer Therapeutics and (iii) our legacy patent licensing activities.&amp;#xa0; The following represents selected financial information for our segments for the nine and three months ended July 31, 2019 and 2018 and as of July 31, 2019 and October 31, 2018:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table width=&quot;867&quot; style=&quot;WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;For the Nine Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Net loss:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,024,785)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(3,783,854)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,807,668)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,583,070)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(875,138)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(484,640)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(9,707,591)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(8,851,564)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,953,760 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,692,865&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,084,694 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,807,515 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,070,408&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,266,448&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,108,862&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,766,828&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,108,862&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,766,828&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Plus non-cash share-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,902,512&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,227,016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total operating costs and expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;10,011,374&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9,993,844&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;table width=&quot;867&quot; style=&quot;WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:30pt&quot;&gt; &lt;td style=&quot;HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;For the Three Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Net loss:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(917,363)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(2,359,568)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(1,203,468)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(2,901,708)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(45,217)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(332,300)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(2,166,048)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(5,593,576)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&amp;#xa0; &lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;507,356&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;569,512&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;801,704&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;359,006&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;44,454&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;411,453&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,353,514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,339,971&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,353,514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,339,971&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Plus non-cash share-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;830,898&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,628,333&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total operating costs and expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,184,412&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,968,304&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;table width=&quot;867&quot; style=&quot;WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31,&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;October 31,&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total assets:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,201,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,545,803&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,279,496&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,157,359&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;361,977&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,745,380&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6,842,706&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6,448,542&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in&quot;&gt;Operating costs and expenses excluding non-cash share-based compensation expense is the measurement the chief operating decision-maker uses in managing the enterprise.&amp;#xa0; &amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c0_From1Nov2018To31Jul2019">&lt;table width=&quot;867&quot; style=&quot;WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;For the Nine Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Net loss:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,024,785)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(3,783,854)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,807,668)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(4,583,070)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(875,138)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(484,640)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(9,707,591)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(8,851,564)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,953,760 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,692,865&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,084,694 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,807,515 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,070,408&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,266,448&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,108,862&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,766,828&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,108,862&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,766,828&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Plus non-cash share-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,902,512&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,227,016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total operating costs and expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;10,011,374&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;9,993,844&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;867&quot; style=&quot;WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:30pt&quot;&gt; &lt;td style=&quot;HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;5&quot; style=&quot;BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;For the Three Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15pt&quot;&gt; &lt;td style=&quot;HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Net loss:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(917,363)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(2,359,568)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(1,203,468)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(2,901,708)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(45,217)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(332,300)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(2,166,048)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;(5,593,576)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&amp;#xa0; &lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;507,356&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;569,512&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;801,704&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;359,006&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;44,454&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;411,453&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,353,514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,339,971&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:31.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Operating costs and expenses excluding non-cash&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; share based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,353,514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,339,971&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Plus non-cash share-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;830,898&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;4,628,333&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total operating costs and expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,184,412&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;5,968,304&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table width=&quot;867&quot; style=&quot;WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;July 31,&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td colspan=&quot;2&quot; style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;October 31,&lt;/font&gt;&lt;/p&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total assets:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Diagnostics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,201,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,545,803&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Cancer Therapeutics&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;3,279,496&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;2,157,359&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:15.75pt&quot;&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent licensing&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;361,977&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&amp;#xa0;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;1,745,380&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&quot;HEIGHT:16.5pt&quot;&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6,842,706&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot;&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style=&quot;BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt; &lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;6,448,542&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c204_From1Nov2018To31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">-4024785</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c205_From1Nov2017To31Jul2018_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">-3783854</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c206_From1Nov2018To31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">-4807668</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c207_From1Nov2017To31Jul2018_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">-4583070</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c208_From1Nov2018To31Jul2019_OperatingSegmentsMember_PatentLicensingMember" decimals="0">-875138</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c209_From1Nov2017To31Jul2018_OperatingSegmentsMember_PatentLicensingMember" decimals="0">-484640</us-gaap:ProfitLoss>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c204_From1Nov2018To31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">1953760</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c205_From1Nov2017To31Jul2018_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">1692865</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c206_From1Nov2018To31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">2084694</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c207_From1Nov2017To31Jul2018_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">1807515</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c208_From1Nov2018To31Jul2019_OperatingSegmentsMember_PatentLicensingMember" decimals="0">1070408</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c209_From1Nov2017To31Jul2018_OperatingSegmentsMember_PatentLicensingMember" decimals="0">1266448</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">5108862</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">4766828</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c0_From1Nov2018To31Jul2019" decimals="0">4902512</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c10_From1Nov2017To31Jul2018" decimals="0">5227016</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c210_From1May2019To31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">-917363</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c211_From1May2018To31Jul2018_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">-2359568</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c212_From1May2019To31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">-1203468</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c213_From1May2018To31Jul2018_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">-2901708</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c214_From1May2019To31Jul2019_OperatingSegmentsMember_PatentLicensingMember" decimals="0">-45217</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c215_From1May2018To31Jul2018_OperatingSegmentsMember_PatentLicensingMember" decimals="0">-332300</us-gaap:ProfitLoss>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c210_From1May2019To31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">507356</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c211_From1May2018To31Jul2018_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">569512</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c212_From1May2019To31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">801704</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c213_From1May2018To31Jul2018_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">359006</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c214_From1May2019To31Jul2019_OperatingSegmentsMember_PatentLicensingMember" decimals="0">44454</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c215_From1May2018To31Jul2018_OperatingSegmentsMember_PatentLicensingMember" decimals="0">411453</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">1353514</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">1339971</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c8_From1May2019To31Jul2019" decimals="0">830898</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c9_From1May2018To31Jul2018" decimals="0">4628333</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:Assets unitRef="usd" contextRef="c216_AsOf31Jul2019_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">3201233</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c217_AsOf31Oct2018_OperatingSegmentsMember_CancerDiagnosticsMember" decimals="0">2545803</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c218_AsOf31Jul2019_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">3279496</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c219_AsOf31Oct2018_OperatingSegmentsMember_CancerTherapeuticsMember" decimals="0">2157359</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c220_AsOf31Jul2019_OperatingSegmentsMember_PatentLicensingMember" decimals="0">361977</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c221_AsOf31Oct2018_OperatingSegmentsMember_PatentLicensingMember" decimals="0">1745380</us-gaap:Assets>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>anix-20190731.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Fri Sep 06 16:14:09 EDT 2019 -->
<xs:schema elementFormDefault="qualified" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:anix="http://www.anixa.com/20190731" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" targetNamespace="http://www.anixa.com/20190731" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="anix-20190731_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="anix-20190731_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="anix-20190731_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="anix-20190731_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet" id="anix_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet_Parentheticals" id="anix_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement" id="anix_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement_Parentheticals" id="anix_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ShareholdersEquityType2or3" id="anix_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ShareholdersEquityType2or3_Parentheticals" id="anix_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ConsolidatedCashFlow" id="anix_r_ConsolidatedCashFlow">
        <link:definition>007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/BUSINESSANDFUNDING" id="anix_r_BUSINESSANDFUNDING">
        <link:definition>008 - Disclosure - BUSINESS AND FUNDING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/SUBSEQUENTEVENT" id="anix_r_SUBSEQUENTEVENT">
        <link:definition>009 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATION" id="anix_r_STOCKBASEDCOMPENSATION">
        <link:definition>010 - Disclosure - STOCK BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/FAIRVALUEMEASUREMENTS" id="anix_r_FAIRVALUEMEASUREMENTS">
        <link:definition>011 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ACCRUEDEXPENSES" id="anix_r_ACCRUEDEXPENSES">
        <link:definition>012 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK" id="anix_r_NETLOSSPERSHAREOFCOMMONSTOCK">
        <link:definition>013 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS" id="anix_r_EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS">
        <link:definition>014 - Disclosure - EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/INCOMETAXES" id="anix_r_INCOMETAXES">
        <link:definition>015 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/COMMITMENTANDCONTINGENCES" id="anix_r_COMMITMENTANDCONTINGENCES">
        <link:definition>016 - Disclosure - COMMITMENT AND CONTINGENCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/SEGMENTINFORMATION" id="anix_r_SEGMENTINFORMATION">
        <link:definition>017 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGTables" id="anix_r_BUSINESSANDFUNDINGTables">
        <link:definition>018 - Disclosure - BUSINESS AND FUNDING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables" id="anix_r_STOCKBASEDCOMPENSATIONTables">
        <link:definition>019 - Disclosure - STOCK BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables" id="anix_r_FAIRVALUEMEASUREMENTSTables">
        <link:definition>020 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ACCRUEDEXPENSESTables" id="anix_r_ACCRUEDEXPENSESTables">
        <link:definition>021 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/SEGMENTINFORMATIONTables" id="anix_r_SEGMENTINFORMATIONTables">
        <link:definition>022 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGDetails" id="anix_r_BUSINESSANDFUNDINGDetails">
        <link:definition>023 - Disclosure - BUSINESS AND FUNDING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGDetailsPatents" id="anix_r_BUSINESSANDFUNDINGDetailsPatents">
        <link:definition>024 - Disclosure - BUSINESS AND FUNDING (Details) - Patents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/ChangesinnoncontrollinginterestTable" id="anix_r_ChangesinnoncontrollinginterestTable">
        <link:definition>025 - Disclosure - BUSINESS AND FUNDING (Details) - Changes in noncontrolling interest</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense" id="anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense">
        <link:definition>026 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionActivity" id="anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionActivity">
        <link:definition>027 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Option Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionPlans" id="anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionPlans">
        <link:definition>028 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Option Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockAwards" id="anix_r_STOCKBASEDCOMPENSATIONDetailsStockAwards">
        <link:definition>029 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Awards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan" id="anix_r_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan">
        <link:definition>030 - Disclosure - STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFff3V94A/j32DU7427Jw8InVI47JA69IOx7V4lOXX/2m3HByT2wphuUafpSj5RBg+CV/W7y65PyzbhN3cS/eE3Ah61Tb0kL40rQIGzbvZnkSeW4cs+KHNoxrbiunkCVzngOjwm5GjXDL] CSR-->
      <link:roleType roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsWarrants" id="anix_r_STOCKBASEDCOMPENSATIONDetailsWarrants">
        <link:definition>031 - Disclosure - STOCK BASED COMPENSATION (Details) - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Informationregardingthe2003SharePlanTable" id="anix_r_Informationregardingthe2003SharePlanTable">
        <link:definition>032 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding the 2003 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable" id="anix_r_Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable">
        <link:definition>033 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2003 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Informationregardingthe2010SharePlanTable" id="anix_r_Informationregardingthe2010SharePlanTable">
        <link:definition>034 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable" id="anix_r_Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable">
        <link:definition>035 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Informationregardingthe2018SharePlanTable" id="anix_r_Informationregardingthe2018SharePlanTable">
        <link:definition>036 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable" id="anix_r_Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable">
        <link:definition>037 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2018 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" id="anix_r_Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable">
        <link:definition>038 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable" id="anix_r_Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable">
        <link:definition>039 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/HierarchyforfinancialassetsmeasuredatfairvalueTable" id="anix_r_HierarchyforfinancialassetsmeasuredatfairvalueTable">
        <link:definition>040 - Disclosure - FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/AccruedliabilitiesTable" id="anix_r_AccruedliabilitiesTable">
        <link:definition>041 - Disclosure - ACCRUED EXPENSES (Details) - Accrued liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCKDetails" id="anix_r_NETLOSSPERSHAREOFCOMMONSTOCKDetails">
        <link:definition>042 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/COMMITMENTANDCONTINGENCESDetails" id="anix_r_COMMITMENTANDCONTINGENCESDetails">
        <link:definition>043 - Disclosure - COMMITMENT AND CONTINGENCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/SegmentsInformationTable" id="anix_r_SegmentsInformationTable">
        <link:definition>044 - Disclosure - SEGMENT INFORMATION (Details) - Segments Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anixa.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>
  <xs:element name="ChangesInNoncontrollingInterestAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_ChangesInNoncontrollingInterestAbstract"/>
  <xs:element name="InformationRegardingThe2003SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_InformationRegardingThe2003SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract"/>
  <xs:element name="InformationRegardingThe2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_InformationRegardingThe2010SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract"/>
  <xs:element name="InformationRegardingThe2018SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_InformationRegardingThe2018SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract"/>
  <xs:element name="InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract"/>
  <xs:element name="HierarchyForFinancialAssetsMeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract"/>
  <xs:element name="AccruedLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_AccruedLiabilitiesAbstract"/>
  <xs:element name="SegmentsInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_SegmentsInformationAbstract"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00"/>
  <xs:element name="TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000"/>
  <xs:element name="NetLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_NetLossAbstract"/>
  <xs:element name="OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract"/>
  <xs:element name="NetLossAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_NetLossAbstract0"/>
  <xs:element name="OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0"/>
  <xs:element name="TotalAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_TotalAssetsAbstract"/>
  <xs:element name="FiniteLivedPatentsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_FiniteLivedPatentsNet"/>
  <xs:element name="FiniteLivedPatentsImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anix_FiniteLivedPatentsImpairment"/>
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue"/>
  <xs:element name="StockIssuedDuringPeriodValueAtTheMarketOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anix_StockIssuedDuringPeriodValueAtTheMarketOffering"/>
  <xs:element name="StockIssuedDuringPeriodSharesAtTheMarketOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering"/>
  <xs:element name="CommonStockOfferingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_CommonStockOfferingExpenses"/>
  <xs:element name="StockOptionsAndWarrantsIssuedToConsultants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_StockOptionsAndWarrantsIssuedToConsultants"/>
  <xs:element name="StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan"/>
  <xs:element name="IssuanceOfStockForServicesOrClaims" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_IssuanceOfStockForServicesOrClaims"/>
  <xs:element name="IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee"/>
  <xs:element name="ScheduleOfChangesInNoncontrollingInterestTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock"/>
  <xs:element name="STOCKBASEDCOMPENSATIONTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONTablesTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONTablesLineItems"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
  <xs:element name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems"/>
  <xs:element name="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable"/>
  <xs:element name="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems"/>
  <xs:element name="AccruedRoyaltyAndContingentLegalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anix_AccruedRoyaltyAndContingentLegalFees"/>
  <xs:element name="AccruedCollaborativeResearchAndLicenseExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anix_AccruedCollaborativeResearchAndLicenseExpenses"/>
  <xs:element name="BUSINESSANDFUNDINGDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_BUSINESSANDFUNDINGDetailsTable"/>
  <xs:element name="BUSINESSANDFUNDINGDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_BUSINESSANDFUNDINGDetailsLineItems"/>
  <xs:element name="BUSINESSANDFUNDINGDetailsPatentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_BUSINESSANDFUNDINGDetailsPatentsTable"/>
  <xs:element name="BUSINESSANDFUNDINGDetailsPatentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems"/>
  <xs:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems"/>
  <xs:element name="ConsultationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anix_ConsultationExpense"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems"/>
  <xs:element name="NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable"/>
  <xs:element name="NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems"/>
  <xs:element name="COMMITMENTANDCONTINGENCESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anix_COMMITMENTANDCONTINGENCESDetailsTable"/>
  <xs:element name="COMMITMENTANDCONTINGENCESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_COMMITMENTANDCONTINGENCESDetailsLineItems"/>
  <xs:element name="A2003SharePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_A2003SharePlanMember"/>
  <xs:element name="A2010SharePlanAnd2018SharePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_A2010SharePlanAnd2018SharePlanMember"/>
  <xs:element name="A2010SharePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_A2010SharePlanMember"/>
  <xs:element name="A2018SharePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_A2018SharePlanMember"/>
  <xs:element name="CancerDiagnosticsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_CancerDiagnosticsMember"/>
  <xs:element name="CancerTherapeuticsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_CancerTherapeuticsMember"/>
  <xs:element name="ChairmanPresidentAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_ChairmanPresidentAndChiefExecutiveOfficerMember"/>
  <xs:element name="ConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_ConsultantMember"/>
  <xs:element name="EmployeeStockPurchasePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_EmployeeStockPurchasePlanMember"/>
  <xs:element name="PatentLicensingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_PatentLicensingMember"/>
  <xs:element name="RangeOfExercisePrices067Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices067Member"/>
  <xs:element name="RangeOfExercisePrices067To1700Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices067To1700Member"/>
  <xs:element name="RangeOfExercisePrices227To301Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices227To301Member"/>
  <xs:element name="RangeOfExercisePrices258To556Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices258To556Member"/>
  <xs:element name="RangeOfExercisePrices346To575Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices346To575Member"/>
  <xs:element name="RangeOfExercisePrices346To700Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices346To700Member"/>
  <xs:element name="RangeOfExercisePrices370To384Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices370To384Member"/>
  <xs:element name="RangeOfExercisePrices370To461Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_RangeOfExercisePrices370To461Member"/>
  <xs:element name="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
  <xs:element name="WarrantWithExercisePriceOf13875Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_WarrantWithExercisePriceOf13875Member"/>
  <xs:element name="WarrantWithExercisePriceOf503Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_WarrantWithExercisePriceOf503Member"/>
  <xs:element name="WarrantWithExercisePriceOf925Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_WarrantWithExercisePriceOf925Member"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anix_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>anix-20190731_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Fri Sep 06 16:14:09 EDT 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedBalanceSheet" roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedIncomeStatement" roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedCashFlow" roleURI="http://www.anixa.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_AccruedliabilitiesTable" roleURI="http://www.anixa.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SegmentsInformationTable" roleURI="http://www.anixa.com/role/SegmentsInformationTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ReceivablesNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_FiniteLivedPatentsNet" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="anix_FiniteLivedPatentsNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquity" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_MinorityInterest" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_RoyaltyExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InvestmentIncomeInterest" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFff3V94A/j32DU7427Jw8InVI47JA69IOx7V4lOXX/2m3HByT2wphuUafpSj5RBg+CV/W7y65PyzbhN3cS/eE3Ah61Tb0kL40rQIGzbvZnkSeW4cs+KHNozLDK+04G8zHTKf30pUl2Ch] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockOptionPlanExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsAndWarrantsIssuedToConsultants" xlink:href="anix-20190731.xsd#anix_StockOptionsAndWarrantsIssuedToConsultants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="anix_StockOptionsAndWarrantsIssuedToConsultants" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" xlink:href="anix-20190731.xsd#anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_IssuanceOfStockForServicesOrClaims" xlink:href="anix-20190731.xsd#anix_IssuanceOfStockForServicesOrClaims"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="anix_IssuanceOfStockForServicesOrClaims" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" xlink:href="anix-20190731.xsd#anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedRoyaltyAndContingentLegalFees" xlink:href="anix-20190731.xsd#anix_AccruedRoyaltyAndContingentLegalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="anix_AccruedRoyaltyAndContingentLegalFees" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedCollaborativeResearchAndLicenseExpenses" xlink:href="anix-20190731.xsd#anix_AccruedCollaborativeResearchAndLicenseExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="anix_AccruedCollaborativeResearchAndLicenseExpenses" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SegmentsInformationTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>anix-20190731_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Fri Sep 06 16:14:09 EDT 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedBalanceSheet" roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedIncomeStatement" roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ShareholdersEquityType2or3" roleURI="http://www.anixa.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.anixa.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedCashFlow" roleURI="http://www.anixa.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDING" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDING"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SUBSEQUENTEVENT" roleURI="http://www.anixa.com/role/SUBSEQUENTEVENT"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATION" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATION"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_FAIRVALUEMEASUREMENTS" roleURI="http://www.anixa.com/role/FAIRVALUEMEASUREMENTS"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ACCRUEDEXPENSES" roleURI="http://www.anixa.com/role/ACCRUEDEXPENSES"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_NETLOSSPERSHAREOFCOMMONSTOCK" roleURI="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS" roleURI="http://www.anixa.com/role/EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_INCOMETAXES" roleURI="http://www.anixa.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_COMMITMENTANDCONTINGENCES" roleURI="http://www.anixa.com/role/COMMITMENTANDCONTINGENCES"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SEGMENTINFORMATION" roleURI="http://www.anixa.com/role/SEGMENTINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDINGTables" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONTables" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_FAIRVALUEMEASUREMENTSTables" roleURI="http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ACCRUEDEXPENSESTables" roleURI="http://www.anixa.com/role/ACCRUEDEXPENSESTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SEGMENTINFORMATIONTables" roleURI="http://www.anixa.com/role/SEGMENTINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ChangesinnoncontrollinginterestTable" roleURI="http://www.anixa.com/role/ChangesinnoncontrollinginterestTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingthe2003SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingthe2010SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingthe2018SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingthe2018SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_HierarchyforfinancialassetsmeasuredatfairvalueTable" roleURI="http://www.anixa.com/role/HierarchyforfinancialassetsmeasuredatfairvalueTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_AccruedliabilitiesTable" roleURI="http://www.anixa.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SegmentsInformationTable" roleURI="http://www.anixa.com/role/SegmentsInformationTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDINGDetails" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGDetails"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDINGDetailsPatents" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGDetailsPatents"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionActivity" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionActivity"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionPlans" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionPlans"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockAwards" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockAwards"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsWarrants" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsWarrants"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_NETLOSSPERSHAREOFCOMMONSTOCKDetails" roleURI="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCKDetails"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_COMMITMENTANDCONTINGENCESDetails" roleURI="http://www.anixa.com/role/COMMITMENTANDCONTINGENCESDetails"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#DocumentAndEntityInformation" roleURI="http://www.anixa.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_FiniteLivedPatentsNet" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anix_FiniteLivedPatentsNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_MinorityInterest" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_FiniteLivedPatentsImpairment" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsImpairment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anix_FiniteLivedPatentsImpairment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ParentMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" xlink:href="anix-20190731.xsd#anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockIssuedDuringPeriodValueAtTheMarketOffering" xlink:href="anix-20190731.xsd#anix_StockIssuedDuringPeriodValueAtTheMarketOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anix_StockIssuedDuringPeriodValueAtTheMarketOffering" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering" xlink:href="anix-20190731.xsd#anix_StockIssuedDuringPeriodSharesAtTheMarketOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_CommonStockOfferingExpenses" xlink:href="anix-20190731.xsd#anix_CommonStockOfferingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anix_CommonStockOfferingExpenses" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsAndWarrantsIssuedToConsultants" xlink:href="anix-20190731.xsd#anix_StockOptionsAndWarrantsIssuedToConsultants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="anix_StockOptionsAndWarrantsIssuedToConsultants" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" xlink:href="anix-20190731.xsd#anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_IssuanceOfStockForServicesOrClaims" xlink:href="anix-20190731.xsd#anix_IssuanceOfStockForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="anix_IssuanceOfStockForServicesOrClaims" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" xlink:href="anix-20190731.xsd#anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDING">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SUBSEQUENTEVENT">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATION">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/FAIRVALUEMEASUREMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ACCRUEDEXPENSES">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/COMMITMENTANDCONTINGENCES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SEGMENTINFORMATION">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDINGTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock" xlink:href="anix-20190731.xsd#anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONTablesLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONTablesTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONTablesLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONTablesTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2003SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2010SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2018SharePlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ACCRUEDEXPENSESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SEGMENTINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ChangesinnoncontrollinginterestTable">
    <loc xlink:type="locator" xlink:label="anix_ChangesInNoncontrollingInterestAbstract" xlink:href="anix-20190731.xsd#anix_ChangesInNoncontrollingInterestAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_ChangesInNoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_ChangesInNoncontrollingInterestAbstract" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="anix_InformationRegardingThe2003SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2003SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2003SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices067To1700Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067To1700Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices067To1700Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices067Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices067Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices227To301Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices227To301Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices227To301Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices346To575Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices346To575Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices346To575Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices346To700Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices346To700Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices346To700Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1" xbrldt:closed="true"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFff3V94A/j32DU7427Jw8InVI47JA69IOx7V4lOXX/2m3HByT2wphuUafpSj5RBg+CV/W7y65PyzbhN3cS/eE3Ah61Tb0kL40rQIGzbvZnkSeW4cs+KHNozv41dUxrxemAaqmmEZzqdt] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingthe2018SharePlanTable">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2018SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2018SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices370To461Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices370To461Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices370To461Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices370To384Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices370To384Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices370To384Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices067Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices067Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices258To556Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices258To556Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="anix_RangeOfExercisePrices258To556Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/HierarchyforfinancialassetsmeasuredatfairvalueTable">
    <loc xlink:type="locator" xlink:label="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:href="anix-20190731.xsd#anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:href="anix-20190731.xsd#anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="anix_AccruedLiabilitiesAbstract" xlink:href="anix-20190731.xsd#anix_AccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_AccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedRoyaltyAndContingentLegalFees" xlink:href="anix-20190731.xsd#anix_AccruedRoyaltyAndContingentLegalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_AccruedLiabilitiesAbstract" xlink:to="anix_AccruedRoyaltyAndContingentLegalFees" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedCollaborativeResearchAndLicenseExpenses" xlink:href="anix-20190731.xsd#anix_AccruedCollaborativeResearchAndLicenseExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_AccruedLiabilitiesAbstract" xlink:to="anix_AccruedCollaborativeResearchAndLicenseExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_AccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_AccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SegmentsInformationTable">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_CancerDiagnosticsMember" xlink:href="anix-20190731.xsd#anix_CancerDiagnosticsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="anix_CancerDiagnosticsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_CancerTherapeuticsMember" xlink:href="anix-20190731.xsd#anix_CancerTherapeuticsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="anix_CancerTherapeuticsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_PatentLicensingMember" xlink:href="anix-20190731.xsd#anix_PatentLicensingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="anix_PatentLicensingMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_NetLossAbstract" xlink:href="anix-20190731.xsd#anix_NetLossAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="anix_NetLossAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_NetLossAbstract" xlink:to="us-gaap_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:href="anix-20190731.xsd#anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CostsAndExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_TotalAssetsAbstract" xlink:href="anix-20190731.xsd#anix_TotalAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="anix_TotalAssetsAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_TotalAssetsAbstract" xlink:to="us-gaap_Assets" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDINGDetails">
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsTable" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="anix_BUSINESSANDFUNDINGDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_BUSINESSANDFUNDINGDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDINGDetailsPatents">
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsPatentsLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsPatentsTable" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsPatentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="anix_BUSINESSANDFUNDINGDetailsPatentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_FiniteLivedPatentsNet" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="anix_FiniteLivedPatentsNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:href="anix-20190731.xsd#anix_ChairmanPresidentAndChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="anix_ConsultantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionActivity">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="srt_RangeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanAnd2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanAnd2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2010SharePlanAnd2018SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionPlans">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2018SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockAwards">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_AwardTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_A2018SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="anix_ConsultantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:href="anix-20190731.xsd#anix_ChairmanPresidentAndChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultationExpense" xlink:href="anix-20190731.xsd#anix_ConsultationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="anix_ConsultationExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_EmployeeStockPurchasePlanMember" xlink:href="anix-20190731.xsd#anix_EmployeeStockPurchasePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="anix_EmployeeStockPurchasePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsWarrants">
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="anix_ConsultantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_WarrantWithExercisePriceOf925Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf925Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="anix_WarrantWithExercisePriceOf925Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_WarrantWithExercisePriceOf13875Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf13875Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="anix_WarrantWithExercisePriceOf13875Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_WarrantWithExercisePriceOf503Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf503Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="anix_WarrantWithExercisePriceOf503Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultationExpense" xlink:href="anix-20190731.xsd#anix_ConsultationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="anix_ConsultationExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="invest_InvestmentWarrantsExpirationDate" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="invest_InvestmentWarrantsExpirationDate" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCKDetails">
    <loc xlink:type="locator" xlink:label="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:href="anix-20190731.xsd#anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:href="anix-20190731.xsd#anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:to="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/COMMITMENTANDCONTINGENCESDetails">
    <loc xlink:type="locator" xlink:label="anix_COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:href="anix-20190731.xsd#anix_COMMITMENTANDCONTINGENCESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anix_COMMITMENTANDCONTINGENCESDetailsTable" xlink:href="anix-20190731.xsd#anix_COMMITMENTANDCONTINGENCESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anix_COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:to="anix_COMMITMENTANDCONTINGENCESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anix_COMMITMENTANDCONTINGENCESDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anix_COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:to="us-gaap_SharePrice" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anixa.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="16" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>anix-20190731_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Fri Sep 06 16:14:09 EDT 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_FiniteLivedPatentsNet" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_FiniteLivedPatentsNet_lbl" xml:lang="en-US">Patents, net of impairment of $1,001,729 and $582,979, respectively, and accumulated amortization of $2,034,382 and $1,615,632, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FiniteLivedPatentsNet" xlink:to="anix_FiniteLivedPatentsNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_FiniteLivedPatentsNet_lbl0" xml:lang="en-US">Finite Lived Patents Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FiniteLivedPatentsNet" xlink:to="anix_FiniteLivedPatentsNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_FiniteLivedPatentsImpairment" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsImpairment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_FiniteLivedPatentsImpairment_lbl" xml:lang="en-US">Patents, impairment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FiniteLivedPatentsImpairment" xlink:to="anix_FiniteLivedPatentsImpairment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Patents, accumulated amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $86,789 and $53,799, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, accumulated depreciation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xml:lang="en-US">Equity Interest Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $.01 per share; 48,000,000 shares authorized; 20,162,851 and 18,908,632 shares issued and outstanding, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interest (Note 1)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_MinorityInterest_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_MinorityInterest_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Inventor royalties, contingent legal fees, litigation and licensing expenses related to patent assertion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses (including non-cash share-based compensation expenses of $338,449 and $2,472,489, $2,567,294 and $2,668,315, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Non-cash share-based compensation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Plus non-cash share-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses (including non-cash share-based compensation expenses of $492,449 and $2,155,844 $2,335,218 and $2,558,701, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment in carrying amount of patent asset (Note 1)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl0" xml:lang="en-US">Impairment in carrying amount of patent assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating costs and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl1" xml:lang="en-US">Net Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net loss attributable to noncontrolling interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl0" xml:lang="en-US">Net loss attributable to noncontrolling interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to common shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock option compensation to employees and directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" xlink:href="anix-20190731.xsd#anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue_lbl" xml:lang="en-US">Stock options and warrants issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" xlink:to="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued upon exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Restricted stock award compensation to employee pursuant to stock incentive plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xml:lang="en-US">Common stock issued pursuant to employee stock purchase plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US">Common stock issued pursuant to employee stock purchase plan (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockIssuedDuringPeriodValueAtTheMarketOffering" xlink:href="anix-20190731.xsd#anix_StockIssuedDuringPeriodValueAtTheMarketOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockIssuedDuringPeriodValueAtTheMarketOffering_lbl" xml:lang="en-US">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockIssuedDuringPeriodValueAtTheMarketOffering" xlink:to="anix_StockIssuedDuringPeriodValueAtTheMarketOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering" xlink:href="anix-20190731.xsd#anix_StockIssuedDuringPeriodSharesAtTheMarketOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering_lbl" xml:lang="en-US">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198 (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering" xlink:to="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_CommonStockOfferingExpenses" xlink:href="anix-20190731.xsd#anix_CommonStockOfferingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_CommonStockOfferingExpenses_lbl" xml:lang="en-US">Common Stock, offering expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_CommonStockOfferingExpenses" xlink:to="anix_CommonStockOfferingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Restricted stock award compensation to employee pursuant to stock incentive plan (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common stock issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common stock issued to consultants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xml:lang="en-US">Issuance of noncontrolling interest in Certainty Therapeutics, Inc</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ParentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ParentMember_lbl" xml:lang="en-US">Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ParentMember" xlink:to="us-gaap_ParentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option compensation to employees and directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsAndWarrantsIssuedToConsultants" xlink:href="anix-20190731.xsd#anix_StockOptionsAndWarrantsIssuedToConsultants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockOptionsAndWarrantsIssuedToConsultants_lbl" xml:lang="en-US">Stock options and warrants issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsAndWarrantsIssuedToConsultants" xlink:to="anix_StockOptionsAndWarrantsIssuedToConsultants_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" xlink:href="anix-20190731.xsd#anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan_lbl" xml:lang="en-US">Restricted stock award compensation to employee pursuant to stock incentive plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" xlink:to="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_IssuanceOfStockForServicesOrClaims" xlink:href="anix-20190731.xsd#anix_IssuanceOfStockForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_IssuanceOfStockForServicesOrClaims_lbl" xml:lang="en-US">Common stock issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_IssuanceOfStockForServicesOrClaims" xlink:to="anix_IssuanceOfStockForServicesOrClaims_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" xlink:href="anix-20190731.xsd#anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee_lbl" xml:lang="en-US">Issuance of noncontrolling interest in Certainty Therapeutics, Inc. expensed as a license fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" xlink:to="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Disbursements to acquire short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xml:lang="en-US">Proceeds from maturities of short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Net proceeds from sale of common stock in at-the-market offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xml:lang="en-US">Proceeds from sale of common stock pursuant to employee stock purchase plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of employee stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ChangesInNoncontrollingInterestAbstract" xlink:href="anix-20190731.xsd#anix_ChangesInNoncontrollingInterestAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ChangesInNoncontrollingInterestAbstract_lbl" xml:lang="en-US">Changes in noncontrolling interest [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ChangesInNoncontrollingInterestAbstract" xlink:to="anix_ChangesInNoncontrollingInterestAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_A2003SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2003SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_A2003SharePlanMember_lbl" xml:lang="en-US">2003 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2003SharePlanMember" xlink:to="anix_A2003SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_InformationRegardingThe2003SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2003SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_InformationRegardingThe2003SharePlanAbstract_lbl" xml:lang="en-US">Information regarding the 2003 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_InformationRegardingThe2003SharePlanAbstract" xlink:to="anix_InformationRegardingThe2003SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Options outstanding (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Exercised (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl" xml:lang="en-US">Options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl0" xml:lang="en-US">Options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl" xml:lang="en-US">Options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl0" xml:lang="en-US">Options outstanding and exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Forfeited (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding and exercisable under the 2003 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:to="anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices067To1700Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067To1700Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices067To1700Member_lbl" xml:lang="en-US">Range Of Exercise Prices $0.67 To $17.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices067To1700Member" xlink:to="anix_RangeOfExercisePrices067To1700Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl" xml:lang="en-US">Options Outstnding and Exercisable, Numbers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl0" xml:lang="en-US">Options Outstanding and Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:to="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_A2010SharePlanMember_lbl" xml:lang="en-US">2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2010SharePlanMember" xlink:to="anix_A2010SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_InformationRegardingThe2010SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_InformationRegardingThe2010SharePlanAbstract_lbl" xml:lang="en-US">Information regarding the 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_InformationRegardingThe2010SharePlanAbstract" xlink:to="anix_InformationRegardingThe2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Granted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Options outstanding (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options exercisable (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Options exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Options exercisable (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding and exercisable under the 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract" xlink:to="anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices067Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices067Member_lbl" xml:lang="en-US">Range Of Exercise Prices $0.67 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices067Member" xlink:to="anix_RangeOfExercisePrices067Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Outstanding,Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl0" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Exercisable,Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices227To301Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices227To301Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices227To301Member_lbl" xml:lang="en-US">Range Of Exercise Prices $2.27 To $3.01 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices227To301Member" xlink:to="anix_RangeOfExercisePrices227To301Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices346To575Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices346To575Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices346To575Member_lbl" xml:lang="en-US">Range Of Exercise Prices $3.46 To $5.75 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices346To575Member" xlink:to="anix_RangeOfExercisePrices346To575Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices346To700Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices346To700Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices346To700Member_lbl" xml:lang="en-US">Range Of Exercise Prices $3.46 To $7.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices346To700Member" xlink:to="anix_RangeOfExercisePrices346To700Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_A2018SharePlanMember_lbl" xml:lang="en-US">2018 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2018SharePlanMember" xlink:to="anix_A2018SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_InformationRegardingThe2018SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2018SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_InformationRegardingThe2018SharePlanAbstract_lbl" xml:lang="en-US">Information regarding the 2018 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_InformationRegardingThe2018SharePlanAbstract" xlink:to="anix_InformationRegardingThe2018SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding and exercisable under the 2018 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract" xlink:to="anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices370To461Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices370To461Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices370To461Member_lbl" xml:lang="en-US">Range Of Exercise Prices $3.70 To $4.61 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices370To461Member" xlink:to="anix_RangeOfExercisePrices370To461Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices370To384Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices370To384Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices370To384Member_lbl" xml:lang="en-US">Range Of Exercise Prices $3.70 To $3.84 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices370To384Member" xlink:to="anix_RangeOfExercisePrices370To384Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_lbl" xml:lang="en-US">Stock Options Not Granted Under 2003 Share Plan 2010 Share Plan Or 2018 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:to="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract_lbl" xml:lang="en-US">Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract" xlink:to="anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract_lbl" xml:lang="en-US">Stock options outstanding and exercisable that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract" xlink:to="anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_RangeOfExercisePrices258To556Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices258To556Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_RangeOfExercisePrices258To556Member_lbl" xml:lang="en-US">Range Of Exercise Prices $2.58 To $5.56 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices258To556Member" xlink:to="anix_RangeOfExercisePrices258To556Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract" xlink:href="anix-20190731.xsd#anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Hierarchy for financial assets measured at fair value [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract" xlink:to="anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xml:lang="en-US">Certificates of Deposit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xml:lang="en-US">Short-term Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Certificates of deposit &#8211; Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedLiabilitiesAbstract" xlink:href="anix-20190731.xsd#anix_AccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_AccruedLiabilitiesAbstract_lbl" xml:lang="en-US">Accrued liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AccruedLiabilitiesAbstract" xlink:to="anix_AccruedLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Payroll and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedRoyaltyAndContingentLegalFees" xlink:href="anix-20190731.xsd#anix_AccruedRoyaltyAndContingentLegalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_AccruedRoyaltyAndContingentLegalFees_lbl" xml:lang="en-US">Accrued royalty and contingent legal fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AccruedRoyaltyAndContingentLegalFees" xlink:to="anix_AccruedRoyaltyAndContingentLegalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_AccruedCollaborativeResearchAndLicenseExpenses" xlink:href="anix-20190731.xsd#anix_AccruedCollaborativeResearchAndLicenseExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_AccruedCollaborativeResearchAndLicenseExpenses_lbl" xml:lang="en-US">Accrued collaborative research and license expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AccruedCollaborativeResearchAndLicenseExpenses" xlink:to="anix_AccruedCollaborativeResearchAndLicenseExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl0" xml:lang="en-US">Net loss per common share attributable to common shareholders:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_SegmentsInformationAbstract" xlink:href="anix-20190731.xsd#anix_SegmentsInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_SegmentsInformationAbstract_lbl" xml:lang="en-US">Segments Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_SegmentsInformationAbstract" xlink:to="anix_SegmentsInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US">Consolidation Items [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating Segments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_CancerDiagnosticsMember" xlink:href="anix-20190731.xsd#anix_CancerDiagnosticsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_CancerDiagnosticsMember_lbl" xml:lang="en-US">Cancer Diagnostics [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_CancerDiagnosticsMember" xlink:to="anix_CancerDiagnosticsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_CancerTherapeuticsMember" xlink:href="anix-20190731.xsd#anix_CancerTherapeuticsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_CancerTherapeuticsMember_lbl" xml:lang="en-US">Cancer Therapeutics [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_CancerTherapeuticsMember" xlink:to="anix_CancerTherapeuticsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_PatentLicensingMember" xlink:href="anix-20190731.xsd#anix_PatentLicensingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_PatentLicensingMember_lbl" xml:lang="en-US">Patent Licensing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_PatentLicensingMember" xlink:to="anix_PatentLicensingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Operating costs and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND EQUITY</label>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFff3V94A/j32DU7427Jw8InVI47JA69IOx7V4lOXX/2m3HByT2wphuUafpSj5RBg+CV/W7y65PyzbhN3cS/eE3Ah61Tb0kL40rQIGzbvZnkSeW4cs+KHNozGfiumtT77TCBFNUfJe3f6] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xml:lang="en-US">Operating costs and expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average common shares outstanding:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract" xlink:href="anix-20190731.xsd#anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract_lbl" xml:lang="en-US">The accompanying notes are an integral part of these condensed consolidated financial statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0" xlink:href="anix-20190731.xsd#anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0_lbl" xml:lang="en-US">The accompanying notes are an integral part of these condensed consolidated financial statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00" xlink:href="anix-20190731.xsd#anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00_lbl" xml:lang="en-US">The accompanying notes are an integral part of these condensed consolidated financial statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000" xlink:href="anix-20190731.xsd#anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000_lbl" xml:lang="en-US">The accompanying notes are an integral part of these condensed consolidated financial statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Reconciliation of net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock" xlink:href="anix-20190731.xsd#anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US">Schedule Of Changes In Noncontrolling Interest [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock" xlink:to="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_NetLossAbstract" xlink:href="anix-20190731.xsd#anix_NetLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_NetLossAbstract_lbl" xml:lang="en-US">Net loss:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_NetLossAbstract" xlink:to="anix_NetLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:href="anix-20190731.xsd#anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract_lbl" xml:lang="en-US">Operating costs and expenses excluding non-cash share based compensation expense:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:to="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_NetLossAbstract0" xlink:href="anix-20190731.xsd#anix_NetLossAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_NetLossAbstract0_lbl" xml:lang="en-US">Net loss:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_NetLossAbstract0" xlink:to="anix_NetLossAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0" xlink:href="anix-20190731.xsd#anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0_lbl" xml:lang="en-US">Operating costs and expenses excluding non-cash share based compensation expense:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0" xlink:to="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_TotalAssetsAbstract" xlink:href="anix-20190731.xsd#anix_TotalAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_TotalAssetsAbstract_lbl" xml:lang="en-US">Total assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TotalAssetsAbstract" xlink:to="anix_TotalAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:href="anix-20190731.xsd#anix_ChairmanPresidentAndChiefExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ChairmanPresidentAndChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chairman President And Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:to="anix_ChairmanPresidentAndChiefExecutiveOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ConsultantMember" xlink:to="anix_ConsultantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_A2010SharePlanAnd2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanAnd2018SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_A2010SharePlanAnd2018SharePlanMember_lbl" xml:lang="en-US">2010 Share Plan And 2018 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2010SharePlanAnd2018SharePlanMember" xlink:to="anix_A2010SharePlanAnd2018SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_EmployeeStockPurchasePlanMember" xlink:href="anix-20190731.xsd#anix_EmployeeStockPurchasePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_EmployeeStockPurchasePlanMember_lbl" xml:lang="en-US">Employee Stock Purchase Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_EmployeeStockPurchasePlanMember" xlink:to="anix_EmployeeStockPurchasePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_WarrantWithExercisePriceOf925Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf925Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_WarrantWithExercisePriceOf925Member_lbl" xml:lang="en-US">Warrant With Exercise Price Of $9.25 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_WarrantWithExercisePriceOf925Member" xlink:to="anix_WarrantWithExercisePriceOf925Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_WarrantWithExercisePriceOf13875Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf13875Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_WarrantWithExercisePriceOf13875Member_lbl" xml:lang="en-US">Warrant With Exercise Price Of $13.875 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_WarrantWithExercisePriceOf13875Member" xlink:to="anix_WarrantWithExercisePriceOf13875Member_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_WarrantWithExercisePriceOf503Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf503Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_WarrantWithExercisePriceOf503Member_lbl" xml:lang="en-US">Warrant With Exercise Price Of $5.03 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_WarrantWithExercisePriceOf503Member" xlink:to="anix_WarrantWithExercisePriceOf503Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Other (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises_lbl" xml:lang="en-US">Share based Compensation Arrangement By Share based Payment Award Options Withheld In Connection With Cashless Exercises (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" xlink:to="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_ConsultationExpense" xlink:href="anix-20190731.xsd#anix_ConsultationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anix_ConsultationExpense_lbl" xml:lang="en-US">Consultation Expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ConsultationExpense" xlink:to="anix_ConsultationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:label="invest_InvestmentWarrantsExpirationDate" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="invest_InvestmentWarrantsExpirationDate_lbl" xml:lang="en-US">Investment Warrants Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentWarrantsExpirationDate" xlink:to="invest_InvestmentWarrantsExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONTablesTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONTablesTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONTablesTable" xlink:to="anix_STOCKBASEDCOMPENSATIONTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONTablesLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONTablesLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Tables) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONTablesLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xml:lang="en-US">Exercise Price Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US">Measurement Frequency [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:href="anix-20190731.xsd#anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:href="anix-20190731.xsd#anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationItemsDomain_lbl" xml:lang="en-US">Consolidation Items [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US">Segments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsTable" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_BUSINESSANDFUNDINGDetailsTable_lbl" xml:lang="en-US">BUSINESS AND FUNDING (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_BUSINESSANDFUNDINGDetailsTable" xlink:to="anix_BUSINESSANDFUNDINGDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_BUSINESSANDFUNDINGDetailsLineItems_lbl" xml:lang="en-US">BUSINESS AND FUNDING (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_BUSINESSANDFUNDINGDetailsLineItems" xlink:to="anix_BUSINESSANDFUNDINGDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsPatentsTable" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsPatentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_BUSINESSANDFUNDINGDetailsPatentsTable_lbl" xml:lang="en-US">BUSINESS AND FUNDING (Details) - Patents [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsTable" xlink:to="anix_BUSINESSANDFUNDINGDetailsPatentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsPatentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems_lbl" xml:lang="en-US">BUSINESS AND FUNDING (Details) - Patents [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="anix_BUSINESSANDFUNDINGDetailsPatentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Option Activity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Option Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Option Plans [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Option Plans [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Awards [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Warrants [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems_lbl" xml:lang="en-US">STOCK BASED COMPENSATION (Details) - Warrants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:href="anix-20190731.xsd#anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable_lbl" xml:lang="en-US">NET LOSS PER SHARE OF COMMON STOCK (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:to="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:href="anix-20190731.xsd#anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems_lbl" xml:lang="en-US">NET LOSS PER SHARE OF COMMON STOCK (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:to="anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_COMMITMENTANDCONTINGENCESDetailsTable" xlink:href="anix-20190731.xsd#anix_COMMITMENTANDCONTINGENCESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_COMMITMENTANDCONTINGENCESDetailsTable_lbl" xml:lang="en-US">COMMITMENT AND CONTINGENCES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_COMMITMENTANDCONTINGENCESDetailsTable" xlink:to="anix_COMMITMENTANDCONTINGENCESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anix_COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:href="anix-20190731.xsd#anix_COMMITMENTANDCONTINGENCESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_COMMITMENTANDCONTINGENCESDetailsLineItems_lbl" xml:lang="en-US">COMMITMENT AND CONTINGENCES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:to="anix_COMMITMENTANDCONTINGENCESDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_AccruedCollaborativeResearchAndLicenseExpenses_lbl0" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for collaborative research and license.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AccruedCollaborativeResearchAndLicenseExpenses" xlink:to="anix_AccruedCollaborativeResearchAndLicenseExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_AccruedRoyaltyAndContingentLegalFees_lbl0" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties and contingent legal fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AccruedRoyaltyAndContingentLegalFees" xlink:to="anix_AccruedRoyaltyAndContingentLegalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue_lbl0" xml:lang="en-US">Amount of adjustment to additional paid-in capital for stock option and warrants issued during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" xlink:to="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_CommonStockOfferingExpenses_lbl0" xml:lang="en-US">Amount of expense related to the common stock offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_CommonStockOfferingExpenses" xlink:to="anix_CommonStockOfferingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ConsultationExpense_lbl0" xml:lang="en-US">Amount charged to consultation expense for the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ConsultationExpense" xlink:to="anix_ConsultationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_FiniteLivedPatentsImpairment_lbl0" xml:lang="en-US">Accumulated amount of impairment for patents.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FiniteLivedPatentsImpairment" xlink:to="anix_FiniteLivedPatentsImpairment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_FiniteLivedPatentsNet_lbl1" xml:lang="en-US">Net carrying amount after accumulated amortization as of the balance sheet date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_FiniteLivedPatentsNet" xlink:to="anix_FiniteLivedPatentsNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee_lbl0" xml:lang="en-US">Issuance of noncontrolling interest expensed as a license fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" xlink:to="anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_IssuanceOfStockForServicesOrClaims_lbl0" xml:lang="en-US">Fair value of stock issued during the period as payment for services rendered.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_IssuanceOfStockForServicesOrClaims" xlink:to="anix_IssuanceOfStockForServicesOrClaims_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure for the changes in noncontrolling interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock" xlink:to="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl1" xml:lang="en-US">Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl1" xml:lang="en-US">Number of options outstanding and exercisable, including both vested and non-vested options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl1" xml:lang="en-US">The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl1" xml:lang="en-US">The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises_lbl0" xml:lang="en-US">Number of options withheld in connection with cashless exercises during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" xlink:to="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm_lbl0" xml:lang="en-US">Weighted average remaining contractual term of outstanding and exercisable stock options, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents the reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:to="anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan_lbl0" xml:lang="en-US">Stock award compensation to employee and directors pursuant to stock incentive plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" xlink:to="anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering_lbl0" xml:lang="en-US">Number of stock issued during the period related to the market offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering" xlink:to="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_StockIssuedDuringPeriodValueAtTheMarketOffering_lbl0" xml:lang="en-US">Equity impact of the value of stock issued during period at the market offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockIssuedDuringPeriodValueAtTheMarketOffering" xlink:to="anix_StockIssuedDuringPeriodValueAtTheMarketOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anix_StockOptionsAndWarrantsIssuedToConsultants_lbl0" xml:lang="en-US">The noncash expense that accounts for the value of stock options and warrants issued to consultants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsAndWarrantsIssuedToConsultants" xlink:to="anix_StockOptionsAndWarrantsIssuedToConsultants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_A2003SharePlanMember_lbl0" xml:lang="en-US">A2003 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2003SharePlanMember" xlink:to="anix_A2003SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_A2010SharePlanAnd2018SharePlanMember_lbl0" xml:lang="en-US">A2010 Share Plan And 2018 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2010SharePlanAnd2018SharePlanMember" xlink:to="anix_A2010SharePlanAnd2018SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_A2010SharePlanMember_lbl0" xml:lang="en-US">A2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2010SharePlanMember" xlink:to="anix_A2010SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_A2018SharePlanMember_lbl0" xml:lang="en-US">A2018 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_A2018SharePlanMember" xlink:to="anix_A2018SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_CancerDiagnosticsMember_lbl0" xml:lang="en-US">Cancer Diagnostics [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_CancerDiagnosticsMember" xlink:to="anix_CancerDiagnosticsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_CancerTherapeuticsMember_lbl0" xml:lang="en-US">Cancer Therapeutics [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_CancerTherapeuticsMember" xlink:to="anix_CancerTherapeuticsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ChairmanPresidentAndChiefExecutiveOfficerMember_lbl0" xml:lang="en-US">Chairman President And Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:to="anix_ChairmanPresidentAndChiefExecutiveOfficerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ConsultantMember_lbl0" xml:lang="en-US">Consultant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ConsultantMember" xlink:to="anix_ConsultantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_EmployeeStockPurchasePlanMember_lbl0" xml:lang="en-US">Employee Stock Purchase Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_EmployeeStockPurchasePlanMember" xlink:to="anix_EmployeeStockPurchasePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_PatentLicensingMember_lbl0" xml:lang="en-US">Patent Licensing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_PatentLicensingMember" xlink:to="anix_PatentLicensingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices067Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 067 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices067Member" xlink:to="anix_RangeOfExercisePrices067Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices067To1700Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 067 To 1700 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices067To1700Member" xlink:to="anix_RangeOfExercisePrices067To1700Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices227To301Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 227 To 301 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices227To301Member" xlink:to="anix_RangeOfExercisePrices227To301Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices258To556Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 258 To 556 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices258To556Member" xlink:to="anix_RangeOfExercisePrices258To556Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices346To575Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 346 To 575 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices346To575Member" xlink:to="anix_RangeOfExercisePrices346To575Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices346To700Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 346 To 700 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices346To700Member" xlink:to="anix_RangeOfExercisePrices346To700Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices370To384Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 370 To 384 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices370To384Member" xlink:to="anix_RangeOfExercisePrices370To384Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_RangeOfExercisePrices370To461Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 370 To 461 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_RangeOfExercisePrices370To461Member" xlink:to="anix_RangeOfExercisePrices370To461Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_lbl0" xml:lang="en-US">Stock Options Not Granted Under 2003 Share Plan 2010 Share Plan Or 2018 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:to="anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_WarrantWithExercisePriceOf13875Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 13875 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_WarrantWithExercisePriceOf13875Member" xlink:to="anix_WarrantWithExercisePriceOf13875Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_WarrantWithExercisePriceOf503Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 503 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_WarrantWithExercisePriceOf503Member" xlink:to="anix_WarrantWithExercisePriceOf503Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_WarrantWithExercisePriceOf925Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_WarrantWithExercisePriceOf925Member" xlink:to="anix_WarrantWithExercisePriceOf925Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_NetLossAbstract_lbl0" xml:lang="en-US">NetLossAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_NetLossAbstract" xlink:to="anix_NetLossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises_lbl1" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" xlink:to="anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl2" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl2" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue_lbl1" xml:lang="en-US">AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" xlink:to="anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0_lbl0" xml:lang="en-US">OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0" xlink:to="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract_lbl0" xml:lang="en-US">OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:to="anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_TotalAssetsAbstract_lbl0" xml:lang="en-US">TotalAssetsAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TotalAssetsAbstract" xlink:to="anix_TotalAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ConsultationExpense_lbl1" xml:lang="en-US">ConsultationExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ConsultationExpense" xlink:to="anix_ConsultationExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock_lbl1" xml:lang="en-US">ScheduleOfChangesInNoncontrollingInterestTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock" xlink:to="anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_NetLossAbstract0_lbl0" xml:lang="en-US">NetLossAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_NetLossAbstract0" xlink:to="anix_NetLossAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract000_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesAtTheMarketOffering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering" xlink:to="anix_StockIssuedDuringPeriodSharesAtTheMarketOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00_lbl0" xml:lang="en-US">TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00" xlink:to="anix_TheAccompanyingNotesAreAnIntegralPartOfTheseCondensedConsolidatedFinancialStatementsAbstract00_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0" xml:lang="en-US">Payments to Acquire Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl0" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl0" xml:lang="en-US">Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_InvestmentWarrantsExpirationDate_lbl0" xml:lang="en-US">Investment Warrants Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentWarrantsExpirationDate" xlink:to="invest_InvestmentWarrantsExpirationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xml:lang="en-US">Stockholders&apos; Equity, Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl0" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl0" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl0" xml:lang="en-US">Operating Costs and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>anix-20190731_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Fri Sep 06 16:14:09 EDT 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedBalanceSheet" roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.anixa.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedIncomeStatement" roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.anixa.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ShareholdersEquityType2or3" roleURI="http://www.anixa.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.anixa.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ConsolidatedCashFlow" roleURI="http://www.anixa.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDING" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDING"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SUBSEQUENTEVENT" roleURI="http://www.anixa.com/role/SUBSEQUENTEVENT"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATION" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATION"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_FAIRVALUEMEASUREMENTS" roleURI="http://www.anixa.com/role/FAIRVALUEMEASUREMENTS"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ACCRUEDEXPENSES" roleURI="http://www.anixa.com/role/ACCRUEDEXPENSES"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_NETLOSSPERSHAREOFCOMMONSTOCK" roleURI="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS" roleURI="http://www.anixa.com/role/EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_INCOMETAXES" roleURI="http://www.anixa.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_COMMITMENTANDCONTINGENCES" roleURI="http://www.anixa.com/role/COMMITMENTANDCONTINGENCES"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SEGMENTINFORMATION" roleURI="http://www.anixa.com/role/SEGMENTINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDINGTables" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONTables" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_FAIRVALUEMEASUREMENTSTables" roleURI="http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ACCRUEDEXPENSESTables" roleURI="http://www.anixa.com/role/ACCRUEDEXPENSESTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SEGMENTINFORMATIONTables" roleURI="http://www.anixa.com/role/SEGMENTINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_ChangesinnoncontrollinginterestTable" roleURI="http://www.anixa.com/role/ChangesinnoncontrollinginterestTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingthe2003SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingthe2010SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingthe2018SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingthe2018SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" roleURI="http://www.anixa.com/role/Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable" roleURI="http://www.anixa.com/role/Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_HierarchyforfinancialassetsmeasuredatfairvalueTable" roleURI="http://www.anixa.com/role/HierarchyforfinancialassetsmeasuredatfairvalueTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_AccruedliabilitiesTable" roleURI="http://www.anixa.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_SegmentsInformationTable" roleURI="http://www.anixa.com/role/SegmentsInformationTable"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDINGDetails" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGDetails"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_BUSINESSANDFUNDINGDetailsPatents" roleURI="http://www.anixa.com/role/BUSINESSANDFUNDINGDetailsPatents"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionActivity" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionActivity"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockOptionPlans" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionPlans"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsStockAwards" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockAwards"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_STOCKBASEDCOMPENSATIONDetailsWarrants" roleURI="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsWarrants"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_NETLOSSPERSHAREOFCOMMONSTOCKDetails" roleURI="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCKDetails"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#anix_r_COMMITMENTANDCONTINGENCESDetails" roleURI="http://www.anixa.com/role/COMMITMENTANDCONTINGENCESDetails"/>
  <roleRef xlink:type="simple" xlink:href="anix-20190731.xsd#DocumentAndEntityInformation" roleURI="http://www.anixa.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedPatentsNet" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="FiniteLivedPatentsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_MinorityInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedPatentsImpairment" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsImpairment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="FiniteLivedPatentsImpairment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_ParentMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_NoncontrollingInterestMember" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" xlink:href="anix-20190731.xsd#anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueAtTheMarketOffering" xlink:href="anix-20190731.xsd#anix_StockIssuedDuringPeriodValueAtTheMarketOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAtTheMarketOffering" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesAtTheMarketOffering" xlink:href="anix-20190731.xsd#anix_StockIssuedDuringPeriodSharesAtTheMarketOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAtTheMarketOffering" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_0" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CommonStockOfferingExpenses" xlink:href="anix-20190731.xsd#anix_CommonStockOfferingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CommonStockOfferingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockOptionsAndWarrantsIssuedToConsultants" xlink:href="anix-20190731.xsd#anix_StockOptionsAndWarrantsIssuedToConsultants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="StockOptionsAndWarrantsIssuedToConsultants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" xlink:href="anix-20190731.xsd#anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfStockForServicesOrClaims" xlink:href="anix-20190731.xsd#anix_IssuanceOfStockForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IssuanceOfStockForServicesOrClaims" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" xlink:href="anix-20190731.xsd#anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IssuanceOfNoncontrollingInterestExpensedAsALicenseFee" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDING">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SUBSEQUENTEVENT">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATION">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/FAIRVALUEMEASUREMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ACCRUEDEXPENSES">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/COMMITMENTANDCONTINGENCES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SEGMENTINFORMATION">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDINGTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInNoncontrollingInterestTableTextBlock" xlink:href="anix-20190731.xsd#anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfChangesInNoncontrollingInterestTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONTablesTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONTablesTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONTablesLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONTablesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONTablesTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2018SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONTablesTable" xlink:to="STOCKBASEDCOMPENSATIONTablesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ACCRUEDEXPENSESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SEGMENTINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/ChangesinnoncontrollinginterestTable">
    <loc xlink:type="locator" xlink:label="ChangesInNoncontrollingInterestAbstract" xlink:href="anix-20190731.xsd#anix_ChangesInNoncontrollingInterestAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInNoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInNoncontrollingInterestAbstract" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterest_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInNoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterest_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingThe2003SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2003SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices067To1700Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067To1700Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices067To1700Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingThe2010SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2010SharePlanAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable">
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFff3V94A/j32DU7427Jw8InVI47JA69IOx7V4lOXX/2m3HByT2wphuUafpSj5RBg+CV/W7y65PyzbhN3cS/eE3Ah61Tb0kL40rQIGzbvZnkSeW4cs+KHNoxWHI2n3hN92vSMwuwG3M9b] CSR-->
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingAndExercisableUnderThe2010SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices067Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices067Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices227To301Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices227To301Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices227To301Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices346To575Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices346To575Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices346To575Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices346To700Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices346To700Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices346To700Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingthe2018SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingThe2018SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingThe2018SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2018SharePlanAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2018SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingAndExercisableUnderThe2018SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2018SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices370To461Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices370To461Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices370To461Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices370To384Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices370To384Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices370To384Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract" xlink:href="anix-20190731.xsd#anix_InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingStockOptionsOutstandingThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018SharePlanAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract" xlink:href="anix-20190731.xsd#anix_StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingAndExercisableThatWereNotGrantedUnderThe2003SharePlanThe2010SharePlanOrThe2018PlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices067Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices067Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices067Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices258To556Member" xlink:href="anix-20190731.xsd#anix_RangeOfExercisePrices258To556Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices258To556Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="anix-20190731.xsd#anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/HierarchyforfinancialassetsmeasuredatfairvalueTable">
    <loc xlink:type="locator" xlink:label="HierarchyForFinancialAssetsMeasuredAtFairValueAbstract" xlink:href="anix-20190731.xsd#anix_HierarchyForFinancialAssetsMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:href="anix-20190731.xsd#anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable"/>
    <loc xlink:type="locator" xlink:label="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:href="anix-20190731.xsd#anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="HierarchyForFinancialAssetsMeasuredAtFairValueAbstract" xlink:to="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CertificatesOfDepositMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_ShortTermInvestmentsMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueTable" xlink:to="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesAbstract" xlink:href="anix-20190731.xsd#anix_AccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedRoyaltyAndContingentLegalFees" xlink:href="anix-20190731.xsd#anix_AccruedRoyaltyAndContingentLegalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="AccruedRoyaltyAndContingentLegalFees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedCollaborativeResearchAndLicenseExpenses" xlink:href="anix-20190731.xsd#anix_AccruedCollaborativeResearchAndLicenseExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="AccruedCollaborativeResearchAndLicenseExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/SegmentsInformationTable">
    <loc xlink:type="locator" xlink:label="SegmentsInformationAbstract" xlink:href="anix-20190731.xsd#anix_SegmentsInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentsInformationAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="us-gaap_OperatingSegmentsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CancerDiagnosticsMember" xlink:href="anix-20190731.xsd#anix_CancerDiagnosticsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="CancerDiagnosticsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CancerTherapeuticsMember" xlink:href="anix-20190731.xsd#anix_CancerTherapeuticsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="CancerTherapeuticsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PatentLicensingMember" xlink:href="anix-20190731.xsd#anix_PatentLicensingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="PatentLicensingMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="NetLossAbstract" xlink:href="anix-20190731.xsd#anix_NetLossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="NetLossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossAbstract" xlink:to="us-gaap_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:href="anix-20190731.xsd#anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CostsAndExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="TotalAssetsAbstract" xlink:href="anix-20190731.xsd#anix_TotalAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="TotalAssetsAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TotalAssetsAbstract" xlink:to="us-gaap_Assets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDINGDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="BUSINESSANDFUNDINGDetailsTable" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsTable"/>
    <loc xlink:type="locator" xlink:label="BUSINESSANDFUNDINGDetailsLineItems" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="BUSINESSANDFUNDINGDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsTable" xlink:to="srt_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsTable" xlink:to="BUSINESSANDFUNDINGDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/BUSINESSANDFUNDINGDetailsPatents">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="BUSINESSANDFUNDINGDetailsPatentsTable" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsPatentsTable"/>
    <loc xlink:type="locator" xlink:label="BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:href="anix-20190731.xsd#anix_BUSINESSANDFUNDINGDetailsPatentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="BUSINESSANDFUNDINGDetailsPatentsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsPatentsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsPatentsTable" xlink:to="BUSINESSANDFUNDINGDetailsPatentsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedPatentsNet" xlink:href="anix-20190731.xsd#anix_FiniteLivedPatentsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="FiniteLivedPatentsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BUSINESSANDFUNDINGDetailsPatentsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="srt_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:href="anix-20190731.xsd#anix_ChairmanPresidentAndChiefExecutiveOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ChairmanPresidentAndChiefExecutiveOfficerMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ConsultantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionActivity">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanAnd2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanAnd2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanAnd2018SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="srt_RangeAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" xlink:href="anix-20190731.xsd#anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionPlans">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2018SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockAwards">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2018SharePlanMember" xlink:href="anix-20190731.xsd#anix_A2018SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2018SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_AwardTypeAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ConsultantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChairmanPresidentAndChiefExecutiveOfficerMember" xlink:href="anix-20190731.xsd#anix_ChairmanPresidentAndChiefExecutiveOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ChairmanPresidentAndChiefExecutiveOfficerMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsultationExpense" xlink:href="anix-20190731.xsd#anix_ConsultationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="ConsultationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="EmployeeStockPurchasePlanMember" xlink:href="anix-20190731.xsd#anix_EmployeeStockPurchasePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="EmployeeStockPurchasePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsWarrants">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsWarrantsTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:href="anix-20190731.xsd#anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf925Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf925Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf925Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf13875Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf13875Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf13875Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf503Member" xlink:href="anix-20190731.xsd#anix_WarrantWithExercisePriceOf503Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf503Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConsultantMember" xlink:href="anix-20190731.xsd#anix_ConsultantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ConsultantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsultationExpense" xlink:href="anix-20190731.xsd#anix_ConsultationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="ConsultationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="invest_InvestmentWarrantsExpirationDate" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems" xlink:to="invest_InvestmentWarrantsExpirationDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCKDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:href="anix-20190731.xsd#anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable"/>
    <loc xlink:type="locator" xlink:label="NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:href="anix-20190731.xsd#anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NETLOSSPERSHAREOFCOMMONSTOCKDetailsTable" xlink:to="NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/COMMITMENTANDCONTINGENCESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="COMMITMENTANDCONTINGENCESDetailsTable" xlink:href="anix-20190731.xsd#anix_COMMITMENTANDCONTINGENCESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:href="anix-20190731.xsd#anix_COMMITMENTANDCONTINGENCESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="COMMITMENTANDCONTINGENCESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTANDCONTINGENCESDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTANDCONTINGENCESDetailsTable" xlink:to="COMMITMENTANDCONTINGENCESDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTANDCONTINGENCESDetailsLineItems" xlink:to="us-gaap_SharePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anixa.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="anix-20190731.xsd#anix_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6607583280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31, <br />2019</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">October 31, <br />2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Payroll and related expenses</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">64,627 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">62,965 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Accrued royalty and contingent legal fees</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">449,691</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">366,670 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Accrued collaborative research and license expenses</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">351,994</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">187,500 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Accrued other</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">9,459</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">65,964 </font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">875,771</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">683,099 </font></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771302592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING (Details) - Changes in noncontrolling interest - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ChangesInNoncontrollingInterestAbstract', window );"><strong>Changes in noncontrolling interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (251,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">$ (26,020)<span></span>
</td>
<td class="num">$ (116,650)<span></span>
</td>
<td class="num">(148,030)<span></span>
</td>
<td class="num">$ (158,032)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Balance</a></td>
<td class="num">$ (399,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (399,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ChangesInNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ChangesInNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6782613744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (9,707,591)<span></span>
</td>
<td class="num">$ (8,851,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option compensation to employees and directors</a></td>
<td class="nump">2,808,910<span></span>
</td>
<td class="nump">3,598,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockOptionsAndWarrantsIssuedToConsultants', window );">Stock options and warrants issued to consultants</a></td>
<td class="nump">139,161<span></span>
</td>
<td class="nump">254,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan', window );">Restricted stock award compensation to employee pursuant to stock incentive plan</a></td>
<td class="nump">1,954,441<span></span>
</td>
<td class="nump">1,373,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_IssuanceOfStockForServicesOrClaims', window );">Common stock issued to consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation of property and equipment</a></td>
<td class="nump">32,990<span></span>
</td>
<td class="nump">12,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">418,750<span></span>
</td>
<td class="nump">243,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment in carrying amount of patent assets</a></td>
<td class="nump">418,750<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee', window );">Issuance of noncontrolling interest in Certainty Therapeutics, Inc. expensed as a license fee</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">64,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="nump">305,919<span></span>
</td>
<td class="num">(40,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">45,847<span></span>
</td>
<td class="num">(163,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(14,234)<span></span>
</td>
<td class="num">(60,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">192,672<span></span>
</td>
<td class="nump">300,888<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(3,404,385)<span></span>
</td>
<td class="num">(3,252,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Disbursements to acquire short-term investments in certificates of deposit</a></td>
<td class="num">(2,350,000)<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from maturities of short-term investments in certificates of deposit</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">4,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(175,457)<span></span>
</td>
<td class="num">(31,853)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(275,457)<span></span>
</td>
<td class="nump">718,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of common stock in at-the-market offering</a></td>
<td class="nump">4,899,745<span></span>
</td>
<td class="nump">1,786,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from sale of common stock pursuant to employee stock purchase plan</a></td>
<td class="nump">18,560<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of employee stock options</a></td>
<td class="nump">102,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">5,020,805<span></span>
</td>
<td class="nump">1,786,029<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">1,340,963<span></span>
</td>
<td class="num">(748,275)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">3,055,890<span></span>
</td>
<td class="nump">3,339,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 4,396,853<span></span>
</td>
<td class="nump">$ 2,591,099<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of noncontrolling interest expensed as a license fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_IssuanceOfNoncontrollingInterestExpensedAsALicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_IssuanceOfStockForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of stock issued during the period as payment for services rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_IssuanceOfStockForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock award compensation to employee and directors pursuant to stock incentive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_StockAwardCompensationToEmployeeAndDirectorsPursuantToStockIncentivePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_StockOptionsAndWarrantsIssuedToConsultants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock options and warrants issued to consultants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_StockOptionsAndWarrantsIssuedToConsultants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>222</ContextCount>
  <ElementCount>247</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ConsolidatedCashFlow</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - BUSINESS AND FUNDING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/BUSINESSANDFUNDING</Role>
      <ShortName>BUSINESS AND FUNDING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/SUBSEQUENTEVENT</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - STOCK BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ACCRUEDEXPENSES</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK</Role>
      <ShortName>NET LOSS PER SHARE OF COMMON STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/EFFECTOFRECENTLYADOPTEDANDISSUEDPRONOUNCEMENTS</Role>
      <ShortName>EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - COMMITMENT AND CONTINGENCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/COMMITMENTANDCONTINGENCES</Role>
      <ShortName>COMMITMENT AND CONTINGENCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - BUSINESS AND FUNDING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/BUSINESSANDFUNDINGTables</Role>
      <ShortName>BUSINESS AND FUNDING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anixa.com/role/BUSINESSANDFUNDING</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - STOCK BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anixa.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ACCRUEDEXPENSESTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anixa.com/role/ACCRUEDEXPENSES</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anixa.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - BUSINESS AND FUNDING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/BUSINESSANDFUNDINGDetails</Role>
      <ShortName>BUSINESS AND FUNDING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/BUSINESSANDFUNDINGTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - BUSINESS AND FUNDING (Details) - Patents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/BUSINESSANDFUNDINGDetailsPatents</Role>
      <ShortName>BUSINESS AND FUNDING (Details) - Patents</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/BUSINESSANDFUNDINGTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - BUSINESS AND FUNDING (Details) - Changes in noncontrolling interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/ChangesinnoncontrollinginterestTable</Role>
      <ShortName>BUSINESS AND FUNDING (Details) - Changes in noncontrolling interest</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/BUSINESSANDFUNDINGTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpense</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Option Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionActivity</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock Option Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Option Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockOptionPlans</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock Option Plans</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock Awards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsStockAwards</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock Awards</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlan</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - STOCK BASED COMPENSATION (Details) - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONDetailsWarrants</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Warrants</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding the 2003 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Informationregardingthe2003SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Information regarding the 2003 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2003 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2003 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Informationregardingthe2010SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2010SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Informationregardingthe2018SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2018 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Stockoptionsoutstandingandexercisableunderthe2018SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2018 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Informationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/Stockoptionsoutstandingandexercisablethatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018PlanTable</Role>
      <ShortName>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/HierarchyforfinancialassetsmeasuredatfairvalueTable</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - ACCRUED EXPENSES (Details) - Accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/AccruedliabilitiesTable</Role>
      <ShortName>ACCRUED EXPENSES (Details) - Accrued liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/ACCRUEDEXPENSESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCKDetails</Role>
      <ShortName>NET LOSS PER SHARE OF COMMON STOCK (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/NETLOSSPERSHAREOFCOMMONSTOCK</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - COMMITMENT AND CONTINGENCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/COMMITMENTANDCONTINGENCESDetails</Role>
      <ShortName>COMMITMENT AND CONTINGENCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/COMMITMENTANDCONTINGENCES</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="anix-20190731.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - SEGMENT INFORMATION (Details) - Segments Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anixa.com/role/SegmentsInformationTable</Role>
      <ShortName>SEGMENT INFORMATION (Details) - Segments Information</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anixa.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>anix-20190731.xml</File>
    <File>anix-20190731.xsd</File>
    <File>anix-20190731_cal.xml</File>
    <File>anix-20190731_def.xml</File>
    <File>anix-20190731_lab.xml</File>
    <File>anix-20190731_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/invest/2013-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6783418512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 362,500<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 1,112,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties, contingent legal fees, litigation and licensing expenses related to patent assertion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">241,157<span></span>
</td>
<td class="nump">166,250<span></span>
</td>
<td class="nump">767,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">41,875<span></span>
</td>
<td class="nump">81,324<span></span>
</td>
<td class="nump">418,750<span></span>
</td>
<td class="nump">243,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (including non-cash share-based compensation expenses of $338,449 and $2,472,489, $2,567,294 and $2,668,315, respectively)</a></td>
<td class="nump">1,085,574<span></span>
</td>
<td class="nump">2,942,071<span></span>
</td>
<td class="nump">4,602,239<span></span>
</td>
<td class="nump">4,380,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General and administrative expenses (including non-cash share-based compensation expenses of $492,449 and $2,155,844 $2,335,218 and $2,558,701, respectively)</a></td>
<td class="nump">1,056,963<span></span>
</td>
<td class="nump">2,703,752<span></span>
</td>
<td class="nump">4,405,385<span></span>
</td>
<td class="nump">4,602,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment in carrying amount of patent asset (Note 1)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">418,750<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">2,184,412<span></span>
</td>
<td class="nump">5,968,304<span></span>
</td>
<td class="nump">10,011,374<span></span>
</td>
<td class="nump">9,993,844<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(2,184,412)<span></span>
</td>
<td class="num">(5,605,804)<span></span>
</td>
<td class="num">(9,761,374)<span></span>
</td>
<td class="num">(8,881,344)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">18,364<span></span>
</td>
<td class="nump">12,228<span></span>
</td>
<td class="nump">53,783<span></span>
</td>
<td class="nump">29,780<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(2,166,048)<span></span>
</td>
<td class="num">(5,593,576)<span></span>
</td>
<td class="num">(9,707,591)<span></span>
</td>
<td class="num">(8,851,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(2,166,048)<span></span>
</td>
<td class="num">(5,593,576)<span></span>
</td>
<td class="num">(9,707,591)<span></span>
</td>
<td class="num">(8,851,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to noncontrolling interest</a></td>
<td class="num">(26,020)<span></span>
</td>
<td class="num">(116,650)<span></span>
</td>
<td class="num">(148,030)<span></span>
</td>
<td class="num">(158,032)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common shareholders</a></td>
<td class="num">$ (2,140,028)<span></span>
</td>
<td class="num">$ (5,476,926)<span></span>
</td>
<td class="num">$ (9,559,561)<span></span>
</td>
<td class="num">$ (8,693,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per common share attributable to common shareholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted (in Dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted (in Shares)</a></td>
<td class="nump">20,100,915<span></span>
</td>
<td class="nump">18,431,025<span></span>
</td>
<td class="nump">19,638,833<span></span>
</td>
<td class="nump">17,257,546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6634420336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE OF COMMON STOCK (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems', window );"><strong>NET LOSS PER SHARE OF COMMON STOCK (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">7,268,668<span></span>
</td>
<td class="nump">7,238,446<span></span>
</td>
<td class="nump">7,268,668<span></span>
</td>
<td class="nump">7,238,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems', window );"><strong>NET LOSS PER SHARE OF COMMON STOCK (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">545,000<span></span>
</td>
<td class="nump">854,400<span></span>
</td>
<td class="nump">545,000<span></span>
</td>
<td class="nump">854,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_NETLOSSPERSHAREOFCOMMONSTOCKDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>20
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_>%W$?:]=5OWCXW/@JJ!7_]"?0%02P,$%     @ -(@F3YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M92;5#T22(N?LX?&A6CW1AP)M(K69I9XT>V>^J6R%FKT781[<=9@1L1\0>(9
M$R)0L2<!# GLL4/'?PL<7$0$"T1@!I&A1S-Z#--CD!X;>CRC)]8&N(@4%DA
M@<2A9Y: BUC! BDHD#KTM27@(E (*V2@0N;RD57$ 9(82#>4.<1AAM.%P[("
MA5:ND'5:]@!DX;BL08FURX\M"0"2P!(HA$T5NA%2VU8 )EM06; N<B.L;!4
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M5U4;HH"8TS39A7Q[>2C"<]M]M?%[?;[6.3^TU7&XLLHN]V;S_P%02P,$%
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MF^$K3/WL*9F:_PX74)@>E&"-PB@7OZ3HG3=Z8D$I6KR-IVSC.4S\5]@Z@$\
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M_&"+(:'VX?@)SW8:L\GPII]_$%N^<?$74$L#!!0    ( #2()D\A\XY]M@$
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M3IIF@6V@:5%LP 8$'=8]*S9M"]7%D^2X^_M1LNMYG5\DD>(Y/*2H;##VU;4
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M73C>^K.9QFPR'/;S#V++-R[^ E!+ P04    "  TB"9/X(1<\K,!  #2 P
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M'4_[$!\#?D@8[>I,0B47Q.=@?*YRF@1!H*!T@4'X[0KWH%0@\C)^S9QT21F
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M+NQ<M7VP71A9=SV>]!\:Z5]02P,$%     @ -(@F3X6EI&RV 0  T@,  !D
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M\&S',1L-;[KI!['Y&^?O4$L#!!0    ( #2()D]HH?1HMP$  -(#   9
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M:3AKVL#E_IW]LRO>%'.D"IX$^]6>=+,+LS X047/3#^+X0M,!<5A,%7_#2[
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MJ+3=IF8OQXDT&EKTT[1%\\@O_@)02P,$%     @ -(@F3W$'%WHA @  ! 8
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MX\RY FTP>-"=*/5('C84SLHL5WHMNL'4;11O^IF+AL&?_P-02P,$%     @
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MZY%2 3)\[TD6M)1OQ+ @<!1JFLHY,YW2+ 1M^T< #2]1_@]02P,$%     @
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M<L^&:3\<!.W,2^:-SVGQ%U!+ P04    "  TB"9/:ZM"S? "  #$#   &0
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MGQ%'64I):]%NMQHD7PJX]L5BGF10K9UZ)MPR$;UGWLI/W;LDZC&[#N.-,'!
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MADF)+UP.8S&F76_L)IPT?=]WAY^/[!]02P,$%     @ -(@F3POGXML* @
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M7KAIX Z*]^.@0].T+?X!4$L#!!0    ( #2()D^DRA*["P,  +L+   9
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M(+-ETT%*)30G6NA=/.E*>NR4XJ!,D^MVVY>3?4?)9BB5H[%>7_\#4$L#!!0
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MEWR3I8;W3/0<.U6VPZ>WN[2=JDP63:7*OXW?13U\7TW^]S <0": ;@$\^66
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M'A84<JFGD9KS[I+J%I(U_?V+AC^!]!]02P,$%     @ -(@F3_$$5+U= @
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MDTOJ.,B2!(..MGU<E6YL+ZM27#5O>[:7D;IV'95_GAD7XRY.X_>!E_;2:#L
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MRMJEZ[N7P%MY+*0.@"QM\)'\)/)7\\K5"0PJ^[(BM2A9[7!R6+HO_F*+--X
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MXS^*D^R,\8# 9(.7H<>GLA@2.A^V.]S;Z<),AC?#_!;8\B#K_U!+ P04
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M=$J;=0H/RL_ONGG93F?[/S\!E7_[-N-639*WQE''S"\,WC":WR/+&($KD?@
MKE$@%<4<(W.\'V 1$UH$,?S2R=.OG:QBA',Z$T[6D[?V_*Z>FG8@2 >B=2#N
M')A@0BZ,:IECRWQ 4(J) %P0H)262QU,\9( K69:6@A*2(#&2)!*T$E*,DE)
M5,G2#A3I0$55$HP%5;HP\B94X))+"*9\07$^'!VDOHPY"<P8%:ZRF!-:*8.&
M3E"3"6HBP2"@N8X&,IR9<+4L8DPH-)R'/4QPEJ&$,+^8DXB:@:+S,V1^)LK/
M!./,330.@A$BC&<1<](J7XE0'V(.& /@H08\Q:"UEONAZ00MF:"-EKA@2#L
M1DLS(]8 #[691<$J(_QTA!T^%%QUX&V+*R&,%'W1]VPL0$3?4T$@=X5'P.%B
M"K0< Q\@IQTD[]0/-%=!L1<4B%Q:J4Q8;8+T\R^TD<%BHTBN#?<%[\F4WC=
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M%D7M?/SLHY_AO4LWUX?,;>OFJ_;?R\M]V>6A+D[=76!RO9"<_0]02P,$%
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M4QA]V3CSS<.V,H+3Z_RY_-M)GB3X_OL@77JA]5??2Q ;UJF75;[O=&"$@=,
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M%-BV]\#&*W&@)/>I]([:,B,T+P$H$HTD,;US$K]HV625V0D/&(B$E?_"]A+
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ME<QA6U,9F897L5L'L%J8E8\;A4!<Q"N]:E(<A)IM+&0\X8^,$HYM@:GE@6!
MS]N0MRL?F)?T(6T&@'&+=M3R@5C9-).)5/H]L)PP"H%2('O8LM200E=E-KP5
MMH5MA3GJ>: 3]$<W:#/$&\^6'(49)??X)5A'21RL,,&/?'Y N(UL $0"\M0+
M;0O8'MT3^#3-_!CX9DD#A7X0;QZ,?P=;_8_[/+Q'*@>M!G(.Y<8B!.&-$P*\
M]TCM-AIG;"  0_YB6W<>'2?1+R0DEGGH27\$9/R[ZL+H73F'?!/V0IJ$B-9;
M<&W!*$SN?-+DE#P?F-C3FEM98"+;-'PPR:U(- 5RV>1A1DYA:6,X':5LTB%
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M&+>.:AL44-I314AW<2RB;RD=3%%,V!B58M(-M"'T@83(KH!.LPBJ8Y>+#H1
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M1,(C)( 8^%>0-8WB3PBAZ8#UWZ@['<K?L'?8P'7AM]%4_B8HK(/TU',L4"%
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MSRK-@4].KC^=G5IG_X-7O<\JMM.5]X!<P,)EMEPF.=;E;C:=Q*W$U!(?ZN^
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M'I-S/DY/J69/3Z*UMK;=Q12K1H8X?(CFV%5-DE ETMQD>JN$U ,&+6<>/<,
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M3JY[_'P)ZE9$T"%IZ;6G]UI&U4LJ\QOWP&]>>(&'F NF]*YG$3S8;I3'\B;
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M]*!)?]"$'C3M#YK2@V;]03-ZD R!C$-^$L*:K[4 KH7OM0"PA2^V +*%;[8
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MP    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( #2()D\GZ(<.@@   +$    0              "  >D   !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ -(@F3]/3<@?O    *P(  !$
M     ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ -(@F3YE<
MG",0!@  G"<  !,              ( !MP(  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    "  TB"9/+=ENEY<"   ,"@  &               @ 'X
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ -(@F3W)Q
M<_S. P  .Q$  !@              ( !Q0L  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( #2()D_(H6(PU@(  ,<+   8
M  "  <D/  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  T
MB"9/]JL.#T\$  !#$P  &               @ '5$@  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ -(@F3T,T7T)" @  MP8  !@
M         ( !6A<  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( #2()D_Z?8_=H0<  +@J   8              "  =(9  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  TB"9/NBGF00D"  !6!0
M&               @ &I(0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ -(@F3_*-Q1M%!   Y1(  !@              ( !Z",  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( #2()D]/:?RDL@$
M -(#   8              "  6,H  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    "  TB"9/WHSY\;<!  #2 P  &0              @ %+
M*@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( #2()D_
M$\CVM@$  -(#   9              "  3DL  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ -(@F3R'SCGVV 0  T@,  !D
M     ( !)BX  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #2()D],3W5EM@$  -(#   9              "
M <4W  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ -(@F
M3Z([[B2V 0  T@,  !D              ( !LCD  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    "  TB"9/4)O(7[<!  #2 P  &0
M        @ &?.P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( #2()D^/_S-V20(  '0(   9              "  8T]  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ -(@F3X6EI&RV 0  T@,
M !D              ( !#4   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    "  TB"9/:*'T:+<!  #2 P  &0              @ 'Z00
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( #2()D\^@C#8
MMP$  -(#   9              "  >A#  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ -(@F3TJ=I+T9 @  _@4  !D
M ( !UD4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  T
MB"9/<0<7>B$"   $!@  &0              @ $F2   >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( #2()D]2E@B$/P(  )4&   9
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M970S,"YX;6Q02P$"% ,4    "  TB"9/6O$WG/,!   5!0  &0
M    @ %+6   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M #2()D^JUP/U" ,  #\-   9              "  75:  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ -(@F3Q-ZYU>  @  B @  !D
M             ( !M%T  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    "  TB"9/"^?BVPH"  !Y!0  &0              @ %K8   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( #2()D^DRA*["P,
M +L+   9              "  :QB  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ -(@F3Q-4.*>N P  0Q$  !D              ( !
M[F4  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  TB"9/
MQEG,8<("   X"@  &0              @ '3:0  >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( #2()D\ S@_0F (  (4)   9
M      "  <QL  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ -(@F3[K W0X  @  $ 8  !D              ( !FV\  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  TB"9/\014O5T"  #Q!P
M&0              @ '2<0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( #2()D\Y9!H^E ,   P4   9              "  69T  !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ -(@F3R&O)ZX>
M @  #08  !D              ( !,7@  'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    "  TB"9/GIWUQ4<"   \!P  &0
M@ &&>@  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( #2(
M)D^<]%F,IP$  )P#   9              "  01]  !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ -(@F3YV41Q^)!   G!0  !D
M         ( !XGX  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    "  TB"9/5!IYJWP\  !_%@$ %               @ &B@P  >&PO<VAA
M<F5D4W1R:6YG<RYX;6Q02P$"% ,4    "  TB"9/_"PT[C<"  #;"0  #0
M            @ %0P   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #2()D^'
M??Q2V0,  'D>   /              "  ;+"  !X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    "  TB"9/9VT:EL !  "\&P  &@              @ &XQ@
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  TB"9/-QE]
MR+@!  #;&P  $P              @ &PR   6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     -@ V *P.  "9R@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6768687056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan - 2018 Share Plan [Member]<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Information regarding the 2018 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">3,482,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="nump">$ 3.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(8,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">3,470,000<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding (in Dollars) | $</a></td>
<td class="nump">$ 3,337,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">1,321,111<span></span>
</td>
<td class="nump">167,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable (in Dollars) | $</a></td>
<td class="nump">$ 1,273,443<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2018SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771350416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Information regarding the 2003 Share Plan - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_InformationRegardingThe2003SharePlanAbstract', window );"><strong>Information regarding the 2003 Share Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">12,000<span></span>
</td>
<td class="nump">30,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding</a></td>
<td class="nump">$ 2.77<span></span>
</td>
<td class="nump">$ 3.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="num">(10,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">$ 3.63<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber', window );">Options outstanding and exercisable</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Options outstanding and exercisable</a></td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="nump">$ 2.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue', window );">Options outstanding and exercisable</a></td>
<td class="nump">$ 23,694<span></span>
</td>
<td class="nump">$ 13,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_InformationRegardingThe2003SharePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_InformationRegardingThe2003SharePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding and exercisable, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6607355792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt;">2.&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">SUBSEQUENT EVENT</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;">On August 21, 2019, the Company entered into a settlement agreement in connection with a putative shareholder derivative complaint filed in the Court of Chancery of the State of Delaware on November 5, 2018. See Note 9 to these condensed consolidation financial statements for additional information. Management reviewed for subsequent events through the date of filing of this Quarterly Report on Form 10-Q and noted no other items requiring disclosure.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6604710912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE OF COMMON STOCK<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0in;">6.&#xa0;&#xa0; &#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">NET LOSS PER SHARE OF COMMON STOCK</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Basic net loss per common share (&#8220;Basic EPS&#8221;) is computed by dividing net loss by the weighted average number of common shares outstanding.&#xa0; Diluted net loss per common share (&#8220;Diluted EPS&#8221;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&#xa0; Diluted EPS for all periods presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&#xa0; For this reason, excluded from the calculation of Diluted EPS for the nine and three months ended July 31, 2019 and 2018, were stock options to purchase 7,268,668 and 7,238,446 shares, respectively, and warrants to purchase 545,000 and 854,400 shares, respectively.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6607871888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">10.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">SEGMENT INFORMATION</font>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in"><font style="COLOR:black">We follow the accounting guidance of ASC 280 &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;).&#xa0; Reportable operating segments are determined based on the management approach.&#xa0; The management approach, as defined by ASC 280, is based on the way that the chief operating decision-maker organizes the segments within an enterprise for making operating decisions and assessing performance.&#xa0; While our results of operations are primarily reviewed on a consolidated basis, the chief operating decision-maker manages the enterprise in three reportable segments, each with different operating and potential revenue generating characteristics: (i) Cancer Diagnostics, (ii) Cancer Therapeutics and (iii) our legacy patent licensing activities.&#xa0; The following represents selected financial information for our segments for the nine and three months ended July 31, 2019 and 2018 and as of July 31, 2019 and October 31, 2018:</font></p><br/><table width="867" style="WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="2" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">For the Nine Months Ended</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31,</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2019</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Net loss:</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,024,785)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(3,783,854)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,807,668)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,583,070)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(875,138)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(484,640)</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(9,707,591)</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(8,851,564)</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense:</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,953,760 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,692,865</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,084,694 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,807,515 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,070,408</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,266,448</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,108,862</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,766,828</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,108,862</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,766,828</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Plus non-cash share-based compensation expense</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,902,512</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,227,016</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total operating costs and expenses</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">10,011,374</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">9,993,844</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr></table><br/><table width="867" style="WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:30pt"> <td style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">For the Three Months Ended</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31,</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2019</font></p></td> <td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Net loss:</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(917,363)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(2,359,568)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(1,203,468)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(2,901,708)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(45,217)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(332,300)</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(2,166,048)</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(5,593,576)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash&#xa0; </font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense:</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">507,356</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">569,512</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">801,704</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">359,006</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">44,454</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">411,453</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,353,514</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,339,971</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,353,514</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,339,971</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Plus non-cash share-based compensation expense</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">830,898</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,628,333</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total operating costs and expenses</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,184,412</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,968,304</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr></table><br/><table width="867" style="WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="2" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31,</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2019</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="2" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">October 31,</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total assets:</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,201,233</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,545,803</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,279,496</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,157,359</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">361,977</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,745,380</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">6,842,706</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">6,448,542</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in">Operating costs and expenses excluding non-cash share-based compensation expense is the measurement the chief operating decision-maker uses in managing the enterprise.&#xa0; &#xa0;</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6770808816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2010 Share Plan - 2010 Share Plan [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember', window );">Range Of Exercise Prices $0.67 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number</a></td>
<td class="nump">938,000<span></span>
</td>
<td class="nump">943,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 343 days<span></span>
</td>
<td class="text">6 years 343 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number</a></td>
<td class="nump">799,388<span></span>
</td>
<td class="nump">653,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 215 days<span></span>
</td>
<td class="text">6 years 65 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember', window );">Range Of Exercise Prices $2.27 To $3.01 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number</a></td>
<td class="nump">600,134<span></span>
</td>
<td class="nump">729,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">3 years 295 days<span></span>
</td>
<td class="text">5 years 76 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number</a></td>
<td class="nump">600,134<span></span>
</td>
<td class="nump">579,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">3 years 295 days<span></span>
</td>
<td class="text">5 years 102 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember', window );">Range Of Exercise Prices $3.46 To $5.75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number</a></td>
<td class="nump">472,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 186 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 4.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number</a></td>
<td class="nump">240,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 69 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember', window );">Range Of Exercise Prices $3.46 To $7.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 270 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 167 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices067Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices067Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices227To301Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices227To301Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices346To575Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices346To575Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices346To700Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices346To700Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6768608640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Warrants - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf925Member', window );">Warrant With Exercise Price Of $9.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Investment Warrants Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 19,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf13875Member', window );">Warrant With Exercise Price Of $13.875 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="nump">$ 13.875<span></span>
</td>
<td class="nump">$ 13.875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Investment Warrants Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 19,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf503Member', window );">Warrant With Exercise Price Of $5.03 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Investment Warrants Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Warrant [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="nump">$ 3.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ConsultationExpense', window );">Consultation Expense (in Dollars)</a></td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ConsultationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to consultation expense for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ConsultationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsWarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of warrants held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentWarrantsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf925Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf925Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf13875Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf13875Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf503Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=anix_WarrantWithExercisePriceOf503Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6634020384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock', window );">Schedule Of Changes In Noncontrolling Interest [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Balance at October 31, 2018</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(251,377)</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:83%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Net loss attributable to noncontrolling interest</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(148,030)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Balance at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(399,407)</font></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the changes in noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ScheduleOfChangesInNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6636449376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payment Arrangement [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt;">3.&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">STOCK BASED COMPENSATION AND WARRANTS</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The Company maintains stock equity incentive plans under which the Company grants incentive stock options, non-qualified stock options, stock appreciation rights, stock awards, performance awards, or stock units to employees, directors and consultants.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Stock Option Compensation Expense </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="color: black;">The compensation cost for service-based stock options granted to employees and directors is measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, and is expensed on a straight-line basis over the requisite service period (the vesting period of the stock option).&#xa0; </font>We recorded stock-based compensation expense related to service-based stock options granted to employees and directors of approximately $2,433,000 and $1,153,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $784,000 and $702,000 during the three months ended July 31, 2019 and 2018, respectively.</p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="color: black;">For stock options granted to employees and directors that vest based on market conditions, such as the trading price of the Company&#x2019;s common stock exceeding certain price targets, we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&#xa0; </font><font style="color: black;">On May 8, 2018, we issued market condition options to purchase 1,500,000 shares of common stock, </font>to our Chairman, President and Chief Executive Officer, <font style="color: black;">vesting at target trading prices of $5.00 to $8.00 per share before May 31, 2021, with implied service periods of three to seven months.&#xa0; In October 2018, the first tranche of 500,000 shares of market condition options became exercisable upon achieving an average closing price above $5.00 per share for twenty consecutive trading days.&#xa0; </font>We recorded stock-based compensation expense related to market condition stock options granted to employees of approximately $376,000 and $2,446,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $-0- and $2,446,000 during the three months ended July 31, 2019 and 2018, respectively. &#xa0;</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="COLOR:black">On November 1, 2018 we adopted Accounting Standards Update 2018-07 (&#8220;ASU 2018-07&#8221;) for stock options granted to consultants.&#xa0; Upon adoption of ASU 2018-07 we estimated the fair value of unvested service-based and performance-based stock options at the date of adoption, using the Black-Scholes pricing model.&#xa0; Subsequent to adoption of ASU 2018-07, future grants to consultants are measured at the grant date, based on the fair value of the award using the Black-Scholes pricing model, consistent with our policy for grants to employees and directors.&#xa0; In prior periods, in accordance with US GAAP, we estimated the fair value of service-based and performance-based stock options granted to consultants at each reporting period using the Black-Scholes pricing model.&#xa0; We recognize the fair value of stock options granted to consultants as consulting expense over the requisite or implied service period of the grant.&#xa0; </font>We recorded stock-based consulting expense related to stock options granted to consultants of approximately $75,000 and $197,000 during the nine months ended July 31, 2019 and 2018, respectively, and approximately $25,000 and $49,000 during the three months ended July 31, 2019 and 2018, respectively.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Stock Option Activity </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><a name="_Hlk507419595">During the nine months ended July 31, 2019 and 2018, we granted options to purchase 10,000 shares and 3,897,000 shares of common stock, respectively, &#xa0;to employees, directors and consultants, with exercise prices ranging from $2.30 to $3.84 per share, pursuant to the Anixa Biosciences, Inc. 2010 Share Incentive Plan (the "2010 Share Plan&#8221;) and the Anixa Biosciences, Inc. 2018 Share Plan (the &#8220;2018 Share Plan&#8221;)</a>.&#xa0; &#xa0;&#xa0;During the nine months ended July 31, 2019 and 2018, stock options to purchase 40,000 and 48,600 shares of common stock, respectively, were exercised with aggregate proceeds of approximately $103,000 and $-0-, respectively.&#xa0; Under certain circumstances, stock options may be exercised on a cashless basis. &#xa0;During the nine months ended July 31, 2019 and 2018, -0- and 8,784 shares of common stock, respectively, were withheld in connection with cashless exercises of stock options.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Stock&#xa0;Option&#xa0;Plans</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">As of July 31, 2019, we have three stock option plans:&#xa0; the Anixa Biosciences, Inc. 2003 Share Incentive Plan (the "2003 Share Plan"), the 2010 Share Plan and the 2018 Share Plan, which were adopted by our Board of Directors on April 21, 2003, July 14, 2010 and January 25, 2018, respectively.&#xa0; The 2018 Share Plan was approved by our shareholders on March 29, 2018.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><i><font style="text-decoration:underline">2003 Plan</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors and consultants.&#xa0; In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the ability to grant future options on April 21, 2013. &#xa0;Information regarding the 2003 Share Plan for the nine months ended July 31, 2019 is as follows:</p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:45pt"> <td style="HEIGHT:45pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 16%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted <br />Average Exercise Price Per Share</font></p></td> <td style="HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate Intrinsic Value</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">12,000</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.77</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,000)</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.63</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">8,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.34</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;&#xa0;23,694</font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of July 31, 2019: </font></p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise <br />Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 - $17.00</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">0.19</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.34</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Information regarding the 2003 Share Plan for the nine months ended July 31, 2018 is as follows:</p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" rowspan="3"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate <br />Intrinsic <br />Value</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">30,600</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.16 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(10,600)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(8,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 7.04</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">12,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.77</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;13,054</font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of July 31, 2018: </font></p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">&#xa0;&#xa0; $ 0.67 - $17.00</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">12,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">.99</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.77</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><i><font style="text-decoration:underline">2010 Plan</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors and consultants.&#xa0; As of July 31, 2019, the 2010 Share Plan had 889,200 shares available for future grants.&#xa0; Information regarding the 2010 Share Plan for the nine months ended July 31, 2019 is as follows: </p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,131,868</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.11</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Granted</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">10,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.64</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(32,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.27</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(99,200)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.78</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,010,668</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.03</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;5,422,886</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,639,556</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.92</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;4,609,165</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of July 31, 2019:</p><br/><table width="800" style="WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining <br />Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">938,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.94</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">799,388</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.59</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.27 -$ 3.01</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">600,134</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.81</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">600,134</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.81</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.46 -$ 5.75</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">472,534</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.51</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 4.05</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">240,034</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.19</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 4.43</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><a name="_Hlk10191405">Information regarding the 2010 Share Plan for the nine months ended July 31, 2018 is as follows: </a></p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,637,246</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.50</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Granted</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">475,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.22</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(38,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(49,800)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.15</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,024,446</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.90</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;2,965,764</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,284,190</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.73</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;2,108,817</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><a name="_Hlk10190711">The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of July 31, 2018:</a></p><br/><table width="800" style="WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining <br />Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">943,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">6.94</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">653,142</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">6.18</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.27 -$ 3.01</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">729,712</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.21</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.61</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">579,314</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.28</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.60</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.46 -$ 7.00</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">351,734</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.74</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">51,734</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">1.46</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 5.27</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <i><font style="text-decoration:underline">2018 Plan</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The 2018 Share Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, performance awards <font style="FONT-SIZE:11pt">and</font> stock units to employees, directors and consultants.&#xa0; As of July 31, 2019, the 2018 Share Plan had 2,008,000 shares available for future grants.&#xa0; Information regarding options outstanding under the 2018 Share Plan for the nine months ended July 31, 2019 is as follows:</p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,482,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.84</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(8,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.84</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,470,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;3,337,300</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,321,111</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;1,273,443</font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2019: </font></p><br/><table width="831" style="WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.70 -$ 4.61</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,470,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.78</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,321,111</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.77</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Information regarding the 2018 Share Plan for the nine months ended July 31, 2018 is as follows: </p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate <br />Intrinsic&#xa0; <br />Value</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -0-</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Granted</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,422,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.71</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,422,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.71</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;-0-</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">167,779</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;-0-</font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of July 31, 2018: </font></p><br/><table width="831" style="WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.70 -$ 3.84</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,422,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">9.77</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.71</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">167,779</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">9.76</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><i><font style="text-decoration:underline">Outside of Share Plans</font></i></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in">In addition to options granted under the 2003 Share Plan, the 2010 Share Plan and the 2018 Share Plan, the Board of Directors approved the grant of stock options to purchase 1,780,000 shares to employees and directors outside of Share Plans.&#xa0; Information regarding stock options outstanding that were granted outside of Share Plans for the nine months ended July 31, 2019 is as follows: </p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$1.58</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2019&#xa0;&#xa0; </font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$1.58</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;5,583,900</font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following table summarizes information about stock options outstanding and exercisable that were granted outside of Share Plans as of July 31, 2019:</font></p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,046,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.05</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58-$ 5.56</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">734,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2.59</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.88 </font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Information regarding stock options outstanding that were granted outside of Share Plans for the nine months ended July 31, 2018 is as follows: </font></p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.58</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2018&#xa0; </font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.58</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;3,206,700</font></p></td></tr></table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The following table summarizes information about stock options outstanding and exercisable that were granted outside of Share Plans as of July 31, 2018:</font></p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,046,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">4.05</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58-$ 5.56</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">734,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:29.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.59</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.88</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline"><font style="COLOR:black">Stock Awards <a name="_DV_M176"></a></font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><a name="_Hlk2789464">For stock awards granted to employees, directors and consultants that vest upon grant we recognize expense at the date of grant based on the grant date market price of the underlying common stock.&#xa0; During the nine months ended July 31, 2018, we issued 5,347 shares of common stock that vested upon grant to consultants for services rendered.&#xa0; We recorded consulting expense for the shares of common stock issued to consultants of approximately $15,000 for the nine months ended July 31, 2018 and $-0- for the three months ended July 31, 2018.&#xa0; We did not grant any stock awards that vested upon grant during the nine months ended July 31, 2019.</a></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;">On May 8, 2018, a restricted stock award of 1,500,000 shares of common stock was granted under the 2018 Share Plan to our Chairman, President and Chief Executive Officer.&#xa0; The restricted stock award vests in its entirety upon achievement of a target trading price of $11.00 per share of the Company&#x2019;s common stock before May 31, 2021. &#xa0;&#xa0;<font style="color: black;">For restricted stock awards vesting </font>upon achievement of <font style="color: black;">a price target of our common stock we use a Monte Carlo Simulation in estimating the fair value at grant date and recognize compensation cost over the implied service period (median time to vest).&#xa0; </font>We recorded stock-based compensation expense related to the restricted stock award of approximately $1,954,000 and $1,374,000 during the nine months ended July 31, 2019 and 2018, respectively, and $-0- and approximately $1,374,000 during the three months ended July 31, 2019 and 2018, respectively.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Employee Stock Purchase Plan</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The Company maintains the Anixa Biosciences, Inc. Employee Stock Purchase Plan which permits eligible employees to purchase shares at not less than 85% of the market value of the Company&#8217;s common stock on the offering date or the purchase date of the applicable offering period, whichever is lower.&#xa0; The plan was adopted by our Board of Directors on August 13, 2018 and approved by our shareholders on September 27, 2018.&#xa0; During the nine months ended July 31, 2019, employees purchased 5,411 shares at a purchase price of $3.43 per share pursuant to the plan.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Warrants</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">During the nine months ended July 31, 2019 we issued a warrant, expiring on November 1, 2023, to purchase 25,000 shares of common stock at $4.04 per share, vesting over 12 months, to a consultant for investor relations services. &#xa0;We recorded consulting expense of approximately $64,000 during the nine months ended July 31, 2019 and approximately $21,000 during the three months ended July 31, 2019, based on the fair value of the warrant recognized on a straight-line basis over the vesting period. &#xa0;</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In July 2018 we issued a warrant exercisable at $3.65 per share vested upon grant to purchase 25,000 shares of common stock to a consultant for investor relations services.&#xa0; We recorded consulting expense of approximately $57,000 during the three months ended July 31, 2018, based on the fair value of the warrant. &#xa0;This warrant was exercised in October 2018.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:40.5pt">As of July 31, 2019, we also had warrants outstanding to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019 and warrants to purchase 500,000 shares of common stock at $5.03 per share expiring on November 30, 2021.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6635248112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0in;">7.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">EFFECT OF RECENTLY ADOPTED AND ISSUED PRONOUNCEMENTS</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#8220;ASU 2014-09&#8221;), Revenue from Contracts with Customers.&#xa0; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &#xa0;<a name="_Hlk501045300">The Company adopted ASU 2014-09 on November&#xa0;1, 2018.&#xa0; The adoption of ASU 2014-09 </a>did not have a material impact on our <a name="_Hlk502247174">consolidated financial statements,</a> other than required additional disclosure of accounting policies. &#xa0;See Note 1 regarding our revenue recognition policy.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#8220;ASU 2016-02&#8221;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities.&#xa0; The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method.&#xa0; The requirements of this standard include a significant increase in required disclosures.&#xa0; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&#xa0;and related disclosures, and our analysis is currently ongoing.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6592009520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><table width="867" style="WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="2" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">For the Nine Months Ended</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31,</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2019</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Net loss:</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,024,785)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(3,783,854)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,807,668)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,583,070)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(875,138)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(484,640)</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(9,707,591)</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(8,851,564)</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense:</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,953,760 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,692,865</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,084,694 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,807,515 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,070,408</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,266,448</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,108,862</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,766,828</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,108,862</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,766,828</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Plus non-cash share-based compensation expense</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,902,512</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,227,016</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total operating costs and expenses</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">10,011,374</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">9,993,844</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr></table><table width="867" style="WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:30pt"> <td style="HEIGHT:30pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:30pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">For the Three Months Ended</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31,</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2019</font></p></td> <td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Net loss:</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(917,363)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(2,359,568)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(1,203,468)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(2,901,708)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(45,217)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(332,300)</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(2,166,048)</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(5,593,576)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash&#xa0; </font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense:</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">507,356</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">569,512</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">801,704</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">359,006</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">44,454</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">411,453</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,353,514</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,339,971</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:31.5pt"> <td style="HEIGHT:31.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Operating costs and expenses excluding non-cash</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">&#xa0;&#xa0;&#xa0; share based compensation expense</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,353,514</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,339,971</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Plus non-cash share-based compensation expense</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">830,898</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">4,628,333</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total operating costs and expenses</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,184,412</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">5,968,304</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr></table><table width="867" style="WIDTH:650pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="2" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31,</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2019</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="2" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">October 31,</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total assets:</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Diagnostics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,201,233</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,545,803</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Cancer Therapeutics</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12.02%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,279,496</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,157,359</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Patent licensing</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">361,977</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,745,380</font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Total</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:1.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">6,842,706</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">6,448,542</font></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8721-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6783123888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense - Share-based Payment Arrangement, Option [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 08, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 784,000<span></span>
</td>
<td class="nump">$ 702,000<span></span>
</td>
<td class="nump">$ 2,433,000<span></span>
</td>
<td class="nump">$ 1,153,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Chairman President And Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,446,000<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">2,446,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in Shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 49,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 197,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Chairman President And Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Chairman President And Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 8.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsStockOptionCompensationExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ChairmanPresidentAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ChairmanPresidentAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6780148608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Sep. 05, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Anixa Biosciences Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,207,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000715446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6782869632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expenses</a></td>
<td class="nump">$ 338,449<span></span>
</td>
<td class="nump">$ 2,472,489<span></span>
</td>
<td class="nump">$ 2,567,294<span></span>
</td>
<td class="nump">$ 2,668,315<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expenses</a></td>
<td class="nump">$ 492,449<span></span>
</td>
<td class="nump">$ 2,155,844<span></span>
</td>
<td class="nump">$ 2,335,218<span></span>
</td>
<td class="nump">$ 2,558,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6634020384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:"><a name="_DV_M76"></a>1.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">BUSINESS&#xa0;AND&#xa0;FUNDING</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 12pt;"><font style="text-decoration: underline;">Description of Business </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;Anixa&#8221; means Anixa Biosciences, Inc. and its consolidated subsidiaries.&#xa0; </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">Our primary operations involve research and development of cancer therapeutics and diagnostics.&#xa0; Our cancer therapeutics programs consist of development of a vaccine against triple negative breast cancer (&#8220;TNBC&#8221;) and development of chimeric endocrine receptor T-cell (&#8220;CER-T&#8221;) technology, a novel form of CAR-T technology, initially focused on treating ovarian cancer. &#xa0;Our cancer diagnostics program consists of development of the artificial intelligence (AI) driven Cchek&#8482; liquid biopsy platform for early cancer detection.&#xa0; </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-indent: 0.5in;"><font style="color: black;">We hold an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by The Cleveland Clinic Foundation (&#x201c;Cleveland Clinic&#x201d;) related to certain breast cancer vaccine technology developed at Cleveland Clinic.&#xa0; We are working in collaboration with Cleveland Clinic to develop a method to vaccinate women against contracting breast cancer, focused specifically on TNBC, the most lethal form of the disease.&#xa0; A specific protein, alpha-lactalbumin, has been identified that is only present during lactation in healthy women, but reappears in many forms of breast cancer, especially TNBC. Animal studies have shown that vaccinating against this protein prevents breast cancer in mice.&#xa0; We are working with researchers at Cleveland Clinic to advance this vaccine toward human clinical testing, and we anticipate filing an Investigational New Drug (&#x201c;IND&#x201d;) application with the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) by the end of the 2019 calendar year.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">Our subsidiary, Certainty Therapeutics, Inc. (&#8220;Certainty&#8221;), is developing immuno-therapy drugs against cancer.&#xa0; Certainty holds an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by The Wistar Institute (&#8220;Wistar&#8221;) relating to Wistar&#8217;s CER-T technology.&#xa0; We have initially focused on the development of a treatment for ovarian cancer, but we may also pursue applications of the technology for the development of treatments for additional solid tumors.&#xa0; The license agreement requires Certainty to make certain cash and equity payments to Wistar.&#xa0; With respect to Certainty&#8217;s equity obligations to Wistar, Certainty issued to Wistar shares of its common stock equal to five percent (5%) of the common stock of Certainty.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-indent: 0.5in;"><font style="color: black;">Certainty, in collaboration with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&#x201c;Moffitt&#x201d;), is advancing toward human clinical testing of its CER-T technology for treating ovarian cancer. Certainty is working with researchers at Moffitt to complete studies necessary to submit an IND application with the FDA.&#xa0; We anticipate filing the IND with the FDA by the end of the 2019 calendar year, with human clinical trials commencing thereafter, in 2020. &#xa0;The collaboration between Certainty and Moffitt was recently extended through November 2020, so the parties may continue research on Certainty&#x2019;s CER-T technology.&#xa0; </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">Our subsidiary, Anixa Diagnostics Corporation (&#8220;Anixa Diagnostics&#8221;), is developing Cchek&#8482;, an AI driven platform of non-invasive blood tests for the early detection of cancer which is based on the body&#8217;s immune response to the presence of a malignancy.&#xa0; We have demonstrated the efficacy of Cchek&#8482; with 20 different types of cancer, including:&#xa0; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, prostate, bladder, cervical, head and neck, gastric and testicular cancers.&#xa0; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">We are currently developing tests for the detection of multiple types of cancer and are working with our development and commercialization partner, ResearchDx, a CLIA-certified laboratory, to launch Cchek&#8482; Prostate Cancer Confirmation as a Laboratory Developed Test during the fourth calendar quarter of 2019.&#xa0; </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">Over the next several quarters, we expect the development of our breast cancer vaccine, Certainty&#8217;s CER-T technology and Anixa Diagnostic&#8217;s Cchek&#8482; to be the primary focus of the Company.&#xa0; As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&#xa0; We do not expect these activities to be a significant part of the Company&#8217;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><font style="COLOR:black">Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &#xa0;We have not generated any revenue to date from our cancer therapeutics and diagnostics programs. In addition, while we pursue our cancer therapeutics and diagnostics programs, we may also make investments in and form new companies to develop additional emerging technologies.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Funding and Management&#8217;s Plans</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; background: white; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><a name="_Hlk523132922"></a><a name="_Hlk2590843"></a><a name="_Hlk9517505"></a><font style="color: black;">Based on currently available information as of September 5, 2019, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next twelve months.&#xa0; </font><font style="color: black;">However, our projections of future cash needs and cash flows may differ from actual results.&#xa0; </font><font style="color: black;">If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies or new technology or technologies that are synergistic with or complementary to our technologies, we may be required to obtain more working capital.&#xa0; During the nine months ended July 31, 2019, we raised approximately $4,900,000 through our at-the-market equity offering of 1,208,808 shares of common stock which is currently effective (we can sell an additional 267,302 shares under our current at-the-market equity program) and may remain available for us to use in the future.&#xa0; Further, we have an additional at-the-market equity offering under which we may issue up to $50 million of common stock, which is currently effective and may remain available to us in the future.&#xa0; We may seek to obtain working capital during our fiscal year 2019 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&#xa0; W</font><font style="color: black;">e cannot be certain that additional funding will be available on acceptable terms, or at all.&#xa0; If we do identify sources for additional funding, </font><font style="color: black;">the sale of additional equity securities or convertible debt could result in dilution to our stockholders.&#xa0; Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities.&#xa0; We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all.&#xa0; </font><font style="color: black;">If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&#xa0; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations</font><font style="color: black;">.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Basis of Presentation</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X.&#xa0; Accordingly, certain information and disclosures required by generally accepted accounting principles in annual financial statements have been omitted or condensed.&#xa0; These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures included in our Annual Report on Form 10-K for the year ended October 31, 2018.&#xa0; The accompanying October 31, 2018 consolidated balance sheet data was derived from the audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;).&#xa0; The condensed consolidated financial statements include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of our financial position as of July 31, 2019, and results of operations and cash flows for the interim periods represented.&#xa0; The results of operations for the nine months ended July 31, 2019 are not necessarily indicative of the results to be expected for the entire year.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Noncontrolling Interest</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Noncontrolling interest represents Wistar&#8217;s equity ownership in Certainty and is presented as a component of equity.&#xa0; The following table sets forth the changes in noncontrolling interest for the nine months ended July 31, 2019:</p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Balance at October 31, 2018</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(251,377)</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:83%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Net loss attributable to noncontrolling interest</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(148,030)</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:83%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 83%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Balance at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 15%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(399,407)</font></p></td></tr></table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Revenue Recognition</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt;  TEXT-INDENT:0.5in"><a name="_Hlk507773489"><font style="COLOR:black">Since fiscal 2016 our revenue has been derived solely from technology licensing and the sale of patented technologies.&#xa0; Revenue is recognized upon transfer of control of intellectual property rights and satisfaction of other contractual performance obligations to licensees in an amount that reflects the consideration we expect to receive.&#xa0; </font></a></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:12pt;  TEXT-INDENT:0.5in"><font style="COLOR:black">On November 1, 2018 we adopted Accounting Standards Update 2014-09 (&#8220;ASU 2014-09&#8221;), Revenue from Contracts with Customers.&#xa0; Upon adoption of ASU 2014-09 we are required to make certain judgments and estimates in connection with the accounting for revenue.&#xa0; Such areas may include determining the existence of a contract and identifying each party&#8217;s rights and obligations to transfer goods and services, identifying the performance obligations in the contract, determining the transaction price and allocating the transaction price to separate performance obligations, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct from other promised goods or services and evaluating whether a license transfers to a customer at a point in time or over time.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Our revenue arrangements provide for the payment of contractually determined, one-time, paid-up license fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&#xa0;&#xa0;These arrangements typically include some combination of the following:&#xa0;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#xa0;&#xa0;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&#xa0;&#xa0;<a name="_Hlk9510034">Pursuant to the terms of these agreements, we have no further obligations with respect to the granted intellectual property rights, including no obligation to maintain or upgrade the technology, or provide future support or services.</a>&#xa0; Licensees obtained control of the intellectual property rights they have acquired upon execution of the agreement.&#xa0; As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is probable and all other revenue recognition criteria have been met.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline"><font style="COLOR:black">Cost of Revenues </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="COLOR:black">Cost of revenues include the costs and expenses incurred in connection with our patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external counsel, other patent-related legal expenses paid to external counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs.&#xa0;&#xa0;These costs are included under the caption &#8220;Operating costs and expenses&#8221; in the accompanying condensed consolidated statements of operations.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt;"><font style="text-decoration: underline;">Patents</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;">Our only identifiable intangible assets are patents and patent rights related to our legacy patent licensing operations.&#xa0; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&#xa0; No patent acquisition costs were capitalized during the nine months ended July 31, 2019 and 2018. &#xa0;We recorded patent amortization expense of approximately $419,000 and $244,000 during the nine-month periods ended July 31, 2019 and 2018, respectively.&#xa0; In evaluating the carrying amount of capitalized patents at January 31, 2019, we determined that based on estimated undiscounted future cash flows a write-down of the carrying amount of approximately $419,000, to a carrying value of approximately $168,000, should be recorded as of January 31, 2019.&#xa0; The carrying value of capitalized patents has been amortized to $-0- as of July 31, 2019. Our estimates of future cash flows were based on our most recent assessment of the market for potential licensees, as well as the status of ongoing negotiations with potential licensees. While we may be able to generate future cash flows from this patent portfolio, as of July 31, 2019, we cannot reasonably determine an estimate of any such future cash flows.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6633526400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - Accrued liabilities - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AccruedLiabilitiesAbstract', window );"><strong>Accrued liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">$ 64,627<span></span>
</td>
<td class="nump">$ 62,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AccruedRoyaltyAndContingentLegalFees', window );">Accrued royalty and contingent legal fees</a></td>
<td class="nump">449,691<span></span>
</td>
<td class="nump">366,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AccruedCollaborativeResearchAndLicenseExpenses', window );">Accrued collaborative research and license expenses</a></td>
<td class="nump">351,994<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">9,459<span></span>
</td>
<td class="nump">65,964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 875,771<span></span>
</td>
<td class="nump">$ 683,099<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_AccruedCollaborativeResearchAndLicenseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for collaborative research and license.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_AccruedCollaborativeResearchAndLicenseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_AccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_AccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_AccruedRoyaltyAndContingentLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties and contingent legal fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_AccruedRoyaltyAndContingentLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6640509536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in -0.15in 12pt 0in; text-autospace: ideograph-numeric;">5.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">ACCRUED EXPENSES</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in">Accrued expenses consist of the following as of:</p><br/><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">July 31, <br />2019</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">October 31, <br />2018</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Payroll and related expenses</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">64,627 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">62,965 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Accrued royalty and contingent legal fees</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">449,691</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">366,670 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Accrued collaborative research and license expenses</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">351,994</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">187,500 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Accrued other</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">9,459</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">65,964 </font></p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 70%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">875,771</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">683,099 </font></p></td></tr></table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6782902464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENT AND CONTINGENCES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Courier New'; font-size:  10pt; ">
<p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 0in 0pt;"><font style="font-size: 12pt; font-family: 'Times New Roman','serif';">9.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">COMMITMENT AND CONTINGENCES</font>&#xa0; </font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><a name="_Hlk18064185"><font style="text-decoration:underline"><font style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Litigation Matters</font></font></a></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in"><font style="COLOR:black">Other than below and lawsuits we have historically brought to enforce our patent rights, we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &#xa0;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in"><font style="COLOR:black">On November 5, 2018, a putative shareholder derivative complaint was filed in the Court of Chancery of the State of Delaware, captioned Howland v. Kumar et al., C.A. No. 2018-0804-KSJM (the &#8220;Derivative Action&#8221;), that alleged claims for breach of fiduciary duty and unjust enrichment.&#xa0; The Derivative Action named as defendants certain of the Company&#8217;s current and former officers and directors (the &#8220;Individual Defendants&#8221;), and the Company was named solely as a nominal defendant.&#xa0; <a name="_Hlk2942011"></a><a name="_Hlk2854829">On August 21, 2019, the Company entered into a settlement pursuant to which the Company agreed to certain changes in its corporate governance policies and to reprice certain stock options that were repriced on September 6, 2017 to $0.67 to the option price immediately prior to that repricing.&#xa0; The Company also agreed to pay certain legal fees, with such fees to be paid from the Company&#8217;s D&amp;O insurance.&#xa0; As a result of this settlement, all of the claims asserted in the Derivative Action will be dismissed.&#xa0; The Individual Defendants have denied, and continue to deny, any and all allegations of wrongdoing or liability asserted in the Derivative Action.&#xa0; The Individual Defendants have further asserted, and continue to assert, that at all relevant times, they acted in good faith and in a manner that they reasonably believed to be in the best interests of the Company and its stockholders.&#xa0; The Individual Defendants have entered into the settlement solely to eliminate the uncertainty, distraction, disruption, burden, risk, and expense of further litigation.</a></font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6770911360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2018 Share Plan - 2018 Share Plan [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember', window );">Range Of Exercise Prices $3.70 To $4.61 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number</a></td>
<td class="nump">3,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 284 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number</a></td>
<td class="nump">1,321,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 281 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember', window );">Range Of Exercise Prices $3.70 To $3.84 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 281 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 277 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices370To461Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices370To461Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices370To384Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices370To384Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6621276592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable under the 2003 Share Plan - 2003 Share Plan [Member] - Range Of Exercise Prices $0.67 To $17.00 [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstnding and Exercisable, Numbers</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">69 days<span></span>
</td>
<td class="text">361 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="nump">$ 2.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding and exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices067To1700Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices067To1700Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6784081616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 08, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 784,000<span></span>
</td>
<td class="nump">$ 702,000<span></span>
</td>
<td class="nump">$ 2,433,000<span></span>
</td>
<td class="nump">$ 1,153,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">197,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member] | Chairman President And Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,446,000<span></span>
</td>
<td class="nump">$ 376,000<span></span>
</td>
<td class="nump">$ 2,446,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Share-based Payment Arrangement, Option [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ConsultationExpense', window );">Consultation Expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember', window );">2018 Share Plan [Member] | Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,374,000<span></span>
</td>
<td class="nump">$ 1,954,000<span></span>
</td>
<td class="nump">$ 1,374,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember', window );">2018 Share Plan [Member] | Restricted Stock [Member] | Chairman President And Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Awards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ConsultationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to consultation expense for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ConsultationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsStockAwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ChairmanPresidentAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=anix_ChairmanPresidentAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6634483328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Money market funds &#x2013;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#xa0;</p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">3,370,661</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">3,370,661</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Certificates of deposit &#x2013;</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;Short-term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,100,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;2,100,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">3,370,661</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,850,000</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">6,220,661</font></p>
</td>
</tr>
</table><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Money market funds &#x2013;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#xa0;</p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,031,331</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,031,331</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Certificates of deposit &#x2013;</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;Short-term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,000,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,000,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,031,331</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,750,000&#xa0; </font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">4,781,331</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6782591072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING (Details) - Patents - Patents [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Jan. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_BUSINESSANDFUNDINGDetailsPatentsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) - Patents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 419,000<span></span>
</td>
<td class="nump">$ 244,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FiniteLivedPatentsNet', window );">Finite Lived Patents Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,000<span></span>
</td>
<td class="nump">$ 419,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_BUSINESSANDFUNDINGDetailsPatentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_BUSINESSANDFUNDINGDetailsPatentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_FiniteLivedPatentsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount after accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_FiniteLivedPatentsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771423616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Plans - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)</a></td>
<td class="nump">889,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember', window );">2018 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)</a></td>
<td class="nump">2,008,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember', window );">Stock Options Not Granted Under 2003 Share Plan 2010 Share Plan Or 2018 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">1,780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsStockOptionPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6641760080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENT AND CONTINGENCES (Details)<br></strong></div></th>
<th class="th">
<div>Aug. 21, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_COMMITMENTANDCONTINGENCESDetailsLineItems', window );"><strong>COMMITMENT AND CONTINGENCES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_COMMITMENTANDCONTINGENCESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_COMMITMENTANDCONTINGENCESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771361200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock options outstanding and exercisable that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Plan - Stock Options Not Granted Under 2003 Share Plan 2010 Share Plan Or 2018 Share Plan [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember', window );">Range Of Exercise Prices $0.67 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstanding and Exercisable, Number</a></td>
<td class="nump">1,046,000<span></span>
</td>
<td class="nump">1,046,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">3 years 18 days<span></span>
</td>
<td class="text">4 years 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember', window );">Range Of Exercise Prices $2.58 To $5.56 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstanding and Exercisable, Number</a></td>
<td class="nump">734,000<span></span>
</td>
<td class="nump">734,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">2 years 215 days<span></span>
</td>
<td class="text">3 years 215 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.88<span></span>
</td>
<td class="nump">$ 2.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding and exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices067Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices067Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices258To556Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=anix_RangeOfExercisePrices258To556Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6784051920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FiniteLivedPatentsImpairment', window );">Patents, impairment (in Dollars)</a></td>
<td class="nump">$ 1,001,729<span></span>
</td>
<td class="nump">$ 582,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Patents, accumulated amortization (in Dollars)</a></td>
<td class="nump">2,034,382<span></span>
</td>
<td class="nump">1,615,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation (in Dollars)</a></td>
<td class="nump">$ 86,789<span></span>
</td>
<td class="nump">$ 53,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">48,000,000<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">20,162,851<span></span>
</td>
<td class="nump">18,908,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">20,162,851<span></span>
</td>
<td class="nump">18,908,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">19,860<span></span>
</td>
<td class="nump">19,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_FiniteLivedPatentsImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of impairment for patents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_FiniteLivedPatentsImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6645247376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_CommonStockOfferingExpenses', window );">Common Stock, offering expenses</a></td>
<td class="nump">$ 111,275<span></span>
</td>
<td class="nump">$ 58,198<span></span>
</td>
<td class="nump">$ 264,186<span></span>
</td>
<td class="nump">$ 141,140<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_CommonStockOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to the common stock offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_CommonStockOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771299264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Activity - 2010 Share Plan And 2018 Share Plan [Member] - Share-based Payment Arrangement, Option [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">3,897,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanAnd2018SharePlanMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanAnd2018SharePlanMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanAnd2018SharePlanMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Stock Option Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="nump">$ 103,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises', window );">Share based Compensation Arrangement By Share based Payment Award Options Withheld In Connection With Cashless Exercises (in Shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,784<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsStockOptionActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options withheld in connection with cashless exercises during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWithheldInConnectionWithCashlessExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2010SharePlanAnd2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2010SharePlanAnd2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6780238992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2003SharePlanMember', window );">2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONTablesLineItems', window );"><strong>STOCK BASED COMPENSATION (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:45pt"> <td style="HEIGHT:45pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 16%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted <br />Average Exercise Price Per Share</font></p></td> <td style="HEIGHT:45pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:45pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate Intrinsic Value</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">12,000</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.77</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:60%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,000)</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.63</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:60%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 60%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">8,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 16%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.34</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:10%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 10%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;&#xa0;23,694</font></p></td></tr></table><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" rowspan="3"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate <br />Intrinsic <br />Value</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">30,600</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.16 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(10,600)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(8,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 7.04</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">12,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.77</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;13,054</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise <br />Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 - $17.00</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">0.19</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.34</font></p></td></tr></table><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="4" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">&#xa0;&#xa0; $ 0.67 - $17.00</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">12,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">.99</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.77</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONTablesLineItems', window );"><strong>STOCK BASED COMPENSATION (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,131,868</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.11</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Granted</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">10,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.64</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(32,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.27</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(99,200)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.78</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,010,668</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.03</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;5,422,886</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,639,556</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.92</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;4,609,165</font></p></td></tr></table><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,637,246</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.50</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Granted</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">475,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.22</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(38,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(49,800)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.15</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">2,024,446</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.90</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;2,965,764</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,284,190</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.73</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;2,108,817</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table width="800" style="WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining <br />Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">938,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.94</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">799,388</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.59</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.27 -$ 3.01</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">600,134</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.81</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">600,134</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.81</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.46 -$ 5.75</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">472,534</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.51</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 4.05</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">240,034</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.19</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 4.43</font></p></td></tr></table><table width="800" style="WIDTH:600pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:48.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:37.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:22.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining <br />Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:10.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:13.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">943,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">6.94</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">653,142</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">6.18</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.27 -$ 3.01</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">729,712</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.21</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.61</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">579,314</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">5.28</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.60</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.46 -$ 7.00</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">351,734</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.74</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:10.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">51,734</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:13.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">1.46</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:11.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 5.27</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember', window );">2018 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONTablesLineItems', window );"><strong>STOCK BASED COMPENSATION (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,482,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Exercised</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(4,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.84</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Forfeited</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">(8,000)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.84</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">&#xa0;</p></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,470,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;3,337,300</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2019</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,321,111</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;1,273,443</font></p></td></tr></table><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate <br />Intrinsic&#xa0; <br />Value</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -0-</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;">&#xa0;</p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Granted</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,422,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.71</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,422,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.71</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;-0-</font></p></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options exercisable at July 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">167,779</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;-0-</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table width="831" style="WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.70 -$ 4.61</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,470,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.78</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,321,111</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">8.77</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td></tr></table><table width="831" style="WIDTH:622.95pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td colspan="6" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Options Exercisable</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="6" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.70 -$ 3.84</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">3,422,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">9.77</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.71</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">167,779</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 14%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">9.76</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 3.73</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember', window );">Stock Options Not Granted Under 2003 Share Plan 2010 Share Plan Or 2018 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONTablesLineItems', window );"><strong>STOCK BASED COMPENSATION (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2018</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$1.58</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2019&#xa0;&#xa0; </font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$1.58</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;5,583,900</font></p></td></tr></table><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Shares</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average Exercise</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Price Per Share</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" rowspan="3" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Aggregate</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Intrinsic</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Value</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:16.5pt"> <td style="HEIGHT:16.5pt; WIDTH:52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding at October 31, 2017</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.58</font></p></td> <td style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:17.25pt"> <td style="HEIGHT:17.25pt; WIDTH:52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 52%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">Options outstanding and exercisable at <br />&#xa0;&#xa0;&#xa0;July 31, 2018&#xa0; </font></p></td> <td style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,780,000</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 1.58</font></p></td> <td style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:17.25pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="COLOR:black">$ &#xa0;&#xa0;&#xa0;3,206,700</font></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 </font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,046,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.05</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67 </font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58-$ 5.56</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">734,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 30%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">2.59</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.88 </font></p></td></tr></table><table width="733" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" cellpadding="0" cellspacing="0"> <tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Range of</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Prices</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Number</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Outstanding</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">and</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercisable</font></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Remaining</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Contractual Life</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">(in years)</font></p></td> <td style="HEIGHT:15pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" rowspan="5" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Weighted</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Average</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">Exercise Price</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">1,046,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">4.05</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 0.67</font></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.58-$ 5.56</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 22%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt;  text-align: right;"><font style="COLOR:black">734,000</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:29.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">3.59</font></p></td> <td style="HEIGHT:15.75pt; WIDTH:2.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;"></td> <td style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 20%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt;  text-align: center;"><font style="COLOR:black">$ 2.88</font></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771094864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jul. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Stock Issued During Period, Value, Other | $</a></td>
<td class="nump">$ 4,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period, Shares, Other (in Shares) | shares</a></td>
<td class="nump">1,208,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in Shares) | shares</a></td>
<td class="nump">267,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_BUSINESSANDFUNDINGDetailsLineItems', window );"><strong>BUSINESS AND FUNDING (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues | $</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_BUSINESSANDFUNDINGDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_BUSINESSANDFUNDINGDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6782706992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details) - Segments Information - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_NetLossAbstract', window );"><strong>Net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">$ (2,166,048)<span></span>
</td>
<td class="num">$ (5,593,576)<span></span>
</td>
<td class="num">$ (9,707,591)<span></span>
</td>
<td class="num">$ (8,851,564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract', window );"><strong>Operating costs and expenses excluding non-cash share based compensation expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating costs and expenses</a></td>
<td class="nump">1,353,514<span></span>
</td>
<td class="nump">1,339,971<span></span>
</td>
<td class="nump">5,108,862<span></span>
</td>
<td class="nump">4,766,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Plus non-cash share-based compensation expense</a></td>
<td class="nump">830,898<span></span>
</td>
<td class="nump">4,628,333<span></span>
</td>
<td class="nump">4,902,512<span></span>
</td>
<td class="nump">5,227,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">2,184,412<span></span>
</td>
<td class="nump">5,968,304<span></span>
</td>
<td class="nump">10,011,374<span></span>
</td>
<td class="nump">9,993,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_TotalAssetsAbstract', window );"><strong>Total assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">6,842,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,842,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,448,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Cancer Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_NetLossAbstract', window );"><strong>Net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(917,363)<span></span>
</td>
<td class="num">(2,359,568)<span></span>
</td>
<td class="num">(4,024,785)<span></span>
</td>
<td class="num">(3,783,854)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract', window );"><strong>Operating costs and expenses excluding non-cash share based compensation expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating costs and expenses</a></td>
<td class="nump">507,356<span></span>
</td>
<td class="nump">569,512<span></span>
</td>
<td class="nump">1,953,760<span></span>
</td>
<td class="nump">1,692,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_TotalAssetsAbstract', window );"><strong>Total assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,201,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,201,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,545,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Cancer Therapeutics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_NetLossAbstract', window );"><strong>Net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(1,203,468)<span></span>
</td>
<td class="num">(2,901,708)<span></span>
</td>
<td class="num">(4,807,668)<span></span>
</td>
<td class="num">(4,583,070)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract', window );"><strong>Operating costs and expenses excluding non-cash share based compensation expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating costs and expenses</a></td>
<td class="nump">801,704<span></span>
</td>
<td class="nump">359,006<span></span>
</td>
<td class="nump">2,084,694<span></span>
</td>
<td class="nump">1,807,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_TotalAssetsAbstract', window );"><strong>Total assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,279,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,279,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,157,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Patent Licensing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_NetLossAbstract', window );"><strong>Net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(45,217)<span></span>
</td>
<td class="num">(332,300)<span></span>
</td>
<td class="num">(875,138)<span></span>
</td>
<td class="num">(484,640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract', window );"><strong>Operating costs and expenses excluding non-cash share based compensation expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating costs and expenses</a></td>
<td class="nump">44,454<span></span>
</td>
<td class="nump">$ 411,453<span></span>
</td>
<td class="nump">1,070,408<span></span>
</td>
<td class="nump">$ 1,266,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_TotalAssetsAbstract', window );"><strong>Total assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">$ 361,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,745,380<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_NetLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_NetLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_OperatingCostsAndExpensesExcludingNonCashShareBasedCompensationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_TotalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_TotalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=anix_CancerDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=anix_CancerDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=anix_CancerTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=anix_CancerTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=anix_PatentLicensingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=anix_PatentLicensingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771919504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 6,220,661<span></span>
</td>
<td class="nump">$ 4,781,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">3,370,661<span></span>
</td>
<td class="nump">2,031,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">2,850,000<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,370,661<span></span>
</td>
<td class="nump">2,031,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,370,661<span></span>
</td>
<td class="nump">2,031,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Certificates of deposit &#8211; Short-term investments</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Short-term Investments [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Certificates of deposit &#8211; Short-term investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Short-term Investments [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Certificates of deposit &#8211; Short-term investments</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Short-term Investments [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems', window );"><strong>FAIR VALUE MEASUREMENTS (Details) - Hierarchy for financial assets measured at fair value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Certificates of deposit &#8211; Short-term investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_FAIRVALUEMEASUREMENTSDetailsHierarchyforfinancialassetsmeasuredatfairvalueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6782547952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,396,853<span></span>
</td>
<td class="nump">$ 3,055,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments in certificates of deposit</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">306,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">129,644<span></span>
</td>
<td class="nump">175,491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,627,569<span></span>
</td>
<td class="nump">5,538,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_FiniteLivedPatentsNet', window );">Patents, net of impairment of $1,001,729 and $582,979, respectively, and accumulated amortization of $2,034,382 and $1,615,632, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">837,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $86,789 and $53,799, respectively</a></td>
<td class="nump">215,137<span></span>
</td>
<td class="nump">72,670<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,842,706<span></span>
</td>
<td class="nump">6,448,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">567,778<span></span>
</td>
<td class="nump">582,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">875,771<span></span>
</td>
<td class="nump">683,099<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,443,549<span></span>
</td>
<td class="nump">1,265,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.01 per share; 48,000,000 shares authorized; 20,162,851 and 18,908,632 shares issued and outstanding, respectively</a></td>
<td class="nump">201,628<span></span>
</td>
<td class="nump">189,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">185,326,706<span></span>
</td>
<td class="nump">175,415,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(179,729,770)<span></span>
</td>
<td class="num">(170,170,209)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">5,798,564<span></span>
</td>
<td class="nump">5,434,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest (Note 1)</a></td>
<td class="num">(399,407)<span></span>
</td>
<td class="num">(251,377)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">5,399,157<span></span>
</td>
<td class="nump">5,183,431<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">6,842,706<span></span>
</td>
<td class="nump">6,448,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_FiniteLivedPatentsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount after accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_FiniteLivedPatentsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>57
<FILENAME>0001513162-19-000202-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-19-000202-xbrl.zip
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MR-.U2E&X6#_15A/K1X\LM?M7SRB!B^ZC(D7[P^L*I;8PLB;7F&23IX?U,_'
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M_C :LQKR56>;*&"@Q4C*>GU:E&5)V,T5D:] PAV:(N#7XP)Y7Y ?>N;*;!
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MO%YJ_,^6[;CA#@'R#L&,-)G(?"QI2;]Z.Y N,_@>-(@X82HU^#9SKFW<S0N
M<XMW9QS[PO==ZW'MXP#XP?GBV)@@UUDLX)'#^:4 OP1%VR6M*@1M+9@U/LT]
MH!1T28X;MV:F&0M,(1RL4ZNW\L]]0^7G Z4I*YFP%J0L9W7C>KDR+'=YX&(F
M&&5QDKN"LADC%.!!Q.S-:2=:05KB$HL]"G S["<+@$@7 V(>Y6*)T?HG*54Y
M) 8#[=!C,BP_>%H5ZB5_3_"B"HHJU4I^PFFO7!B-/ 9_+Q"Q#G;BY[DK40<L
M0JB:GDS\:R$H<R&I\:GN41%)F[0RU62J<VNX-RZIM#))N!^VR4Q,9%,45"57
M39NEQ&I] 5(:G4*QY+?I*=!]TXNU/X=0Z4]D[MFD+<MWLG4K3'0UE_ T 3OS
M^Y+4EF5Q(]1>>]ZZ&;[NH9(.7 P A8BLQ,X:B2Q>2] $.U.U!762VP1C2Y![
MD!DKM:)6@S5K:!JE5N<:G49)&U>1_]34R4<QRQ5YW0#)A<S>(1PN:OUJ(?00
MOM9%:'&CUR!;D[:O/I(;9' ^R;%E\8,LW(Y\1P3RQGQL?:; F+LV!@ZB<T>R
M4C>=)>W6#@X2$<MZNI1LQUA;]8F5R=K!L ;(*F2)]G&*[CHIV9+<'1A6(V@?
MC^A>5'P1HSI!Q>U)#6S:&>8=0%H-#-M)VAUZ1O9Z]SZ]GM=:)[\@K,SK)WGM
M4]*UD:JH\(E-,/KN[9K0_6/F5URGE@25I,8>,J; YW5,34>R@I _T]2XSJNQ
MP <12+5C34*L-D!1,8JRD-AJ28YPR!2+"E50,9*:H*"PB#55$_0=)"16)F.K
M?#>S]$IN19DGB^8%75-B*X\[!ZR+N*)XT05)E-LFKBB4".?XXM351%YAG(FR
M-$E4!^^C+V75/(1OAKZPS0_XYF>'+"@?9FQ2.;NN*)H<MW0[1DS77%0DKK"A
MFL@BKPGM$E<8>"HOBM*D7>(*PTZ6=#Y1-+V'NN0N.2*[RS\C&[G& F]SF$O+
M)@=#\:')6N&GJ!,U=EBHV-#;A2,'4UP8DQHO:8K8 8H+ U7F%4E7.D!Q<?2"
M;BE*-9(3-&]VM;=M+;VN#K_5<<P7:[&S:JU,!-X( 3OPV0X!51UR*0*:(GX7
M\K8SJ&3FZ)&:Z@!BM41[HJ#+LI#(&).#9"6PQ<DH:LJ4":[JEYLBHW RP/,"
MN*J==%2EH;#%F4PFDBX7IB%JO7)M3YTE^N1XM0#C; L9&0.E=*0D*47!<::H
MO*+'T5$[*44!<C;1U"1 :B>E,$[.=!W2(7DO+4DS%AV?I<\4J2,L'$'I4KS(
M-F^H+6]>A::BV!%$,5Y)WRA-14&D2)HNM413\>1PHL77('82E:(JQ!J];!>?
M]UD#!@,P.K;W'LT<%]'G'HQOR$O7 (-M2[Z%5D5^1O[<,0N>)R]AUU25EQ.8
M:&T"V]K8"=X5-\3*1%(TE?&NDN?@-25^.)WQKHRK4P0EZ5Q:95X&]^"=04#V
M'E+!V>XC,P?LFE08K4R"=OAH.S2@@='*I$^IT_?PYAJCXY07V;P_XTQBD:&K
M&^&#AZYNPPX>^@ 3D!H[,?@7Y&]T^]!S-,5!H?)B+(8J343#\RB,, ' K1PV
MD<8F41BK@JSS4D<G41SU B2^\0W]*IC*G\:S82WHCV.% L')I/>&9TUKLI4R
MS\>SL))$I*.7&N=0W.C*FCH1U2[.H;CU!L^AJ$(7YU#"#:C@_?(UHM D$K,(
MSR2'M6GD*;PU92W6?KR&:4=Y7"%5$(%Z?AQOVK%GZ'?U$UH([Y30N.ULG]!"
MH*:$QMNPM$]H,>122I52+$V0^ANRGN;X@-XSY#=/Z,L:U[/>S,A/8S5=N3.H
M#MNPZ(WG)T)L&ZP:0>]:F%4AC ?U<K(D\&(O9E5((8*S4JJDZY+4AUD5TQXZ
M+4U4-$56:YA6LO!FL7"FN$(Y5$-DXM:ZD(Z2=80B>\E"GA[]OK/4(?/DBH3W
M?N(G/PN1EW&$]?!IB7F*5&%:HJR)LEYA7C7/2<I3HRIS4E1-G,A'GY.<IT-5
MYJ2JNA2W\T>:DY*K4L7J+[S,V<D3L2O*I>8JUR$3% 5%2>P='TE\6JZ:'30[
M25)$03_Z[/1<A3MH=B Z+7Z0ILKL2AR_V+I'*Y8QY1WTVSI@L.,D6O,-;LK-
M(*.[65TM;UIN7\2GIIW3EBR;!=M=S7K*A?252^DF8YG3S^I.5E_CH]8;68GI
M0^H&;OV9.?,"3<@J3KOE.:=.0?V>_8ILZ:>[D373\^K"_.<ZV#Q\<'*4,]NF
M$WIN5F0#\PX!09[EHWOD/EM31&^ON$-3Y\FV]C8WDG,]<!EK(0)B)D+\3$,[
M4\L(N3K 4R67ISOT[I@L[!@#"Q^T.R;JHMYGA0;=O!Z"O=\,%]]7%81#^YO
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M],%RT=1W7.]V[>**(__!H:[/GH*]MY[KNPXFO&FJ5LI:GFSYTQHUSW8SW;!
M[&9&GHO5=M^XEPO#6E95G&_>N6TM?GKCNVOTYFU":0\;LVQA>\$AMRSO![0"
M7EK&OG7:HLB5Q$E\NS#^^NU4O>C@Q9DARH*<-WJ&9+(#I, $FQ?>Q2=@'OSY
M$55U1EL :8Z*LO66U:E(><NP-/,#HO][;=^A*;*>\099+1[I3.*5B1 [2+-S
MQ'?U$%>8G3*OQ0.,/;2E=6#[\5L7K2 3_H @:'(AK:$2 +-WX\^1>^%YJ!X_
M?R8K>OP0635*VIA1<?U7)3%^<V'5*>V>SL5TZJPA>+@U7K%0:Y&%((N2O(OP
MU*#I7/$@*@OS]TSE)T)9,O?3";;1_&09C];"\JUZ3(8 .;8F[J$T-6[MQ!9/
M"GA>U_4*U";+^)%_:7ASR-R?+1.9[U^_@N&^MF]6R 47:#]=3"$VJHW#9Y+,
MRY(>JV\K/O[6N9):*"\.8TE41#E^"58YTI.K-,9KN/<V_=<:(M/[N>/Z#\A=
M7MO/*-B8JR65E93D_E>AD=_53&T)M\A7(S>]!C9%R/3(L0]C@4/;IM@KIME;
M:.AM/!Q,<7$6:]5)WHT*>!% WW_%B90/WA%70JWP([789DTA^Q/E1W_7 -7%
MC32^>.UPJG-,#95/_59:3#&[^/#I0V*UT%V8VYJ@"W(==,=U8I/MQ%8GZV!S
M=&%GX5%WVHW2=)8_ UN.T'P+AQ])W4=^@&5(7H.</5 =!.WBU_::SI[1RC10
M*LP)'KNC':S8UT#^("K+L*> C?AHV0"KVFV;PHN\SN\/0#.&+V;;2M)=70E+
M$9Z@'/\,_P<[FV?P^."0-M47^ MP1,D/8D_2;=KM9".H=[[Z-IT;]A.Z,WQT
M-9NA:3W>'_*&B1ISI.U.H;L,+)Z^:+(NQF^/;)^#6RR$$5+OO0!(N^XKO&+_
MO3Z[>_)*DC21XF?]"PV8)>B#J-QS:DU4)@(_F1Q(Y8W[9-C6GV3)&N]3.0O+
M)/]X;W@6C'[K(@]>0S]:>Y:-/.\#\J:N%19W!BLPY+S"PIJ"S7B *;Q?X BB
MH,*^^\^%_X-I/7.>_[I /_WGO]:._\,,?GLV,Y;6XO6<^T]CN?J!?/Q@+<$J
M?D$OW)VS-.S-%Z/-GQY ;+;YYP\<>9=G_8G..4%<^3]P=(C_?((_,4/P^*O$
MZ!]OOCR<W5__S]4Y_0'Y]\>+S]>?_OO\0&(^7]S]?/WEG+=L#O^'OO_AZA\/
M9Q=?'V[N;R\NK\XW]&'2#,XVEB%EOW_X]??/FII\XJV!_Q+&9)Q__V;P/]3S
M%X=?CKF78 Z6Z1F T7$)+L[7MHG<!6!C0]3[K_?77Z[N[S>ONOCR8?./CU^_
M?+C^\C,A';\^FL<J_.O1?1O^N=K&15R6*:"L'&];+OC#$?V?0![XSQ^XI>$^
M6?8YEQ!&DK5[9\]%TX_],J8CG#/C0M7AJLRX02Q2V'VZ_OG+.2[JMF:O6_CD
M,^ )08/SY!JK^9F]7L([I\$3UU\^7'UY..?'BF7OX>+ES:>;N_/'A3']8_/D
M!<0[.%2<(Q=9]HBJ_;_KHLC_\()&T;^$'^+?K+V\;YRUF_C*GZ/XUWB_U[!?
MXT\X;OR!"]OZ9L2_7B(<YY./N?>6XX&U@_3%&W'@OL:<89N<Y7O8Z@5V%*;B
MA;U#P#".4XK%@) 'A)NURZU<<';N*^?015%@*F?9S\[B&7'8*1GN=$Y8;J)G
MM'#HN@NHVA1GE"Z6-="%UKXU]>ACEO%D.Q[^=UP.>*2LGZQ</+$EE:;ED5>G
M1C*X9V,*X3+BC"?#LN$9B'A6"\39Z,G 90'<(XYM_/#]W\>@]?#E_64,67_)
MG,G<(CSED&TZ8$UL//$I6OF TH>S*5HL$J^\O+H[>TB\TT?3N>TLG*?7$1!K
M._!VL);N$K_\\@*>3CQAX1-(QF+Q"L],B1J"[?)A!MBW<\XS0-BP@[F,N0T+
M8QR,\3AD8,@_+X.!6!\-%\ &88.Q  )\F)/UA'6*^_[B^B^<Z0(7;>YR.D=_
M!#.#4/0';F%!@&-RCY:S\EZYU<+PR;3@OSC !<P@I ?!!#%T#M6\6IT.<2 &
M3!1\1Z1L:4]$M(T^N?8=;V5,8>P,=2./6."!;!]^C/5MG_^:@KS=<XYH7.S9
MWQ"'CZ$"$#GT#8)Q#P/XQ7$7Y@L,.^)<Y]58^*]GC\!A#(@%W9[G? ?;; [8
MC<MB R$"U]<@T56P1,DY+S;&D\N%6_[PK\=7[@$ <+G H,#POP0?"FC_".$D
MC4%#>'^#*''Z0_K!S7<F8-V%K["]!7)"4I+:%^KJ!O(A'.%7AK]%1QPROV&<
M$F[\@:<.[P8F+HS'( 3@7BQ_OCT1("48 ;1OB?RY0\BCA "Q\#[0A,AX$-88
M4Z)M"=)'D4)Z*\@ 0%N(EL*XV(J,B!HM0>NX!8QA;%0<?VY:'DZOXI.YB%Z#
MY>,31VLL5G/C#!#A&XO']1)_-#<\[A$!?1;&%CR.F3L'1EF@RC:,OZ*I 6>N
M*1[PCPDW@#US!%B9O](9CKC'M0\",E8KP ZVXH!V^Y702<Q":K:(T$?FB"<X
MQ@X7TAX ,62(H&)S Y#IS0%3E*"0H9B*R!+/+2^<'J;TF6R")!&!Z0 0[Q T
MD6OH;!"0GH$3+%+#?";=R<BH$= <7%3&S==+;#;)LS )GRX?CXC!?X'A@+=3
M:X7A,+,69 HV%ZPR/QGTH (Q*A_<]5-2(:ZCB#K0 6 P:&4,DA@!7\?W8] I
MQR0CDK=<F"!AL,ENAI9]_'"1?"FH*7X-^* 04SAG QY">FD:+O<*S!FS:&9?
M-!/%@>!I+ZF!\HD!C$*.((I,N/3PP;A;'V$-# P+L4;+Y=IVSFCT D8-).QM
MC IUUS&(;P;'YMYKW=[_!L #V%P#=9:_!MC')TR_3 0QQ+!C F#@Y->"]H/'
MD:@G9M13VDQL179D@ZUC.J CX0[Y)XXEDC$/-6.@LDOC%0RFYW K7 Z*XFKG
MA3H2\S+X31F#14-YY DC.I;$D>2!\]=+QTV$JIA[H12,)Q<A\BH7D=U +R98
MX-32^&,CHZGAT5 9D083W"K82MRP-,&UP.BM\/HA/+$%0L+WX%7.XR(P4[&W
MQ1%NT79'T7<</4N'.4!S);SQ RJ$EXO@G=A".F )06J )%Q>RWVO_,=?0K8F
M'L=1;#A.)0MT E%=Q*!13M2"N?K+F/N$$/?9F<TL'SP<=8^7"-=D$MS<A?E6
MI+5)8T5=1_#[A/L@QHJZ1ZK#.WQBB(FT2E,-RDM$XE#;Z;C#Z>$($3)_")90
M%%+8D%=Y'LXVX5LPU4O+)W[XRX=LIPI>,ATV;/EQ_!Q^0?Q'A;SIB/XDS228
M]8(J# J8B9=)C)F/31,(5^1%/IZ7/1!]B0O\$?DO.*+;L P+-^3+"P1\.+^T
M?3"4@#\@B(1\KK-^FG-?('O$Y[C(,".P483X%4[?@'_8)&)3;]GK6';NV&GC
M@5$QV6.U62Q1)I:@BU$?8HGWI>.NG&1HMUG-BC^Y*ZA(I]PX7N4NKL.,/$JY
M <2V8X.I>C9( /&XP)$F5F@O<GPT)8]R\=@BS<O< IC R(]&S"L_.F;2UY (
MA^!JY00A" $?24 @[":N>TEL+[PW,P0P$?@-$O$23 -1,YQ'35^)%TFO+Q#]
M$WG(GO!),NR$_-<5=5IA+&"%&U;GL=%H?C'B%FL<X6.3#,G/$F<+@+=1:+K@
M>V"5BQ.W5]>QS!&H$=D. Z&,L+T!S0,W;RQ&'%A:O.X#/_5\Y("!FI(7+9#E
M+%]C_[96FW\\KQ?/V(A , 8.%YMJ@)!IX@&GY'@&?C$D:#0A ,OWQXA[,LAN
M'?F$6./I>F&$RSJ)(.3]]A3)K\+1PM^ M,($$;-[Y@!NX95/B 2E/GIR\(IH
M' MAZ,F2B9T&($A1IVO7I:8ZIK5)O4MHW'*]\,GB9 K)1'A;.2^65CQ>Q0\1
MS^/BQ#S8+R36W\:X"N.##]_P0N/EI^N+,QQ[TD6#P $YV%J!YBZ,M0U*OZ5S
MMR& PO##L6>6NZ0C@6LRN$_1B[@/T<K- P94L 01 @TF$#E4""E=',; A+'O
M88ZFL*-YIDOB8"&^P>/ <!>BD("=D*Q"(H2^T1QA.[G!^,E<?AOEI!-;,1]&
M7-IC)7^1!A!@ZQ$%CH'N')!L+XRS@MV>Q$J81R <$KQ 3\0A1/L-H_@/P: M
M<4X-L=N3\03( WDL+ @4X4\<]L'$:7)&UG V!3R6':QS(P,/! [+?5WA'QG@
M/IRWN  '!Z0V<313;#_)@:B4$S,=\+-^C.,X!]P,0N=N<!ZX0+) "-2$4XO-
M(<% QWYR2$"]V5^QP7+ 2 G1;@T4))S@<+%SPNN-M&P(_@*##XS$=^C@C-;'
M3 G,#S@""SX#90#>890P*U],^U98A[:U#^.5K&I"O(T#=W#O$%.8W,QUEG$U
MBD'2IH&/!Y812X1B%D=#X=,6WLF,XIKH]?25^)?(]Q<H5'%\*H1F_O&D(XRW
M,%B?D(UHP$75A[X.KXJ3+ F_ULG9?4MMV$6[<6-(.Z.EDA&.'V$R -=@):;L
MZT:)Y1RR9F+%:N8M&MJ00-<&.$V)%@5J$"WM;Q9N@#<XW7]*L/10H//Y0+^$
M^5HP5X#ZC@*3+-B6+''(*/#(_%UC^KD9]R/0$L+Y<V1-$H:-5.-N<_V8BT./
MH-Q/+M[8.L>@]5'I]:)=BT')^J!?%G\HHB1(XD04LZJ$,G\A*A->EZ7"ST\4
M05-X)>_YHLM3[\.\;Q/.&L^&M2 G""T;:UX4 (+-N4?@.<DJA#(BX1Q1X$>T
ML$ 9Z680-@'HFT47E/#"YX@N?Z)-2=P(;QZY_AE8TF5"W\D2*7%\0!3YU6SA
MO'@0$B\6V+]Z:YPT6B2G<;C9&B_BP' Q]QB&WB1F\E\0+E: Q-.?[Z[]*,JN
M7YP71#)'A]1'./^D\3WAS6SMKW%>@,FV<24V#=HWL\!VCB:TU/8:=,T>?#:D
M!O70=ST+!4D'!L'-@8I<$7"9(B /$V%BDH'O&T<2.8W'L* J%KW@+ 8"M(20
MHD4I^)L^BA*_'^%(Q9J1D&<1+'A3>K#UQU$,/6P#L=4TB /)KD;H". ?V#/$
M/"Y&0,S\TXE@TKQ7&[L'[(&"),L-%B+QU(.U1TQ;TB$''NH1A8$764QW'LG*
M_M*)96Y3VLDL+LD/F\3(QGN2%(L<7=K[ZQK431)BFN0:I%+?6 &VOEDXP(,G
MOI-'$YX?\3P?+082U/MXR^EL25IM1=L!8<\O *0P$GE]I/-Z;,D_L7X?K?YL
ME!^1BE^\D/3]"UE*@* #=,^PXVY65+61Q(OA:XESHJX_P%XF:8'/IY4VF*,T
MGH_9&ZR\:R_<X KB=JI6<9Y^Q DF5L*7(-9)4K>;+Y18.O- LF2'A%NO\,#?
M*3P'#F81+I/%V#7:S:_<69'IY,_F-TJ$A] ?,5RE(!4FV)C),\O#R]%XH9JN
M75.3%ZQ$1Q#!8:879E8!%SP$E%-#Z6R>?#3L/[@IX-KRN9DQ#<\YPQ.K]2/$
MK^0OB&ZQZIKHT:=& "^E.3"Q3?)A!7L3Q!:\8(HX<+Z>!4Q(3+BR=2. Q('M
MXV9KC6KW1OJS(#P)7<9&#MB)37'U%I4*&#YJ?/#O%PFEO2;F"/*PH/("&!=D
M5:F-PF"P476#'4\(XH%LEKS E#[C11U,/I'#U%DOS,!_8("9UH)P/[1C7JRU
M?2+MC@9:O(X2.4GFN%9X]QLI('OTXU\'EM%;/_XS,-ZA8(*'Z"XW7N;"-NT9
M[Z"0-/0U1C=9OW!>;+(U943=C</<&04GF#8\\,CB%R1[* 2XL_8]WZ"BWY"7
MTC-LSIXLDAQ!/..MW:!FQ""[R@0QH:>+AQHQ%Y[08K)5!:[/ X"0Y0M2%(>G
M'#@*ZE$=O%_@$9X$OXLO<! ]Q&$35N$(9R2<"+#EK7&=I;=1Z-"DN40:8)8(
M#))8=V.?$L;3_7^"BJ1@<,HY(P$+@C@!^#HSGB'MB'0D6T4.B5" US,@-&;M
M8LA/&SZ#AB1@3NR(2,(1_ H2;Y%Y4C^P61(Q3 P3<"(0)P NL35/!!U!T$7@
M$PM@<+(9V3/ &B4KP_E@OQ\0@B<8"HPJA&7/K4>+AL*T?<,K7;?!VR=FN/^)
MP%B2;7;X'+!(=6UM;_8QS8@)))P<A8H#1@A?Q!BL!9GK:80HX!L*6NZ%WHK"
M(+8L!4X+W#9=4(B"N(SBUPU;*LNZ:TM,[R\N__;SW<W7+Q_.@QRPXJ+3X=D[
M.=V#V1P_W],Q=A5ESJX%-[P'#EZ71NXT_L++K@3<#LZH/?K7IEY_HW]D-X+:
M4*+>I!ARA?OYN'3U%[_8-8D1)_$\-=ZXS(@Z>AQ)1X>CL+^ ]ZX6@1O'=5.N
MM4S$+[%T%]N<L&X !S;N>AH5V7S$ZU$"?_9W6INQ!E.IG_$2%N<=>EHOZ"ON
MS_Z1<+J$6" $^]Q-\59R2!-BNX5#K4&4;8#=+CPSLF)FKQ.+PIE\=):6[T<E
M8E00J5HG$H-3)I61%226@>=Q\1XGJ7JQ_[FVI\D*CA@,]KP0,R:L+HXSB*Z4
M4BA@4WM!)WZ'5CBSA;%".?TM6A8@03--OFZFOH,7,H+\2T\7>B50FWXX2?6C
ML2 @].8(,@[XS,A8$HY-.7.6N+;-=' IC..'4\->-Q<3V0#(0$H0M'RUR>#W
M>$AB>B[(>KF1J%'X>L_]?'%Q&Z],2#.F#!;B\]@$=AXM&+ Q]/'Z!TZG\#1L
M@X1'Q'&-0K+QQFJXA1HM-XY(0K\I&B)Q.0X)W,WH86BX(0RR$2NVF)5*ORG,
M\L*"6! 8@BE4CA4Y4!O;<-_2I)SW1HM5NU<&Z%P!%>%\K06.,4Q2%/6,PC Y
M'(-N147+:%$1"$#%1;%JX5[XEMH=;[+K(1>V/1R@ZTW-U KO3HM@ZF65\X;)
MQ0N8$6]NK; :)LO52%U_@'-:%X -I6,'*D=?D%: &5#AO)"E,)):D Z  ,W
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M_U*Q)/EL?: #$8,PGARXF30D3'9F=:!+F&S(P7['D4'HG7(9?XFCB:J,-+5
M0X2"89=&_&&QN(L^>]2JUA/ 0!AD(;HM0LX3-QMDA7*MMJS"(JK.1%3"2-3E
MD7"H]TKJ>;?SW12M;'6E]5A)*]"58IAH._G+18X6!0F\/M*+%.+'HB#ZYZ#;
MH?":(&P>>YBCH'4):8-" @EOO5P:KO4G$&[%NJ48C\X:"\:9_L$Y68L\MIF(
M1]:VB=S,SBH&_'"6#%;.">?+MDW1^;!UR7;;%)4?<-N4+JS9AM0"1V,'D=4,
M@53=JI/UL=J!S;I>F-F6G7J8@-QL#$"ME5E'O[4BB6JE1E1+VECNPAXT@W4^
MK*\V?JRV591A6/M"NMNA2]@JEXD$S5P[JZ3)_A_*R:ONE_7R$;DYVCKHF3?F
M@UN[@V4W;!O2\*AM/5/QG@"=M3$[R>9&=VAI6#9>8J + AQ9$;B$W[K&U%\;
M"^Z3-3M)SGP/+WQ%ANO56BHY=,,?71;!#']/<,X,_TF:M_#0'T?Z5_9T?>DX
M)HYEK_V"^NEFKZ66VE@0LW73"U/QG@"=!3$G&<1$V>LI3IXEZ0-(TIM-Q06V
M!MLG-#,O=I)&[.1OSSC5,H"#DINC%P@T0GT_$LNC4S_XQ;FC<[C?U#=G/D^@
M-0R[_2>591OV$^*<V2G&)\EMDEIO,&2NNGEGUP<:CUV-/10^#L"Y'MU0])#]
M0Z.1F8-^TS@T<]#'\&YS9K5HB%8YK:$X.W9BPR3()-A["?;!(S*4]1UE3()]
MDF [&S^LN]K ;@0(8N2&Y=I VA+4%A^)[HYBL/G&71-9JOL&L]!?] V"T=%-
MAL&V[: ZGA1H+#E\"$:'R!@$!^&*CVE.F"ONF2M6%6DDR+5>[]A;.R@Q.W@T
M5URUR>_ (!@6D3,(=M45M[-$PI9#6KTR2=2X,WS/,2_TM.3HT+CKA(U+\S&6
M)DY&FM!$C-5I:(5+&R>,K3;LES(6:[9:W8=6N&3!H-6X:U3K=HD=VEYF+O%8
M+E'1)B-):&+YM=O0DIC=:L<E-K&<T&UH!4L'#%K-N\0".Y>LDN(DP""-914O
M'6CCNK>S647%< Q3\_&4I @C36+;V:RBXICV4!]K#(*LHN+8+OG0*_I81<5P
M,=C"T@;SQ*R@XMAF4("\A$&0%50<U1,K8[&/=Y:6N^9U<Z"FA;\(8*Q<.1#)
MF6CJN.2>TW-R;^G"LM&&7GQ#*;FZ=%LPUK:(^GIE[ .]JE6/7]6Z<IUGRP1Z
M9@Z]R_7)-8!_SHRS; QSZQEQB2MA1Z#*]K_6H DS"YGI[^@_C=7*15.+7BM+
M8H;-5R^&:\*_5L@E-\_"(,%G7*;P8BP5XDN"AIWL4!F\?FU;OL?Y#H>6JX7S
MBA ,95I C.^X'KG!=@ITKA<^3-(;QR!TL75E[604WFV;8-C<,#EQQ/,Z/JO!
M>?@+>/&S82W([;68C;.UOW8#3B8&N8[=MNNB)Y@UOO0FZZ[=Q-VZB?%#.=D
M8&X)LY]['(*GS23QG.7A:WCIU;_>>2Z M^_<U:2PVU1<#M1Q*,J []Q5&BDQ
M4PZ^A9%U.QM*E)!QS+2/TR@<[!"S56N_LD94]&@:*O*=T5!""M/0PM!F;;(1
M=_(]H[E;"-*(D6,VCD4A@\/XQ=,3SE+\DU3P:]MW+=NSIJ<X^5^-Q;H+'?&[
MFI+UR7!WE58&GHX)I$^TM@.>5@H)]P"J2_%'N3V PM[F)F,!U/"YFZGO/$*
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MA(_(FFV9 8V %0%_X-=87DE)@\7#9I/[#.\$SACNPN'NK>5Z08]8@@ P9?C
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M+O%J(WB*.1:$B(K.]*$Q4IO 7<RQ($14=&B2E9%0MRF&B(K>\&#SIEA2!%X
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MVD?%PO!R *U *TNT@OH 6H%6H+59]7%JCR]H0M+]Z0 IQ"YPYS]QRDB#!CG
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M/""' &(.((=@U\$[Y!" S ]#YB&'8*!QI9!# #K^*!UOC@R- C4/JAU2!XZ
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MYG:(*(C(%WFQP.O-D"0<6!2IVJ*D*Y'.:+H@Z-7)!?Q+&ZN^P,)@B?,GDSC
MW\\"&[&Y%[EO>*$./CY]+E)(>;6)-2929PA@6 %:J"APGN,H7>O\0H=Y'=V;
MA9/301F2*+ZOLH39Y :[-1&Q&WBYG&"EN? U\A ?+4'L^<]HE-_)9AZ_=X>)
M\3$4=MT"4S/BGA ^6#X^L&>N/8G0\GD(/N,;ED/5WR-*?WAXE/$\0=M(:OTX
M$=.UJTNFM *D&9P%IN:''[M3;)DQD^"!8ZY,?XENW9BT$<<.M^PS>$_8QA-K
M0H9+UFF!=AE$BM; !=&ENR!6MEI3K!%SBXAXQ<+V,@X(CD-,Y1#CA405;4W>
M.%GD.;Q!N2B>RH2>_'2F<4EI(<]G;(N#\ZQ^YP5W<B7/W15$"ZMX%E?^7.V!
M-N*C7^WDK5G<UM;MT[VW9Q%9BE80D<6EY)!-4#ZD:5V_I7%E>*.YXZWIA$;^
M CT&%P+9(B.](YU"<D]*F8B#)M.ODU"P"VYWE9+TIF1EDD>4'!!>X%QY$:E4
M&%JK6](L]FQS1RJL+?G.W2,:FQ]<<"30[/T60BK8'W++I5PN[3'L5!3H>BPW
M 3.QQ$P2,!,P4UW,) ,S 3-59Z8G/[+<8E;:P4A9,MI>N"6+HPVT581]-GZQ
M!KB>$:TO@1][TPMNF:-8>C4/K%OS*U??*GWV/?LMVS[-T'R$V08:07FYV%6^
M5S\P,?(#YP%75OA*-HD3_ 'OB=&JXUW4GM&75XX;/"DUSI+LK,M/E28X;PEV
M:_'-)=AC&82B9=DP%^1'%:S#07W2JBE(LP8/K.@.+QNEE![!>S(OZP*O:86;
M,UHE_"BG "BAAI50P007ZQ-VD$>CXE?Y '\/U&1U3LZ/@M!42#HH(U!&H(Q
M&5$AZ:",0!FQKXQ.V9BTZ$X;H!Q<V4%$ A^B)%IE:J,W.-&Z]^R J# Q4-K\
M9,V:A6.5%C.<SR0NJ.&\"+B+>>[256%/D;'6% HP69^9#%08<%?C*NSPT>D)
M$+Z. ,33]EZK]*S5S'2^CDT@W\=7/XC.(YSNZGC?[3":'T"X1YY4'ANS4NB0
M:#J.I?N3RA..)9M=B]*GQ"TO!M/ZLA9KO"L"K9*3Z6A_(L@XR#C(>(&,2[PH
M[-W8@:2#I(.D]T#2P9J#C(.,]UO&5^MXBETOY^C0CCVK3'\Q]+-*DHJQE>?;
ME/M".Q17O3_A1AI)Z/?<U(^?7;M)U<?.^M47$G_D2B6:LONE8ELUUAA5OJ'0
M&CQ@ /D&^0;Y+NG(,/:?4(-\@WR#?#,KW_6X+T"R0;)!LNF2;(V7I&IAU:O^
M;_@O5JN&88(MSK/F2WIO'[]]O;O%]][>W%Y__/8T_O#I^IMHK/_FG47<"YW4
M'+N?1/ZS'61EQXR+TH,P=PUBM>@;"\EJS;*5;PSJED%!EQJ4)=0M V:"NF7
M3+0R$]0M V:JZ[#LJ!T_U"V#NF7#S<>$Q/BZ74%0MPSJEAU[ B7((B_+4+<,
ME!!4YX!2013,"90* F4$R@B4$15S LH(E!$H(T8V)E"WK$DY@+IE4+>,)<YG
M$A= T1_@+JA;!DP&*@RXBVGN@KIE#$)\J%M&X4DE5$$80A4$J'0",@XRWF\9
MES B@KIE(.D@Z3V7=+#F(.,@X_V6\5.L.50K:])] =7*H"8"U$1@*F0#:IZ
M?(-\LR+?V;ETB;!/D'60=9!U9F4=*I>!9(-D]U&R%5XWJ@56LU.Y++GOZ]/]
MX\/XZOK"F=K^"UKUUW,OGJ-G3M[74=I,$M9_DU0%NX\#Q&/>^5:]LNC5BC@K
ML%>%RTBI,GSO9KDRQYNX\=0F=<\65D2JHN' XT7@+^P@>B-_X #D!8[.P/P]
M>5U_=!SBI^7*HD7VY-5S_A.C.?_Q:GOV=SO@T+_PD_V F[Q:WHN-7\Q-G& 2
MS\,($4\N3$G@-R)TXJ//D8.(]F><,U^@9Y.WVW\Y812.<M@05W>ST>K,T0^G
M:[799KC*&_HEHOZOA>V%=LASUF3BQYB.A?5&"J?AP:&+06RO;N.L!1K\7^21
MI$(<>B:F[;LSC=$43ZP@>,,CMN;)LZ9XR#XI)1>N(EH\*T*S@\E 7X3+Z2(A
M+OD!%$9ZDTE&<Q,E9>>6KTV&EZY#GM+5X$<;X'F-PVS??;!>;%G:Q5$K$=T0
MNW=H_/CS+^_B\/S%LA87-^AU_\)O^^B$$]?'@PN?D%+YX/J3/R\3SQ?'_;)U
M^YBPZ.>4>^Z]+QE#?L#\N'P"Y@&LH[[8LU_/)L*WF\"?BW?^=UQ,[\F7Q=]C
M%WTTSRZ)_F>V"E[3(6A4'MM <2"H@0?,Q 0S00T\8*;:F EJX $SU74$>Y3O
M"&K@00V\X>;V0I&%NIV*4 ,/:N =QWLU=EF#2B_#54)0Z:4)DPQEITX^?@5E
M!,H(E!$H(U!&H(Q &3$H>*=L3* &7I-R #7PH 8>2YS/)"Z  E+ 75 ##Y@,
M5!AP%]/<!37P&(3X4 ./PI-*J*@QA(H:4#4'9!QDO-\R+O$BU, #20=)[[VD
M@S4'&0<9[[>,K];Q%+L.U?":=&1 -3RHLP%U-I@*WH Z.B#?(-]LR+?$&_M/
MJ$&^0;Y!OIF5;ZB !Y(-DMU'R=9X2:H65KU> 8_9"E=-QY=0Z9.%RA]0X J8
MB0EF@@)7P$RU,1,4N )FJNM4Y:BM(12X@@)7PTW<@PSJNGT&4. *"EP=>U11
M6V,N*.,P7"4$91R:,,E04^;DTQ501J",0!F!,@)E!,H(E!&#@G?*Q@0*7#4I
M!U#@"@I<L<3Y3.("J X#W 4%KH#)0(4!=S'-75#@BD&(#P6N*#RIA'3Y(:3+
M0TD,D'&0\7[+N(01$12X DD'2>^YI(,U!QD'&>^WC)]BS:&L59/N"RAK!<GS
MD#S/5,@&%,< ^0;Y9D6^LW/I$F&?(.L@ZR#KS,HZE+@"R0;)[J-D*[QN5 NL
M7I6X^N5=')Z_6-;BXL9R@G]9;FR/R9[[LVV%<6!/[[TO]B0. C3#'ZS0"9_0
MR#ZX_N3/2\(M'/=+]@ <53OVIO@_UZN0VN5C/SKAQ/7Q,[G8<Z(O]NS7LSB<
MGG$3- #T4')A(FKJMW%X/Y/%WV-7$D3S&\GV_TR2_6]PKO]G>_YL!]^6S[WU
M%G$4DC(@XN9WZ2!(Y,-R&,E-9]S4GCASRPU_/1/.+F59%S1-7$U'Z=%<<@U-
MA';Z1$A'3<1?X87GN+^>14%LG[V[;&8T^NFCD>D;C7'D:%IBQ 9&:FZ,-)]#
M<#_[F&00U":3;2R>+E0<TG'2M;:Z:/N%_CE5RS0P%V+%N:!/-G7IE"&ULH3Y
MP=ZN8O*.'J&\,4(2ZO=D!_/<0QL3R;H&H50;1 4AE$1A?0GW#V-#KU89\R:V
M.7+,U82MKD%LXI(R@VAR<=:7)T&O1P]J$Y[LD9M#!KN0@DU]=R*IF]ACCW1L
MSJVQH;N:)G43/.QAZAW&H3(!&Y9@8S8T23IQX>HQ5$:&0^XG$2+/:&FG(PFR
MB/:.%.UT#/'TB:!OIV-(IX^&/C1ER$>.IB5&;&"DRL9(V=_I&&K%(?5HIV-H
M%>>"0MG43QD22SL=P]@8(8L['<.L-H@J.QVAHYV.N8EM6-SIF)NXI.:=SM&+
M4P<F-S?A2?F=SI;!;GC[8&YBCR-V.INZJVE2-\%#RSN=C9G:F U%-TY=N,G$
MCQ$_/EAO^,0(:7]T!5$]_>18SX[K1(X=KGZ]/!M:)T[X=A/X<_'._XYI>_)7
M&[)+?!@U=;YO'\1EYV[''KSE3O'28[PVCVCSQW[_&X?(&+^M'_R="R-1Q<G'
MZ%7DO#+]21SYZ:FF,[7]E\!:O)Y[\1P]>Y([^%-'50J\%19]VSIW)#0A#O(#
M*W)\1#H"^G;@.IZ=(V9\=?7EZ_5'[OI_'J[O'J\?"PXC\:?GX%WV<7WR;^[O
MGLX?;__?]44R]^3OF_'GVT]_7! BR5U;TY]]P:\^ILN0_?F>>[K^GZ?S\:?;
MW^XNEBOQ>?SEM]N[B_P);'K?UZ?[QX?QU?7%]O0G=]S>?;R^>[H01FCU<G.0
M" -G_[6PO1 1B?@^=,((%U>*7FW$2Z[K_T &@+-PP:6+PFE)N@SM[@"4G[!_
MWWY\^L=%VGKHP_V7C]=?SJ_N/WT:/SQ>7YS<>:BPDU!Q]R$B3SLBX/]Q??O;
M/YXNTHR&S7NG>^Y]SR6#TW&,P,/XX\?;N]_./]P_/=U_OB"2DEU[NG]8O_#I
M^N9I_<H7\F!R*8T\T(OJ.JP?P6>'YBFUNUL@Y,>0K@&A"4<H;(XI_3XE"-^1
MC))T<$B_3 >Y.W/CQ)E('YU<P*\MGAJQ**JG5"Q%5T*=-7_8)=.[ND0<"+5
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M&M5 2 '5L*L8E"":E3>7NY>U%)-LG\RL+657/H4Z)*7"K(#HL"$ZU,1'08I
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MS*2 K-/-SK:NC^13$Z4!X0@]T>20_\'.6M&;_P&5_XK63.1-5>9U3>#Z'Q-
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MI^3&X1+,)I#NO&Y(!U%,M+$'1#%1NHSMQGW+ F^8)?J@0A@3A#&QKXBHT$*
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M(+Q4)M2))7Q.-:TT,1L;J@!Z!;0;NZ(J*F\(]84_4K$/!K!5$FQ!MP!J-LH
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MRJ"C&OBN:,B/$%]3L5S\-[Z_,(S51:'P]/3T4<1%D2CK$&FF+D)$+H#C8]P
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MF+E^&_0'K6%]W,$%P(=)KSYI=G"9G,*D%,;MGQ'5^ 17TR,X3J?- S+F?+3
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MP1T9YO4F5I7&W&-,GV]3TMO HTNVAH]0"R@/Q2EC"+C3=<7'3#33JG<)=1M
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MQRZR8_&@$E&)YT)J5$B1DJ5$T<8<7(0=L"X1=;#38=QK>SV!!UAE:&,3QS0
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MS9]?Z >)[S]?!M\^__CQXVGPU]U7/2OKBV38\].OMS=3<XE6QHGE>+[AF)2
M9_WL!1_>N*;A!Z(MY>LH]QOTMY/MUT[H1R?G%R>7YS^]>/,=B^0[<W]')C[
MV]/PC\=47D='OV#71A.T. I>\6=_\XA^/?:LU:--.0\^6V*T^/78<*R7$RKJ
ML_<AK?^BG_R)_R2:]5S;FE,E71DV?>?I$B'_^(@.?3<9)-Z6/F10+9_2OY[F
M/GP*S=Z?8P,CQU\BWS(-VZO$[>%8(,P/R$1<H:E/?EX18MP,'SY/F03GLJJ4
M2X:3]P[3)1EYZ=ISLOCUOJTM?S,C@URX^)*)YX+'"8_ '(H(F7TT6?S'U=HU
MO&7?=I^Y[6'W8*!Y.8Q=W4T'P]YTVAE>]^^&UX/A)R:V,AX[C?8M*>J^NYKV
M_G77&\YZG\G_V)1Z\(Q$(4UGH^[O5YUI[[H[NAWWAM/.;# :LG&5_:B\N=OO
M#":?.S=WO=M>9WHW(?\,9U,FUK*?E&7QG6YW<M>[[GVE+]UCX^CP&8DJ'/9F
M-Z/I=-R;3'_K3'JC/E''[6@8J(>)M\(!9-I^K]_O=6>C_J37)0JY^:-S/1K/
M>M=DI@VF4R*=\60T'-T-NQR:YAQ2E@D,AD1&O5GG*Z/ZX]^7MO 2+0UF]+W(
MVW9'PQE9JGKD3=DXRG]:YNK2^T0I#(;]T>268V5)/R;3#-,K_,RXMQ';!IO[
ML#3G,'M=Y6"Q< "9@LQ<9CD8+7I>WC9RL/1R\)?]I#3'+V7E/#K.>UC>&65I
M. _(LQS')<ZZXY,!R6,/%CW\(\\/R+&M-"P#25N8G86+5\%I'*,' ],0!_%Y
MZ7$Z<(W'Y'3'SCK[:-*,PG?-O]U'2M%SUSZ--5"BY/_H!6'3\BBU-?D-B[]5
M51HREY!<"9^?R=17:C1%^A)ZJZHTZM'7!ZGZ.AQ-E;Y$WJHJ#6A]>=G\^4O#
M?R9+LN/Z#]@@J_,\<PTXM#&W@J34<5>K/57E'<#\Y+$D\;CPFX6P@<WEAEC%
MPG(,Q[0,V_ \Y'LK9'AKC.:&OS L_&38:\0N$9%QI04+3!.OT=RVC'O+MGP+
M>>Q\YSTK-1Z%'F@$UHM-10Y3RWM8FA>:/FY=(]^P&*.A^4^#QADC(F/#I\*I
MQNEV$(DA\<SC840N6#Q&P>)!TWW(\0*M]E[HCXQ&46%\X$-TFHD.36-:_D;J
MF^T&E3I1&8G3E;E*G"!O1/"@<YQPYYDX [+>(AJLKA?HD8'<#4(![?&:[#N&
M%VR>U5\G?^AZ)LX7 U-G08)B=B/)6]>*PM@\FP;+.!)M*3<0R\-SZ2 2Q'SM
MFFNZVW><><_QR?(6V_69F"P<8,<@<=18><RII=B60M BBK<!ZW.+T*7%+R=S
MM##6MG]\%)&)L[P;PW+\4_+(:?2=T_3CD7<(S*N[,BQ'F-7PZ;VE0C"[)$-@
M<WV/3G:$^?C-&B"V:X((.!#,R0JM[A'FE&[B45"3-6R;CS?ZP(XC8J>68]&)
M=4-H)[A"+\2AG*/YEB_ZL% ISTY+A)[MF@DB-JV(<O&6AFW<(_O7X[5W\F 8
MCW_NZCX(<VA ?O0RA12\ZL+P[H/WC1X^I6O2*;)];_M)L$J=G)U'M5+_54#E
M5 +/T>D(D-_$$2JAS Y.LDQTO^4D,@,V.XF>66!WQ:(5W\V7@XOG"/]Z?$:^
M&UCPSS3$3VRL9P??(K,@/"/N_VZ['IK_>NR3HVWL)?FT$9:V#*(4PL#SR#%Y
MA.F_E*NKH.BE\V*!V!4S[=W2*UV'F<MNH4X35AO7)[LDTYH^U"2 *BGYZV@?
MK%N5,=IPJDQO]UEZY+5W=@W'!5RJ84C]_GFF6L/ ZMUZGJKT2P4<:?B\8 Y7
MVQV[-*XZ6H3G;J %.)]8*U;< EDQJ$=$.W%"<(MI!I6$OZ5BW2RUR[ABLL3$
ML.E)4@G,^I>C%(5+7465L*UB(BH9$[$CC-$\H'8;'0_EJR23#J"#D3SN\N\^
M:1<LKJ%LJ0'YBE.$+>1UZM)4$;G8.]2NK_SU/+'/% D+2$&=(*G:76/::M"Y
M]WS:)P:AFFQ"4$Y<N4K8#L\YXH%9SVA/1<<)6BOH!'\R;)I([/A= ^.-Y3Q\
MILEND#V'B;#*"51HIHG]ATV&( >GZ=+%_@SAU<!Y(LOR*LPE ZQR6724[D?,
MZLD6$=0A9X),1$R EMD.D1^Q!Z&1;$+J%C=F?>1(*%+(19%"1%VV1\.:1]4#
M9**._"7""7:!/+A2LNV80$P"C-1W*7L^@>LI2R.-5TFV\-_(\0V"G'.?OCFZ
ML9[0/*HN&J(#^>=DJ[.?;*K75?2R+$N2V(KD/B+L;X+B29KH)E[#(^4P)6)9
M2U$!/;46S^82%PL,=NF!6W,:.R<.!2!W>=F.?K.O6"4J#0Z>B9YTR),A,VVE
M.S2;EMCE&.GQK=032(Q\#4?Z FKJ9A.O)>=H+^_(+SVNW#%-=TTVN;&QH6XX
MI'.534GEL;[<7A-+8(ZH0 [S42E_FD,@U>004[KF<:LG3V)0!_QZM).KEG;H
MI4 A!=ZT4 #37:VL,*A#8W"NXUO. W),"X%X;D7D5*YJ;*Y"H; B_;R3G8ZI
MU;$K=N4:K1P&S^T]9#(3+-2?108LO\RB#1[_+%-&0(DQ.CU=!U89*1HJIP6/
M(M+"8=GAQ?RP^3R0@V&/#6L^<+K&H^4;-H0Z\DBICLKP:"977# [_H1VJSAH
MWC.P0UO!B0^X7JUM6GI^301E6D#IEE*JK5G36"3($%23XPW4XP6T:D)E"0DF
M!G=K.2Z.E?5 *"-%HRT[3EHXI0$TT1TGS=C ,>TUA608NSB0D.]CZW[M!\56
M[C"!D@2I/4F<*8ZC5IM]8KI@.$^!Q,U5Q,M;</8M%UNDL _%6]XOI\F^N7T?
M8@W]=(?XO+J]3K?7Z?8ZW5ZGV^MT>YUNK]/M=;J]CFW%U>UU]:V;NKU.M]>)
M9:1T>YUNK]/M=17+M@>K1\/"JU2="G/U=FP U4%T@4+N^.N7KEDB\R%&DLQ>
MPWFPR'P-*V=C>97.BH8.OT<X:/*GB0 7+2AM%9%M:=)1L#)OGR%[Q,BT FKD
M9QL%4G,27.36JX.DD&7QUOP8KCPU *4WDPO]V, C'+S9/"A9&",<@&3#>S2Y
ME)N\@O,*L3PE*D.) 3&OL_:7+K:^[T/X<,I+46S!2ETF,Y#6@RRBH>=<EY(B
M:DTO+2P25'F:4I9J1OM[!NK23YQD&Y64$!E,$6BLKJ[._8J%; O6/2;IE2:6
M*^JMCBVJB%SS'<="847J^2@[XGM($VYKRB/5!F\O5TS;TWIAW%>.9H!WID)Z
MK=11UKYT7EJ(77OIS.&UY^)5J[I81A?+B'A9'O;W'$Q-Y!C8<AF3LN39F#+(
M;X>*R!\<<%&1D(4M$ I+KH]? 1&).\=[1*:UL-"<.07+IH1< G"N46'NM=3L
M=FK(%XWLM&LA.:;,JPQ=*,F[5E<'7,IU@IZ0LX;IEMV-W08G9R\(J J=$5DY
M#=IRVW6]H ,W@M3R(#MBRXFV03D,HH-":YJX&\/V-[O;[0"F29*"PCXR9@M-
M3)P# 4G?PW?IGUAN9[0XS B"Y-:**2H-4 GIJDR$("GR"?(0>3$*DGI-%EG;
M#9)PD!.JD&#KYE>Q^," ,Z<HZ&CZA!S"M$USJ_,5$1=EU+>>$*#^&"FKW;B$
M=,DJ4RA,NWTY3'KV]UZB-K=/KCM_MFR0AG<^!MJWP'(*N#2'+1;?3/(+$],\
MH*$NO2:DI[2,RIM[*_G\82SRQO5 U)%%1BD> 9=3'Y<-R\HGMO3MX+]#<I!=
MT[FT&J^3?"FQE-L(*F:K_3YA.$2E6A.KB,S#=;PKM' Q"K\W,UZ0=]B:3R9R
M<I2PG/H6^4MW#@R-7R?[S<^TUJI,!CP&<8,DO$6;PQ7QUA8PL#)YI-H0D\D5
M$Q3RP1B[9'RH+30V>@L*3^*R*"T,$A'V$/G[6:@*?82?B<9OL )R90"F$)M0
M25Z>#,L.&8GE^R.,C"O#LTQX#9>ST/P=D%NH0/5'6W2O;1T:9)(AEU;CIV.^
ME,KKCV1H); !&MFS[+4/4QU61E+=R;W,1(L4E1(<4+_C%V0]+&F7T1-Q8!_0
M<$U?9[1(U4%!3B]N'MK@/O(+EKG03*J28ZS4,%D%.5&XSHI.$%9;*)(_:ZI1
M=>5A%FZ7+D34A8CUHW8=&.8-_3*5#Q!.3!$Y,%=>(E!,H;C "AURJ,+AQA03
MK &MI  _AL%B&33&7M4H76$PJ#+E*E,*,2-3:ZRH6?*+4^!P35C(*@U#,JU!
MS&4J[)@G<)4J'B1*#0\#[=(KIW!AJI0[=O!W--^>_=&\ZZXHY8![P%HD1LIM
M.'&S"I&Q_KF60U7 :@*HF6)A7;CX\EATL=!G*'V&JK;=;+D(#9+.(=<)+M6"
M1MO,) BE*PB\S6R)P7@%![2@(8P/"<&CV;* ;A:9:!K!-B4L0#CB UJ0V,,9
MJFD&_F8E[4"""<>2E7!><YJ(RNQNX7*1TPW/?*P1\GFS[]6"TT<Q084I!F;5
ME(@,"-OY\#XMR*A!)J563)L\*8$ -H;Y%D  X?CXK1!_4B*E5=9"Y429]4MP
M2BBDI_9 SJR68IG!W/JF;QM3'XN1?,N8W(9-:+RJ-$A5LW65A4M5U&\IYNW]
MM8X*VV=NCA^3';<+3&GT&!373Q"Q)<_RT13A)\ND('26.Y\@TWT(!0OC-];#
M>BMBK'6I47:':("?SL3]GL^.,_]B8&Q0G/5@=F1<6YV#,R^'4F/+2V5*$] )
M".E<KS'==@(;"VC&3;'W@K!I>4 ; 3<3C=5X!;G"7BN;YB7<SU0KN8B+MCAP
MG+(M;8R2/9$GQ$?$ENE'H,*=9P///V&@!BHQ1MJPJ0N*N!RP&6!:-T'E99RT
M=1$OE3!8IU:1!88?]UT<.8NU3^XT ^U=O_,D6MJD)7TBJU1K'@=-Q]#G%2@+
MQK3LZ=I;/=KN!H7.X'B-S24Y"=(K:NJ>MOF,M'U/+A Q7 ]1H>WE<E3_K"Y@
MI;W+=KF4MXHOB-MQATN*;+#CSY;HUL!_(W^T6""<PI;/"8SPCMG<\*F8B+9Z
MDI.:*N(AN@E"KI[R!VWRHBHHIJVN)(>FLG,= \?$B,QGB@@S7=][UMPR\";*
MG=![4AT3I#*R C=-5KD,86_U+S]RI:%>"J%>SHNOZU)<F9W1[:H+M76AMKYU
M0]^ZH6_=T+=N_,BW;@2.=JR >.M+9T/UYAP]BIYO^'&P\-59>WQK1_/H&MZR
M;[O/QZ)A7NW(:$=&.S+:D=&.C'9D7H<CLPL?(9_NCF/L/EED=[W:W'D4_6H'
M[=XQ?>N)" KVDBL!+EH0^!&1+4@]^(\1C1,WY9)H'4AV.:PNH\DMR(MXLBFI
M/&3(T5*>"*7##.TS*U$Y8*K*ER(#.QY9](W4!05%J2>VX=JK*6[!E?=EB.DM
MJ.^*%^K/W&V>.8"BQ,@DCWOC-:9I$7_FAGDTA^S%%!\G7=E1I%49Q%Z#SJ4(
MO;Q%@MLBMKFOT2(@&"LF&N&N;5B'1_L<73,,H[!&4H(26>3$<J&,R/9XC1Z)
M>5@&5+M38OSV3K9L<8'U(NC+.^6KCO$VSZ*+6(30+O4E@C4K6NQ6P:+&@PH[
M7W;%2.1"SSM>YX:L\^3'/F)K!10;66UMC=0MDDN@#"T&@@BV0<'/-0K_C;U+
MU*D(&;_AH-[^#9='U QWP\C2]P29R'JBP78H)/ "@@J]77[++U9F0HZRH^#Y
M9,<8D3UB?HT6"&.TO=>4')9&_A)A."]+D)-7I' VR4,AM:7YZ9BFNW9\;VQL
MH'*WY435;L^R59P2*1 (2"9E,N+\QC+N+3O86FK3YR%==<U? .I,"14&$8O9
M85";%7L%7A6/J&&N=LOA(+RQ5G4JM(B+]J9""V4+!"RXV0*ZF-_6%D;3I8O]
M&<(KX&NFV0@W<!XSV'\2IY!)P&!W[Q#V383FP<734\.F$>RZ-,Q&N9&!#UXE
M,PH9IIKAT,((-V27\#<T:T1O'Z?=+(]1$1_\/,ZG_@HG<X&H&5QJJ25*&:^B
M=C]^!?KF$34+@)U,??<MQW!,U7Y8$1?M]<,*90MRLHKO(/M(>JR] 'J'SB;:
MR,V9P?+S-N<<T8+@W2><@@#! 0H?(X=2 ]??"JJ+BQ#L]KP4P3H !<N)OK9I
M6(PG*/>$R\Z]VFWS%4Q7'E&#N4N4 _H?=<6?R%F,N.M[A#OZ!^*F)S^(?3.$
M"$E'6*.2A-Z+N32<!S0AOD5OL4 PKE;-;] "-ZUNG9:6\HD:)N'S@+L.F3(8
M;P@C&6#3\NRIG'!S.VTY!<A0\E=7T^W5W70P[$VGG>%U_VYX/1A^.A9.C$8Y
MN^!"!=LR@8][!=0$S7^$'XATPN*^?3,R^>7*\"QOM!ACY!%]AA^M/6((GG>-
M/!-;6S3Q-$\SHI K&^AT!,NP6I>NW)CB$P]8=4S7)=:# 71W->W]ZZXWG/4^
MD_^)]L>O[SWT;4WOPWL*5BC >9I+2QA'_V! T"F63TRM4U*BP$3G5;Z\&F37
MLU'W]ZO.M'?='=V.>\-I9S88#8]%RSJN+8^^RAJ'<91=4\L$V0&\A.OY7@"G
M=4\O!=D&S2&G046.A M<F.E>Q>F"SJFJ+*G=F.285J(?I*J*V+I>:YG'_<Y@
M\KES<]>[[76F=Q/RSW V%<6CZQL6#ESFO81 YV@AO0H'_JQQ06=8,4&%E: L
M&HU/C1+)L=8DU&+ZG6YW<M>[[GVEVU=O*NB:106/7NB2XK5A@YI\$3GQF]62
MQ9O;L1/U?WN%@LX$45:4>G<,-I!H2A,5=Z.FS[ WNQE-I^/>9/I;9](;]8DC
M>#L:!HZA>$QB>_?M&.%@"X6<2[FT1$\ZAP."SI1\8DKG0ID"$Y>VY\NK.2>=
M7K_?Z\Y&_4FO2WRCFS\ZUZ/QK'?=&5X/IE.R?XPGH^'H;MBMYCH-T7,LHH%=
MA_QHHM 5=>;=()[L[<KL@^]8CFD]VM U&M79$MZ6*A 'G7E2^%*=@)5F;LET
MG0R-->AX-!B27:TWZWSM"<_L@4-&0S/C9;^E S>*YI*KTG5S."CH#"NDI[QQ
MJDR=!ZTU!9)KD*53[VTPHWL8V=FZH^%L,/S4([N:Z+F(5D-9_F[JN\%T1XZ9
M\&TA)P(? ^+MA4QT0&<+)P?JNM2$;"*1K^64-6-S<3T1\]XG.KL&P_YH<KN/
MEHNE5$((W0EZI/ FS@-H/BB/EG ^Z&# FF8)"UFU.:(2I29R1"PR;,X9*EVU
M, O;_RN@);6T>"%$<#.7:+ZF73T[GS@;XB004\ZTR$/)$QQ;J>VS50]4DQU+
M2;;"W&E\1O ;5,&0-]F8^GGFPS22&$)2T=@9*/H"',Z@H1528/G\XM];<KDX
MJH/I"U:MVX8S-%:($4F?/XT1'Q^L3K 42I_/*A.UYPD!P71[1"28H?2%M1##
M;Z\?2K_(Y+(DS@Z?7UWH3*CY,L2N!#5?3/)L2/DBVT/GXNSL,D@$4(JW"7>A
M<$?(?%!M1C!S[NY6_NPWE0V%M25U?B8HU/2##1=JQIO*1I7:D?H@*M34@TT7
M:OI-63K1*V' #UW_$P4R1_,[XEGCQ'1)J'F$154AD9S" IT2]<F4*4-_E5 X
M:'>>V]?,Q:OJ$@CW8;O7INA8+"E:5)VK^N.L8F<1F8I@6&U!;"2\@7OM+UUL
M?8\,_. &"^]JLVT,'6/+1!,:/%!K0]6Y5I,+ [8S"<IDA4I15V,;"_?H4ELR
M;H@">HL,.O1\1$%BUYC>?AET!-53?<O*@]H,M'!-+K.(FY0V.ZC2W4^;'[58
M=[]\LM21UNDI"?#3IK+=:H)O5.UN.A==.1_7[I3TWB4Y&'K@+%R\"OM0-]$?
MZW(:N5AI3^I:5-;-26='B4?+<1*)1RN>>.3=HL++OXLSFMES*N\.=,:Q1.?,
MK>40_]S?; >$F PI&HK.U)QZB9M[6DQ@P*Q#Y(?EAO1NS8[O8^M^[0?;D)O-
M-X3*^)E0$#VKJE0!2;-%1NHI:MZOLQ@]&)ABUOA+E @(BJ]AL=$GV]%G!Z-S
M+61< PI[ )FAB Z]3?,A2+63'>FPI3>X@C$*B(W6ON<;#N5MN$['H"7Y!M*9
M5+2>BMA(PH>0KRVP55DBKU^0];#TT;SSA+#Q@!(1L(;;6R'K"J.8#;+$8NW"
M7$X?7@H;7!9\O::AH!#:+ S!U@97*<"%DN..'(L1$+GL?"NS]7HEYKOED7A1
MX6LT;HF2^P8M-KN:5<V"QJEB.^V[>($LGP;-MR_2Q*TSB\T?>)O,U%KY]=A*
MUL0,7ENW*O*^@PJHSV8LB]S:+@43Y2^<DN>#T@M'0G;I^3_K))M7307,0_LV
MWGI44WJ!>7.LB7T1K-O&7M?2IE*+$/>J@[W*P/')^<NSS R<[+I-\("7%KIZ
M]>J*X9+W^K+I]-#NAB_@[E^ _!_M7V!-J]ARH^PR756F^KET]=Q-=IL@I$-:
MF5/!SBJX"D2HZZ2!.89*P:6Z)>NQW'JJ3>5U:.H6S?P6S7KG;(46SZIZU&V>
MNLWSM;=Y2EC^LZ8PU!((P2:@9]_@M11$X2!W'TOU3.#6= @V(0^=3'L#X+(@
MR1CS50RS3P&P"K/90=FCPOVRO=:H(1I:!=$0:&ZT2&C3.WOW?N:>OS\[XQ R
MTT#JX!\!M]:=VMAD":)&J:\7YG=&BUA =-MZG8B+5HA:0W.F]/I'\/B22I5+
M[K+?O\J]I%?)#>-'+W201)H@JE#R98KH2O,*:\.>(;QB-^ZF,:ZV0[A.ZV^:
MY(&P:61*E/-5927*57"K]X Z38,-H4=MCU$,9TB\QR@;>^0:^89E>RRD<Y*=
M7(BC0N1X P%RZ%<%5^4F!7>RXP%@K6(0)2BM_,*7D"C4:4(1)%?1>5(I%Z@S
M@3H3J#.!&IN4!9M46AA*-S,W!PBOJN\!W^I<5UI?MSHWH]6Y-7;*=,@MB.^H
M,-T 67?7 ?0)NUZ-%2G5V-0FR:/3\AB+DJ;#)*^-6STELJ^L'T>QL<JT@-+.
M68TE\1I,2AQI(K\[%<HUU$@334&::/@Z)X9#D=\@J^BLHW$H6FB;%5 J"EIB
M-4K%:T>I:/B2*HIAD=]]JSAZ5-39W8QU-9]957"HS5Y:"Y0;&>-'R=FXJAR7
MX*@TPPPS@5:T]3'H<AM$EWOGIT1&&[>;2V)=>Y]5=;\U7>FW=&76@Z9?X+[\
M!9)K_#F8O<)P^ZK/[D *WAIE,Z[LXH1TR2IJ;$##7TJ9C>WXN]&0+AK214.Z
M_!BUFNI@"#2D"Z>[H0LY=2&GAG31D"[,Q]6*"M>0+AK2A759T) N&M)%0[KH
M)HR&-6$4PI!( '-I@J !=]12)!<.O<E1V\7%^YE[>79>57<'X_R8"CP4)@24
M22;ARS?O9N[;]V^K:O%@G!]3BX?"9,#<D*A%":!8!^/\P%I,HV*5P$>H=7CS
M09(:[P(7L/[:X8)J-P6&VS)_^<^3DZ/_^7+[^<W__L]7\W']\H?S]N/\^_NG
MAS\VSMWU^OG3>_SQ_>\7?]W--I[]_LG\?F;_T__'^>=OE]^7RSM[<8W&IY-_
MW7V_^[?U_/7\W^_PW;??/O_SZ]/"^7MIWL_[B\7EYX]O.J=_75Y<W[U_<_'^
MG\\?!L[GP9OW_^R\^S@8O;S__,8>??UZ>K&Z_.UJ,[MX?ERN[XS%X_2OMY.K
MAW]T/Y]^>;]Y]W:\^7Z_'%Z:TU/4N^PLWYW/[L_^OGESAO\U^/3]_NG?SM]3
M].6-Z?WC]]^&[O>G-^?SNQ?\@E8=X]MJU?OW]V]S_W^/NM/)R4G%Z!X U!,?
MN--%?74 ];_:Z]F#!&H(%%@2Z)VJM;U@XI$K]& Y]&VO##*<66?=C*+WTY-&
M@4W5>[5K1>\@C:'6&D<Q@W7M*$HV!< [9&7-5V$LS.:[2Q5>3:_\]5H2:&-P
M;2^8>*3Y[A'O^RCH'7KM4^+08ACZB=5CK'Y(ER/7!3JZ)YU2(@3P:!:Y.C%6
M#R5=RZNV"F.UP""J8JRFA*\Q5IN*L9HS3S3&JB[-U:6YT.4]^\G'6=Z3>K#I
MY3WI-]48JS\PQFJ)[P&H2XVQJC%6FVRG&F-58ZPVP20UQJK&6&V.L6J,58VQ
MRFE2&F.U26O<*\=8K6N=TQBK&F.UH0ZCQEBM=T5][1BK=2VI&F-59;RHW1BK
M]8>'-,:JQEBMV?HTQJK&6&V3D6J,58VQ"F6A&F,U V,UHZBQ 7TF*64VMJWD
M1F.L:HQ5C;'Z8]1JUCMG-<:J+N34A9P:8Q6.38VQJC%6F^90:XS5ZBK6&*L:
M8[4IUJB;,-K2A%& :??^;.:^>5<9K/-@G->#-L %$'@@S-H@5P/"EQ_>2-'B
M?IP?6(LQ84J&7 5Y/PWSV' #%,BR 9@" \RCM!R;(/L:[%"C]R@7MP8[;,5\
MT6"'C9.Y!CO48(>M=)<TV&'3EG\-=M@L9#<-=MBR^:'!#C78(1UK5UCI95<0
M^DO#?T88.:[_0!NVT7Q?17AVN0M.'][<[N;7&<*C"4*_2DZ9HBR$POK8KP?<
ML1[+:J4J6@(^6?N$$@>SK,G8-#AF\\ Q:UUG--BFKM'4-9J0=1YQP)>AZW\*
MYV[@G2<F;F+6CK!H=8A$<@H/4R45)3)E"K3.91\'-19H0_KOE+B"@+:AL44U
MMNB/9/=U8I6&DI;'>\>9EX!4Y.WMP#RTJ']:X5$>VA!*L\O-L5WV%;UNBWXE
M>%2OT,PK(J0V:>DN@KNJV^ ST*RTD2LS\ARLK++D<7,P-JH*/YXJ4UX*E9/H
M:F#ETXW&X]!X'!J/X\=(#VD\#IWKT;F>5Y+KT7@<&H]#XW$TSJ'6>!S55:SQ
M.#0>1U.L4==IZ#H-8*")LW?OJV),[(=X/5TZ// 2,1'6IK:+MQ]F[MNW[ZKJ
M[F"<'U.!A\*4C ]2$'P7?+E\1(AD8+Y"D@::,Q59R?J"EBI5#F:] !WI2=[Y
MNA39C;MIC+_VMN[F2EXZ#(C\B<[YJK*J4%1PJ_> .DV# <>CKJ3\;Q9A$)O+
MS<+%9%##,2W#-CP/^=X*&=X:H[GA+PP+/]&" O$FU'YG,/G<N;GKW?8ZT[L)
M^6<XFT:U&7P\Y"35<Z88!%W1D[X\7MA;-F73K"VM#6TUNW5!NE8JIZ]%HII]
MPD10\W.UN0TYHR3Z&'U;(\?<0*5S6,C"G639&B&!IET\X,@D?;!T]XYZ%FVX
M? D+V5HRM 7I#XYID:G/(HF6ZA-(ES#9!D9M*DP>P.F2-;@OHM"NX2V)BTC_
MZ7U;6V0=H1?T0JW'!=2 E->8-;A(T"!I[0GR?.+/$R\_FW3VIUEA8CFZK\2/
MZH6Z?)K$=5U-]#!YY2H\P2SI50U"X5I?GSF %F7%MJS=C[OE[@8](;L&Q[R(
MLLK2*07.>:$2& *2LCPZ+\U(O7YZ/@.J-P*^*5/FZ!4(6O8]($)LU.?+%VJ\
M&5X]I+[9EOE*^AXXCVO?"UC.O/)%LFXSR*F,X@LM<YGJS)(C?.PD1O6B7NU=
MO%;M77!4<<C3WF6]VKM\K=J[/-!>Z47MW-J[=1VTN37PW\COKYTYX-$XAY)*
MG<F('L15F"=,L)6SB[!O+2SR%>2-%M?HT?4L'TZ%1>1>DQX+Q0K8/>1BG]9E
M#)PG\D(KV$A5 ;7Z<;R@%%DD4J@K<#(W@@DRUQA;SD,-&V,1776JY4B0E1XP
M4M*$.D=FV]N.IVO+HX0(6_7E$;*(*P+> ZX,$% "5 (IMGS4I/P2BNK0NFI2
M>IG$@0*%G8#9FG2<3^S5J[= S@TJS.N8)J$YMRWCWK+)D,C;%=^)7/H<CG:S
M'ZUS[P7UN$Q59 6/"R9/>ZM'V]T@-$$V\73C(W?)]AI61TDW^G*B"N&KRE44
M-V(&^8%<=!UQ.7$WANUOZ-;H.C[QA@C%&_1@V'V$V HSF092Y%RPJ8)#'K)]
M@SCIKFN33UUL^-83,0</T662,')CF<CQ4.^%UCKS*85UR-:HAUE&4 >SD;]$
M.,TWX%I70E'=+L^WSI4)3BIHZ<Y#J%-1[==1N7KR835K Q\,:Z[C.) Q?THL
M9A8..4&/+J9+?FSHE/\I-7K&0K<ZC%\^E:M-],<ZL/F8V0#:C/+Q]CC4GX.>
MQR[BZI!X/-;@8?_/+D7IM*UYP$[P,HRE2N3AF*+);X=*+A@=JKM$!,:)U_ZI
MCHL$)QF0()L4<Q61H)9J*QG)J! JM\I\%4 5_1118ZKMJ:P')7@^U54!5X\S
M]<F!.,!07GMD'?:\[=8/!FE72+#M2QJC6*&BWQ$50-2W! 'U>&TLUIO02U)
M4+=*Q:D P9VE%*$2J*R2&I@6-Z$P IGS!IVZ6W;@4KIYI-1$2%F\G438($]0
M4IOV@K-RUW!,A*\MX\%Q/=\R,W62$V_+>U8Q+$G6FKL+J>6^+Y1H9TNBRT>T
M%I)MQL,J[VIGD&S6Z\KUE )B8[+ .7X8 ,VI#<D1;/:3ZJH[BH6:\YX@Z#-#
MY-^X'E]J[? 9M;AOG#&-[+<&V?K&V%U8 2&(W2XVNKJH:X[Y) #%8U*07MD9
M,+';.;MD=0\1S<+D2._%M-?!U8^N0^MALO%THF]S30'))!NQ>?)-(=E"!TMC
MY?$)ZH&FB*F;HC"S(]-S38L8Z&S7L8._HWDASR"I+S;*[9K0O&(MKSD2JAZM
M88)FS<N6*2EWDA5=!"BPJ\Y<W[##PC.NK3'K.?7G%[[-+?/=62ZFJU!%";):
MA2,K*GHIL*!T<2.[<UA+\OWJ;CH8]J;3SO"Z?S>\'@P_156=G)?T!8+('2QE
M@84SBV$8H7-U[KCLF'TE0\!Y/]D@?.P"WTWY,B%(N.&--TO'<ZL14U(N<?^0
M.@ --GO;IN/25_W("=?MQF8.2+/+N(:8:&G>.?.ZD=1+ Z3X8^/+RR<?BE51
M!IE%J-)3*73\6^/%6JU7<FTU.:B2(VK.+-R*]>"UH1K7:*.4O[E%_M*=[UMI
M1L\.PM[2>AR318W\;CR '"G9B2ORX_AV4P&9PO4(4U3L@>>MT?QZ33L@"57+
MG0=--$&9+DA6N)2HPI8-,5TRR+$\?B=1@2$$>MT:C%-5<**5K[^$&-D:R>1J
M<(B>@S\!%3DQ47XMDS$ET?*PD.PE584Z#PBKP-4 6EC3JLP//2D/BX0Y:^]8
MZ(*@LE$EA4E2HXD4>)2-+B%FDA@)S* Y(R=YJB@/H"0%4V];P X7@PH.W5A/
MB/BB/CEO6(29,/!XM;DU_G)QE[9F@T&;<I!7CF_*9>$)\!$>(<- T>=SL*>?
MOH2S)E5GLE!'/7P1=BG_Q&!4>;; FZ!V( 13$<4KK1BN5_>0-Q9$*Q-<:7&2
M@-KLON BEZC)2LH+JDIC15.NWX-<ZVAQR"M(OK.8HKHB'"&WBE6.4H/-(:S-
MWL0B!H>(+?N?_633 I>ESFR. ,! \/*G=$KPX+M5I+ VSI0R.;) +]33VS\;
M=7^_ZDQ[U]W1[;@WG'9F@]$P>M/878Y9Y5>"]3P52/*=OZ40$JU:JD"<_>1>
MF0A4]#C[3"]3\_N[22L+NM9+!U]S/84LFQ>IN."=I+KJ0E==M*/J8N=]/QMX
M/B-?A H.)@DH#__)7$UR9,@0!A!#!,^J6N]@3*TD:*F]VNR_,S8V]+. M3U_
MSIQ>GPT;(@3ALX;I61!&S)PD26AQ"-U 00< , N$0 !E2DH#DTJL"6P#B?!.
MQP;V-S/"H6>8E%O"8OPO4+L+!W6P5(2ZC8=']C 53'$Z<%M*!A7EN##\=I^G
M.=#D49H0U-6FF2I2N,S*5A!DAF<+'AU;!^"R/?G$U$(= /JW64#=&;*6>P]Q
M4.%-9"B_L#TQ:",+VY.O#0'RIUL&6.^?XD?Y61H67AG.&"//FM-9YLR[2PLM
M>B_(7%/$[M%B89D(\X#_<(ZI]@:Q/*=FCPS$*R(8;!"*P$4V0,/)O.<M3Q6'
M#ZF\XJM<TJE7!$,VS-R ZCO7JJONE9U"*9,HX*UY)3Y$G@L1EI>'I<H#)RQ3
M5A+1X&+P!S$88?V!790J[JN&<O'(-H%-RR,L1\Q^0=;#DBR%G2>$C0>T_?L8
MDTVD6:$UH3=05W&AS%0EFP!4 Y/HC O^]QEY_JZMX[Q1"V86?XH*M1JW6F;J
MC@5G1WJ+7.SM=Q,"9N/EY^(5KED"JF# !6I:65G') <PR]\(7LW'2R8E<BG5
M5>G1N==X(7KRZ\22(P,&[JO5A^6JD[LH[$"4$K!UQ-H&HE H5.XM,7Y+LFN9
M5I[H'4@(#20E U^"T:CBB2PSS)(X>]5#=:'#Y,":5FC )WG6_%8%")H!6?>(
MI^&'+L@(TW_I1+S:0%:@,=.&4UC-BQB[M,$2FH4<4/IPJQ\S[5HF:,'*R#LI
MV%4<%S#('L9*'F:AY=&PPO6W#OU"5"7H;H*"-3:[A4!:SYSN(- =!+J#X#5T
M$)1Z:=EM Y)AYW77@#+W3G<-Z*X!W360;4V$Q97K!*LE7*%KFHC*JC+>(W'R
M5HR4N*07E.E:9%V+K&N1=2TRAV1KJ$7N$,F<!5.-SB8RJ<CO'W:_<U2],@VD
MKA(V?ZW@$ /8GB!<:1+5$WPB7_1WA4Z?,-"ED1!L*@10EI*Y!E6AND+>LNJZ
M)+NMJZ[D8+_Q1<!RS%.FPJ& SG2IFV(C$J]ODQQV&V/71&CN]<F;UJ;X<J*O
M93-C$"_,M9&!*=V7[Z+W.:O4%\M?+I$]'SA=UW%0T)%,/Z,WU-K(VQ>%,_FT
M]7'3\@6B;MVQ7*;9M*I9>I 0NO^1BT!*/5)*3 ^&%KHGDHN6_"K9V+!UWR=9
M38'<Y;%Q =9\[Z0NC>6QZPIUL3**-"$5TX@$H:Z,_8$K8S/">L+1S":D3+@"
MF%#!^!TIX1!Q5DBXT4+-C0++C</'3UE#UP^B+6A^1QQ1?'%V=KEC(J'F$195
MA41R"NXR9%2?3)DRA+1J#?P/UY2OT2*,O72>B+-!78N^BX/7;%3TOXS7%D1-
M\EUS>$V6KS<ZY?3:4DZ ]L:0;RH&L6Q(5"5X&:" 2CBV[%C*X:A 8920C,P(
M2GS$Y@5/<I3%$3=)2$R'3!H0,LFP81TMT=$2'2W1?<1MZ",N6;XD]@_KYF&@
MY5 W#^OFX28V#^NV0,%%-[L=4'Z-FFX(5+5DZX9 W1"H&P*SK4E?(U33-B-P
M9Y!LS%E]:9"^-*A(1?K2(-U#+7(HTCW4NH<:L(=Z/\L]'ULFF>C <R^;D+H>
MU;HTFB-@R??JZEHQJ *\'_E6(LF2U#=Q0=W$!="S7-1]&'[>=_$4X2?"#DPQ
M$A\'C;T.HZ!B0E38,/7;VV6 BBZZ@(%KL8L_IZ!.55(!2Z84U-V]I L#FV8E
M==0$-@8W40-0O"Z;! ">R&]*EV>J]5G5JS0 AA[N1I0:)Z(?XS4VE^1-Z GO
M6!3A0(A:2L+B%;T,-(31&X3H2JI4+AD?ROT3J%IFUS);#7.99"M7-.MZY@I)
M0S:[KU+=K(N;=7&S+FXNV9MRIR%':*]LC,;"6Y:^/"RRI0@HT(Y+ZMF/%K'L
M(CD(F BPQ16&VX8B//'Y(G5H57(:JG)L) QY;AFG4<_@XT;%M/)X?'U&)U6#
M36OJ)W,@^,-!D".:+ >OT2@#Y..\F0&-FJV24]D,M8(-Z<[^8N @9'<L_S[E
M[= 2PR'I(3D/O.PD) 4ZDL.!S26!P$:N>MCB& =RJMZ(+99E-OQ@_+ 6CDYJ
MUZ%A:JA 1C%!J&.SA,!&IEDG<\B%HH0Y8Q_0@NYD/"0$W]16$.5@LMUT(UM*
M6(!=B0>T(%L0,U2C-!(B1SN0%<^Z^QM\391Z=;1N_@9:2'7SMV[^;G+S=]<V
M/&^TB%:;$9[0(R34RIQ/K-U+<8$0@0)#F13AEMLB<G4X0P4+;*D!ERH*N/NZ
M@";,REFJ+*6^JRQ]Z?[F)I<JE"Z9DIN;=7NS;F_6[<V*VINCR0[77IDDH*:V
M7O34&U?+@:"D3AG=SR?]:/2C=NWGA+RKMNAS6W,T7>C-78GJ_-'BX\5;#@-G
M&4=I0S##:6YG_TQ"D9L0*:%[?OGAO1QUQ$=2.0WDZ",A%Y"K/O)IOSV[E**1
M_3BO8(+$A,($3R_GJ+^[E0&9:TR$AKRN8=MH?K79'I*B+]87<N-@J:F-C(4%
M M+T46O4]<!:#[DYK\T\2AEY?491+GME*)^%2"V?R1EDUU(/8B%2^6LBC@&3
MT<C5DMQ&Z!\#WZ"\(JP(W*#@<FD>45O.$U'EGX/@'ZKC+5>$GH4#RM?D )L_
M#SUD_O3@/IV& ]%9>!G]3'5S&9M_K*2:60%;J"UF*99?SEQ7F>JP-[L93:?C
MWF3Z6V?2&_7).]^.AH$,HE<6N3^(8=B4! NG,]> 0@L- P7VZE3FP>J^*TA$
M,;N%B%U$BFX(ZCB^-;?L '-I[P;W7DQ[3>9$GXB![G+K<"D=+7H&=LCVY6WK
MS*\VV0. X<<#L@ODD;"ET'CG4@*$'E*', 6UV11A>X=+:2HN7ZAA*I9;#2<&
M/8CR81)[;.I7BP[?+ M@2Q1JJ%VQ0";K$B@--E>G=&&4DIW*E5UB77%MZ*S<
M-4Q[NQS&5 4:1+U[R6IA,YI:SK=4 (/9;6\XZPS)>7XX&PP_]8;=WG1_N!4)
M2I6,RG>V91]-J'2B9'3V0RW;2#5W6W*K8A]68Q.,HA[+];V'OJUI*]03^1]D
M6U$>*>7WF7%9;B*HG2<\D%J^#&J =Y+E$E/=$%1BL27Z@3ZEY9($NN^K2$TJ
M&RPE* GN('5 $LY)SR:D\%J+LB6D0#'0U8+AA0V@*,$Q$%\E;K.0#Y$E'Y:^
MC5K<WFO77*_"FPAZQ*>G=;T+%Z]"7%EN4Y@CZ\_MB+&!<KQ<RI5WF!<D0X1&
M07XXM(72X?F--V?(#%]7%K<[Y[<6UY=5(]10BV4A(5/#K9G0)"?HP?)\&FR@
M$0D)6LD<5D4:F5<[V?*0''J),T4W&(G3(!A.0<Q#=!:$KR_]>@A*HKO&F%#H
M6YYIV'\@ _><>7;E!+>T<X>NWV_A%7R^5.16#.TG4ZR./\0)&ZU]SS><N>4\
M2%MJ"HDT7RLLDI);9D2I=@A[<\IBWS9DJ"(YGA(GDE?P!R)@@?D7F0*$ #;L
M ?$;7WY'&WE6?S"NFAR'H+$?RB22_3OY[DVTYDW0HXMID23%-EK+<)4+AV^%
M_1<+*%+)>\G3H6_9"'?)IO/@8GF3(3EJ6];\ UE$$O\@;Y'?LA16!LOS@;+'
M;<<*E".32/@?9:Y 6U)[AZM//I%Y3C\<N17K3JY8MD<M275A:5JASF&4$!^[
M#:?= LEL]2"M+VF_Y$U7AFU?K3W"5=9M>X++?W+4MBS_![+82ET6EM.>4&^%
M\ /9VC]A]]E?TMH!PY&W]V:/WH(X1*%PMMK(/Q(+3H ELFW9*D@,VHH]($L8
M6Y%+/.5&*GX)($X".80+G3SC3P_=EN4G2RI;%12TQ CJ($ TH2 S3X@X7$9T
MZI"FAYSA6S07\@2T54G!V3@_G?7+*:5$+S>A7_O_4$L#!!0    ( #2()D_(
M=,WJ85T  .CS!  5    86YI>"TR,#$Y,#<S,5]L86(N>&UL[7WM<]RXD??W
M^ROP;%)7NW4C>R19EKQ)[FKTME%B:W22O)O<5BI%<3 :[G+(69(C:_S7/WCA
M.P$0! F \OI#LK)$-!K=/S0:C4;CS__SO/;!$XQB+PS^\LW^J^DW  9NN/""
MQ[]\\_%N;W9W=G7US?_\-P#_\>?_M[<'?H !C)P$+L###GAGWR;K[\ >. O7
MFSO7 U=!@O[J)MX31+\+$%WT;_3W59)LOG_]^M.G3Z]<]&GL>A&,PVWDPAC_
M NSMH0Y UL=9!'$/WX/+R -W< .F;\'^V^_WWWP_?0<NSN_!P73_'6WS'W_V
MO>#7!R>&  TDB/_R3:FKYX?(?Q5&CZ\/IM/#U]F'W] OOW_&OZA\_^F0?+W_
M[MV[U^2O^:>QQ_H0D=U__8\/[^_<%5P[>UX0)T[@X@YB[_N8_/)]Z#H)$6TK
M7X#[!?[77O;9'O[5WO[!WN'^J^=X\0T1W'\ \.<H].$M7 +"^??);@/_\DWL
MK3<^9HC\;A7!)9L1/XI>X_:O _B(18\[>8<[V7^+._E#^NOWS@/TOP'XRX^W
M5]PQO:O0HHU>F^3S'N$9*C%;:EEP[.-_OT><57B&SPD,%G"1<8W)"-1,>B&@
MRNABRJ%;H>ECN(111I)T_)=OMO'>H^-L_GV7(!;7,$CFRTLO0%#S'/\FC#T,
ML-E#G."9QY0AX63IQ ^$G93<:SR+7D,_B;/?[.'?[$WW4VC]H5._2%SIF##3
ME5%E<[V3I*CVE.7P;__!)],7-<:F# 9['^^^^>^\*0B7(&\,LM;@YZS]O_Y,
M6?CO0E?XG[.HJC G<C,FT8\M TN_>.V&R$ILDKW*&)=1N%93=1(JB.:U,@K/
MG'@U"Q;X/Q>_;;TGQT?=Q;/DS(FB'5HV?G3\+7LJ]X2A7,>O:QK3BD0IECA0
MQ(V $RR BW^ 1?,">1: UTF[9>3)BV)@2[&!D1<N$/"CY/T0JIIVT15P$O
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ME3Y*/BR0^41-.N-*'(X!T;;S%7KAI0W<8LDKF>A2LG%&C%V:A(-B47MSIE?
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M+GG-,%<$2I@<JVH-[W%X5D.#);NY3'!TB[^D)6T!47.CWHQI9THD^>+!==X
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M/9(\>COBW2);A2VGW$W1*%8NN'2\B%2,.?=BUP_C+<[T8"X7PV0 "OLS?$-
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MK,TQ<_$/L"!A$X:===WNGO$DT@.0,$J\I8<^@?%\>0XW8>PE^NR?J#NC?IN
M$1[&2BU N 1IF[%X<!**K."K9?S*14'#*,%W@*^")Q@GQ(+J0Y.@-Z//E?*X
MX)V#X 9[R"BN0:F)W5P'>056[\X)AZYNEDKT#"V.+3V:W0F(F9$T4(O40/WG
M'TX.]O?_!$JP\PKZELV6G*++F).0C>JN@ ;9# &.WYE9K''YX,#L/DP<OQ&:
MM6JT6O56QH]XO+TWE*>[_,<\D/L>/B%AZ(]CB'JV=<XDY*K]Q*DX$,#N_?7L
MQ[%%-22TS0ELM,E%N9A33O@JV&R3F%!EINL/#$!&=T9]>@$C$C$,VF@"2#/
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MP^EJI?/N$;LCTX]X,+EH<4!H\>CO;=YG$VJI63B:-3[U.O?E4F7!@NQITD(
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M9@5"BX8 M[1AL3MJ%..NBQS4HXT][_K.UOBM=ATF>!C&C-\)&83MCA?4,^H
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M!SQ(1_:+K79C6/-<L'YX,CB$AI@338]<VZR8N8GWY"6[X=>!*N4QXK["X6!
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M<%]&\#8M2G(91DOH)3B_V$#)[/QQR%*W(WD><G@Y#AI_;5.76>^;7?]X_BF
M4;SR-H@Q%V?*/7(- *^F-8)(1@045.P>!4D/EJ7PCI*RE6M<W!YNSRZN7+(>
M239QP3]+"=QACN617N:KV?N*;I'PR?&Q>4)]'AP7RL[@_;#T).;Y'EGQF#QQ
M)%Y(L].G9U"TL/IXA&@0G&,GSF!?AN]3?=<NKY> ,/0#+C:BT0%JO"E8U*C
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MZ;P3#(!)GSSR42;&O6"^0M>&]P<*)DN,3^[% $JTB7=-G2/=W/39\;'6BW0
M'(P?$(%E(7U1O8TV/XUV;%04"BS.@HT<TT/89)")-[/-G6\M+,/;QEDU\I:X
M8THI4*V!C=YR 4'NG:0T'2GLIM-43*<Y;?YM.IAD]V\G>A<=:"X*<$S8"9)
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M*9EV)L!:V@8&74G/RF8B<>W+1<T.5[Q+$Z&%'S97&C;)730E"FR05;N*0-+
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M+MPEB@F9/"I7Q4V],J]*M3%5TH@!II[-%,9W/<<BQ66-F"CFQN6N;UGCOF4
M&U<D*;*T3 ::JML=FE=7*<S.MEWR2&&XS&296MH_^?!Q[IY^/#GA, -,"ZF<
M_R91SPB'V0@)W/[2J4T]CS616 .)IPEB% 4')\N$7[CKK$VYAS7"%;(Q4^QW
M2;W1T(,=TOD-\?R[0.3M#FBCU(M.O-U,^'&*UH9%9L.3X9KDRK,Q[#GRUNQR
MKQOBRDUU,XJA&]EK5(S9HBEJ4%)S$@(JZZ("V^[D:$PNX,87:5#1GQC. UW1
MGU@:IJ*_:$'N:H'"X1F7*# LVV>G$I-Q@ $EX'S4!4R)1LO:9RJDK%'FKD2
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M2O%N5&<WJE/3B58-CNH\_W@R=]]]J#W3,;-.>YNHQ>? 92BIT^3.$+?S3^]
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M)O #PUG@:S.8C2L%T@;^L=!*3>D)P:Z'M[$@6QG:!@33TNOIY0!0690A N3
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M+3(P,3DP-S,Q+GAM;%!+ 0(4 Q0    ( #2()D_V5X'G.!$  */#   1
M          "  >?+  !A;FEX+3(P,3DP-S,Q+GAS9%!+ 0(4 Q0    ( #2(
M)D_S7H8*@PH  +)P   5              "  4[=  !A;FEX+3(P,3DP-S,Q
M7V-A;"YX;6Q02P$"% ,4    "  TB"9/ZP+?SLHS  ";\@, %0
M    @ $$Z   86YI>"TR,#$Y,#<S,5]D968N>&UL4$L! A0#%     @ -(@F
M3\ATS>IA70  Z/,$ !4              ( ! 1P! &%N:7@M,C Q.3 W,S%?
M;&%B+GAM;%!+ 0(4 Q0    ( #2()D\J&1"FHC,  '/1 P 5
M  "  95Y 0!A;FEX+3(P,3DP-S,Q7W!R92YX;6Q02P4&      8 !@"* 0
&:JT!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6784232800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Parent [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Oct. 31, 2017</a></td>
<td class="nump">$ 166,028<span></span>
</td>
<td class="nump">$ 163,931,079<span></span>
</td>
<td class="num">$ (156,174,184)<span></span>
</td>
<td class="nump">$ 7,922,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,922,923<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Oct. 31, 2017</a></td>
<td class="nump">16,602,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,598,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,598,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,598,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue', window );">Stock options and warrants issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 254,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="num">(398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="nump">39,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock award compensation to employee pursuant to stock incentive plan</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">1,358,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,373,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,373,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock award compensation to employee pursuant to stock incentive plan (in Shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued to consultants</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">14,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued to consultants (in Shares)</a></td>
<td class="nump">5,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodValueAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198</a></td>
<td class="nump">$ 5,482<span></span>
</td>
<td class="nump">1,780,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,786,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,786,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodSharesAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198 (in Shares)</a></td>
<td class="nump">548,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Issuance of noncontrolling interest in Certainty Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,974<span></span>
</td>
<td class="num">$ (4,318)<span></span>
</td>
<td class="nump">64,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,693,532)<span></span>
</td>
<td class="num">(8,693,532)<span></span>
</td>
<td class="num">(158,032)<span></span>
</td>
<td class="num">(8,851,564)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Jul. 31, 2018</a></td>
<td class="nump">$ 186,961<span></span>
</td>
<td class="nump">171,007,167<span></span>
</td>
<td class="num">(164,867,716)<span></span>
</td>
<td class="nump">6,326,412<span></span>
</td>
<td class="num">(162,350)<span></span>
</td>
<td class="nump">6,164,062<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Jul. 31, 2018</a></td>
<td class="nump">18,696,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Apr. 30, 2018</a></td>
<td class="nump">$ 168,504<span></span>
</td>
<td class="nump">165,288,632<span></span>
</td>
<td class="num">(159,390,790)<span></span>
</td>
<td class="nump">6,066,346<span></span>
</td>
<td class="num">(45,700)<span></span>
</td>
<td class="nump">6,020,646<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Apr. 30, 2018</a></td>
<td class="nump">16,850,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,126,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,126,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,126,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue', window );">Stock options and warrants issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock award compensation to employee pursuant to stock incentive plan</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">1,358,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,373,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,373,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock award compensation to employee pursuant to stock incentive plan (in Shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodValueAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198</a></td>
<td class="nump">$ 3,457<span></span>
</td>
<td class="nump">1,105,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,108,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,108,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodSharesAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198 (in Shares)</a></td>
<td class="nump">345,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,476,926)<span></span>
</td>
<td class="num">(5,476,926)<span></span>
</td>
<td class="num">(116,650)<span></span>
</td>
<td class="num">(5,593,576)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Jul. 31, 2018</a></td>
<td class="nump">$ 186,961<span></span>
</td>
<td class="nump">171,007,167<span></span>
</td>
<td class="num">(164,867,716)<span></span>
</td>
<td class="nump">6,326,412<span></span>
</td>
<td class="num">(162,350)<span></span>
</td>
<td class="nump">6,164,062<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Jul. 31, 2018</a></td>
<td class="nump">18,696,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Oct. 31, 2018</a></td>
<td class="nump">$ 189,086<span></span>
</td>
<td class="nump">175,415,931<span></span>
</td>
<td class="num">(170,170,209)<span></span>
</td>
<td class="nump">5,434,808<span></span>
</td>
<td class="num">(251,377)<span></span>
</td>
<td class="nump">5,183,431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Oct. 31, 2018</a></td>
<td class="nump">18,908,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,808,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,808,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,808,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue', window );">Stock options and warrants issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">102,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock award compensation to employee pursuant to stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,954,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,954,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,954,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued pursuant to employee stock purchase plan</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">18,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued pursuant to employee stock purchase plan (in Shares)</a></td>
<td class="nump">5,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodValueAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198</a></td>
<td class="nump">$ 12,088<span></span>
</td>
<td class="nump">4,887,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,899,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,899,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodSharesAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198 (in Shares)</a></td>
<td class="nump">1,208,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,559,561)<span></span>
</td>
<td class="num">(9,559,561)<span></span>
</td>
<td class="num">(148,030)<span></span>
</td>
<td class="num">(9,707,591)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Jul. 31, 2019</a></td>
<td class="nump">$ 201,628<span></span>
</td>
<td class="nump">185,326,706<span></span>
</td>
<td class="num">(179,729,770)<span></span>
</td>
<td class="nump">5,798,564<span></span>
</td>
<td class="num">(399,407)<span></span>
</td>
<td class="nump">5,399,157<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Jul. 31, 2019</a></td>
<td class="nump">20,162,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Apr. 30, 2019</a></td>
<td class="nump">$ 200,050<span></span>
</td>
<td class="nump">183,932,744<span></span>
</td>
<td class="num">(177,589,742)<span></span>
</td>
<td class="nump">6,543,052<span></span>
</td>
<td class="num">(373,387)<span></span>
</td>
<td class="nump">6,169,665<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Apr. 30, 2019</a></td>
<td class="nump">20,005,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue', window );">Stock options and warrants issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">22,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodValueAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198</a></td>
<td class="nump">$ 1,478<span></span>
</td>
<td class="nump">540,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_StockIssuedDuringPeriodSharesAtTheMarketOffering', window );">Common stock issued in at-the-market offering, net of offering expenses of $264,186/$111,275/$141,140/$58,198 (in Shares)</a></td>
<td class="nump">147,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,140,028)<span></span>
</td>
<td class="num">(2,140,028)<span></span>
</td>
<td class="num">(26,020)<span></span>
</td>
<td class="num">(2,166,048)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Jul. 31, 2019</a></td>
<td class="nump">$ 201,628<span></span>
</td>
<td class="nump">$ 185,326,706<span></span>
</td>
<td class="num">$ (179,729,770)<span></span>
</td>
<td class="nump">$ 5,798,564<span></span>
</td>
<td class="num">$ (399,407)<span></span>
</td>
<td class="nump">$ 5,399,157<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Jul. 31, 2019</a></td>
<td class="nump">20,162,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of adjustment to additional paid-in capital for stock option and warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_AdjustmentsToAdditionalPaidInCapitalStockOptionAndWarrantsIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_StockIssuedDuringPeriodSharesAtTheMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued during the period related to the market offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_StockIssuedDuringPeriodSharesAtTheMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_StockIssuedDuringPeriodValueAtTheMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock issued during period at the market offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_StockIssuedDuringPeriodValueAtTheMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6640499168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt;">4.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">FAIR VALUE MEASUREMENTS</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">US GAAP defines fair value and establishes a framework for measuring fair value. &#xa0;We have categorized our financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. &#xa0;If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Financial assets and liabilities recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Level 1 - Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Level 2 - Financial assets and liabilities whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. &#xa0;</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:">Level 3 &#8211; Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#8217;s own assumptions about the assumptions a market participant would use in pricing the asset and liabilities. </p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of July 31, 2019: </p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Money market funds &#x2013;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#xa0;</p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">3,370,661</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">3,370,661</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Certificates of deposit &#x2013;</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;Short-term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,100,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;2,100,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">3,370,661</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,850,000</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">6,220,661</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><a name="FIS_UNIDENTIFIED_TABLE_18"></a>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2018:<a name="FIS_UNIDENTIFIED_TABLE_19"></a></p><br/><table style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 1</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 2</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Level 3</font></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Money market funds &#x2013;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 31.5pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: 0px; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#xa0;</p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,031,331</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="height: 31.5pt; width: 10%; background: #cceeff; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,031,331</font></p>
</td>
</tr>
<tr style="height: 31.5pt;">
<td style="height: 31.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Certificates of deposit &#x2013;</font></p>
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="height: 31.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#xa0;</td>
<td style="height: 31.5pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 46%; background: #cceeff; white-space: nowrap; padding: 0in 0in 0in 10pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">&#xa0;Short-term investments</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,000,000</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 10%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,000,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 46%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,031,331</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">2,750,000&#xa0; </font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">-</font></p>
</td>
<td style="height: 16.5pt; width: 2%; white-space: nowrap; padding: 0in;">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><font style="color: black;">4,781,331</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in"><a name="FIS_UNIDENTIFIED_TABLE_20"></a>Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&#xa0; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&#xa0; Cash and cash equivalents are stated at carrying value which approximates fair value.&#xa0; <a name="eolPage32"></a></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6636705584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:  'Times New Roman','serif'; font-size:  12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">8.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration: underline;">INCOME TAXES </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="COLOR:black">We file Federal, New York and California state income tax returns.&#xa0; Due to net operating losses, the statute of limitations for Federal and New York State income tax returns remains open to examination by taxing authorities since the fiscal year ended October 31, 1999.&#xa0; We account for interest and penalties related to income tax matters, if any, in general and administrative expenses. &#xa0;There are no unrecognized income tax benefits as of </font>July 31<font style="COLOR:black">, 2019 and October 31, 2018.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="color: black;">We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&#xa0; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</font> We have substantial net operating loss carryforwards for Federal, New York State and California income tax returns. These net operating loss carryforwards could be subject to limitations under Internal Revenue Code section 382. Management has not performed an analysis of the potential limitations. We have provided a full valuation allowance against our deferred tax asset due to our historical pre-tax losses and the uncertainty regarding the realizability of these deferred tax assets.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6771337248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan - 2010 Share Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Information regarding the 2010 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">2,131,868<span></span>
</td>
<td class="nump">1,637,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding</a></td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">$ 3.64<span></span>
</td>
<td class="nump">$ 3.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(32,000)<span></span>
</td>
<td class="num">(38,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(99,200)<span></span>
</td>
<td class="num">(49,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">$ 3.78<span></span>
</td>
<td class="nump">$ 2.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">2,010,668<span></span>
</td>
<td class="nump">2,024,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding</a></td>
<td class="nump">$ 2.03<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding</a></td>
<td class="nump">$ 5,422,886<span></span>
</td>
<td class="nump">$ 2,965,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">1,639,556<span></span>
</td>
<td class="nump">1,284,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">$ 4,609,165<span></span>
</td>
<td class="nump">$ 2,108,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingthe2010SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6772896336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan - Employee Stock Purchase Plan [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Employee Stock Purchase Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased', window );">Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsEmployeeStockPurchasePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6604746400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan - Stock Options Not Granted Under 2003 Share Plan 2010 Share Plan Or 2018 Share Plan [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems', window );"><strong>STOCK BASED COMPENSATION (Details) - Information regarding stock options outstanding that were not granted under the 2003 Share Plan, the 2010 Share Plan or the 2018 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">1,780,000<span></span>
</td>
<td class="nump">1,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding</a></td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber', window );">Options outstanding and exercisable</a></td>
<td class="nump">1,780,000<span></span>
</td>
<td class="nump">1,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Options outstanding and exercisable</a></td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue', window );">Options outstanding and exercisable</a></td>
<td class="nump">$ 5,583,900<span></span>
</td>
<td class="nump">$ 3,206,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_STOCKBASEDCOMPENSATIONDetailsInformationregardingstockoptionsoutstandingthatwerenotgrantedunderthe2003SharePlanthe2010SharePlanorthe2018SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding and exercisable, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">anix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>anix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=anix_StockOptionsNotGrantedUnder2003SharePlan2010SharePlanOr2018SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
